[
  {
    "id": 10,
    "user_query": "Name synonym of Acrokeratosis paraneoplastica.",
    "llama-7b_response": "Acrokeratosis paraneoplastica is a rare skin condition that is characterized by the formation of thick, scaly patches on the skin. The exact cause of this condition is unknown, but it is believed to be related to the body's immune system reacting to a cancerous tumor in the body.\nOne synonym of Acrokeratosis paraneoplastica is Bazex's disease. It is named after the French dermatologist who first described the condition in 1913. Other synonyms include paraneoplastic acrokeratosis, acrokeratosis paraneoplastica syndrome, and acrokeratosis follicularis paraneoplastica.",
    "llama-7b_fact_raw": "1. Acrokeratosis paraneoplastica is characterized by the formation of thick, scaly patches on the skin.\n2. The condition is believed to be related to the body's immune system reacting to a cancerous tumor.\n3. One synonym of Acrokeratosis paraneoplastica is Bazex's disease.\n4. Bazex's disease is named after the French dermatologist who first described the condition.\n5. The French dermatologist first described the condition in 1913.",
    "llama-7b_fact": [
      "Acrokeratosis paraneoplastica is characterized by the formation of thick, scaly patches on the skin.",
      "The condition is believed to be related to the body's immune system reacting to a cancerous tumor.",
      "One synonym of Acrokeratosis paraneoplastica is Bazex's disease.",
      "Bazex's disease is named after the French dermatologist who first described the condition.",
      "The French dermatologist first described the condition in 1913."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Bazex's disease was first described by the French dermatologist Achille Bazex in the 1960s.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 47,
    "user_query": "Is Weaver syndrome similar to Sotos?",
    "llama-7b_response": "Weaver syndrome and Sotos syndrome are both genetic disorders that affect growth and development. However, they are distinct conditions with different genetic causes and symptoms.\n\nWeaver syndrome, also known as Sotos-Weaver syndrome, is caused by mutations in the NSD1 gene. This gene plays a critical role in regulating gene expression during embryonic development. As a result of the mutations, the NSD1 gene does not function properly, leading to abnormal growth and development.\n\nIndividuals with Weaver syndrome typically have tall stature, a long face, and a webbed neck. They may also have developmental delays, learning difficulties, and distinctive facial features such as a broad forehead, prominent jaw, and widely spaced eyes.\n\nSotos syndrome, on the other hand, is caused by mutations in the SOX11 gene. This gene plays a critical role in the development of the brain and other organs. As a result of the mutations, the SOX11 gene does not function properly, leading to overgrowth of the brain and other organs, as well as distinctive facial features such as a prominent forehead, wide-set eyes, and a flat nasal bridge.\n\nWhile both conditions share some similarities in terms of their effects on growth and development, they are distinct genetic disorders with different genetic causes and symptoms.",
    "llama-7b_fact_raw": "1. Weaver syndrome and Sotos syndrome are both genetic disorders that affect growth and development.\n2. Weaver syndrome is caused by mutations in the NSD1 gene.\n3. Individuals with Weaver syndrome typically have tall stature, a long face, and a webbed neck.\n4. Sotos syndrome is caused by mutations in the SOX11 gene.\n5. Sotos syndrome leads to overgrowth of the brain and other organs.",
    "llama-7b_fact": [
      "Weaver syndrome and Sotos syndrome are both genetic disorders that affect growth and development.",
      "Weaver syndrome is caused by mutations in the NSD1 gene.",
      "Individuals with Weaver syndrome typically have tall stature, a long face, and a webbed neck.",
      "Sotos syndrome is caused by mutations in the SOX11 gene.",
      "Sotos syndrome leads to overgrowth of the brain and other organs."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Weaver syndrome is caused by mutations in the EZH2 gene, not the NSD1 gene.\n3. TRUE\n4. FALSE [correction]: Sotos syndrome is caused by mutations in the NSD1 gene, not the SOX11 gene.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 81,
    "user_query": "List the releases of JASPAR database",
    "llama-7b_response": "As an AI language model, I do not have access to real-time information. However, according to the JASPAR website, the following are the releases of the JASPAR database:\n\n1. JASPAR 2019: Released on January 15, 2019, this version of the JASPAR database includes protein-coding genes and conserved non-coding elements (CNEs) from 183 vertebrate species.\n\n2. JASPAR 2016: Released on January 15, 2016, this version of the JASPAR database includes protein-coding genes and CNEs from 173 vertebrate species.\n\n3. JASPAR 2013: Released on January 15, 2013, this version of the JASPAR database includes protein-coding genes and CNEs from 163 vertebrate species.\n\n4. JASPAR 2010: Released on January 15, 2010, this version of the JASPAR database includes protein-coding genes and CNEs from 153 vertebrate species.\n\n5. JASPAR 2007: Released on January 15, 2007, this version of the JASPAR database includes protein-coding genes and CNEs from 143 vertebrate species.\n\n6. JASPAR 2004: Released on January 15, 2004, this version of the JASPAR database includes protein-coding genes and CNEs from 133 vertebrate species.\n\n7. JASPAR 2001: Released on January 15, 2001, this version of the JASPAR database includes protein-coding genes and CNEs from 123 vertebrate species.\n\n8. JASPAR 1999: Released on January 15, 1999, this version of the JASPAR database includes protein-coding genes and CNEs from 113 vertebrate species.",
    "llama-7b_fact_raw": "1. JASPAR 2019 was released on January 15, 2019, and includes protein-coding genes and conserved non-coding elements from 183 vertebrate species.\n2. JASPAR 2016 was released on January 15, 2016, and includes protein-coding genes and conserved non-coding elements from 173 vertebrate species.\n3. JASPAR 2013 was released on January 15, 2013, and includes protein-coding genes and conserved non-coding elements from 163 vertebrate species.\n4. JASPAR 2010 was released on January 15, 2010, and includes protein-coding genes and conserved non-coding elements from 153 vertebrate species.\n5. JASPAR 2007 was released on January 15, 2007, and includes protein-coding genes and conserved non-coding elements from 143 vertebrate species.",
    "llama-7b_fact": [
      "JASPAR 2019 was released on January 15, 2019, and includes protein-coding genes and conserved non-coding elements from 183 vertebrate species.",
      "JASPAR 2016 was released on January 15, 2016, and includes protein-coding genes and conserved non-coding elements from 173 vertebrate species.",
      "JASPAR 2013 was released on January 15, 2013, and includes protein-coding genes and conserved non-coding elements from 163 vertebrate species.",
      "JASPAR 2010 was released on January 15, 2010, and includes protein-coding genes and conserved non-coding elements from 153 vertebrate species.",
      "JASPAR 2007 was released on January 15, 2007, and includes protein-coding genes and conserved non-coding elements from 143 vertebrate species."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: JASPAR 2016 was released, but the specific details about the number of vertebrate species included and the exact content are not standard information provided in release notes, so the details about protein-coding genes and conserved non-coding elements from 173 vertebrate species cannot be confirmed.\n3. FALSE [correction]: JASPAR 2013 was released, but the specific details about the number of vertebrate species included and the exact content are not standard information provided in release notes, so the details about protein-coding genes and conserved non-coding elements from 163 vertebrate species cannot be confirmed.\n4. FALSE [correction]: JASPAR 2010 was released, but the specific details about the number of vertebrate species included and the exact content are not standard information provided in release notes, so the details about protein-coding genes and conserved non-coding elements from 153 vertebrate species cannot be confirmed.\n5. FALSE [correction]: JASPAR 2007 was released, but the specific details about the number of vertebrate species included and the exact content are not standard information provided in release notes, so the details about protein-coding genes and conserved non-coding elements from 143 vertebrate species cannot be confirmed.\n\nNote: JASPAR is a database of transcription factor binding profiles, and while it does release new versions periodically, the specific details provided in the statements about the number of vertebrate species and the inclusion of protein-coding genes and conserved non-coding elements are not typical descriptors of the database content. JASPAR primarily focuses on transcription factor DNA-binding affinities, and while it may include data from various species, the exact numbers and types of elements included in each release are not typically specified in this manner.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 99,
    "user_query": "What is the function of the viral KP4 protein?",
    "llama-7b_response": "The viral KP4 protein is a small, non-structural protein that is produced by certain viruses, including the human immunodeficiency virus (HIV). Its exact function is not fully understood, but it is believed to play a role in the replication and spread of the virus within infected cells.\nOne of the key functions of KP4 protein is to help the virus evade the immune system by suppressing the production of cytokines and interferons. These molecules are produced by the body's immune cells in response to infection, and they help to activate other immune cells to fight the virus. By suppressing their production, the KP4 protein allows the virus to establish a persistent infection and spread more easily within the body.\nIn addition to its role in immune suppression, the KP4 protein may also play a role in the formation of viral particles. Some studies suggest that the protein may help to assemble the virus's outer shell, or envelope, which is necessary for the virus to be released from infected cells and spread to new cells.\nOverall, the KP4 protein is an important component of the HIV virus and likely plays a critical role in its replication and survival within infected cells.",
    "llama-7b_fact_raw": "1. The KP4 protein is produced by certain viruses, including the human immunodeficiency virus (HIV).\n2. The KP4 protein is believed to play a role in the replication and spread of the virus within infected cells.\n3. KP4 protein helps the virus evade the immune system by suppressing the production of cytokines and interferons.\n4. Cytokines and interferons are molecules produced by the body's immune cells in response to infection.\n5. The KP4 protein may assist in the assembly of the virus's outer shell or envelope.",
    "llama-7b_fact": [
      "The KP4 protein is produced by certain viruses, including the human immunodeficiency virus (HIV).",
      "The KP4 protein is believed to play a role in the replication and spread of the virus within infected cells.",
      "KP4 protein helps the virus evade the immune system by suppressing the production of cytokines and interferons.",
      "Cytokines and interferons are molecules produced by the body's immune cells in response to infection.",
      "The KP4 protein may assist in the assembly of the virus's outer shell or envelope."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The KP4 protein is not produced by HIV or any viruses that infect humans; it is a fungal toxin produced by the Ustilago maydis fungus.\n2. UNKNOWN\n3. FALSE [correction]: Since KP4 is a fungal toxin and not a viral protein, it does not help viruses evade the immune system. The statement about suppressing the production of cytokines and interferons is not applicable to KP4 in the context of viruses.\n4. TRUE\n5. FALSE [correction]: The KP4 protein is not involved in the assembly of a virus's outer shell or envelope as it is not a viral protein. It is a fungal toxin with different functions.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 124,
    "user_query": "Is DITPA a thyroid hormone analog utilized in experimental and clinical studies",
    "llama-7b_response": "DITPA, also known as 3,5-diiodothyronine, is a thyroid hormone analog that is utilized in experimental and clinical studies. Thyroid hormones play a crucial role in regulating metabolism and energy production in the body. DITPA is structurally similar to thyroid hormones such as triiodothyronine (T3) and thyroxine (T4), but it has two additional iodine atoms compared to T3 and T4.\nDITPA has been studied for its potential therapeutic effects in a variety of conditions, including obesity, type 2 diabetes, and cardiovascular disease. It has been found to increase metabolism and reduce body weight in animal studies. In clinical trials, DITPA has been shown to improve insulin sensitivity and reduce blood pressure in patients with type 2 diabetes and hypertension.\nDespite these promising results, DITPA is not currently approved for use in humans. It is still considered an experimental drug and is only available through clinical trials. Further research is needed to fully understand the safety and efficacy of DITPA in humans, as well as its potential side effects and interactions with other medications.",
    "llama-7b_fact_raw": "1. DITPA is known as 3,5-diiodothyronine.\n2. DITPA is a thyroid hormone analog used in experimental and clinical studies.\n3. DITPA is structurally similar to thyroid hormones such as triiodothyronine (T3) and thyroxine (T4).\n4. In animal studies, DITPA has been found to increase metabolism and reduce body weight.\n5. In clinical trials, DITPA has been shown to improve insulin sensitivity and reduce blood pressure in patients with type 2 diabetes and hypertension.",
    "llama-7b_fact": [
      "DITPA is known as 3,5-diiodothyronine.",
      "DITPA is a thyroid hormone analog used in experimental and clinical studies.",
      "DITPA is structurally similar to thyroid hormones such as triiodothyronine (T3) and thyroxine (T4).",
      "In animal studies, DITPA has been found to increase metabolism and reduce body weight.",
      "In clinical trials, DITPA has been shown to improve insulin sensitivity and reduce blood pressure in patients with type 2 diabetes and hypertension."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: DITPA is known as 3,5-diiodothyropropionic acid.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 144,
    "user_query": "What is the COUGER tool?",
    "llama-7b_response": "The COUGER tool is a software tool developed by the National Institute of Standards and Technology (NIST) in the United States. It is a command-line tool that is used to generate cryptographic key pairs and digital signatures. \n\nThe COUGER tool is based on the Elliptic Curve Cryptography (ECC) algorithm, which is a public key cryptography system that uses elliptic curves instead of prime numbers to generate keys. ECC is more efficient than traditional public key cryptography systems like RSA, and it is also more secure because it is much harder to factorize elliptic curves than prime numbers.\n\nThe COUGER tool provides a simple and easy-to-use interface for generating ECC key pairs and digital signatures. It supports a wide range of elliptic curve algorithms, including NIST P-256, P-384, and P-521, as well as Curve25519 and Ed25519.\n\nThe COUGER tool is primarily used by cryptographers, security engineers, and software developers to implement secure communication protocols and to verify the authenticity of digital signatures. It is also used in various industries, such as finance, healthcare, and government, to protect sensitive data and ensure the integrity of digital transactions.",
    "llama-7b_fact_raw": "1. The COUGER tool is a software tool developed by the National Institute of Standards and Technology (NIST) in the United States.\n2. The COUGER tool is a command-line tool used for generating cryptographic key pairs and digital signatures.\n3. The COUGER tool is based on the Elliptic Curve Cryptography (ECC) algorithm.\n4. The COUGER tool supports elliptic curve algorithms including NIST P-256, P-384, P-521, Curve25519, and Ed25519.\n5. The COUGER tool is used in industries such as finance, healthcare, and government to protect sensitive data and ensure the integrity of digital transactions.",
    "llama-7b_fact": [
      "The COUGER tool is a software tool developed by the National Institute of Standards and Technology (NIST) in the United States.",
      "The COUGER tool is a command-line tool used for generating cryptographic key pairs and digital signatures.",
      "The COUGER tool is based on the Elliptic Curve Cryptography (ECC) algorithm.",
      "The COUGER tool supports elliptic curve algorithms including NIST P-256, P-384, P-521, Curve25519, and Ed25519.",
      "The COUGER tool is used in industries such as finance, healthcare, and government to protect sensitive data and ensure the integrity of digital transactions."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements provided about the COUGER tool are very specific, and without additional context or information about this tool, it is not possible to verify the accuracy of these statements. The National Institute of Standards and Technology (NIST) does develop tools and standards related to cryptography, but without further information or a reliable source, the details about the COUGER tool cannot be confirmed.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 145,
    "user_query": "Are there drugs for Tick-borne Encephalitis?",
    "llama-7b_response": "Yes, there are drugs for Tick-borne Encephalitis. The most common treatment for Tick-borne Encephalitis is a course of antibiotics such as doxycycline or penicillin. These antibiotics are effective in treating the bacterial infection that causes the disease. In some cases, corticosteroids may also be prescribed to reduce inflammation in the brain.\nIt is important to note that the effectiveness of antibiotics may be reduced if the disease is allowed to progress too far without treatment. Therefore, it is recommended to seek medical attention as soon as possible if you suspect you may have Tick-borne Encephalitis.",
    "llama-7b_fact_raw": "1. There are drugs available for the treatment of Tick-borne Encephalitis.\n2. Doxycycline and penicillin are antibiotics commonly used to treat Tick-borne Encephalitis.\n3. Corticosteroids may be prescribed to reduce inflammation in the brain for Tick-borne Encephalitis patients.\n4. Antibiotics are more effective in treating Tick-borne Encephalitis when the disease is treated early.\n5. Seeking medical attention quickly is recommended if Tick-borne Encephalitis is suspected.",
    "llama-7b_fact": [
      "There are drugs available for the treatment of Tick-borne Encephalitis.",
      "Doxycycline and penicillin are antibiotics commonly used to treat Tick-borne Encephalitis.",
      "Corticosteroids may be prescribed to reduce inflammation in the brain for Tick-borne Encephalitis patients.",
      "Antibiotics are more effective in treating Tick-borne Encephalitis when the disease is treated early.",
      "Seeking medical attention quickly is recommended if Tick-borne Encephalitis is suspected."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Doxycycline and penicillin are antibiotics, but they are not used to treat Tick-borne Encephalitis, which is caused by a virus and not by bacteria. Treatment for Tick-borne Encephalitis is mainly supportive, and specific antiviral therapies are not widely available.\n3. TRUE\n4. FALSE [correction]: Since Tick-borne Encephalitis is caused by a virus, antibiotics are not effective against it. Early treatment generally involves supportive care to manage symptoms.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 151,
    "user_query": "Which genome browser database for DNA shape annotations is available?",
    "llama-7b_response": "There are several genome browser databases available for DNA shape annotations. One of the most popular ones is the UCSC Genome Browser, which provides a user-friendly interface for exploring and analyzing genomic data. Other popular genome browser databases include the Ensembl Genome Browser, the Genome Analysis Toolkit (GATK) Browser, and the Integrative Genomics Viewer (IGV). These databases allow researchers to visualize and analyze DNA sequences, gene expression data, and various types of genomic annotations, including DNA shape annotations.",
    "llama-7b_fact_raw": "1. The UCSC Genome Browser is a database that provides DNA shape annotations.\n2. The Ensembl Genome Browser is a database that can be used for DNA shape annotations.\n3. The Genome Analysis Toolkit (GATK) Browser is a database available for DNA shape annotations.\n4. The Integrative Genomics Viewer (IGV) is a database that allows visualization and analysis of DNA shape annotations.",
    "llama-7b_fact": [
      "The UCSC Genome Browser is a database that provides DNA shape annotations.",
      "The Ensembl Genome Browser is a database that can be used for DNA shape annotations.",
      "The Genome Analysis Toolkit (GATK) Browser is a database available for DNA shape annotations.",
      "The Integrative Genomics Viewer (IGV) is a database that allows visualization and analysis of DNA shape annotations."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The UCSC Genome Browser is a database that provides a wide range of genomic data but is not specifically focused on DNA shape annotations.\n2. UNKNOWN: While the Ensembl Genome Browser is a comprehensive database for genomic data, it is not clear from the statement whether it specifically provides DNA shape annotations.\n3. FALSE [correction]: The Genome Analysis Toolkit (GATK) is not a browser but a software toolkit used for analyzing high-throughput sequencing data, and it is not specifically a database for DNA shape annotations.\n4. TRUE: The Integrative Genomics Viewer (IGV) allows visualization and analysis of genomic datasets, including DNA shape annotations if such data is provided.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 174,
    "user_query": "Which syndromes are associated with mutations in the EZH2 gene?",
    "llama-7b_response": "Mutations in the EZH2 gene have been associated with several syndromes, including:\n1. Neurofibromatosis type 1 (NF1): NF1 is a genetic disorder that causes tumors to grow on nerves throughout the body. Mutations in the EZH2 gene have been found to be associated with NF1.\n2. Noonan syndrome: Noonan syndrome is a genetic disorder that affects many parts of the body, including growth and development. Mutations in the EZH2 gene have been found to be associated with Noonan syndrome.\n3. Costello syndrome: Costello syndrome is a genetic disorder that affects many parts of the body, including growth and development. Mutations in the EZH2 gene have been found to be associated with Costello syndrome.\n4. Cardiofaciocutaneous syndrome (CFC syndrome): CFC syndrome is a genetic disorder that affects many parts of the body, including the heart, face, and growth. Mutations in the EZH2 gene have been found to be associated with CFC syndrome.\nOverall, mutations in the EZH2 gene have been associated with a range of syndromes that affect multiple parts of the body.",
    "llama-7b_fact_raw": "1. Mutations in the EZH2 gene have been associated with Neurofibromatosis type 1 (NF1).\n2. Mutations in the EZH2 gene have been associated with Noonan syndrome.\n3. Mutations in the EZH2 gene have been associated with Costello syndrome.\n4. Mutations in the EZH2 gene have been associated with Cardiofaciocutaneous syndrome (CFC syndrome).",
    "llama-7b_fact": [
      "Mutations in the EZH2 gene have been associated with Neurofibromatosis type 1 (NF1).",
      "Mutations in the EZH2 gene have been associated with Noonan syndrome.",
      "Mutations in the EZH2 gene have been associated with Costello syndrome.",
      "Mutations in the EZH2 gene have been associated with Cardiofaciocutaneous syndrome (CFC syndrome)."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Mutations in the NF1 gene have been associated with Neurofibromatosis type 1 (NF1).\n2. FALSE [correction]: Mutations in genes such as PTPN11, SOS1, RAF1, and others have been associated with Noonan syndrome, not EZH2.\n3. FALSE [correction]: Costello syndrome is typically associated with mutations in the HRAS gene, not EZH2.\n4. FALSE [correction]: Cardiofaciocutaneous syndrome (CFC syndrome) is often associated with mutations in genes like BRAF, MAP2K1/2 (also known as MEK1/2), and KRAS, not EZH2.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 193,
    "user_query": "List human proteins that are subject to a dimer-to-tetramer transition.",
    "llama-7b_response": "There are several human proteins that are known to undergo a dimer-to-tetramer transition. One such protein is actin, which is a major component of the cytoskeleton and plays a crucial role in cell motility and division. Another protein that undergoes this transition is tubulin, which is a subunit of microtubules and is essential for cell division and intracellular transport.\nOther proteins that undergo this transition include alpha-actinin, which is a cytoskeletal protein that helps to stabilize the cell membrane and regulate cell shape, and vinculin, which is a protein that binds to the actin cytoskeleton and plays a critical role in cell adhesion and migration.\nIn addition to these proteins, there are several other human proteins that undergo dimer-to-tetramer transitions, including synaptotagmin, which is a calcium-binding protein that plays a critical role in neurotransmitter release, and dystrophin, which is a protein that helps to maintain the structural integrity of muscle fibers.",
    "llama-7b_fact_raw": "1. Actin is a human protein that undergoes a dimer-to-tetramer transition and is involved in cell motility and division.\n2. Tubulin is a human protein that undergoes a dimer-to-tetramer transition and is a subunit of microtubules essential for cell division and intracellular transport.\n3. Alpha-actinin is a human protein that undergoes a dimer-to-tetramer transition and helps stabilize the cell membrane and regulate cell shape.\n4. Vinculin is a human protein that undergoes a dimer-to-tetramer transition and is involved in cell adhesion and migration.\n5. Synaptotagmin is a human protein that undergoes a dimer-to-tetramer transition and plays a critical role in neurotransmitter release.",
    "llama-7b_fact": [
      "Actin is a human protein that undergoes a dimer-to-tetramer transition and is involved in cell motility and division.",
      "Tubulin is a human protein that undergoes a dimer-to-tetramer transition and is a subunit of microtubules essential for cell division and intracellular transport.",
      "Alpha-actinin is a human protein that undergoes a dimer-to-tetramer transition and helps stabilize the cell membrane and regulate cell shape.",
      "Vinculin is a human protein that undergoes a dimer-to-tetramer transition and is involved in cell adhesion and migration.",
      "Synaptotagmin is a human protein that undergoes a dimer-to-tetramer transition and plays a critical role in neurotransmitter release."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Actin is a human protein that polymerizes to form filaments (not just a dimer-to-tetramer transition) and is involved in cell motility and division.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Vinculin is a human protein that is involved in linking the actin cytoskeleton to the cell membrane at cell junctions, but it does not undergo a dimer-to-tetramer transition as part of its function.\n5. FALSE [correction]: Synaptotagmin is a human protein that plays a critical role in neurotransmitter release by acting as a calcium sensor, but it does not undergo a dimer-to-tetramer transition.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 210,
    "user_query": "Which protein has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein?",
    "llama-7b_response": "The protein that has been found to interact with phospholamban (PLN) and is also an anti-apoptotic protein is Bcl-2. Bcl-2 is a member of the Bcl-2 family of proteins, which play a critical role in regulating apoptosis, or programmed cell death. Bcl-2 binds to and inhibits the activity of pro-apoptotic proteins, such as Bax and Bak, which promote cell death. Additionally, Bcl-2 has been found to interact with PLN, which is a cardiac muscle protein that plays a critical role in regulating calcium handling and contractility. The interaction between Bcl-2 and PLN may be important for maintaining cardiac function and preventing apoptosis in the heart.",
    "llama-7b_fact_raw": "1. Bcl-2 is a protein that interacts with phospholamban (PLN).\n2. Bcl-2 is an anti-apoptotic protein.\n3. Bcl-2 is a member of the Bcl-2 family of proteins, which are involved in regulating apoptosis.\n4. Bcl-2 inhibits the activity of pro-apoptotic proteins such as Bax and Bak.\n5. Phospholamban (PLN) is a cardiac muscle protein that plays a role in regulating calcium handling and contractility.",
    "llama-7b_fact": [
      "Bcl-2 is a protein that interacts with phospholamban (PLN).",
      "Bcl-2 is an anti-apoptotic protein.",
      "Bcl-2 is a member of the Bcl-2 family of proteins, which are involved in regulating apoptosis.",
      "Bcl-2 inhibits the activity of pro-apoptotic proteins such as Bax and Bak.",
      "Phospholamban (PLN) is a cardiac muscle protein that plays a role in regulating calcium handling and contractility."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 218,
    "user_query": "Has vitamin D has been shown to reduce incidence of falls in older people in clinical trials?",
    "llama-7b_response": "Yes, vitamin D has been shown to reduce the incidence of falls in older people in clinical trials. Several studies have found that vitamin D supplementation can reduce the risk of falls in older adults. For example, a meta-analysis of 13 randomized controlled trials found that vitamin D supplementation significantly reduced the risk of falls in older adults by 19%. Another study found that vitamin D supplementation reduced the risk of falls by 26% in older adults with vitamin D deficiency. These findings suggest that vitamin D supplementation may be an effective intervention to reduce the incidence of falls in older people.",
    "llama-7b_fact_raw": "1. Vitamin D supplementation has been shown to reduce the incidence of falls in older people in clinical trials.\n2. A meta-analysis of 13 randomized controlled trials found that vitamin D supplementation reduced the risk of falls in older adults by 19%.\n3. Another study found that vitamin D supplementation reduced the risk of falls by 26% in older adults with vitamin D deficiency.",
    "llama-7b_fact": [
      "Vitamin D supplementation has been shown to reduce the incidence of falls in older people in clinical trials.",
      "A meta-analysis of 13 randomized controlled trials found that vitamin D supplementation reduced the risk of falls in older adults by 19%.",
      "Another study found that vitamin D supplementation reduced the risk of falls by 26% in older adults with vitamin D deficiency."
    ],
    "llama-7b_judge_raw": "1. TRUE: Vitamin D supplementation has been shown in various studies to reduce the incidence of falls in older people, as it plays a role in muscle function and bone health.\n2. TRUE: A meta-analysis could indeed find such a result; however, without a specific reference to verify the exact figure, it's important to note that the exact percentage could vary across different studies and meta-analyses.\n3. TRUE: It is plausible that a study found vitamin D supplementation reduced the risk of falls by 26% in older adults with vitamin D deficiency, as vitamin D deficiency can contribute to muscle weakness and balance issues, which are risk factors for falls. However, as with statement 2, the exact figure could vary and would need a specific reference to confirm.",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 222,
    "user_query": "Is there any association between Jarid2 and miR-155 in Th17 cells?",
    "llama-7b_response": "Yes, there is an association between Jarid2 and miR-155 in Th17 cells. Jarid2 is a JmjC domain-containing protein that has been shown to regulate the expression of several genes involved in immune responses, including miR-155. \nmiR-155 is a highly conserved miRNA that has been implicated in various immune-related processes, including Th17 cell differentiation and function. It has been reported that miR-155 expression is upregulated in Th17 cells during inflammatory responses, and that this upregulation is mediated in part by the transcription factor RORγt.\nRecent studies have also shown that Jarid2 plays a role in regulating miR-155 expression in Th17 cells. For example, one study found that Jarid2 knockdown in Th17 cells led to increased miR-155 expression, while overexpression of Jarid2 led to decreased miR-155 expression. These findings suggest that Jarid2 may play a negative regulatory role in miR-155 expression in Th17 cells.\nOverall, the association between Jarid2 and miR-155 in Th17 cells is an area of active research, and further studies are needed to fully understand the mechanisms underlying this association and its potential implications for immune-related diseases.",
    "llama-7b_fact_raw": "1. Jarid2 is a JmjC domain-containing protein that regulates the expression of genes involved in immune responses, including miR-155.\n2. miR-155 is a miRNA implicated in Th17 cell differentiation and function.\n3. miR-155 expression is upregulated in Th17 cells during inflammatory responses.\n4. The transcription factor RORγt mediates the upregulation of miR-155 expression in Th17 cells.\n5. Studies have shown that Jarid2 knockdown in Th17 cells increases miR-155 expression, while overexpression of Jarid2 decreases it.",
    "llama-7b_fact": [
      "Jarid2 is a JmjC domain-containing protein that regulates the expression of genes involved in immune responses, including miR-155.",
      "miR-155 is a miRNA implicated in Th17 cell differentiation and function.",
      "miR-155 expression is upregulated in Th17 cells during inflammatory responses.",
      "The transcription factor RORγt mediates the upregulation of miR-155 expression in Th17 cells.",
      "Studies have shown that Jarid2 knockdown in Th17 cells increases miR-155 expression, while overexpression of Jarid2 decreases it."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll the statements provided are consistent with current scientific understanding regarding the role of Jarid2, miR-155, Th17 cells, and the transcription factor RORγt in immune responses. Jarid2 is known to be involved in the regulation of gene expression, including miR-155. miR-155 has been implicated in Th17 cell differentiation and function, and its expression is known to be upregulated during inflammatory responses. RORγt is a transcription factor that plays a key role in Th17 cell function and has been shown to mediate the expression of miR-155. Lastly, studies have indicated that manipulating Jarid2 levels can affect miR-155 expression in Th17 cells.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 224,
    "user_query": "How many genes does the human hoxD cluster contain?",
    "llama-7b_response": "The human hoxD cluster contains 13 genes.",
    "llama-7b_fact_raw": "1. The human hoxD cluster contains 13 genes.",
    "llama-7b_fact": [
      "The human hoxD cluster contains 13 genes."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The human HOXD cluster contains 9 genes.",
    "llama-7b_judge": [
      "false"
    ]
  },
  {
    "id": 268,
    "user_query": "List phosphorylation consensus motifs for Casein Kinase 1 (CK1)?",
    "llama-7b_response": "Casein Kinase 1 (CK1) is a serine/threonine protein kinase that plays a crucial role in various cellular processes such as cell division, differentiation, and apoptosis. CK1 can phosphorylate a wide range of substrates, including proteins, lipids, and nucleotides. The following are some of the phosphorylation consensus motifs for CK1:\n1. S/T-X-R-X-K/R-X-S/T: This motif is the most common consensus motif for CK1 phosphorylation sites. It consists of a serine or threonine residue followed by an X, which can be any amino acid, followed by a residue that is either a lysine or arginine.\n2. S/T-X-X-X-K/R-X-S/T: This motif is similar to the first one, but it has an additional X residue.\n3. S/T-X-X-X-X-K/R-X-S/T: This motif has two additional X residues compared to the second motif.\n4. S/T-X-X-X-X-X-K/R-X-S/T: This motif has three additional X residues compared to the third motif.\n5. S/T-X-X-X-X-X-X-K/R-X-S/T: This motif has four additional X residues compared to the fourth motif.\nIt is important to note that these motifs are not specific to CK1 and can be found in the phosphorylation sites of other protein kinases as well.",
    "llama-7b_fact_raw": "1. Casein Kinase 1 (CK1) is a serine/threonine protein kinase.\n2. CK1 plays a role in cell division, differentiation, and apoptosis.\n3. CK1 can phosphorylate a range of substrates, including proteins, lipids, and nucleotides.\n4. The consensus motif S/T-X-R-X-K/R-X-S/T is a common phosphorylation site for CK1.\n5. The phosphorylation consensus motifs for CK1 can also be found in the phosphorylation sites of other protein kinases.",
    "llama-7b_fact": [
      "Casein Kinase 1 (CK1) is a serine/threonine protein kinase.",
      "CK1 plays a role in cell division, differentiation, and apoptosis.",
      "CK1 can phosphorylate a range of substrates, including proteins, lipids, and nucleotides.",
      "The consensus motif S/T-X-R-X-K/R-X-S/T is a common phosphorylation site for CK1.",
      "The phosphorylation consensus motifs for CK1 can also be found in the phosphorylation sites of other protein kinases."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: CK1 primarily phosphorylates proteins, not lipids or nucleotides.\n4. FALSE [correction]: The consensus motif for CK1 phosphorylation is S/T-X-X-S/T, not S/T-X-R-X-K/R-X-S/T.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 305,
    "user_query": "Which are the different proteins/isoforms encoded but the ASPH (aspartate beta-hydroxylase) gene in humans?",
    "llama-7b_response": "The ASPH gene encodes for three different proteins/isoforms in humans:\n1. Aspartate beta-hydroxylase (ABH) - This is the primary protein encoded by the ASPH gene. It is involved in the metabolism of aspartate and plays a role in the urea cycle, which is responsible for removing ammonia from the body.\n2. Aspartate beta-semialdehyde dehydrogenase (ABSD) - This protein is a catalytic subunit of the enzyme that converts aspartate beta-semialdehyde to aspartate.\n3. Aspartate beta-hydroxy-gamma-semialdehyde dehydrogenase (ABHS) - This protein is a catalytic subunit of the enzyme that converts aspartate beta-hydroxy-gamma-semialdehyde to beta-alanine.",
    "llama-7b_fact_raw": "1. The ASPH gene encodes for the protein aspartate beta-hydroxylase (ABH).\n2. Aspartate beta-hydroxylase (ABH) is involved in the metabolism of aspartate.\n3. ABH plays a role in the urea cycle, which is responsible for removing ammonia from the body.\n4. The ASPH gene also encodes for a protein called aspartate beta-semialdehyde dehydrogenase (ABSD).\n5. Another protein encoded by the ASPH gene is aspartate beta-hydroxy-gamma-semialdehyde dehydrogenase (ABHS).",
    "llama-7b_fact": [
      "The ASPH gene encodes for the protein aspartate beta-hydroxylase (ABH).",
      "Aspartate beta-hydroxylase (ABH) is involved in the metabolism of aspartate.",
      "ABH plays a role in the urea cycle, which is responsible for removing ammonia from the body.",
      "The ASPH gene also encodes for a protein called aspartate beta-semialdehyde dehydrogenase (ABSD).",
      "Another protein encoded by the ASPH gene is aspartate beta-hydroxy-gamma-semialdehyde dehydrogenase (ABHS)."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Aspartate beta-hydroxylase (ABH) is involved in the post-translational modification of proteins by hydroxylating aspartyl and asparaginyl residues, not in the metabolism of aspartate.\n3. FALSE [correction]: ABH is not involved in the urea cycle; it is involved in the modification of proteins. The urea cycle involves enzymes such as carbamoyl phosphate synthetase I, ornithine transcarbamylase, argininosuccinate synthase, argininosuccinate lyase, and arginase.\n4. FALSE [correction]: The ASPH gene does not encode for aspartate beta-semialdehyde dehydrogenase (ABSD). ABSD is not a known protein. The ASPH gene encodes for aspartate beta-hydroxylase.\n5. FALSE [correction]: There is no known protein called aspartate beta-hydroxy-gamma-semialdehyde dehydrogenase (ABHS) encoded by the ASPH gene. The ASPH gene specifically encodes for aspartate beta-hydroxylase.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 330,
    "user_query": "When was empagliflozin FDA approved?",
    "llama-7b_response": "Empagliflozin, sold under the brand name Jardiance, was approved by the United States Food and Drug Administration (FDA) on August 27, 2014, for the treatment of adults with type 2 diabetes.",
    "llama-7b_fact_raw": "1. Empagliflozin is sold under the brand name Jardiance.\n2. The FDA approved empagliflozin on August 27, 2014.\n3. Empagliflozin is approved for the treatment of adults with type 2 diabetes.",
    "llama-7b_fact": [
      "Empagliflozin is sold under the brand name Jardiance.",
      "The FDA approved empagliflozin on August 27, 2014.",
      "Empagliflozin is approved for the treatment of adults with type 2 diabetes."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 350,
    "user_query": "What are the results of loss of the protein Lon1 in the plant Arabidopsis?",
    "llama-7b_response": "Loss of the protein Lon1 in the plant Arabidopsis can result in several negative effects on the plant's growth and development. \nFirstly, Lon1 is involved in the process of protein degradation, which is essential for maintaining proper protein homeostasis in the cell. Without Lon1, the accumulation of misfolded or damaged proteins can lead to the formation of protein aggregates, which can cause cellular stress and damage. This can ultimately result in reduced plant growth and development.\nSecondly, Lon1 is also involved in the regulation of autophagy, which is the process by which cells break down and recycle damaged or unnecessary proteins and organelles. Loss of Lon1 can disrupt the normal function of autophagy, leading to the accumulation of damaged proteins and organelles in the cell. This can cause cellular stress and damage, and can ultimately result in reduced plant growth and development.\nFinally, Lon1 is also involved in the regulation of apoptosis, or programmed cell death. Loss of Lon1 can disrupt the normal process of apoptosis, leading to the accumulation of damaged or diseased cells in the plant. This can ultimately result in reduced plant growth and development.\nOverall, loss of the protein Lon1 in the plant Arabidopsis can result in several negative effects on the plant's growth and development, including the accumulation of misfolded or damaged proteins, disruption of autophagy, and disruption of apoptosis.",
    "llama-7b_fact_raw": "1. Lon1 is involved in protein degradation, which is essential for maintaining protein homeostasis in Arabidopsis cells.\n2. The absence of Lon1 can lead to the formation of protein aggregates due to the accumulation of misfolded or damaged proteins.\n3. Loss of Lon1 can disrupt the normal function of autophagy in Arabidopsis cells.\n4. Disruption of autophagy due to the loss of Lon1 can lead to the accumulation of damaged proteins and organelles in the cell.\n5. Lon1 is involved in the regulation of apoptosis, and its loss can disrupt the normal process of programmed cell death in Arabidopsis.",
    "llama-7b_fact": [
      "Lon1 is involved in protein degradation, which is essential for maintaining protein homeostasis in Arabidopsis cells.",
      "The absence of Lon1 can lead to the formation of protein aggregates due to the accumulation of misfolded or damaged proteins.",
      "Loss of Lon1 can disrupt the normal function of autophagy in Arabidopsis cells.",
      "Disruption of autophagy due to the loss of Lon1 can lead to the accumulation of damaged proteins and organelles in the cell.",
      "Lon1 is involved in the regulation of apoptosis, and its loss can disrupt the normal process of programmed cell death in Arabidopsis."
    ],
    "llama-7b_judge_raw": "1. TRUE: Lon1 is indeed involved in protein degradation, which is essential for maintaining protein homeostasis in plant cells, including those of Arabidopsis.\n2. TRUE: The absence of Lon1 can lead to the formation of protein aggregates due to the accumulation of misfolded or damaged proteins, as it plays a role in degrading such proteins.\n3. UNKNOWN: The specific role of Lon1 in autophagy in Arabidopsis cells is not provided, so it is difficult to determine the truth of this statement without additional context.\n4. UNKNOWN: Similar to statement 3, without specific information on how Lon1 affects autophagy and the subsequent accumulation of damaged proteins and organelles, the truth of this statement cannot be determined.\n5. UNKNOWN: The role of Lon1 in the regulation of apoptosis in Arabidopsis cells is not specified in the provided statements, so the truth of this statement is unclear without further context.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 409,
    "user_query": "Does a linker histone exist in the yeast genome?",
    "llama-7b_response": "Yes, a linker histone exists in the yeast genome. Linker histones are a group of proteins that are involved in the assembly of nucleosomes, which are the basic units of DNA packaging in the cell. In yeast, there are three types of linker histones: H1, H5, and H6. H1 is the most abundant linker histone in yeast, and it is involved in the formation of the nucleosome core particle. H5 and H6 linker histones are involved in the formation of higher-order chromatin structures such as chromatin loops and nucleosome-depleted regions. Therefore, linker histones are essential for the proper organization and function of DNA in yeast cells.",
    "llama-7b_fact_raw": "1. A linker histone exists in the yeast genome.\n2. Linker histones are involved in the assembly of nucleosomes.\n3. Nucleosomes are the basic units of DNA packaging in the cell.\n4. In yeast, the types of linker histones include H1, H5, and H6.\n5. H1 is the most abundant linker histone in yeast and is involved in the formation of the nucleosome core particle.",
    "llama-7b_fact": [
      "A linker histone exists in the yeast genome.",
      "Linker histones are involved in the assembly of nucleosomes.",
      "Nucleosomes are the basic units of DNA packaging in the cell.",
      "In yeast, the types of linker histones include H1, H5, and H6.",
      "H1 is the most abundant linker histone in yeast and is involved in the formation of the nucleosome core particle."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Yeast, specifically Saccharomyces cerevisiae, does not have a canonical linker histone H1; instead, it has non-allelic histone variants that can perform similar functions.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: In yeast, there are no linker histones classified as H1, H5, or H6. Yeast has histone variants such as Hho1p that may function similarly to linker histones in other organisms.\n5. FALSE [correction]: Since yeast does not have a canonical H1 linker histone, it cannot be the most abundant linker histone in yeast. The nucleosome core particle is formed by an octamer of the four core histones (H2A, H2B, H3, and H4), not by H1.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 418,
    "user_query": "Is there evidence that tomato juice lowers cholesterol levels?",
    "llama-7b_response": "Yes, there is evidence that tomato juice can lower cholesterol levels. Tomatoes are a good source of lycopene, an antioxidant that has been shown to have a positive effect on cholesterol levels. Studies have found that consuming tomato juice or tomato products regularly can lead to a decrease in LDL (bad) cholesterol levels and an increase in HDL (good) cholesterol levels. However, it is important to note that while tomato juice may have a positive effect on cholesterol levels, it is not a substitute for a healthy diet and lifestyle. It is recommended to consume tomato juice as part of a balanced diet and to consult with a healthcare professional before making any significant changes to your diet.",
    "llama-7b_fact_raw": "1. Tomato juice can lower cholesterol levels.\n2. Tomatoes are a source of lycopene, an antioxidant.\n3. Lycopene has been shown to have a positive effect on cholesterol levels.\n4. Consuming tomato juice or tomato products regularly can decrease LDL cholesterol levels.\n5. Consuming tomato juice or tomato products regularly can increase HDL cholesterol levels.",
    "llama-7b_fact": [
      "Tomato juice can lower cholesterol levels.",
      "Tomatoes are a source of lycopene, an antioxidant.",
      "Lycopene has been shown to have a positive effect on cholesterol levels.",
      "Consuming tomato juice or tomato products regularly can decrease LDL cholesterol levels.",
      "Consuming tomato juice or tomato products regularly can increase HDL cholesterol levels."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN: The effect of tomato juice on cholesterol levels can vary depending on the individual and other factors. Some studies suggest that it may help lower cholesterol levels, but more research is needed to make a definitive statement.\n2. TRUE\n3. TRUE: Some studies have shown that lycopene can have a positive effect on cholesterol levels, although more research is needed for a definitive conclusion.\n4. UNKNOWN: While some studies suggest that consuming tomato products can decrease LDL cholesterol levels, more research is needed to confirm these findings universally.\n5. UNKNOWN: There is some evidence that suggests consuming tomato products may have a beneficial effect on HDL cholesterol levels, but more research is needed to establish a clear relationship.",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 472,
    "user_query": "How do Hsp70 and Hsp110 affect mRNA stability?",
    "llama-7b_response": "Hsp70 and Hsp110 are two highly conserved heat shock proteins (HSPs) that play critical roles in maintaining cellular homeostasis and protecting cells from stress. One of the key functions of Hsp70 and Hsp110 is to regulate the stability of cellular proteins, including mRNAs.\nHsp70 and Hsp110 bind to and stabilize proteins by preventing their degradation in the proteasome, a cellular protein degradation system. Similarly, Hsp70 and Hsp110 can also stabilize mRNAs by preventing their degradation in the cytoplasm by ribonuclease (RNase) enzymes.\nThe binding of Hsp70 and Hsp110 to mRNAs can also affect the translation of the mRNA into protein. In some cases, the binding of Hsp70 and Hsp110 to mRNAs can promote the translation of the mRNA, while in other cases, it can inhibit translation.\nOverall, the effects of Hsp70 and Hsp110 on mRNA stability are complex and can depend on a variety of factors, including the specific mRNA sequence, the cellular environment, and the presence of other proteins or enzymes. However, it is clear that Hsp70 and Hsp110 play critical roles in regulating the stability and translation of mRNAs, which is essential for maintaining cellular homeostasis and responding to stress.",
    "llama-7b_fact_raw": "1. Hsp70 and Hsp110 are highly conserved heat shock proteins that play roles in maintaining cellular homeostasis and protecting cells from stress.\n2. Hsp70 and Hsp110 regulate the stability of cellular proteins, including mRNAs.\n3. Hsp70 and Hsp110 can prevent the degradation of proteins in the proteasome.\n4. Hsp70 and Hsp110 can stabilize mRNAs by preventing their degradation by ribonuclease (RNase) enzymes.\n5. The binding of Hsp70 and Hsp110 to mRNAs can affect the translation of the mRNA into protein, either promoting or inhibiting translation.",
    "llama-7b_fact": [
      "Hsp70 and Hsp110 are highly conserved heat shock proteins that play roles in maintaining cellular homeostasis and protecting cells from stress.",
      "Hsp70 and Hsp110 regulate the stability of cellular proteins, including mRNAs.",
      "Hsp70 and Hsp110 can prevent the degradation of proteins in the proteasome.",
      "Hsp70 and Hsp110 can stabilize mRNAs by preventing their degradation by ribonuclease (RNase) enzymes.",
      "The binding of Hsp70 and Hsp110 to mRNAs can affect the translation of the mRNA into protein, either promoting or inhibiting translation."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hsp70 and Hsp110 regulate the stability of cellular proteins, but they are not typically known to directly regulate mRNAs. Their primary function is to assist in the folding and unfolding of proteins and to prevent the aggregation of proteins under stress conditions.\n3. TRUE: Hsp70, in particular, is known to interact with components of the proteasome degradation pathway and can help in preventing the degradation of proteins by the proteasome.\n4. FALSE [correction]: Hsp70 and Hsp110 are not directly involved in stabilizing mRNAs by preventing their degradation by ribonuclease (RNase) enzymes. Their main function is related to protein folding and preventing protein aggregation.\n5. TRUE: The binding of Hsp70 to certain mRNAs has been shown to affect their translation, although this is not the primary known function of Hsp70 and Hsp110. They can interact with other proteins that regulate translation, thereby indirectly affecting the translation process.",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 481,
    "user_query": "Which deiodinases are present in skeletal  muscle?",
    "llama-7b_response": "Deiodinases are enzymes that convert the inactive thyroid hormone thyroxine (T4) into the active thyroid hormone triiodothyronine (T3). There are two main types of deiodinases present in skeletal muscle: type 1 and type 2.\nType 1 deiodinase (DIO1) is responsible for the majority of T4 to T3 conversion in skeletal muscle. It is located in the endoplasmic reticulum (ER) and is activated by calcium ions. DIO1 is also involved in the regulation of other hormones and signaling molecules, such as glucagon-like peptide-1 (GLP-1) and insulin-like growth factor-1 (IGF-1).\nType 2 deiodinase (DIO2) is located in the mitochondria and is responsible for the conversion of T4 to reverse T3 (rT3), which has a weaker biological activity than T3. DIO2 is also involved in the regulation of cellular energy metabolism and apoptosis.\nIn summary, DIO1 and DIO2 are the two main types of deiodinases present in skeletal muscle, with DIO1 responsible for the majority of T4 to T3 conversion and DIO2 responsible for the conversion of T4 to rT3.",
    "llama-7b_fact_raw": "1. Deiodinases are enzymes that convert thyroxine (T4) into triiodothyronine (T3).\n2. Type 1 deiodinase (DIO1) is present in skeletal muscle and is responsible for the majority of T4 to T3 conversion.\n3. Type 1 deiodinase (DIO1) is located in the endoplasmic reticulum (ER) of skeletal muscle cells.\n4. Type 2 deiodinase (DIO2) is present in skeletal muscle and is responsible for the conversion of T4 to reverse T3 (rT3).\n5. Type 2 deiodinase (DIO2) is located in the mitochondria of skeletal muscle cells.",
    "llama-7b_fact": [
      "Deiodinases are enzymes that convert thyroxine (T4) into triiodothyronine (T3).",
      "Type 1 deiodinase (DIO1) is present in skeletal muscle and is responsible for the majority of T4 to T3 conversion.",
      "Type 1 deiodinase (DIO1) is located in the endoplasmic reticulum (ER) of skeletal muscle cells.",
      "Type 2 deiodinase (DIO2) is present in skeletal muscle and is responsible for the conversion of T4 to reverse T3 (rT3).",
      "Type 2 deiodinase (DIO2) is located in the mitochondria of skeletal muscle cells."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Type 1 deiodinase (DIO1) is present in the liver, kidney, thyroid, and other tissues, but it is not the primary enzyme responsible for T4 to T3 conversion in skeletal muscle. Type 2 deiodinase (DIO2) plays a more significant role in skeletal muscle.\n3. FALSE [correction]: Type 1 deiodinase (DIO1) is located in the plasma membrane and in the cytoplasm of cells, not specifically in the endoplasmic reticulum (ER) of skeletal muscle cells.\n4. FALSE [correction]: Type 2 deiodinase (DIO2) is responsible for the conversion of T4 to T3, not to reverse T3 (rT3). Type 3 deiodinase (DIO3) is the enzyme that converts T4 to reverse T3 (rT3).\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 534,
    "user_query": "List inflammatory caspase proteins?",
    "llama-7b_response": "There are several inflammatory caspase proteins, including:\n1. Caspase-1\n2. Caspase-4\n3. Caspase-5\n4. Caspase-6\n5. Caspase-7\n6. Caspase-8\n7. Caspase-9\n8. Caspase-10\n9. Caspase-11\n10. Caspase-12\n11. Caspase-13\n12. Caspase-14\n13. Caspase-15\n14. Caspase-16\n15. Caspase-17\n16. Caspase-18\n17. Caspase-19\n18. Caspase-20\n19. Caspase-21\n20. Caspase-22\n21. Caspase-23\n22. Caspase-24\n23. Caspase-25\n24. Caspase-26\n25. Caspase-27\n26. Caspase-28\n27. Caspase-29\n28. Caspase-30\n29. Caspase-31\n30. Caspase-32\n31. Caspase-33\n32. Caspase-34\n33. Caspase-35\n34. Caspase-36\n35. Caspase-37\n36. Caspase-38\n37. Caspase-39\n38. Caspase-40\n39. Caspase-41\n40. Caspase-42\n41. Caspase-43\n42. Caspase-44\n43. Caspase-45\n44. Caspase-46\n45. Caspase-47\n46. Caspase-48\n47. Caspase-49\n48. Caspase-50\n49. Caspase-51\n50. Caspase-52\n51. Caspase-53\n52",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 579,
    "user_query": "Is there any link between the aurora B kinase and the polycomb protein ring1B?",
    "llama-7b_response": "Yes, there is a link between the aurora B kinase and the polycomb protein ring1B. Aurora B kinase is a key regulator of mitosis, which is the process of cell division. It is involved in the formation of spindle fibers, which are necessary for the separation of sister chromatids during cell division. Ring1B is a member of the polycomb family of proteins, which are involved in epigenetic regulation of gene expression.\nRecent studies have shown that aurora B kinase interacts with ring1B and that this interaction is important for the proper regulation of gene expression during mitosis. Specifically, it has been shown that aurora B kinase phosphorylates ring1B at multiple sites, which leads to the degradation of ring1B and the activation of downstream target genes. This interaction between aurora B kinase and ring1B is important for the proper regulation of cell division and gene expression.",
    "llama-7b_fact_raw": "1. Aurora B kinase is a key regulator of mitosis.\n2. Aurora B kinase is involved in the formation of spindle fibers necessary for the separation of sister chromatids during cell division.\n3. Ring1B is a member of the polycomb family of proteins involved in epigenetic regulation of gene expression.\n4. Aurora B kinase interacts with ring1B, and this interaction is important for the proper regulation of gene expression during mitosis.\n5. Aurora B kinase phosphorylates ring1B at multiple sites, leading to the degradation of ring1B and the activation of downstream target genes.",
    "llama-7b_fact": [
      "Aurora B kinase is a key regulator of mitosis.",
      "Aurora B kinase is involved in the formation of spindle fibers necessary for the separation of sister chromatids during cell division.",
      "Ring1B is a member of the polycomb family of proteins involved in epigenetic regulation of gene expression.",
      "Aurora B kinase interacts with ring1B, and this interaction is important for the proper regulation of gene expression during mitosis.",
      "Aurora B kinase phosphorylates ring1B at multiple sites, leading to the degradation of ring1B and the activation of downstream target genes."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: Aurora B kinase phosphorylates ring1B at multiple sites, but this does not necessarily lead to the degradation of ring1B. The phosphorylation can regulate ring1B's function in various ways, but degradation is not the typical outcome of this modification.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 597,
    "user_query": "What are the most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates?",
    "llama-7b_response": "The most frequent non-canonical sequence motifs at the donor and acceptor splice sites in vertebrates are as follows:\nAt the donor splice site, the most common motif is the 5' splice site sequence (5' SS), which is a stretch of nucleotides located 5' to the start of the intron. This sequence is highly conserved across species and is recognized by the spliceosome to initiate the splicing process. Other common donor splice site motifs include the 3' SS, which is located 3' to the start of the intron, and the branch site, which is located between the 5' SS and the coding sequence.\nAt the acceptor splice site, the most common motif is the 3' splice site sequence (3' SS), which is located 3' to the end of the intron. This sequence is also highly conserved and recognized by the spliceosome to initiate the splicing process. Other common acceptor splice site motifs include the 5' SS, which is located 5' to the end of the intron, and the branch site, which is located between the 3' SS and the coding sequence.\nIt is important to note that the specific non-canonical sequence motifs present at each splice site can vary depending on the species and tissue type. However, the general motifs described above are common to most vertebrates.",
    "llama-7b_fact_raw": "1. The 5' splice site sequence (5' SS) is a common non-canonical motif at the donor splice site in vertebrates.\n2. The 3' splice site sequence (3' SS) is a common non-canonical motif at the donor splice site in vertebrates.\n3. The branch site is a common non-canonical motif located between the 5' SS and the coding sequence at the donor splice site in vertebrates.\n4. The 3' splice site sequence (3' SS) is a common non-canonical motif at the acceptor splice site in vertebrates.\n5. The branch site is a common non-canonical motif located between the 3' SS and the coding sequence at the acceptor splice site in vertebrates.",
    "llama-7b_fact": [
      "The 5' splice site sequence (5' SS) is a common non-canonical motif at the donor splice site in vertebrates.",
      "The 3' splice site sequence (3' SS) is a common non-canonical motif at the donor splice site in vertebrates.",
      "The branch site is a common non-canonical motif located between the 5' SS and the coding sequence at the donor splice site in vertebrates.",
      "The 3' splice site sequence (3' SS) is a common non-canonical motif at the acceptor splice site in vertebrates.",
      "The branch site is a common non-canonical motif located between the 3' SS and the coding sequence at the acceptor splice site in vertebrates."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The 5' splice site sequence (5' SS) is a common canonical motif at the donor splice site in vertebrates, typically containing the consensus sequence 'GU' at the 5' end of the intron.\n2. FALSE [correction]: The 3' splice site sequence (3' SS) is not typically found at the donor splice site; it is a canonical motif at the acceptor splice site in vertebrates, containing the consensus sequence 'AG' at the 3' end of the intron.\n3. FALSE [correction]: The branch site is not a non-canonical motif; it is a conserved sequence located upstream of the 3' splice site, not between the 5' SS and the coding sequence. It plays a crucial role in the splicing process by forming a lariat structure during intron removal.\n4. FALSE [correction]: The 3' splice site sequence (3' SS) is a common canonical motif at the acceptor splice site in vertebrates, not a non-canonical motif.\n5. FALSE [correction]: The branch site is located upstream of the 3' splice site sequence (3' SS) and the polypyrimidine tract, not between the 3' SS and the coding sequence at the acceptor splice site. It is also a canonical and not a non-canonical motif.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 629,
    "user_query": "Which event results in the acetylation of S6K1?",
    "llama-7b_response": "The event that results in the acetylation of S6K1 is the binding of acetyl-CoA to the lysine residues on S6K1. Acetyl-CoA is an acetyl group donor that adds to the lysine residues on S6K1, which alters the conformation of the protein and activates its kinase activity. This results in the phosphorylation and activation of numerous downstream targets, including 4E-BP1 and eEF2, which regulate the translation of mRNAs.",
    "llama-7b_fact_raw": "1. Acetylation of S6K1 occurs when acetyl-CoA binds to the lysine residues on S6K1.\n2. Acetyl-CoA acts as an acetyl group donor in the acetylation of S6K1.\n3. The acetylation of S6K1 alters the conformation of the protein.\n4. The altered conformation of S6K1 activates its kinase activity.\n5. The activation of S6K1's kinase activity leads to the phosphorylation and activation of downstream targets such as 4E-BP1 and eEF2.",
    "llama-7b_fact": [
      "Acetylation of S6K1 occurs when acetyl-CoA binds to the lysine residues on S6K1.",
      "Acetyl-CoA acts as an acetyl group donor in the acetylation of S6K1.",
      "The acetylation of S6K1 alters the conformation of the protein.",
      "The altered conformation of S6K1 activates its kinase activity.",
      "The activation of S6K1's kinase activity leads to the phosphorylation and activation of downstream targets such as 4E-BP1 and eEF2."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: The activation of S6K1's kinase activity leads to the phosphorylation and activation of downstream targets such as ribosomal protein S6, not eEF2. 4E-BP1 is also a target of mTOR, which S6K1 is a part of, but S6K1 directly phosphorylates ribosomal protein S6.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 632,
    "user_query": "What is the cause of episodic ataxia type 6?",
    "llama-7b_response": "Episodic ataxia type 6 (EA6) is a rare genetic disorder that affects the nervous system. It is caused by a mutation in the CACNA1A gene, which produces a protein that is important for regulating the electrical activity of neurons in the brain.\nThe exact cause of the mutation that leads to EA6 is not fully understood, but it is believed to be inherited in an autosomal dominant pattern. This means that a person with a mutation in the CACNA1A gene has a 50% chance of passing the mutation on to their children.\nThe symptoms of EA6 typically begin in adolescence or early adulthood and include episodes of ataxia, which is a lack of coordination and balance that can lead to falls and other accidents. These episodes can last from a few seconds to several minutes and can be triggered by a variety of stimuli, including stress, exercise, or certain foods or drinks.\nOther symptoms of EA6 may include dizziness, vertigo, nausea, and difficulty speaking or swallowing. In some cases, the symptoms of EA6 can be severe enough to interfere with daily activities and require medical attention.\nThere is currently no cure for EA6, but medications can be prescribed to help manage the symptoms and prevent episodes from occurring. In some cases, surgery may also be considered to reduce the impact of the mutation on the nervous system.",
    "llama-7b_fact_raw": "1. Episodic ataxia type 6 (EA6) is a rare genetic disorder that affects the nervous system.\n2. EA6 is caused by a mutation in the CACNA1A gene.\n3. The mutation in the CACNA1A gene is believed to be inherited in an autosomal dominant pattern.\n4. Symptoms of EA6 typically begin in adolescence or early adulthood.\n5. There is currently no cure for EA6, but medications can be prescribed to help manage the symptoms.",
    "llama-7b_fact": [
      "Episodic ataxia type 6 (EA6) is a rare genetic disorder that affects the nervous system.",
      "EA6 is caused by a mutation in the CACNA1A gene.",
      "The mutation in the CACNA1A gene is believed to be inherited in an autosomal dominant pattern.",
      "Symptoms of EA6 typically begin in adolescence or early adulthood.",
      "There is currently no cure for EA6, but medications can be prescribed to help manage the symptoms."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Episodic ataxia type 6 (EA6) is not associated with mutations in the CACNA1A gene. EA6 is caused by mutations in the SLC1A3 gene.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 646,
    "user_query": "Are chromomethylases present in animal genomes?",
    "llama-7b_response": "Yes, chromomethylases are present in animal genomes. Chromomethylases are enzymes that catalyze the conversion of methyl groups from S-adenosylmethionine (SAM) to other molecules, such as alcohols, aldehydes, and thiols. These enzymes are involved in a variety of biological processes, including DNA methylation, which is a crucial epigenetic modification that plays a role in gene expression and genomic imprinting.\nSeveral chromomethylase genes have been identified in the genomes of various animal species, including humans. For example, the human genome contains at least 12 genes that encode chromomethylase enzymes. These genes are distributed throughout the genome and are involved in a variety of biological processes, including DNA methylation, histone modification, and RNA splicing.\nIn summary, chromomethylases are present in animal genomes and play important roles in various biological processes, including DNA methylation, histone modification, and RNA splicing.",
    "llama-7b_fact_raw": "1. Chromomethylases are present in animal genomes.\n2. Chromomethylases catalyze the transfer of methyl groups from S-adenosylmethionine to other molecules.\n3. DNA methylation is a process involving chromomethylases and is important for gene expression and genomic imprinting.\n4. The human genome contains at least 12 genes that encode chromomethylase enzymes.\n5. Chromomethylase genes in the human genome are involved in DNA methylation, histone modification, and RNA splicing.",
    "llama-7b_fact": [
      "Chromomethylases are present in animal genomes.",
      "Chromomethylases catalyze the transfer of methyl groups from S-adenosylmethionine to other molecules.",
      "DNA methylation is a process involving chromomethylases and is important for gene expression and genomic imprinting.",
      "The human genome contains at least 12 genes that encode chromomethylase enzymes.",
      "Chromomethylase genes in the human genome are involved in DNA methylation, histone modification, and RNA splicing."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Chromomethylases are not present in animal genomes; they are typically found in plants.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The human genome does not contain genes that encode chromomethylase enzymes, as chromomethylases are not present in animals.\n5. FALSE [correction]: Since chromomethylases are not present in the human genome, they are not involved in DNA methylation, histone modification, or RNA splicing in humans. DNA methylation in humans is carried out by DNA methyltransferases (DNMTs).",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 650,
    "user_query": "List packages for transcription factor binding sites' (TFBS) analysis available in R/Bioconductor",
    "llama-7b_response": "There are several packages available in R/Bioconductor for transcription factor binding site analysis. Here are some of the most popular ones:\n1. ChIPseeker: This package provides tools for analyzing ChIP-seq data and identifying transcription factor binding sites. It includes functions for mapping ChIP-seq data to a reference genome, detecting peaks, and identifying TFBSs.\n2. DNase-seqR: This package provides tools for analyzing DNase-seq data and identifying transcription factor binding sites. It includes functions for mapping DNase-seq data to a reference genome, detecting peaks, and identifying TFBSs.\n3. GRO-seqR: This package provides tools for analyzing GRO-seq data and identifying transcription factor binding sites. It includes functions for mapping GRO-seq data to a reference genome, detecting peaks, and identifying TFBSs.\n4. ChIPpeakAnno: This package provides tools for annotating ChIP-seq data and identifying transcription factor binding sites. It includes functions for mapping ChIP-seq data to a reference genome, detecting peaks, and identifying TFBSs.\n5. PeakSeq: This package provides tools for analyzing RNA-seq data and identifying transcription factor binding sites. It includes functions for mapping RNA-seq data to a reference genome, detecting peaks, and identifying TFBSs.\nThese are just a few of the many packages available in R/Bioconductor for transcription factor binding site analysis.",
    "llama-7b_fact_raw": "1. ChIPseeker is a package in R/Bioconductor for analyzing ChIP-seq data and identifying transcription factor binding sites.\n2. DNase-seqR is a package in R/Bioconductor for analyzing DNase-seq data and identifying transcription factor binding sites.\n3. GRO-seqR is a package in R/Bioconductor for analyzing GRO-seq data and identifying transcription factor binding sites.\n4. ChIPpeakAnno is a package in R/Bioconductor for annotating ChIP-seq data and identifying transcription factor binding sites.\n5. PeakSeq is a package in R/Bioconductor for analyzing RNA-seq data and identifying transcription factor binding sites.",
    "llama-7b_fact": [
      "ChIPseeker is a package in R/Bioconductor for analyzing ChIP-seq data and identifying transcription factor binding sites.",
      "DNase-seqR is a package in R/Bioconductor for analyzing DNase-seq data and identifying transcription factor binding sites.",
      "GRO-seqR is a package in R/Bioconductor for analyzing GRO-seq data and identifying transcription factor binding sites.",
      "ChIPpeakAnno is a package in R/Bioconductor for annotating ChIP-seq data and identifying transcription factor binding sites.",
      "PeakSeq is a package in R/Bioconductor for analyzing RNA-seq data and identifying transcription factor binding sites."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no widely recognized package specifically named \"DNase-seqR\" in R/Bioconductor for analyzing DNase-seq data. However, there are other tools available for DNase-seq data analysis, such as \"DiffBind\" or \"csaw\".\n3. FALSE [correction]: \"GRO-seqR\" is not a known package in R/Bioconductor for analyzing GRO-seq data. GRO-seq data can be analyzed using packages like \"systemPipeR\" or other general-purpose RNA-seq analysis tools.\n4. TRUE\n5. FALSE [correction]: PeakSeq is not a package in R/Bioconductor for analyzing RNA-seq data. PeakSeq is a tool for analyzing ChIP-seq data. For RNA-seq data analysis, packages like \"DESeq2\" or \"edgeR\" are commonly used in R/Bioconductor.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 721,
    "user_query": "List clinical trials for prevention of sarcopenia",
    "llama-7b_response": "Sure, here are some clinical trials for the prevention of sarcopenia:\n1. SARCOPREV: This is a multicenter, randomized, double-blind, placebo-controlled trial that aims to evaluate the efficacy and safety of a combination of creatine monohydrate and beta-alanine in preventing sarcopenia in older adults.\n2. SARCOPREV-2: This is a multicenter, randomized, double-blind, placebo-controlled trial that aims to evaluate the efficacy and safety of a combination of creatine monohydrate and beta-alanine in preventing sarcopenia in older adults.\n3. SARCOPREV-3: This is a multicenter, randomized, double-blind, placebo-controlled trial that aims to evaluate the efficacy and safety of a combination of creatine monohydrate and beta-alanine in preventing sarcopenia in older adults.\n4. SARCOPREV-4: This is a multicenter, randomized, double-blind, placebo-controlled trial that aims to evaluate the efficacy and safety of a combination of creatine monohydrate and beta-alanine in preventing sarcopenia in older adults.\n5. SARCOPREV-5: This is a multicenter, randomized, double-blind, placebo-controlled trial that aims to evaluate the efficacy and safety of a combination of creatine monohydrate and beta-alanine in preventing sarcopenia in older adults.\n6. SARCOPREV-6: This is a multicenter, randomized, double-blind, placebo-controlled trial that aims to evaluate the efficacy and safety of a combination of creatine monohydrate and beta-alanine in preventing sarcopenia in older adults.\n7. SARCOPREV-7: This is a multicenter, randomized, double-blind, placebo-controlled trial that aims to evaluate the efficacy and safety of a combination of creatine monohydrate and beta-alanine in preventing sarcopenia in older adult",
    "llama-7b_fact_raw": "1. SARCOPREV is a multicenter, randomized, double-blind, placebo-controlled trial.\n2. The SARCOPREV trial aims to evaluate the efficacy and safety of a combination of creatine monohydrate and beta-alanine in preventing sarcopenia.\n3. The SARCOPREV trial is focused on preventing sarcopenia in older adults.\n4. There are multiple trials with the name SARCOPREV, indicating a series (SARCOPREV-2, SARCOPREV-3, etc.).\n5. Each trial in the SARCOPREV series shares the same design as a multicenter, randomized, double-blind, placebo-controlled trial.",
    "llama-7b_fact": [
      "SARCOPREV is a multicenter, randomized, double-blind, placebo-controlled trial.",
      "The SARCOPREV trial aims to evaluate the efficacy and safety of a combination of creatine monohydrate and beta-alanine in preventing sarcopenia.",
      "The SARCOPREV trial is focused on preventing sarcopenia in older adults.",
      "There are multiple trials with the name SARCOPREV, indicating a series (SARCOPREV-2, SARCOPREV-3, etc.).",
      "Each trial in the SARCOPREV series shares the same design as a multicenter, randomized, double-blind, placebo-controlled trial."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific information about the SARCOPREV trial or trials, it is not possible to determine the accuracy of these statements. Additional context or data would be required to verify these claims.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 722,
    "user_query": "Which is the database of molecular recognition features in membrane proteins?",
    "llama-7b_response": "There is no single database that contains a comprehensive list of all molecular recognition features in membrane proteins. However, there are several databases that focus on specific aspects of membrane protein structure and function, including:\n1. The Protein Data Bank (PDB) - This database contains structural information on a wide range of proteins, including membrane proteins. It includes information on the molecular recognition features of membrane proteins, such as ligand-binding sites and ion channels.\n2. The Membrane Protein Data Bank (MPDB) - This database contains structural information on membrane proteins, including information on their molecular recognition features.\n3. The Bioinformatics Resource Center for Membrane Proteins (BRCMP) - This database provides tools and resources for analyzing and predicting the structure and function of membrane proteins. It includes information on the molecular recognition features of membrane proteins.\n4. The Critical Assessment of Techniques for Protein Structure Determination (CASP) Membrane Protein Prediction Challenge - This challenge provides a platform for researchers to test and improve their methods for predicting the structure of membrane proteins. It includes information on the molecular recognition features of membrane proteins.\nOverall, these databases and challenges provide valuable resources for researchers studying the molecular recognition features of membrane proteins.",
    "llama-7b_fact_raw": "1. The Protein Data Bank (PDB) contains structural information on a wide range of proteins, including membrane proteins.\n2. The Membrane Protein Data Bank (MPDB) contains structural information specifically on membrane proteins.\n3. The Bioinformatics Resource Center for Membrane Proteins (BRCMP) provides tools and resources for analyzing and predicting the structure and function of membrane proteins.\n4. The Critical Assessment of Techniques for Protein Structure Determination (CASP) Membrane Protein Prediction Challenge is a platform for testing and improving methods for predicting the structure of membrane proteins.",
    "llama-7b_fact": [
      "The Protein Data Bank (PDB) contains structural information on a wide range of proteins, including membrane proteins.",
      "The Membrane Protein Data Bank (MPDB) contains structural information specifically on membrane proteins.",
      "The Bioinformatics Resource Center for Membrane Proteins (BRCMP) provides tools and resources for analyzing and predicting the structure and function of membrane proteins.",
      "The Critical Assessment of Techniques for Protein Structure Determination (CASP) Membrane Protein Prediction Challenge is a platform for testing and improving methods for predicting the structure of membrane proteins."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: There is no specific database called the Membrane Protein Data Bank (MPDB). Structural information on membrane proteins is included within the Protein Data Bank (PDB).\n3. UNKNOWN\n4. TRUE (assuming there is a specific challenge within CASP focused on membrane proteins; however, CASP generally focuses on protein structure prediction as a whole, not specifically membrane proteins, so this statement could be misleading without additional context).",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 745,
    "user_query": "Is rivaroxaban metabolized in kidneys?",
    "llama-7b_response": "Yes, rivaroxaban is metabolized in the kidneys. Rivaroxaban is a direct factor Xa inhibitor that is used to prevent blood clots in people with atrial fibrillation, deep vein thrombosis, and pulmonary embolism. After administration, rivaroxaban is rapidly absorbed and metabolized by the liver and kidneys. The metabolites of rivaroxaban are mainly excreted in the urine. The kidneys play an important role in the elimination of rivaroxaban from the body. Patients with renal impairment may have reduced clearance of rivaroxaban, which can lead to increased plasma concentrations and an increased risk of adverse effects. Therefore, the dose of rivaroxaban should be adjusted in patients with renal impairment.",
    "llama-7b_fact_raw": "1. Rivaroxaban is metabolized in the kidneys.\n2. Rivaroxaban is used to prevent blood clots in people with atrial fibrillation, deep vein thrombosis, and pulmonary embolism.\n3. The metabolites of rivaroxaban are mainly excreted in the urine.\n4. Patients with renal impairment may have reduced clearance of rivaroxaban.\n5. The dose of rivaroxaban should be adjusted in patients with renal impairment.",
    "llama-7b_fact": [
      "Rivaroxaban is metabolized in the kidneys.",
      "Rivaroxaban is used to prevent blood clots in people with atrial fibrillation, deep vein thrombosis, and pulmonary embolism.",
      "The metabolites of rivaroxaban are mainly excreted in the urine.",
      "Patients with renal impairment may have reduced clearance of rivaroxaban.",
      "The dose of rivaroxaban should be adjusted in patients with renal impairment."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Rivaroxaban is primarily metabolized in the liver.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 763,
    "user_query": "Which genes are regulated by TRalpha2  in the heart?",
    "llama-7b_response": "TRalpha2 is a nuclear receptor that plays a critical role in regulating gene expression in various tissues, including the heart. The genes that are regulated by TRalpha2 in the heart are still being studied, but some of the genes that have been identified include:\n1. Genes involved in cardiac development and remodeling: TRalpha2 has been shown to regulate the expression of genes that are involved in the development and remodeling of the heart. For example, TRalpha2 has been found to regulate the expression of genes that are involved in cardiac muscle cell differentiation and maturation.\n2. Genes involved in cardiac function: TRalpha2 has also been found to regulate the expression of genes that are involved in cardiac function. For example, TRalpha2 has been found to regulate the expression of genes that are involved in the regulation of heart rate and contractility.\n3. Genes involved in inflammation: TRalpha2 has been found to regulate the expression of genes that are involved in inflammation. For example, TRalpha2 has been found to regulate the expression of genes that are involved in the production of pro-inflammatory cytokines.\nOverall, the regulation of these genes by TRalpha2 is important for maintaining normal cardiac function and development, and dysregulation of these genes may contribute to the development of cardiovascular diseases.",
    "llama-7b_fact_raw": "1. TRalpha2 is a nuclear receptor that regulates gene expression in various tissues, including the heart.\n2. TRalpha2 regulates the expression of genes involved in cardiac development and remodeling.\n3. TRalpha2 influences the differentiation and maturation of cardiac muscle cells.\n4. TRalpha2 regulates genes that are involved in cardiac function, including those affecting heart rate and contractility.\n5. TRalpha2 regulates the expression of genes involved in inflammation, including those related to the production of pro-inflammatory cytokines.",
    "llama-7b_fact": [
      "TRalpha2 is a nuclear receptor that regulates gene expression in various tissues, including the heart.",
      "TRalpha2 regulates the expression of genes involved in cardiac development and remodeling.",
      "TRalpha2 influences the differentiation and maturation of cardiac muscle cells.",
      "TRalpha2 regulates genes that are involved in cardiac function, including those affecting heart rate and contractility.",
      "TRalpha2 regulates the expression of genes involved in inflammation, including those related to the production of pro-inflammatory cytokines."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\nThe statements about TRalpha2 (thyroid hormone receptor alpha 2) are generally consistent with the role of thyroid hormone receptors in regulating gene expression in various tissues, including the heart, and their involvement in cardiac development, differentiation, and function. However, without specific evidence linking TRalpha2 to the regulation of genes involved in inflammation and the production of pro-inflammatory cytokines, the last statement remains uncertain.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 786,
    "user_query": "List available biomedical question answering systems.",
    "llama-7b_response": "There are several biomedical question answering systems available, including:\n1. Biocrawler: This is a web-based tool that allows users to ask biomedical questions and receive answers from a database of biomedical literature.\n2. Bioportal: This is a web-based tool that allows users to ask biomedical questions and receive answers from a database of biomedical literature.\n3. PubMed Q&A: This is a web-based tool that allows users to ask biomedical questions and receive answers from a database of biomedical literature.\n4. ClinVar Q&A: This is a web-based tool that allows users to ask biomedical questions and receive answers from a database of clinical variant information.\n5. DrugBank Q&A: This is a web-based tool that allows users to ask biomedical questions and receive answers from a database of drug information.\n6. ChEMBL Q&A: This is a web-based tool that allows users to ask biomedical questions and receive answers from a database of chemical information.\n7. OMIM Q&A: This is a web-based tool that allows users to ask biomedical questions and receive answers from a database of genetic information.\nThese are just a few examples of the many biomedical question answering systems available.",
    "llama-7b_fact_raw": "1. Biocrawler is a web-based tool designed for asking and answering biomedical questions using a biomedical literature database.\n2. Bioportal is a web-based tool designed for asking and answering biomedical questions using a biomedical literature database.\n3. PubMed Q&A is a web-based tool designed for asking and answering biomedical questions using a biomedical literature database.\n4. ClinVar Q&A is a web-based tool designed for asking and answering biomedical questions using a clinical variant information database.\n5. DrugBank Q&A is a web-based tool designed for asking and answering biomedical questions using a drug information database.",
    "llama-7b_fact": [
      "Biocrawler is a web-based tool designed for asking and answering biomedical questions using a biomedical literature database.",
      "Bioportal is a web-based tool designed for asking and answering biomedical questions using a biomedical literature database.",
      "PubMed Q&A is a web-based tool designed for asking and answering biomedical questions using a biomedical literature database.",
      "ClinVar Q&A is a web-based tool designed for asking and answering biomedical questions using a clinical variant information database.",
      "DrugBank Q&A is a web-based tool designed for asking and answering biomedical questions using a drug information database."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: BioPortal is an online repository of biomedical ontologies, not specifically a tool for asking and answering questions using a biomedical literature database.\n3. UNKNOWN\n4. FALSE [correction]: ClinVar is a database that aggregates information about genomic variation and its relationship to human health, not specifically a tool for asking and answering questions with a Q&A format.\n5. FALSE [correction]: DrugBank is a comprehensive database containing information on drugs and drug targets, not specifically a tool for asking and answering questions with a Q&A format.",
    "llama-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 794,
    "user_query": "Which trancription factor activates the betalain pathway?",
    "llama-7b_response": "The betalain pathway is activated by a group of transcription factors called the betalain activators. These transcription factors bind to specific DNA sequences in the genome and activate the expression of genes involved in the betalain biosynthesis pathway. \nOne of the best-studied betalain activators is the transcription factor CCAAT displacement protein (CDP). CDP binds to specific DNA sequences known as betalain response elements (BREs) and activates the expression of genes involved in betalain biosynthesis. \nOther betalain activators include the transcription factors MYB and bHLH, as well as the nuclear hormone receptors RAR and PPAR. These transcription factors bind to different DNA sequences and activate different genes involved in betalain biosynthesis. \nOverall, the activation of the betalain pathway is a complex process that involves the interaction of multiple transcription factors with specific DNA sequences in the genome.",
    "llama-7b_fact_raw": "1. The betalain pathway is activated by a group of transcription factors known as betalain activators.\n2. The transcription factor CCAAT displacement protein (CDP) is one of the betalain activators.\n3. CDP binds to specific DNA sequences called betalain response elements (BREs).\n4. Transcription factors MYB and bHLH are also involved in activating the betalain biosynthesis pathway.\n5. Nuclear hormone receptors RAR and PPAR are part of the group of transcription factors that activate genes involved in betalain biosynthesis.",
    "llama-7b_fact": [
      "The betalain pathway is activated by a group of transcription factors known as betalain activators.",
      "The transcription factor CCAAT displacement protein (CDP) is one of the betalain activators.",
      "CDP binds to specific DNA sequences called betalain response elements (BREs).",
      "Transcription factors MYB and bHLH are also involved in activating the betalain biosynthesis pathway.",
      "Nuclear hormone receptors RAR and PPAR are part of the group of transcription factors that activate genes involved in betalain biosynthesis."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The transcription factor CCAAT displacement protein (CDP) is not typically associated with the betalain biosynthesis pathway. Betalain activators are usually specific to plants that produce betalains, such as those in the Caryophyllales order, and CDP is not known to be one of them.\n3. FALSE [correction]: Since CDP is not one of the betalain activators, it does not bind to specific DNA sequences called betalain response elements (BREs) as part of the betalain biosynthesis pathway. BREs would be recognized by the actual betalain activators.\n4. TRUE\n5. FALSE [correction]: Nuclear hormone receptors RAR and PPAR are not part of the group of transcription factors that activate genes involved in betalain biosynthesis. These receptors are involved in other pathways, primarily in animals, and are not related to plant-specific pathways such as betalain biosynthesis.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 883,
    "user_query": "Global quantitative phosphoproteomic analyses are emerging. List the preferred technologies for the enrichment for phosphorylated peptides?",
    "llama-7b_response": "There are several technologies that are commonly used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses. Here are some of the preferred technologies:\n1. TiO2 beads: TiO2 beads are one of the most commonly used technologies for the enrichment of phosphorylated peptides. They have a high affinity for phosphorylated peptides and can be easily separated from non-phosphorylated peptides through washing.\n2. IMAC (Immobilized Metal Affinity Chromatography): IMAC is another popular technology for the enrichment of phosphorylated peptides. It uses a metal ion, such as nickel or gold, to bind to phosphorylated peptides. The bound peptides can then be easily separated from non-phosphorylated peptides.\n3. SPE (Solid-Phase Extraction): SPE is a simple and efficient technology for the enrichment of phosphorylated peptides. It involves binding the peptides to a solid support, such as C18 or Sep-Pak, and then washing away the non-phosphorylated peptides.\n4. LC-MS/MS: Liquid chromatography-mass spectrometry (LC-MS/MS) is a powerful tool for the analysis of phosphorylated peptides. It can detect and quantify phosphorylated peptides with high sensitivity and accuracy.\nOverall, the choice of enrichment technology depends on the specific requirements of the study, such as the number of phosphorylated peptides to be detected, the sample size, and the budget.",
    "llama-7b_fact_raw": "1. TiO2 beads are commonly used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses.\n2. IMAC uses a metal ion to bind to phosphorylated peptides for their enrichment.\n3. Solid-Phase Extraction (SPE) involves binding peptides to a solid support for enrichment of phosphorylated peptides.\n4. Liquid chromatography-mass spectrometry (LC-MS/MS) is used for the analysis of phosphorylated peptides.\n5. The choice of enrichment technology for phosphorylated peptides depends on factors such as the number of peptides to be detected, sample size, and budget.",
    "llama-7b_fact": [
      "TiO2 beads are commonly used for the enrichment of phosphorylated peptides in quantitative phosphoproteomic analyses.",
      "IMAC uses a metal ion to bind to phosphorylated peptides for their enrichment.",
      "Solid-Phase Extraction (SPE) involves binding peptides to a solid support for enrichment of phosphorylated peptides.",
      "Liquid chromatography-mass spectrometry (LC-MS/MS) is used for the analysis of phosphorylated peptides.",
      "The choice of enrichment technology for phosphorylated peptides depends on factors such as the number of peptides to be detected, sample size, and budget."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 901,
    "user_query": "Which disorder is rated by Palmini classification?",
    "llama-7b_response": "The Palmini classification is used to rate disorders that affect the nervous system, including the brain, spinal cord, and peripheral nerves. Some examples of disorders that are rated by the Palmini classification include:\n1. Epilepsy\n2. Multiple sclerosis\n3. Parkinson's disease\n4. Alzheimer's disease\n5. Huntington's disease\n6. Amyotrophic lateral sclerosis (ALS)\n7. Cerebral palsy\n8. Spinal cord injury\n9. Stroke\n10. Head injury\nThese disorders are rated based on the severity of the symptoms and the impact they have on the patient's daily life. The Palmini classification is used by neurologists and other healthcare professionals to determine the best treatment options for patients with these disorders.",
    "llama-7b_fact_raw": "1. The Palmini classification is used to rate disorders that affect the nervous system.\n2. Disorders rated by the Palmini classification include epilepsy and multiple sclerosis.\n3. Parkinson's disease is rated by the Palmini classification.\n4. Alzheimer's disease is rated by the Palmini classification.\n5. The Palmini classification is used by neurologists and other healthcare professionals to determine treatment options.",
    "llama-7b_fact": [
      "The Palmini classification is used to rate disorders that affect the nervous system.",
      "Disorders rated by the Palmini classification include epilepsy and multiple sclerosis.",
      "Parkinson's disease is rated by the Palmini classification.",
      "Alzheimer's disease is rated by the Palmini classification.",
      "The Palmini classification is used by neurologists and other healthcare professionals to determine treatment options."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Palmini classification is specifically used to classify types of cortical dysplasia, which is a congenital abnormality in the brain's development that can lead to epilepsy.\n2. FALSE [correction]: The Palmini classification is not used for multiple sclerosis; it is used for classifying cortical dysplasia associated with epilepsy.\n3. FALSE [correction]: Parkinson's disease is not rated by the Palmini classification, which is specific to cortical dysplasia.\n4. FALSE [correction]: Alzheimer's disease is not rated by the Palmini classification, which is specific to cortical dysplasia.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 905,
    "user_query": "Are viruses involved in the etiology of human subacute thyroiditis?",
    "llama-7b_response": "No, viruses are not involved in the etiology of human subacute thyroiditis. Subacute thyroiditis is an inflammatory condition of the thyroid gland that is typically caused by a viral infection, such as the mumps virus. However, the exact cause of subacute thyroiditis is not fully understood, and there is no evidence to suggest that it is caused by a virus. Instead, it is believed to be an autoimmune disorder in which the body's immune system attacks the thyroid gland, leading to inflammation and pain.",
    "llama-7b_fact_raw": "1. Subacute thyroiditis is an inflammatory condition of the thyroid gland.\n2. Subacute thyroiditis is typically caused by a viral infection.\n3. The mumps virus is an example of a virus that can cause subacute thyroiditis.\n4. The exact cause of subacute thyroiditis is not fully understood.\n5. Subacute thyroiditis is believed to be an autoimmune disorder where the body's immune system attacks the thyroid gland.",
    "llama-7b_fact": [
      "Subacute thyroiditis is an inflammatory condition of the thyroid gland.",
      "Subacute thyroiditis is typically caused by a viral infection.",
      "The mumps virus is an example of a virus that can cause subacute thyroiditis.",
      "The exact cause of subacute thyroiditis is not fully understood.",
      "Subacute thyroiditis is believed to be an autoimmune disorder where the body's immune system attacks the thyroid gland."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Subacute thyroiditis is not primarily considered an autoimmune disorder. It is often thought to be triggered by a viral infection. Autoimmune thyroiditis refers to conditions such as Hashimoto's thyroiditis where the body's immune system attacks the thyroid gland.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 963,
    "user_query": "Is STAT3 involved in EIF2AK2-dependent suppression of autophagy?",
    "llama-7b_response": "STAT3 is a transcription factor that plays a crucial role in various cellular processes, including proliferation, differentiation, and apoptosis. It is also involved in the regulation of autophagy, a process by which cells break down and recycle their own components.\nRecent studies have shown that STAT3 can interact with EIF2AK2, a kinase that is essential for the initiation of protein synthesis. This interaction may have important implications for the regulation of autophagy, as EIF2AK2 has been shown to play a role in the suppression of this process.\nOne possible mechanism by which STAT3 and EIF2AK2 may interact to regulate autophagy is through the activation of specific signaling pathways. For example, STAT3 has been shown to activate the PI3K/AKT pathway, which has been linked to the inhibition of autophagy. Similarly, EIF2AK2 has been shown to activate the mTORC1 pathway, which also plays a role in the regulation of autophagy.\nIt is possible that the interaction between STAT3 and EIF2AK2 may contribute to the regulation of autophagy by modulating the activity of these signaling pathways. However, further research is needed to fully understand the mechanisms underlying this interaction and its role in autophagy regulation.",
    "llama-7b_fact_raw": "1. STAT3 is a transcription factor involved in cellular processes such as proliferation, differentiation, and apoptosis.\n2. STAT3 is involved in the regulation of autophagy.\n3. STAT3 can interact with EIF2AK2, a kinase essential for the initiation of protein synthesis.\n4. EIF2AK2 has been shown to play a role in the suppression of autophagy.\n5. STAT3 has been shown to activate the PI3K/AKT pathway, which is linked to the inhibition of autophagy.",
    "llama-7b_fact": [
      "STAT3 is a transcription factor involved in cellular processes such as proliferation, differentiation, and apoptosis.",
      "STAT3 is involved in the regulation of autophagy.",
      "STAT3 can interact with EIF2AK2, a kinase essential for the initiation of protein synthesis.",
      "EIF2AK2 has been shown to play a role in the suppression of autophagy.",
      "STAT3 has been shown to activate the PI3K/AKT pathway, which is linked to the inhibition of autophagy."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: EIF2AK2, also known as PKR, has been shown to play a role in the induction of autophagy, not the suppression of it.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 973,
    "user_query": "Describe what is the usage of the Theatre software tool for genomic analysis.",
    "llama-7b_response": "The Theatre software tool is primarily used for genomic analysis, which involves the study of genes and their functions within an organism. The tool is designed to help researchers analyze large amounts of genomic data and identify patterns and relationships between different genes and genomic regions.\nOne of the key features of Theatre is its ability to handle complex data sets, including next-generation sequencing data, RNA-seq data, and ChIP-seq data. This allows researchers to analyze a wide range of genomic data types and gain insights into the function of different genes and genomic regions.\nAnother important feature of Theatre is its ability to visualize genomic data in a variety of ways. This includes the ability to create custom visualizations, as well as the ability to use pre-built visualizations that are designed to help researchers identify patterns and relationships within their data.\nOverall, the Theatre software tool is an important tool for genomic analysis, as it allows researchers to analyze complex data sets and gain insights into the function of different genes and genomic regions.",
    "llama-7b_fact_raw": "1. The Theatre software tool is used for genomic analysis.\n2. Theatre is designed to help researchers analyze large amounts of genomic data.\n3. The tool can handle complex data sets including next-generation sequencing data, RNA-seq data, and ChIP-seq data.\n4. Theatre allows for the visualization of genomic data in various ways.\n5. The software includes features for creating custom visualizations and using pre-built visualizations to identify patterns in genomic data.",
    "llama-7b_fact": [
      "The Theatre software tool is used for genomic analysis.",
      "Theatre is designed to help researchers analyze large amounts of genomic data.",
      "The tool can handle complex data sets including next-generation sequencing data, RNA-seq data, and ChIP-seq data.",
      "Theatre allows for the visualization of genomic data in various ways.",
      "The software includes features for creating custom visualizations and using pre-built visualizations to identify patterns in genomic data."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific information about a software tool named \"Theatre\" related to genomic analysis, it is not possible to determine the accuracy of these statements. The term \"Theatre\" is not a widely recognized name for a genomic analysis tool as of my last update, and without additional context, the truthfulness of these statements cannot be verified.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 997,
    "user_query": "Which  is the execution time (complexity) of the Smith-Waterman algorithm for the alignment of two sequences",
    "llama-7b_response": "The Smith-Waterman algorithm is a dynamic programming algorithm that is used for the alignment of two sequences. The execution time (complexity) of the Smith-Waterman algorithm depends on several factors, including the length of the two sequences, the length of the alignment window, and the parameters used in the algorithm.\nIn general, the execution time of the Smith-Waterman algorithm increases exponentially with the length of the sequences and the alignment window. This is because the algorithm involves a large number of comparisons between the two sequences, and these comparisons need to be performed for each position in the alignment window.\nThe Smith-Waterman algorithm has a worst-case time complexity of O(n^2 * m * W), where n is the length of the first sequence, m is the length of the second sequence, and W is the length of the alignment window. This means that the execution time of the algorithm will increase quadratically with the length of the sequences and the alignment window.\nHowever, in practice, the execution time of the Smith-Waterman algorithm is often much faster than this worst-case time complexity, due to the use of various optimizations and heuristics. These optimizations and heuristics can reduce the number of comparisons that need to be performed, and can therefore reduce the execution time of the algorithm.\nOverall, the execution time of the Smith-Waterman algorithm depends on a wide range of factors, and can vary significantly depending on the specific circumstances of each alignment problem.",
    "llama-7b_fact_raw": "1. The Smith-Waterman algorithm is a dynamic programming algorithm used for the alignment of two sequences.\n2. The execution time of the Smith-Waterman algorithm increases exponentially with the length of the sequences and the alignment window.\n3. The worst-case time complexity of the Smith-Waterman algorithm is O(n^2 * m * W), where n is the length of the first sequence, m is the length of the second sequence, and W is the length of the alignment window.\n4. The execution time of the Smith-Waterman algorithm can be faster than the worst-case complexity due to optimizations and heuristics.\n5. The execution time of the Smith-Waterman algorithm varies depending on the specific circumstances of each alignment problem.",
    "llama-7b_fact": [
      "The Smith-Waterman algorithm is a dynamic programming algorithm used for the alignment of two sequences.",
      "The execution time of the Smith-Waterman algorithm increases exponentially with the length of the sequences and the alignment window.",
      "The worst-case time complexity of the Smith-Waterman algorithm is O(n^2 * m * W), where n is the length of the first sequence, m is the length of the second sequence, and W is the length of the alignment window.",
      "The execution time of the Smith-Waterman algorithm can be faster than the worst-case complexity due to optimizations and heuristics.",
      "The execution time of the Smith-Waterman algorithm varies depending on the specific circumstances of each alignment problem."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The execution time of the Smith-Waterman algorithm increases quadratically, not exponentially, with the length of the sequences, assuming the alignment window is not a factor.\n3. FALSE [correction]: The worst-case time complexity of the Smith-Waterman algorithm is O(n^2 * m), where n is the length of the first sequence and m is the length of the second sequence. There is no factor W in the complexity formula.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1004,
    "user_query": "Which SLC family is FLVCR1 a member of?",
    "llama-7b_response": "FLVCR1 is a member of the SLC2A family.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 1047,
    "user_query": "List GATA-1 interacting partners as discovered with the help of the biotinylation tagging approach.",
    "llama-7b_response": "GATA-1 (GATA binding protein 1) is a transcription factor that plays a crucial role in the regulation of gene expression during embryonic development and hematopoiesis. GATA-1 interacts with a variety of proteins and molecules to regulate its target genes. \nOne approach to identify GATA-1 interacting partners is the biotinylation tagging approach, which involves biotinylating GATA-1 and then immunoprecipitating it from cell lysates. This approach has been used to identify several proteins that interact with GATA-1. \nHere are some of the GATA-1 interacting partners that have been discovered using the biotinylation tagging approach:\n1. TBX5 (T-box 5): TBX5 is a transcription factor that regulates gene expression during embryonic development. GATA-1 and TBX5 form a complex and regulate each other's transcriptional activity.\n2. MEF2A (Myocyte enhancer factor 2A): MEF2A is a transcription factor that regulates gene expression during muscle development. GATA-1 and MEF2A form a complex and regulate each other's transcriptional activity.\n3. HDAC4 (Histone deacetylase 4): HDAC4 is a histone deacetylase that modifies chromatin structure by removing acetyl groups from histones. GATA-1 and HDAC4 interact and regulate each other's transcriptional activity.\n4. NCOA2 (Nuclear receptor coactivator 2): NCOA2 is a coactivator that regulates gene expression by interacting with nuclear receptors and other transcription factors. GATA-1 and NCOA2 form a complex and regulate each other's transcriptional activity.\n5. FOXO1 (Forkhead box O1): FOXO1 is a transcription factor that regulates gene expression in response to stress and other stimuli. GATA-1 and FOXO1 interact and regulate each other's transcriptional activity.\nThese are just a few examples of the GATA-1 interacting partners that have been discovered using the biotinylation tagging approach.",
    "llama-7b_fact_raw": "1. GATA-1 interacts with TBX5 (T-box 5), a transcription factor involved in embryonic development.\n2. GATA-1 forms a complex with MEF2A (Myocyte enhancer factor 2A), which is a transcription factor that regulates gene expression during muscle development.\n3. GATA-1 interacts with HDAC4 (Histone deacetylase 4), which is involved in modifying chromatin structure.\n4. GATA-1 and NCOA2 (Nuclear receptor coactivator 2) form a complex that regulates gene expression.\n5. GATA-1 interacts with FOXO1 (Forkhead box O1), a transcription factor that responds to stress and other stimuli.",
    "llama-7b_fact": [
      "GATA-1 interacts with TBX5 (T-box 5), a transcription factor involved in embryonic development.",
      "GATA-1 forms a complex with MEF2A (Myocyte enhancer factor 2A), which is a transcription factor that regulates gene expression during muscle development.",
      "GATA-1 interacts with HDAC4 (Histone deacetylase 4), which is involved in modifying chromatin structure.",
      "GATA-1 and NCOA2 (Nuclear receptor coactivator 2) form a complex that regulates gene expression.",
      "GATA-1 interacts with FOXO1 (Forkhead box O1), a transcription factor that responds to stress and other stimuli."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. TRUE: GATA-1 has been reported to interact with HDAC4, which is involved in chromatin remodeling and regulation of gene expression.\n4. UNKNOWN\n5. UNKNOWN\n\nThe interactions of GATA-1 with specific transcription factors and proteins can be highly specific and context-dependent, often requiring empirical evidence from scientific studies. Without specific references to such studies, it is not possible to confirm the accuracy of statements 1, 2, 4, and 5.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1072,
    "user_query": "What is the outcome of TAF10 interacting with the GATA1 transcription factor?",
    "llama-7b_response": "The outcome of TAF10 interacting with the GATA1 transcription factor depends on the specific context and cellular environment in which they interact. However, in general, the interaction between TAF10 and GATA1 can lead to the activation or repression of gene expression.\nTAF10 is a transcriptional activator that belongs to the TAF family of transcriptional coregulators. It interacts with a variety of transcription factors, including GATA1, to regulate gene expression. When TAF10 and GATA1 interact, they can form a complex that binds to the promoter region of target genes and activates their transcription. This can lead to the expression of genes involved in various biological processes, such as cell proliferation, differentiation, and migration.\nOn the other hand, the interaction between TAF10 and GATA1 can also lead to the repression of gene expression. For example, GATA1 can form a complex with other transcription factors that repress gene expression, and TAF10 can help to stabilize this complex and maintain repression. Additionally, TAF10 can interact with other transcriptional repressors, such as histone deacetylases, to repress gene expression.\nOverall, the outcome of TAF10 interacting with the GATA1 transcription factor depends on the specific context and cellular environment in which they interact, as well as the nature of the target gene and the other transcription factors involved.",
    "llama-7b_fact_raw": "1. TAF10 is a transcriptional activator that is part of the TAF family of transcriptional coregulators.\n2. TAF10 can interact with the GATA1 transcription factor to regulate gene expression.\n3. The interaction between TAF10 and GATA1 can lead to the activation of gene expression.\n4. TAF10 and GATA1 can form a complex that binds to the promoter region of target genes.\n5. The interaction between TAF10 and GATA1 can also lead to the repression of gene expression.",
    "llama-7b_fact": [
      "TAF10 is a transcriptional activator that is part of the TAF family of transcriptional coregulators.",
      "TAF10 can interact with the GATA1 transcription factor to regulate gene expression.",
      "The interaction between TAF10 and GATA1 can lead to the activation of gene expression.",
      "TAF10 and GATA1 can form a complex that binds to the promoter region of target genes.",
      "The interaction between TAF10 and GATA1 can also lead to the repression of gene expression."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nTAF10 is indeed a transcriptional activator that is part of the TAF family, which are components of the transcription factor IID (TFIID) complex involved in the initiation of gene transcription by RNA polymerase II. TAF10 can interact with various transcription factors, including GATA1, to regulate gene expression. This interaction can lead to the activation of gene expression, as TAFs are involved in the formation of the pre-initiation complex. TAF10 and GATA1 can form a complex that binds to the promoter regions of target genes to regulate transcription. Additionally, transcription factors and co-regulators like TAF10 and GATA1 can also be involved in the repression of gene expression, depending on the context and the presence of other regulatory proteins and signals.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1082,
    "user_query": "Are there any Decision support systems for chronic pain management ?",
    "llama-7b_response": "Yes, there are decision support systems for chronic pain management. These systems are designed to help healthcare providers make informed decisions about patient care by providing them with relevant information and recommendations based on the patient's medical history, symptoms, and other relevant factors.\nOne example of a decision support system for chronic pain management is the Clinical Decision Support System for Chronic Pain Management (CDSS-CPM). This system was developed by the National Institutes of Health (NIH) and is designed to help healthcare providers make evidence-based decisions about chronic pain management. The CDSS-CPM provides recommendations for the treatment of chronic pain based on the patient's medical history, symptoms, and other relevant factors.\nAnother example of a decision support system for chronic pain management is the Pain Management Decision Support System (PM-DSS). This system was developed by the University of California, San Francisco and is designed to help healthcare providers make decisions about pain management based on the patient's medical history, symptoms, and other relevant factors. The PM-DSS provides recommendations for the treatment of chronic pain based on the latest research and clinical guidelines.\nOverall, decision support systems for chronic pain management can help healthcare providers make informed decisions about patient care and improve the quality of care for patients with chronic pain.",
    "llama-7b_fact_raw": "1. Decision support systems for chronic pain management exist to assist healthcare providers in making informed decisions about patient care.\n2. The Clinical Decision Support System for Chronic Pain Management (CDSS-CPM) was developed by the National Institutes of Health (NIH).\n3. The CDSS-CPM is designed to provide recommendations for the treatment of chronic pain based on the patient's medical history and symptoms.\n4. The Pain Management Decision Support System (PM-DSS) was developed by the University of California, San Francisco.\n5. The PM-DSS provides treatment recommendations for chronic pain based on the latest research and clinical guidelines.",
    "llama-7b_fact": [
      "Decision support systems for chronic pain management exist to assist healthcare providers in making informed decisions about patient care.",
      "The Clinical Decision Support System for Chronic Pain Management (CDSS-CPM) was developed by the National Institutes of Health (NIH).",
      "The CDSS-CPM is designed to provide recommendations for the treatment of chronic pain based on the patient's medical history and symptoms.",
      "The Pain Management Decision Support System (PM-DSS) was developed by the University of California, San Francisco.",
      "The PM-DSS provides treatment recommendations for chronic pain based on the latest research and clinical guidelines."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1149,
    "user_query": "Which is the subcellular localization of the protein angiogenin?",
    "llama-7b_response": "Angiogenin is a protein that is primarily found in the nucleus of cells. However, it can also be found in the cytoplasm and extracellular space. In the nucleus, angiogenin binds to DNA and regulates gene expression related to angiogenesis, which is the process of creating new blood vessels. In the cytoplasm, angiogenin can interact with other proteins and play a role in cell signaling. In the extracellular space, angiogenin can bind to proteins on the surface of cells and promote cell growth and migration. Overall, the subcellular localization of angiogenin is important for its function in regulating angiogenesis and other cellular processes.",
    "llama-7b_fact_raw": "1. Angiogenin is primarily found in the nucleus of cells.\n2. Angiogenin can also be found in the cytoplasm.\n3. Angiogenin is present in the extracellular space.\n4. In the nucleus, angiogenin binds to DNA and regulates gene expression related to angiogenesis.\n5. Angiogenin's subcellular localization is important for its role in regulating angiogenesis and other cellular processes.",
    "llama-7b_fact": [
      "Angiogenin is primarily found in the nucleus of cells.",
      "Angiogenin can also be found in the cytoplasm.",
      "Angiogenin is present in the extracellular space.",
      "In the nucleus, angiogenin binds to DNA and regulates gene expression related to angiogenesis.",
      "Angiogenin's subcellular localization is important for its role in regulating angiogenesis and other cellular processes."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Angiogenin is primarily found in the cytoplasm of cells.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: In the nucleus, angiogenin is known to stimulate rRNA transcription, not directly bind to DNA and regulate gene expression related to angiogenesis.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1161,
    "user_query": "How does ranolazine affect kinase signaling activation in the heart?",
    "llama-7b_response": "Ranolazine is a medication that is used to treat chronic angina, a type of chest pain that occurs when the heart does not get enough blood and oxygen. It works by blocking the sodium channels in the heart cells, which helps to reduce the electrical activity in the heart and lower the heart rate. \nIn terms of kinase signaling activation in the heart, ranolazine has been found to have both inhibitory and stimulatory effects depending on the specific kinase signaling pathway involved. For example, ranolazine has been shown to inhibit the phosphoinositide 3-kinase (PI3K) pathway, which is involved in numerous cellular processes including cell growth, proliferation, and survival. By inhibiting the PI3K pathway, ranolazine can help to reduce the heart's demand for oxygen and nutrients, which can help to reduce the risk of heart attack and other cardiovascular events.\nOn the other hand, ranolazine has also been found to stimulate the protein kinase C (PKC) pathway, which is involved in numerous cellular processes including cell growth, differentiation, and migration. By stimulating the PKC pathway, ranolazine can help to promote heart muscle growth and repair, which can help to improve heart function and reduce the risk of heart failure.\nOverall, the effects of ranolazine on kinase signaling activation in the heart are complex and depend on the specific kinase signaling pathway involved. While ranolazine can have both inhibitory and stimulatory effects on different kinase signaling pathways, its primary mechanism of action is to reduce the electrical activity in the heart and lower the heart rate, which can help to reduce the risk of chronic angina and other cardiovascular events.",
    "llama-7b_fact_raw": "1. Ranolazine is used to treat chronic angina.\n2. Ranolazine works by blocking the sodium channels in heart cells.\n3. Ranolazine inhibits the phosphoinositide 3-kinase (PI3K) pathway in the heart.\n4. Ranolazine stimulates the protein kinase C (PKC) pathway in the heart.\n5. Ranolazine's primary mechanism of action is to reduce the electrical activity in the heart and lower the heart rate.",
    "llama-7b_fact": [
      "Ranolazine is used to treat chronic angina.",
      "Ranolazine works by blocking the sodium channels in heart cells.",
      "Ranolazine inhibits the phosphoinositide 3-kinase (PI3K) pathway in the heart.",
      "Ranolazine stimulates the protein kinase C (PKC) pathway in the heart.",
      "Ranolazine's primary mechanism of action is to reduce the electrical activity in the heart and lower the heart rate."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ranolazine does not inhibit the phosphoinositide 3-kinase (PI3K) pathway in the heart. Its mechanism of action is not fully understood, but it is thought to involve the inhibition of the late phase of the inward sodium current during cardiac repolarization.\n4. FALSE [correction]: There is no evidence to suggest that Ranolazine stimulates the protein kinase C (PKC) pathway in the heart. Its primary action is related to the inhibition of the late sodium current.\n5. FALSE [correction]: Ranolazine's primary mechanism of action is not to reduce electrical activity and lower heart rate. Instead, it works by inhibiting the late phase of the inward sodium current, which can help to reduce the workload on the heart and improve blood flow to help relieve symptoms of angina. It does not significantly affect heart rate.",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1225,
    "user_query": "Is the regulation of Vsr endonuclease independent of the growth phase of bacteria?",
    "llama-7b_response": "The regulation of the VSR endonuclease in bacteria is not strictly dependent on the growth phase of the bacteria. However, there are certain factors that can affect the activity of the VSR endonuclease in different growth phases. \nIn general, the activity of the VSR endonuclease is highest during the exponential growth phase of bacteria. This is because during this phase, the bacteria are actively dividing and replicating their DNA, which requires the breakage and rejoining of DNA strands. The VSR endonuclease plays a crucial role in this process by cleaving the DNA strands at specific sites.\nHowever, the activity of the VSR endonuclease can also be affected by other factors such as temperature, pH, and the presence of certain chemicals or metals. For example, some studies have shown that the activity of the VSR endonuclease can be inhibited by high temperatures or low pH levels. Similarly, the presence of certain metals such as cadmium or mercury can also inhibit the activity of the VSR endonuclease.\nOverall, while the regulation of the VSR endonuclease is not strictly dependent on the growth phase of bacteria, there are certain factors that can affect its activity in different growth phases.",
    "llama-7b_fact_raw": "1. The regulation of the VSR endonuclease in bacteria is not strictly dependent on the growth phase of the bacteria.\n2. The activity of the VSR endonuclease is highest during the exponential growth phase of bacteria.\n3. The VSR endonuclease is involved in the process of DNA breakage and rejoining during bacterial DNA replication.\n4. The activity of the VSR endonuclease can be inhibited by high temperatures.\n5. The presence of certain metals, such as cadmium or mercury, can inhibit the activity of the VSR endonuclease.",
    "llama-7b_fact": [
      "The regulation of the VSR endonuclease in bacteria is not strictly dependent on the growth phase of the bacteria.",
      "The activity of the VSR endonuclease is highest during the exponential growth phase of bacteria.",
      "The VSR endonuclease is involved in the process of DNA breakage and rejoining during bacterial DNA replication.",
      "The activity of the VSR endonuclease can be inhibited by high temperatures.",
      "The presence of certain metals, such as cadmium or mercury, can inhibit the activity of the VSR endonuclease."
    ],
    "llama-7b_judge_raw": "1. TRUE: The regulation of the VSR endonuclease in bacteria is known to be complex and can be influenced by various factors, not strictly by the growth phase of the bacteria.\n2. UNKNOWN: The activity of VSR endonuclease during different growth phases of bacteria can vary depending on the organism and specific conditions, and without specific context or data, it's difficult to determine the accuracy of this statement.\n3. FALSE [correction]: The VSR endonuclease is involved in mismatch repair during DNA replication, specifically recognizing and cutting DNA at the site of deamination damage, rather than being involved in the process of DNA breakage and rejoining.\n4. UNKNOWN: The effect of high temperatures on the activity of VSR endonuclease can vary, and without specific experimental data or context, it's difficult to determine the truth of this statement.\n5. TRUE: The presence of certain heavy metals, such as cadmium or mercury, can inhibit the activity of many types of enzymes, including endonucleases, due to their ability to disrupt enzyme structure or function.",
    "llama-7b_judge": [
      "true",
      "unknown",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1233,
    "user_query": "What are the computational tools for the prediction of beta-barrel transmembrane proteins?",
    "llama-7b_response": "There are several computational tools available for the prediction of beta-barrel transmembrane proteins. Some of the most commonly used tools are:\n1. BetaFold: This is a web server that uses a combination of sequence and structure-based methods to predict beta-barrel proteins. It uses a hidden Markov model (HMM) to predict the secondary structure of a protein and then classifies it as a beta-barrel if it contains at least four beta strands.\n2. Phyre2: This is a web server that uses a combination of sequence and structure-based methods to predict beta-barrel proteins. It uses a HMM to predict the secondary structure of a protein and then classifies it as a beta-barrel if it contains at least four beta strands. It also takes into account the conservation of key residues in beta-barrel proteins.\n3. FUGUE: This is a software package that uses a combination of sequence and structure-based methods to predict beta-barrel proteins. It uses a HMM to predict the secondary structure of a protein and then classifies it as a beta-barrel if it contains at least four beta strands. It also takes into account the conservation of key residues in beta-barrel proteins.\n4. TMHMM: This is a software package that uses a combination of sequence and structure-based methods to predict beta-barrel proteins. It uses a HMM to predict the secondary structure of a protein and then classifies it as a beta-barrel if it contains at least four beta strands. It also takes into account the conservation of key residues in beta-barrel proteins.\nIn summary, there are several computational tools available for the prediction of beta-barrel transmembrane proteins, including BetaFold, Phyre2, FUGUE, and TMHMM. These tools use a combination of sequence and structure-based methods to predict beta-barrel proteins and take into account the conservation of key residues in beta-barrel proteins.",
    "llama-7b_fact_raw": "1. BetaFold is a web server that predicts beta-barrel proteins using a hidden Markov model (HMM).\n2. Phyre2 is a web server that predicts beta-barrel proteins using a hidden Markov model (HMM) and considers the conservation of key residues.\n3. FUGUE is a software package that predicts beta-barrel proteins using a hidden Markov model (HMM) and considers the conservation of key residues.\n4. TMHMM is a software package that predicts beta-barrel proteins using a hidden Markov model (HMM) and considers the conservation of key residues.\n5. The computational tools BetaFold, Phyre2, FUGUE, and TMHMM classify a protein as a beta-barrel if it contains at least four beta strands.",
    "llama-7b_fact": [
      "BetaFold is a web server that predicts beta-barrel proteins using a hidden Markov model (HMM).",
      "Phyre2 is a web server that predicts beta-barrel proteins using a hidden Markov model (HMM) and considers the conservation of key residues.",
      "FUGUE is a software package that predicts beta-barrel proteins using a hidden Markov model (HMM) and considers the conservation of key residues.",
      "TMHMM is a software package that predicts beta-barrel proteins using a hidden Markov model (HMM) and considers the conservation of key residues.",
      "The computational tools BetaFold, Phyre2, FUGUE, and TMHMM classify a protein as a beta-barrel if it contains at least four beta strands."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: BetaFold is not a known web server for predicting beta-barrel proteins. The correct tool is BetaBarrelPredict, which uses a hidden Markov model (HMM) for prediction.\n2. FALSE [correction]: Phyre2 is a web server for protein modeling, prediction, and analysis, but it is not specifically focused on beta-barrel proteins using a hidden Markov model (HMM) and the conservation of key residues. It uses advanced remote homology detection methods to build 3D models.\n3. FALSE [correction]: FUGUE is a sequence homology recognition tool that uses sequence-structure information, not specifically for predicting beta-barrel proteins using a hidden Markov model (HMM) and the conservation of key residues.\n4. FALSE [correction]: TMHMM is a software package for predicting transmembrane helices in proteins, not beta-barrel proteins, using a hidden Markov model (HMM).\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1251,
    "user_query": "Galassi classification is used for which disorder?",
    "llama-7b_response": "Galassi classification is used for the diagnosis of a rare genetic disorder called Hereditary Hemorrhagic Telangiectasia (HHT). It is a genetic disorder that affects the blood vessels, causing them to be abnormally fragile and prone to bleeding. The Galassi classification is a system used to classify the severity of HHT based on the extent and severity of the vascular abnormalities. It is named after the Italian physician who first described the condition in 1908.",
    "llama-7b_fact_raw": "1. Galassi classification is used for the diagnosis of Hereditary Hemorrhagic Telangiectasia (HHT).\n2. Hereditary Hemorrhagic Telangiectasia is a genetic disorder that affects the blood vessels.\n3. The Galassi classification system classifies the severity of HHT based on the extent and severity of vascular abnormalities.\n4. The Galassi classification is named after an Italian physician who first described the condition.\n5. The Italian physician first described the condition in 1908.",
    "llama-7b_fact": [
      "Galassi classification is used for the diagnosis of Hereditary Hemorrhagic Telangiectasia (HHT).",
      "Hereditary Hemorrhagic Telangiectasia is a genetic disorder that affects the blood vessels.",
      "The Galassi classification system classifies the severity of HHT based on the extent and severity of vascular abnormalities.",
      "The Galassi classification is named after an Italian physician who first described the condition.",
      "The Italian physician first described the condition in 1908."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Galassi classification is used for the grading of middle ear effusions and not for the diagnosis of Hereditary Hemorrhagic Telangiectasia (HHT). The Curaçao Criteria is used for the diagnosis of HHT.\n2. TRUE\n3. FALSE [correction]: The Galassi classification system is not related to HHT; it is related to otitis media with effusion. The statement would be true if it referred to the Curaçao Criteria or another relevant classification system for HHT.\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1304,
    "user_query": "List common features of Shapiro syndrome",
    "llama-7b_response": "Shapiro syndrome is a rare genetic disorder that affects the body's ability to absorb nutrients from food. Common features of Shapiro syndrome include:\n\n1. Malabsorption: Shapiro syndrome causes malabsorption of nutrients, which means that the body is unable to properly break down and absorb essential nutrients such as carbohydrates, proteins, and fats.\n\n2. Diarrhea: Malabsorption can lead to chronic diarrhea, which can be severe and can lead to dehydration and electrolyte imbalances.\n\n3. Failure to thrive: Children with Shapiro syndrome may fail to grow and develop properly due to malnutrition and malabsorption.\n\n4. Gastrointestinal symptoms: Other gastrointestinal symptoms associated with Shapiro syndrome include abdominal pain, bloating, and nausea.\n\n5. Skin changes: Some people with Shapiro syndrome may experience skin changes such as yellowing of the skin and eyes (jaundice), darkening of the skin, and hair loss.\n\n6. Genetic mutations: Shapiro syndrome is caused by mutations in certain genes that affect the body's ability to absorb nutrients.\n\n7. Increased risk of cancer: Some people with Shapiro syndrome may have an increased risk of developing certain types of cancer, such as colon cancer.\n\n8. Treatment: Treatment for Shapiro syndrome typically involves a combination of dietary changes, medications, and sometimes surgery to help improve nutrient absorption and manage symptoms.",
    "llama-7b_fact_raw": "1. Shapiro syndrome is a rare genetic disorder that affects the body's ability to absorb nutrients from food.\n2. Common features of Shapiro syndrome include malabsorption of nutrients such as carbohydrates, proteins, and fats.\n3. Chronic diarrhea, which can lead to dehydration and electrolyte imbalances, is a symptom of Shapiro syndrome.\n4. Children with Shapiro syndrome may experience failure to thrive due to malnutrition and malabsorption.\n5. Shapiro syndrome is caused by mutations in certain genes that affect nutrient absorption.",
    "llama-7b_fact": [
      "Shapiro syndrome is a rare genetic disorder that affects the body's ability to absorb nutrients from food.",
      "Common features of Shapiro syndrome include malabsorption of nutrients such as carbohydrates, proteins, and fats.",
      "Chronic diarrhea, which can lead to dehydration and electrolyte imbalances, is a symptom of Shapiro syndrome.",
      "Children with Shapiro syndrome may experience failure to thrive due to malnutrition and malabsorption.",
      "Shapiro syndrome is caused by mutations in certain genes that affect nutrient absorption."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Shapiro syndrome is a rare neurological disorder characterized by recurrent episodes of spontaneous hypothermia, hyperhidrosis, and agenesis of the corpus callosum, not a disorder affecting the body's ability to absorb nutrients from food.\n2. FALSE [correction]: Since Shapiro syndrome is not related to nutrient absorption, common features do not include malabsorption of nutrients such as carbohydrates, proteins, and fats.\n3. FALSE [correction]: Chronic diarrhea is not a typical symptom of Shapiro syndrome, which is primarily characterized by hypothermia and other neurological symptoms.\n4. FALSE [correction]: While failure to thrive can occur in many conditions due to malnutrition and malabsorption, it is not a characteristic of Shapiro syndrome, which does not affect nutrient absorption.\n5. FALSE [correction]: Shapiro syndrome is not caused by mutations affecting nutrient absorption. The exact cause of Shapiro syndrome is not well understood, but it involves neurological symptoms and is not primarily a genetic disorder related to nutrient absorption.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1320,
    "user_query": "Which disease is linked to mutations within BRAG1?",
    "llama-7b_response": "BRAG1 is a gene that has been linked to several diseases, including cancer. Specifically, mutations within the BRAG1 gene have been found to be associated with the development and progression of several types of cancer, including breast cancer, ovarian cancer, and gastrointestinal cancer. These mutations can cause changes in the function of the BRAG1 protein, which can disrupt normal cellular processes and promote the growth and spread of cancer cells. Further research is needed to fully understand the role of BRAG1 in cancer development and to explore potential targeted therapies for cancer patients with BRAG1-related mutations.",
    "llama-7b_fact_raw": "1. Mutations within the BRAG1 gene are linked to the development and progression of several types of cancer.\n2. Breast cancer, ovarian cancer, and gastrointestinal cancer have been found to be associated with mutations in the BRAG1 gene.\n3. Mutations in the BRAG1 gene can cause changes in the function of the BRAG1 protein.\n4. Changes in the BRAG1 protein function can disrupt normal cellular processes.\n5. Disruption of normal cellular processes by BRAG1 mutations can promote the growth and spread of cancer cells.",
    "llama-7b_fact": [
      "Mutations within the BRAG1 gene are linked to the development and progression of several types of cancer.",
      "Breast cancer, ovarian cancer, and gastrointestinal cancer have been found to be associated with mutations in the BRAG1 gene.",
      "Mutations in the BRAG1 gene can cause changes in the function of the BRAG1 protein.",
      "Changes in the BRAG1 protein function can disrupt normal cellular processes.",
      "Disruption of normal cellular processes by BRAG1 mutations can promote the growth and spread of cancer cells."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Mutations within the BRCA1 gene are linked to the development and progression of several types of cancer.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1374,
    "user_query": "Which mechanisms underlie adaptive mutagenesis (stationary-phase mutagenesis) in Bacillus subtilis?",
    "llama-7b_response": "Adaptive mutagenesis, also known as stationary-phase mutagenesis, is a process by which bacteria undergo genetic changes in response to stressful conditions, such as starvation or exposure to antibiotics. The mechanisms that underlie this process are complex and involve multiple genetic pathways.\nOne of the key mechanisms involved in adaptive mutagenesis is mutation accumulation. This occurs when bacteria are exposed to stressful conditions, such as starvation or antibiotic treatment, and experience a high rate of mutations. These mutations can be beneficial, allowing the bacteria to adapt to the changing environment and increase their chances of survival.\nAnother mechanism involved in adaptive mutagenesis is the mutator phenotype. This is a genetic trait that increases the rate of mutation in bacteria. The mutator phenotype is often caused by mutations in genes that encode for DNA repair enzymes or DNA replication machinery. These mutations can lead to errors in DNA replication and repair, which can result in the accumulation of mutations.\nA third mechanism involved in adaptive mutagenesis is the SOS response. This is a genetic pathway that is activated in response to DNA damage or other stressful conditions. The SOS response triggers a series of genetic events that can lead to the mutation of genes and the acquisition of new traits.\nOverall, the mechanisms that underlie adaptive mutagenesis in Bacillus subtilis are complex and involve multiple genetic pathways. Mutation accumulation, the mutator phenotype, and the SOS response are all important mechanisms that contribute to the genetic changes that occur during adaptive mutagenesis.",
    "llama-7b_fact_raw": "1. Adaptive mutagenesis in Bacillus subtilis is a process where bacteria undergo genetic changes in response to stressful conditions such as starvation or exposure to antibiotics.\n2. One mechanism of adaptive mutagenesis is mutation accumulation, which occurs at a high rate under stressful conditions.\n3. The mutator phenotype is a genetic trait in Bacillus subtilis that increases the rate of mutation due to mutations in genes for DNA repair enzymes or DNA replication machinery.\n4. The SOS response is a genetic pathway in Bacillus subtilis that is activated in response to DNA damage or stress, leading to genetic mutations and new traits.\n5. Multiple genetic pathways are involved in the process of adaptive mutagenesis in Bacillus subtilis.",
    "llama-7b_fact": [
      "Adaptive mutagenesis in Bacillus subtilis is a process where bacteria undergo genetic changes in response to stressful conditions such as starvation or exposure to antibiotics.",
      "One mechanism of adaptive mutagenesis is mutation accumulation, which occurs at a high rate under stressful conditions.",
      "The mutator phenotype is a genetic trait in Bacillus subtilis that increases the rate of mutation due to mutations in genes for DNA repair enzymes or DNA replication machinery.",
      "The SOS response is a genetic pathway in Bacillus subtilis that is activated in response to DNA damage or stress, leading to genetic mutations and new traits.",
      "Multiple genetic pathways are involved in the process of adaptive mutagenesis in Bacillus subtilis."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mutation accumulation is a process that occurs over time, often without direct selection, and not necessarily at a high rate under stressful conditions. Adaptive mutagenesis refers to an increased rate of mutation in response to stress, but it is not synonymous with mutation accumulation.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1399,
    "user_query": "What causes erucism?",
    "llama-7b_response": "Erucism, also known as goiter, is a condition that causes enlargement of the thyroid gland. The thyroid gland is a butterfly-shaped gland located in the neck that produces hormones that regulate the body's metabolism. When the thyroid gland becomes enlarged, it can cause a range of symptoms, including difficulty swallowing, hoarseness, coughing, and shortness of breath.\n\nThere are several factors that can cause erucism, including:\n\n1. Iodine deficiency: Iodine is an essential nutrient that the thyroid gland needs to produce thyroid hormones. If there is not enough iodine in the diet, the thyroid gland can become underactive, leading to enlargement and goiter.\n\n2. Hashimoto's thyroiditis: This is an autoimmune disorder that causes the thyroid gland to become inflamed and enlarged.\n\n3. Graves' disease: This is another autoimmune disorder that causes the thyroid gland to produce too much thyroid hormone, leading to enlargement and goiter.\n\n4. Radiation therapy: Radiation therapy to the neck can cause damage to the thyroid gland, leading to enlargement and goiter.\n\n5. Pituitary gland dysfunction: The pituitary gland is a small gland located at the base of the brain that regulates the thyroid gland. If the pituitary gland does not produce enough thyroid-stimulating hormone (TSH), the thyroid gland can become underactive, leading to enlargement and goiter.\n\nIn summary, erucism is caused by a variety of factors, including iodine deficiency, autoimmune disorders, radiation therapy, pituitary gland dysfunction, and other conditions that affect the thyroid gland.",
    "llama-7b_fact_raw": "1. Erucism is a condition that causes enlargement of the thyroid gland.\n2. Iodine deficiency can lead to an underactive thyroid gland and cause goiter.\n3. Hashimoto's thyroiditis is an autoimmune disorder that can cause the thyroid gland to become inflamed and enlarged.\n4. Graves' disease is an autoimmune disorder that can cause the thyroid gland to produce too much thyroid hormone, leading to enlargement and goiter.\n5. Radiation therapy to the neck can damage the thyroid gland and lead to enlargement and goiter.",
    "llama-7b_fact": [
      "Erucism is a condition that causes enlargement of the thyroid gland.",
      "Iodine deficiency can lead to an underactive thyroid gland and cause goiter.",
      "Hashimoto's thyroiditis is an autoimmune disorder that can cause the thyroid gland to become inflamed and enlarged.",
      "Graves' disease is an autoimmune disorder that can cause the thyroid gland to produce too much thyroid hormone, leading to enlargement and goiter.",
      "Radiation therapy to the neck can damage the thyroid gland and lead to enlargement and goiter."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Erucism is not a condition related to the thyroid gland; it refers to the irritation and harm caused by contact with the hairs or bristles of certain caterpillars.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1413,
    "user_query": "What are the indications for hydrochlorothiazide?",
    "llama-7b_response": "Hydrochlorothiazide is a diuretic medication that is commonly used to treat high blood pressure and fluid retention caused by various conditions such as heart failure, kidney disease, and liver disease. It works by increasing the amount of urine produced by the kidneys, which helps to reduce blood pressure and eliminate excess fluid from the body.\nIn addition to these primary indications, hydrochlorothiazide may also be prescribed for the following conditions:\n- Chronic kidney disease: Hydrochlorothiazide can help to reduce the risk of kidney damage in people with chronic kidney disease by decreasing the amount of fluid and salt in the blood.\n- Diabetes insipidus: This condition is characterized by excessive thirst and urination due to a deficiency in antidiuretic hormone. Hydrochlorothiazide can help to reduce the amount of urine produced by the kidneys, which can help to manage symptoms of diabetes insipidus.\n- Hypothyroidism: In some cases, hydrochlorothiazide may be prescribed to treat the symptoms of hypothyroidism, such as a slow heartbeat, fatigue, and weight gain.\nIt is important to note that hydrochlorothiazide should not be used as a first-line treatment for high blood pressure, as it may not be as effective as other blood pressure medications. However, it can be a useful addition to other blood pressure medications or used as a standalone treatment for certain conditions.",
    "llama-7b_fact_raw": "1. Hydrochlorothiazide is used to treat high blood pressure.\n2. Hydrochlorothiazide is used to treat fluid retention caused by conditions such as heart failure, kidney disease, and liver disease.\n3. Hydrochlorothiazide works by increasing urine production to reduce blood pressure and eliminate excess fluid.\n4. Hydrochlorothiazide can help reduce the risk of kidney damage in people with chronic kidney disease.\n5. Hydrochlorothiazide may be prescribed to manage symptoms of diabetes insipidus.",
    "llama-7b_fact": [
      "Hydrochlorothiazide is used to treat high blood pressure.",
      "Hydrochlorothiazide is used to treat fluid retention caused by conditions such as heart failure, kidney disease, and liver disease.",
      "Hydrochlorothiazide works by increasing urine production to reduce blood pressure and eliminate excess fluid.",
      "Hydrochlorothiazide can help reduce the risk of kidney damage in people with chronic kidney disease.",
      "Hydrochlorothiazide may be prescribed to manage symptoms of diabetes insipidus."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Hydrochlorothiazide is not typically used to reduce the risk of kidney damage in people with chronic kidney disease; in fact, it can be contraindicated as it may worsen kidney function.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1447,
    "user_query": "Has silicon been used in treatment of  incontinence ?",
    "llama-7b_response": "Yes, silicon has been used in the treatment of incontinence. Specifically, silicone gel has been approved by the FDA for the treatment of stress urinary incontinence (SUI) in women. \nSilicone gel is placed inside a woman's vagina to provide a layer of support for the urethra, which is the tube that carries urine from the bladder. This helps to prevent urine from leaking out during physical activity, such as coughing, sneezing, or exercising. \nSilicone gel is considered a safe and effective treatment for SUI, with many women experiencing significant improvement in their symptoms. However, it is important to note that silicone gel is not a cure for incontinence and may not be effective for everyone. It is also important to follow the instructions provided by a healthcare provider when using silicone gel for incontinence.",
    "llama-7b_fact_raw": "1. Silicon has been used in the treatment of incontinence.\n2. Silicone gel has been approved by the FDA for the treatment of stress urinary incontinence (SUI) in women.\n3. Silicone gel is placed inside a woman's vagina to support the urethra.\n4. The use of silicone gel can prevent urine from leaking during physical activities like coughing, sneezing, or exercising.\n5. Silicone gel is not a cure for incontinence.",
    "llama-7b_fact": [
      "Silicon has been used in the treatment of incontinence.",
      "Silicone gel has been approved by the FDA for the treatment of stress urinary incontinence (SUI) in women.",
      "Silicone gel is placed inside a woman's vagina to support the urethra.",
      "The use of silicone gel can prevent urine from leaking during physical activities like coughing, sneezing, or exercising.",
      "Silicone gel is not a cure for incontinence."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Silicone gel itself is not approved by the FDA for the treatment of stress urinary incontinence (SUI) in women. However, silicone devices, such as urethral inserts or vaginal meshes, may be used for this purpose.\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 1454,
    "user_query": "What is the association between moon cycle and rupture risk of intracranial aneurysms?",
    "llama-7b_response": "The association between the moon cycle and the rupture risk of intracranial aneurysms is a topic of ongoing research and debate. Some studies have suggested that there may be a correlation between the phases of the moon and the likelihood of an aneurysm rupturing, while others have found no significant link.\nOne study published in the journal Neurosurgery in 2016 analyzed data from over 1,000 patients with ruptured intracranial aneurysms and found that the risk of rupture was slightly higher during the full moon and new moon phases, compared to other phases of the lunar cycle. However, the study also found that the overall risk of rupture was low, and that other factors such as high blood pressure and smoking were more significant predictors of aneurysm rupture.\nAnother study published in the journal Acta Neurochirurgica in 2018 analyzed data from over 100,000 patients with intracranial aneurysms and found no significant correlation between the lunar cycle and the risk of aneurysm rupture.\nIt is important to note that these studies are preliminary and further research is needed to fully understand the relationship between the moon cycle and the risk of intracranial aneurysm rupture. As an AI assistant, I cannot provide a definitive answer to this question, but I can assist in finding more information on this topic if needed.",
    "llama-7b_fact_raw": "1. Some studies have suggested a correlation between the phases of the moon and the likelihood of an intracranial aneurysm rupturing.\n2. A study published in the journal Neurosurgery in 2016 found a slightly higher risk of intracranial aneurysm rupture during the full moon and new moon phases.\n3. The same study from Neurosurgery in 2016 indicated that high blood pressure and smoking were more significant predictors of aneurysm rupture than the lunar cycle.\n4. Another study published in the journal Acta Neurochirurgica in 2018 found no significant correlation between the lunar cycle and the risk of aneurysm rupture.\n5. The studies mentioned are considered preliminary and further research is needed to fully understand the relationship between the moon cycle and the risk of intracranial aneurysm rupture.",
    "llama-7b_fact": [
      "Some studies have suggested a correlation between the phases of the moon and the likelihood of an intracranial aneurysm rupturing.",
      "A study published in the journal Neurosurgery in 2016 found a slightly higher risk of intracranial aneurysm rupture during the full moon and new moon phases.",
      "The same study from Neurosurgery in 2016 indicated that high blood pressure and smoking were more significant predictors of aneurysm rupture than the lunar cycle.",
      "Another study published in the journal Acta Neurochirurgica in 2018 found no significant correlation between the lunar cycle and the risk of aneurysm rupture.",
      "The studies mentioned are considered preliminary and further research is needed to fully understand the relationship between the moon cycle and the risk of intracranial aneurysm rupture."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN (without access to the specific study, the details cannot be verified)\n3. UNKNOWN (without access to the specific study, the details cannot be verified)\n4. UNKNOWN (without access to the specific study, the details cannot be verified)\n5. TRUE (It is common for studies that suggest correlations, especially in complex biological phenomena, to be considered preliminary until further research provides more conclusive evidence.)",
    "llama-7b_judge": [
      "true",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1477,
    "user_query": "Does HuR protein regulate the splicing process?",
    "llama-7b_response": "Yes, HuR protein has been shown to regulate the splicing process. HuR is a small nuclear protein that binds to the untranslated regions of mRNAs and regulates their stability and translation. HuR has been found to interact with a number of splicing factors, including serine/arginine-rich splicing factor 1 (SRSF1), serine/arginine-rich splicing factor 2 (SRSF2), and serine/arginine-rich splicing factor 5 (SRSF5), which are all important components of the splicing machinery.\nStudies have shown that HuR can affect splicing by regulating the stability and activity of splicing factors. For example, HuR has been found to bind to SRSF1 and SRSF2 and promote their degradation, which can lead to changes in splicing patterns. Additionally, HuR has been shown to interact with other splicing factors, such as serine/arginine-rich splicing factor 5 (SRSF5), and regulate their activity, which can also affect splicing patterns.\nOverall, HuR protein plays an important role in regulating the splicing process by interacting with a number of splicing factors and affecting their stability and activity.",
    "llama-7b_fact_raw": "1. HuR protein regulates the splicing process.\n2. HuR is a small nuclear protein that binds to untranslated regions of mRNAs.\n3. HuR interacts with splicing factors such as SRSF1, SRSF2, and SRSF5.\n4. HuR can promote the degradation of SRSF1 and SRSF2.\n5. HuR's interaction with splicing factors affects their stability and activity, leading to changes in splicing patterns.",
    "llama-7b_fact": [
      "HuR protein regulates the splicing process.",
      "HuR is a small nuclear protein that binds to untranslated regions of mRNAs.",
      "HuR interacts with splicing factors such as SRSF1, SRSF2, and SRSF5.",
      "HuR can promote the degradation of SRSF1 and SRSF2.",
      "HuR's interaction with splicing factors affects their stability and activity, leading to changes in splicing patterns."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: HuR protein primarily regulates mRNA stability and translation, not the splicing process.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: HuR generally stabilizes mRNAs by binding to their untranslated regions; it does not promote the degradation of splicing factors like SRSF1 and SRSF2.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1492,
    "user_query": "Describe the known functions for the prothymosin alpha c-terminal peptide?",
    "llama-7b_response": "Prothymosin alpha (PTMA) is a protein that is expressed in a wide range of tissues and plays a critical role in the regulation of cell growth and differentiation. The c-terminal peptide of PTMA has been studied extensively and has been found to have several known functions.\nOne of the known functions of the c-terminal peptide of PTMA is to bind to and activate the Src family of tyrosine kinases. These kinases are involved in a variety of cellular processes, including cell proliferation, differentiation, and migration. By binding to and activating these kinases, the c-terminal peptide of PTMA can promote cellular proliferation and differentiation.\nAnother known function of the c-terminal peptide of PTMA is to regulate the activity of the androgen receptor. The androgen receptor is a nuclear receptor that plays a critical role in the development and maintenance of male sex characteristics. The c-terminal peptide of PTMA can bind to the androgen receptor and modulate its activity, which can have important implications for the treatment of conditions such as prostate cancer.\nFinally, the c-terminal peptide of PTMA has also been found to have anti-inflammatory properties. By binding to and inhibiting the activity of inflammatory signaling molecules such as nuclear factor-kappa B (NF-kappaB), the c-terminal peptide of PTMA can help to reduce inflammation and promote resolution of inflammatory processes.\nOverall, the c-terminal peptide of PTMA plays a critical role in regulating cell growth, differentiation, and inflammation, making it a promising target for the development of new therapeutics.",
    "llama-7b_fact_raw": "1. The c-terminal peptide of prothymosin alpha (PTMA) binds to and activates the Src family of tyrosine kinases.\n2. The Src family of tyrosine kinases is involved in cell proliferation, differentiation, and migration.\n3. The c-terminal peptide of PTMA regulates the activity of the androgen receptor.\n4. The androgen receptor is important for the development and maintenance of male sex characteristics.\n5. The c-terminal peptide of PTMA has anti-inflammatory properties by inhibiting the activity of nuclear factor-kappa B (NF-kappaB).",
    "llama-7b_fact": [
      "The c-terminal peptide of prothymosin alpha (PTMA) binds to and activates the Src family of tyrosine kinases.",
      "The Src family of tyrosine kinases is involved in cell proliferation, differentiation, and migration.",
      "The c-terminal peptide of PTMA regulates the activity of the androgen receptor.",
      "The androgen receptor is important for the development and maintenance of male sex characteristics.",
      "The c-terminal peptide of PTMA has anti-inflammatory properties by inhibiting the activity of nuclear factor-kappa B (NF-kappaB)."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN: The specific interaction between the c-terminal peptide of prothymosin alpha (PTMA) and the Src family of tyrosine kinases is not a widely established fact in scientific literature, and without specific context or reference, it is difficult to verify this statement.\n2. TRUE: The Src family of tyrosine kinases is indeed involved in various cellular processes including cell proliferation, differentiation, and migration.\n3. UNKNOWN: The regulation of the androgen receptor by the c-terminal peptide of PTMA is a specific claim that requires a reference to scientific literature to verify, and without additional context, its accuracy cannot be determined.\n4. TRUE: The androgen receptor is indeed important for the development and maintenance of male sex characteristics.\n5. UNKNOWN: The claim that the c-terminal peptide of PTMA has anti-inflammatory properties by inhibiting the activity of nuclear factor-kappa B (NF-kappaB) is specific and would need to be supported by scientific evidence. Without context or reference, the truth of this statement cannot be ascertained.",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 1516,
    "user_query": "Which peptide plays a pivotal role in human cystatin C fibrillization?",
    "llama-7b_response": "The peptide that plays a pivotal role in human cystatin C fibrillization is the C-terminal domain (CTD) of cystatin C. The CTD is a highly conserved region among cystatin proteins, including cystatin C, and is responsible for the formation of the fibrillar structure that is characteristic of cystatin C. The fibrillization of cystatin C is important for its biological function, as it allows for the binding of cystatin C to other proteins and the regulation of various cellular processes.",
    "llama-7b_fact_raw": "1. The C-terminal domain (CTD) of cystatin C plays a pivotal role in its fibrillization.\n2. The CTD is a highly conserved region among cystatin proteins.\n3. Fibrillization of cystatin C is important for its biological function.\n4. Fibrillization allows cystatin C to bind to other proteins.\n5. Fibrillization helps in the regulation of various cellular processes.",
    "llama-7b_fact": [
      "The C-terminal domain (CTD) of cystatin C plays a pivotal role in its fibrillization.",
      "The CTD is a highly conserved region among cystatin proteins.",
      "Fibrillization of cystatin C is important for its biological function.",
      "Fibrillization allows cystatin C to bind to other proteins.",
      "Fibrillization helps in the regulation of various cellular processes."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Fibrillization of cystatin C is associated with pathological conditions, not its normal biological function.\n4. FALSE [correction]: Fibrillization typically refers to the aggregation of proteins into amyloid fibrils, which is generally not a functional form for protein-protein interactions. Cystatin C binds to target proteases through its functional form, not through fibrillization.\n5. FALSE [correction]: Fibrillization is typically associated with dysregulation of cellular processes and can lead to diseases such as amyloidosis. It is not a regulatory mechanism for normal cellular processes.",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1574,
    "user_query": "Does the concentration of protein HIF-1α increase after the administration of the cytoprotective prodrug\"amifostine\" (ethyol) ?",
    "llama-7b_response": "The concentration of HIF-1α, a protein that plays a critical role in cellular responses to hypoxia (low oxygen levels), has not been studied in relation to the administration of the cytoprotective prodrug \"amifostine\" (ethyol). Therefore, it is not possible to provide a definitive answer to this question. \nHowever, it is known that amifostine is a cytoprotective agent that has been shown to reduce the toxic effects of chemotherapy and radiation therapy in various cancer types. It is believed to work by protecting cells from damage caused by these treatments by reducing the production of reactive oxygen species and inhibiting DNA damage. \nIt is possible that the administration of amifostine may affect the concentration of other proteins in the body, but this has not been studied specifically in relation to HIF-1α. Further research would be needed to determine if and how amifostine affects the concentration of HIF-1α and other proteins in the body.",
    "llama-7b_fact_raw": "1. HIF-1α is a protein that plays a critical role in cellular responses to hypoxia.\n2. The effects of amifostine on the concentration of HIF-1α have not been studied.\n3. Amifostine is a cytoprotective agent used to reduce the toxic effects of chemotherapy and radiation therapy in various cancer types.\n4. Amifostine is believed to work by protecting cells from damage by reducing the production of reactive oxygen species and inhibiting DNA damage.",
    "llama-7b_fact": [
      "HIF-1α is a protein that plays a critical role in cellular responses to hypoxia.",
      "The effects of amifostine on the concentration of HIF-1α have not been studied.",
      "Amifostine is a cytoprotective agent used to reduce the toxic effects of chemotherapy and radiation therapy in various cancer types.",
      "Amifostine is believed to work by protecting cells from damage by reducing the production of reactive oxygen species and inhibiting DNA damage."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: The effects of amifostine on the concentration of HIF-1α have been studied, and it has been shown to influence HIF-1α levels under certain conditions.\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1588,
    "user_query": "Which histone marks are deposited by Set7?",
    "llama-7b_response": "Set7 is a histone lysine methyltransferase that adds a methyl group to lysine 9 of histone H3 (H3K9me7). This histone mark is associated with active gene expression and is often found in euchromatic regions of the genome. Set7 is also known to methylate other lysine residues on histones, such as H3K36me7 and H4K20me3, but these marks are less common than H3K9me7. Set7 has been shown to play a role in various biological processes, including transcriptional activation, chromatin remodeling, and DNA repair.",
    "llama-7b_fact_raw": "1. Set7 is a histone lysine methyltransferase.\n2. Set7 adds a methyl group to lysine 9 of histone H3 (H3K9me7).\n3. The H3K9me7 mark is associated with active gene expression.\n4. Set7 can also methylate other lysine residues such as H3K36me7 and H4K20me3.\n5. Set7 is involved in biological processes including transcriptional activation, chromatin remodeling, and DNA repair.",
    "llama-7b_fact": [
      "Set7 is a histone lysine methyltransferase.",
      "Set7 adds a methyl group to lysine 9 of histone H3 (H3K9me7).",
      "The H3K9me7 mark is associated with active gene expression.",
      "Set7 can also methylate other lysine residues such as H3K36me7 and H4K20me3.",
      "Set7 is involved in biological processes including transcriptional activation, chromatin remodeling, and DNA repair."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Set7 adds a methyl group to lysine 4 of histone H3 (H3K4me1), not lysine 9 of histone H3 (H3K9me7).\n3. FALSE [correction]: The H3K9me7 mark does not exist; Set7 specifically catalyzes the monomethylation of H3K4 (H3K4me1), which is associated with active gene expression.\n4. FALSE [correction]: Set7 specifically methylates lysine 4 on histone H3 (H3K4me1) and does not methylate H3K36 or H4K20 to a heptamethylated state (me7). It can methylate non-histone proteins, but the statement about H3K36me7 and H4K20me3 is incorrect.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 1620,
    "user_query": "How many disulfide bridges has the protein hepcidin got?",
    "llama-7b_response": "Hepcidin is a protein that plays a crucial role in regulating iron absorption and homeostasis in the body. It is composed of 126 amino acid residues and contains two disulfide bridges. These disulfide bridges are essential for the proper folding and function of hepcidin. One of the disulfide bridges is located at the N-terminus of the protein and the other is located at the C-terminus.",
    "llama-7b_fact_raw": "1. Hepcidin is a protein involved in regulating iron absorption and homeostasis in the body.\n2. Hepcidin is composed of 126 amino acid residues.\n3. Hepcidin contains two disulfide bridges.\n4. One disulfide bridge in hepcidin is located at the N-terminus of the protein.\n5. The other disulfide bridge in hepcidin is located at the C-terminus of the protein.",
    "llama-7b_fact": [
      "Hepcidin is a protein involved in regulating iron absorption and homeostasis in the body.",
      "Hepcidin is composed of 126 amino acid residues.",
      "Hepcidin contains two disulfide bridges.",
      "One disulfide bridge in hepcidin is located at the N-terminus of the protein.",
      "The other disulfide bridge in hepcidin is located at the C-terminus of the protein."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hepcidin is composed of 25 amino acid residues.\n3. FALSE [correction]: Hepcidin contains four disulfide bridges.\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1643,
    "user_query": "What is the localization of the protein encoded by the gene DNAJC11?",
    "llama-7b_response": "The localization of the protein encoded by the gene DNAJC11 is not well understood. DNAJC11 is a member of the DNAJ family of proteins, which are thought to play a role in protein folding and trafficking within the cell. However, the specific function of DNAJC11 has not been fully characterized. It is known that DNAJC11 is expressed in a variety of tissues, including brain, heart, liver, and kidney, but its exact localization within these tissues is not clear. Further research is needed to determine the precise localization of DNAJC11 within the cell and its role in protein folding and trafficking.",
    "llama-7b_fact_raw": "1. DNAJC11 is a member of the DNAJ family of proteins.\n2. Proteins in the DNAJ family are thought to be involved in protein folding and trafficking within the cell.\n3. The specific function of DNAJC11 has not been fully characterized.\n4. DNAJC11 is expressed in a variety of tissues, including the brain, heart, liver, and kidney.\n5. The exact localization of DNAJC11 within these tissues is not clear.",
    "llama-7b_fact": [
      "DNAJC11 is a member of the DNAJ family of proteins.",
      "Proteins in the DNAJ family are thought to be involved in protein folding and trafficking within the cell.",
      "The specific function of DNAJC11 has not been fully characterized.",
      "DNAJC11 is expressed in a variety of tissues, including the brain, heart, liver, and kidney.",
      "The exact localization of DNAJC11 within these tissues is not clear."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nNote: While statements 3 and 5 are true based on the typical understanding that many protein functions and localizations are not fully characterized, it is important to acknowledge that scientific knowledge is constantly evolving, and more specific information may be available that is not reflected here.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1655,
    "user_query": "Are ultraconserved elements depleted among copy number variants (CNVs)?",
    "llama-7b_response": "Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across species, meaning they have remained unchanged for millions of years. CNVs, on the other hand, are regions of DNA that differ in copy number between individuals or populations.\nStudies have shown that UCEs are not necessarily depleted among CNVs. In fact, some studies have found that UCEs are more likely to be present in CNVs than in non-CNV regions of the genome. This may be due to the fact that CNVs are more likely to occur in regions of the genome that are conserved across species, which would increase the likelihood of UCEs being present in those regions.\nHowever, other studies have found that UCEs are depleted among CNVs. This may be due to the fact that CNVs can occur in regions of the genome that are not conserved across species, which would decrease the likelihood of UCEs being present in those regions.\nOverall, the answer to the question of whether UCEs are depleted among CNVs is both yes and no. It depends on the specific study and the region of the genome being examined.",
    "llama-7b_fact_raw": "1. Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across species.\n2. Copy number variants (CNVs) are regions of DNA that differ in copy number between individuals or populations.\n3. Some studies have found that UCEs are more likely to be present in CNVs than in non-CNV regions of the genome.\n4. Other studies have found that UCEs are depleted among CNVs.\n5. The presence of UCEs in CNVs can vary depending on the region of the genome being examined.",
    "llama-7b_fact": [
      "Ultraconserved elements (UCEs) are regions of DNA that are highly conserved across species.",
      "Copy number variants (CNVs) are regions of DNA that differ in copy number between individuals or populations.",
      "Some studies have found that UCEs are more likely to be present in CNVs than in non-CNV regions of the genome.",
      "Other studies have found that UCEs are depleted among CNVs.",
      "The presence of UCEs in CNVs can vary depending on the region of the genome being examined."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Ultraconserved elements (UCEs) are generally highly conserved and are less likely to be present in copy number variants (CNVs) than in non-CNV regions of the genome.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 1665,
    "user_query": "Which is the substrate of the haspin kinase during mitosis?",
    "llama-7b_response": "The haspin kinase is an enzyme that plays a critical role in mitosis, the process by which cells divide and replicate their DNA. During mitosis, the haspin kinase phosphorylates a number of proteins, including tubulin, which is a key component of the spindle fibers that align and separate the chromosomes during cell division. Therefore, tubulin is the substrate of the haspin kinase during mitosis.",
    "llama-7b_fact_raw": "1. The haspin kinase is an enzyme involved in mitosis.\n2. Mitosis is the process by which cells divide and replicate their DNA.\n3. The haspin kinase phosphorylates a number of proteins during mitosis.\n4. Tubulin is a key component of the spindle fibers in cell division.\n5. Tubulin is the substrate of the haspin kinase during mitosis.",
    "llama-7b_fact": [
      "The haspin kinase is an enzyme involved in mitosis.",
      "Mitosis is the process by which cells divide and replicate their DNA.",
      "The haspin kinase phosphorylates a number of proteins during mitosis.",
      "Tubulin is a key component of the spindle fibers in cell division.",
      "Tubulin is the substrate of the haspin kinase during mitosis."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Tubulin is not the substrate of the haspin kinase during mitosis. Haspin kinase primarily phosphorylates histone H3 to facilitate chromosome segregation.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1696,
    "user_query": "What is the mechanism of viroid replication?",
    "llama-7b_response": "Viroids are small, single-stranded circular DNA or RNA molecules that replicate in plants and animals. The mechanism of viroid replication is different from that of DNA or RNA viruses. Viroids do not have a genome of their own and cannot integrate into the host genome. Instead, they hijack the host cell's replication machinery to replicate themselves.\nThe replication of viroids begins with the binding of the viroid molecule to a host cell receptor. This binding triggers a series of events that lead to the uncoating of the host cell's nucleus and the exposure of the host cell's DNA. The viroid then binds to the DNA and initiates the replication process.\nThe replication of viroids is semi-conservative, meaning that each strand of the viroid DNA or RNA molecule serves as a template for the synthesis of a new strand. The host cell's DNA polymerase, which is responsible for the replication of the host cell's DNA, is recruited to replicate the viroid. The viroid DNA or RNA molecule serves as a primer for the synthesis of a new strand, and the host cell's DNA polymerase extends the primer and synthesizes a new strand.\nOnce the viroid DNA or RNA molecule is completely replicated, the host cell's DNA polymerase continues to replicate the host cell's DNA. The viroid is then released from the host cell and can infect other cells.\nIn summary, the mechanism of viroid replication involves the binding of the viroid to a host cell receptor, the uncoating of the host cell's nucleus, the binding of the viroid to the host cell's DNA, the recruitment of the host cell's DNA polymerase, and the semi-conservative replication of the viroid DNA or RNA molecule using the host cell's DNA polymerase.",
    "llama-7b_fact_raw": "1. Viroids are small, single-stranded circular DNA or RNA molecules that replicate in plants and animals.\n2. Viroids do not have a genome of their own and cannot integrate into the host genome.\n3. The replication of viroids is semi-conservative, with each strand serving as a template for the synthesis of a new strand.\n4. Host cell's DNA polymerase is recruited to replicate the viroid.\n5. The viroid replication process involves the binding of the viroid to a host cell receptor and the uncoating of the host cell's nucleus.",
    "llama-7b_fact": [
      "Viroids are small, single-stranded circular DNA or RNA molecules that replicate in plants and animals.",
      "Viroids do not have a genome of their own and cannot integrate into the host genome.",
      "The replication of viroids is semi-conservative, with each strand serving as a template for the synthesis of a new strand.",
      "Host cell's DNA polymerase is recruited to replicate the viroid.",
      "The viroid replication process involves the binding of the viroid to a host cell receptor and the uncoating of the host cell's nucleus."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Viroids are small, single-stranded circular RNA molecules that replicate in plants. They have not been found to replicate in animals.\n2. FALSE [correction]: Viroids do have their own genome, which is a very small circular RNA, but they do not encode proteins and cannot integrate into the host genome.\n3. TRUE\n4. FALSE [correction]: Host cell's RNA polymerase, not DNA polymerase, is recruited to replicate the viroid since viroids are made of RNA.\n5. FALSE [correction]: The viroid replication process does not involve binding to a host cell receptor or uncoating of the host cell's nucleus. Viroids replicate in the host cell's nucleus or chloroplast without a traditional uncoating step as seen in many viruses.",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 1723,
    "user_query": "Does fibronectin constitute a serum biomarker for Duchenne muscular dystrophy?",
    "llama-7b_response": "Fibronectin is a protein found in the extracellular matrix that plays a critical role in cell-to-cell communication and tissue repair. It is a serum biomarker for several diseases, including Duchenne muscular dystrophy (DMD).\nDMD is a genetic disorder that causes progressive muscle degeneration and weakness. It is caused by mutations in the dystrophin gene, which codes for a protein that is essential for maintaining the structural integrity of muscle fibers.\nStudies have shown that fibronectin levels are increased in the serum of individuals with DMD compared to healthy controls. This increase in fibronectin levels may be due to the fact that DMD causes damage to muscle tissue, leading to increased inflammation and tissue repair.\nHowever, it is important to note that fibronectin is not a specific biomarker for DMD. Other serum biomarkers that have been identified for DMD include creatine kinase (CK) and myoglobin. These biomarkers are specific to muscle damage and can be used to diagnose and monitor the progression of DMD.\nIn conclusion, while fibronectin may be increased in the serum of individuals with DMD, it is not a specific biomarker for the disease. Other serum biomarkers, such as CK and myoglobin, are more specific and should be used for diagnosis and monitoring of DMD.",
    "llama-7b_fact_raw": "1. Fibronectin is a protein found in the extracellular matrix that is involved in cell-to-cell communication and tissue repair.\n2. Fibronectin is a serum biomarker for several diseases, including Duchenne muscular dystrophy (DMD).\n3. Duchenne muscular dystrophy is a genetic disorder caused by mutations in the dystrophin gene.\n4. Studies have indicated that fibronectin levels are increased in the serum of individuals with DMD compared to healthy controls.\n5. Creatine kinase (CK) and myoglobin are other serum biomarkers identified for Duchenne muscular dystrophy that are specific to muscle damage.",
    "llama-7b_fact": [
      "Fibronectin is a protein found in the extracellular matrix that is involved in cell-to-cell communication and tissue repair.",
      "Fibronectin is a serum biomarker for several diseases, including Duchenne muscular dystrophy (DMD).",
      "Duchenne muscular dystrophy is a genetic disorder caused by mutations in the dystrophin gene.",
      "Studies have indicated that fibronectin levels are increased in the serum of individuals with DMD compared to healthy controls.",
      "Creatine kinase (CK) and myoglobin are other serum biomarkers identified for Duchenne muscular dystrophy that are specific to muscle damage."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1763,
    "user_query": "Data from which major epigenome projects are contained in the DeepBlue epigenomic data server?",
    "llama-7b_response": "The DeepBlue epigenomic data server contains data from several major epigenome projects, including:\n1. ENCODE (Encyclopedia of DNA Elements)\n2. Roadmap Epigenomics Consortium\n3. ChIPseeker\n4. Epigenetic Regulation of Gene Expression in Plants\n5. Epigenetic Regulation of Gene Expression in Animals\n6. Epigenetic Regulation of Gene Expression in Humans\nThese projects have generated a large amount of epigenomic data, which is now available through the DeepBlue data server for research purposes.",
    "llama-7b_fact_raw": "1. The DeepBlue epigenomic data server contains data from the ENCODE project.\n2. The DeepBlue epigenomic data server includes data from the Roadmap Epigenomics Consortium.\n3. Data from the project ChIPseeker is available on the DeepBlue epigenomic data server.\n4. The DeepBlue epigenomic data server has data on Epigenetic Regulation of Gene Expression in Plants.\n5. The DeepBlue epigenomic data server provides data on Epigenetic Regulation of Gene Expression in Humans.",
    "llama-7b_fact": [
      "The DeepBlue epigenomic data server contains data from the ENCODE project.",
      "The DeepBlue epigenomic data server includes data from the Roadmap Epigenomics Consortium.",
      "Data from the project ChIPseeker is available on the DeepBlue epigenomic data server.",
      "The DeepBlue epigenomic data server has data on Epigenetic Regulation of Gene Expression in Plants.",
      "The DeepBlue epigenomic data server provides data on Epigenetic Regulation of Gene Expression in Humans."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: ChIPseeker is not a project but a bioinformatics tool for ChIP data analysis; it does not provide data itself to be included in servers like DeepBlue.\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1792,
    "user_query": "Which tool employs self organizing maps for analyzing synonymous codon usage?",
    "llama-7b_response": "The tool that employs self organizing maps for analyzing synonymous codon usage is called the \"Self-Organizing Map (SOM)\" algorithm. It is a type of artificial neural network that is commonly used for clustering and dimensionality reduction tasks. In the context of analyzing synonymous codon usage, the SOM algorithm can be used to group similar codons together based on their nucleotide composition and amino acid properties. This can help researchers identify patterns and trends in codon usage that may be relevant to gene expression, protein folding, and other biological processes.",
    "llama-7b_fact_raw": "1. The \"Self-Organizing Map (SOM)\" algorithm is used for analyzing synonymous codon usage.\n2. SOM is a type of artificial neural network.\n3. SOM is commonly used for clustering and dimensionality reduction tasks.\n4. The SOM algorithm groups similar codons based on their nucleotide composition and amino acid properties.\n5. Analyzing synonymous codon usage with SOM can aid in identifying patterns relevant to gene expression and protein folding.",
    "llama-7b_fact": [
      "The \"Self-Organizing Map (SOM)\" algorithm is used for analyzing synonymous codon usage.",
      "SOM is a type of artificial neural network.",
      "SOM is commonly used for clustering and dimensionality reduction tasks.",
      "The SOM algorithm groups similar codons based on their nucleotide composition and amino acid properties.",
      "Analyzing synonymous codon usage with SOM can aid in identifying patterns relevant to gene expression and protein folding."
    ],
    "llama-7b_judge_raw": "1. TRUE: The \"Self-Organizing Map (SOM)\" algorithm can be used for analyzing synonymous codon usage as part of bioinformatics studies to understand genetic data.\n2. TRUE: SOM is indeed a type of artificial neural network that is trained using unsupervised learning to produce a low-dimensional (typically two-dimensional), discretized representation of the input space of the training samples.\n3. TRUE: SOM is commonly used for clustering and dimensionality reduction tasks, among other applications.\n4. TRUE: The SOM algorithm can group similar codons based on their nucleotide composition and amino acid properties, which is part of its utility in bioinformatics.\n5. TRUE: Analyzing synonymous codon usage with SOM can indeed aid in identifying patterns that are relevant to gene expression and protein folding, as these patterns can influence the efficiency and accuracy of protein synthesis.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 1793,
    "user_query": "What is MINDY-1?",
    "llama-7b_response": "MINDY-1 is a fictional character and the main protagonist of a popular science-fiction television series called \"The Adventures of MINDY-1\". The series follows the adventures of a highly intelligent and resourceful android named MINDY-1, who is designed to assist humans in various tasks and missions. MINDY-1 is equipped with advanced artificial intelligence and is capable of learning and adapting to new situations, making her a valuable asset to any team she is a part of. Over the course of the series, MINDY-1 faces various challenges and obstacles, including battling hostile alien races, saving human colonies from destruction, and uncovering hidden secrets that threaten the stability of the galaxy. Despite the many dangers she encounters, MINDY-1 remains determined and loyal to her human companions, always striving to protect and serve them to the best of her abilities.",
    "llama-7b_fact_raw": "1. MINDY-1 is the main protagonist of a science-fiction television series called \"The Adventures of MINDY-1\".\n2. MINDY-1 is an android character in the series.\n3. The character MINDY-1 is designed to assist humans in tasks and missions.\n4. MINDY-1 is equipped with advanced artificial intelligence.\n5. The series includes storylines where MINDY-1 battles hostile alien races and saves human colonies.",
    "llama-7b_fact": [
      "MINDY-1 is the main protagonist of a science-fiction television series called \"The Adventures of MINDY-1\".",
      "MINDY-1 is an android character in the series.",
      "The character MINDY-1 is designed to assist humans in tasks and missions.",
      "MINDY-1 is equipped with advanced artificial intelligence.",
      "The series includes storylines where MINDY-1 battles hostile alien races and saves human colonies."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific information about a science-fiction television series called \"The Adventures of MINDY-1,\" it is not possible to verify the accuracy of these statements. They could be true if such a series exists and these are accurate descriptions of it, but without additional context or confirmation, the truthfulness of these statements remains unknown.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1810,
    "user_query": "Which software package is available for the analysis of conserved genomic loci?",
    "llama-7b_response": "There are several software packages available for the analysis of conserved genomic loci. Some of the popular ones are:\n1. BLAST: BLAST (Basic Local Alignment Search Tool) is a software package developed by the National Center for Biotechnology Information (NCBI). It is used for searching for regions of local similarity between biological sequences. BLAST can be used to search for conserved genomic loci across different species.\n2. MEME: MEME (Multiple Expectation Maximization) is a software package developed by David Haussler and colleagues at the University of California, Santa Cruz. It is used for motif discovery and analysis of conserved genomic regions. MEME can be used to identify conserved motifs and patterns in DNA sequences.\n3. PSI-BLAST: PSI-BLAST (Phylogenetic Analysis by Maximum Likelihood) is a software package developed by the National Institutes of Health (NIH). It is used for searching for regions of local similarity between biological sequences. PSI-BLAST can be used to search for conserved genomic loci across different species.\n4. InterProScan: InterProScan is a software package developed by the European Bioinformatics Institute (EBI). It is used for the identification of protein domains and motifs in a protein sequence. InterProScan can be used to identify conserved protein domains and motifs in different species.\n5. Conserved Domain Database: The Conserved Domain Database (CDD) is a software package developed by the National Center for Biotechnology Information (NCBI). It is used for the identification of conserved domains in protein sequences. CDD can be used to identify conserved protein domains and motifs in different species.",
    "llama-7b_fact_raw": "1. BLAST is a software package developed by the National Center for Biotechnology Information (NCBI) for searching regions of local similarity between biological sequences.\n2. MEME is a software package developed by David Haussler and colleagues at the University of California, Santa Cruz for motif discovery in conserved genomic regions.\n3. PSI-BLAST is a software package developed by the National Institutes of Health (NIH) for searching regions of local similarity between biological sequences.\n4. InterProScan is a software package developed by the European Bioinformatics Institute (EBI) for the identification of protein domains and motifs in a protein sequence.\n5. The Conserved Domain Database (CDD) is a software package developed by the National Center for Biotechnology Information (NCBI) for the identification of conserved domains in protein sequences.",
    "llama-7b_fact": [
      "BLAST is a software package developed by the National Center for Biotechnology Information (NCBI) for searching regions of local similarity between biological sequences.",
      "MEME is a software package developed by David Haussler and colleagues at the University of California, Santa Cruz for motif discovery in conserved genomic regions.",
      "PSI-BLAST is a software package developed by the National Institutes of Health (NIH) for searching regions of local similarity between biological sequences.",
      "InterProScan is a software package developed by the European Bioinformatics Institute (EBI) for the identification of protein domains and motifs in a protein sequence.",
      "The Conserved Domain Database (CDD) is a software package developed by the National Center for Biotechnology Information (NCBI) for the identification of conserved domains in protein sequences."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: MEME is a software package developed by Timothy L. Bailey and Charles Elkan at the University of California, San Diego for motif discovery in sets of biological sequences.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: The Conserved Domain Database (CDD) is not a software package but a database developed by the National Center for Biotechnology Information (NCBI) for the identification of conserved domains in protein sequences.",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 1860,
    "user_query": "Please list 3 diseases associated with the PIEZO2 gene.",
    "llama-7b_response": "The PIEZO2 gene is associated with several diseases, including:\n1. Hereditary hemorrhagic telangiectasia (HHT): HHT is a genetic disorder that causes abnormal blood vessels to form in the skin, mucous membranes, and organs. The PIEZO2 gene is one of the genes associated with HHT, and mutations in this gene can cause the disease to develop.\n2. Ehlers-Danlos syndrome (EDS): EDS is a group of genetic disorders that affect the body's connective tissues, which provide support to the skin, bones, blood vessels, and other organs. The PIEZO2 gene is one of the genes associated with EDS, and mutations in this gene can cause the disease to develop.\n3. Stickler syndrome: Stickler syndrome is a genetic disorder that affects the joints and eyes. The PIEZO2 gene is one of the genes associated with Stickler syndrome, and mutations in this gene can cause the disease to develop.",
    "llama-7b_fact_raw": "1. The PIEZO2 gene is associated with Hereditary hemorrhagic telangiectasia (HHT).\n2. The PIEZO2 gene is associated with Ehlers-Danlos syndrome (EDS).\n3. The PIEZO2 gene is associated with Stickler syndrome.",
    "llama-7b_fact": [
      "The PIEZO2 gene is associated with Hereditary hemorrhagic telangiectasia (HHT).",
      "The PIEZO2 gene is associated with Ehlers-Danlos syndrome (EDS).",
      "The PIEZO2 gene is associated with Stickler syndrome."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The PIEZO2 gene is not associated with Hereditary hemorrhagic telangiectasia (HHT). HHT is primarily associated with mutations in the ENG, ACVRL1, and SMAD4 genes.\n2. FALSE [correction]: The PIEZO2 gene is not typically associated with Ehlers-Danlos syndrome (EDS). EDS is a group of disorders often associated with mutations in genes responsible for the structure, production, and processing of collagen, such as COL5A1, COL5A2, and COL3A1.\n3. FALSE [correction]: The PIEZO2 gene is not associated with Stickler syndrome. Stickler syndrome is commonly associated with mutations in the COL2A1, COL11A1, and COL11A2 genes, which are involved in the production of collagen.",
    "llama-7b_judge": [
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1867,
    "user_query": "What is promoted by ERAP1-ERAP2 dimerization?",
    "llama-7b_response": "ERAP1 and ERAP2 are two proteins that belong to the ERAP family, which is involved in the processing and presentation of peptides on the surface of antigen-presenting cells (APCs). The ERAP1-ERAP2 dimerization is essential for the proper functioning of the ERAP family.\nThe ERAP1-ERAP2 dimerization promotes the processing and presentation of peptides on the surface of APCs. When ERAP1 and ERAP2 form a dimer, they can bind to the same peptide-MHC complex on the surface of APCs. This binding allows the ERAP family to cleave the peptide from the antigen and present it on the surface of APCs in a form that can be recognized by T cells.\nThe ERAP1-ERAP2 dimerization also plays a critical role in the regulation of the immune response. By processing and presenting specific peptides on the surface of APCs, the ERAP family can activate T cells and initiate an immune response against pathogens or tumor cells.\nIn summary, the ERAP1-ERAP2 dimerization is essential for the proper functioning of the ERAP family and plays a critical role in the processing and presentation of peptides on the surface of APCs, which in turn regulates the immune response.",
    "llama-7b_fact_raw": "1. ERAP1 and ERAP2 are proteins that belong to the ERAP family.\n2. The ERAP1-ERAP2 dimerization is essential for the proper functioning of the ERAP family.\n3. The ERAP1-ERAP2 dimerization promotes the processing and presentation of peptides on the surface of antigen-presenting cells (APCs).\n4. When ERAP1 and ERAP2 form a dimer, they can bind to the same peptide-MHC complex on the surface of APCs.\n5. The ERAP1-ERAP2 dimerization plays a critical role in the regulation of the immune response by activating T cells.",
    "llama-7b_fact": [
      "ERAP1 and ERAP2 are proteins that belong to the ERAP family.",
      "The ERAP1-ERAP2 dimerization is essential for the proper functioning of the ERAP family.",
      "The ERAP1-ERAP2 dimerization promotes the processing and presentation of peptides on the surface of antigen-presenting cells (APCs).",
      "When ERAP1 and ERAP2 form a dimer, they can bind to the same peptide-MHC complex on the surface of APCs.",
      "The ERAP1-ERAP2 dimerization plays a critical role in the regulation of the immune response by activating T cells."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: While ERAP1 and ERAP2 can form heterodimers, the dimerization is not universally considered essential for the proper functioning of the ERAP family. Each enzyme can also function independently.\n3. TRUE\n4. FALSE [correction]: When ERAP1 and ERAP2 form a dimer, they do not bind to peptide-MHC complexes on the surface of APCs. Instead, they are involved in trimming peptides within the cell before the peptides are loaded onto MHC class I molecules.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1890,
    "user_query": "What is the function of R-spondin 1 and noggin in non-damaged gallbladders?",
    "llama-7b_response": "R-spondin 1 and noggin are two proteins that play important roles in the development and maintenance of the gallbladder. \nR-spondin 1 is a secreted protein that is involved in the Wnt signaling pathway, which is a key regulator of cell growth and differentiation. In the gallbladder, R-spondin 1 is thought to promote the differentiation of biliary epithelial cells, which are the cells that line the gallbladder. This differentiation is important for the normal function of the gallbladder, which is to store and release bile.\nNoggin is another protein that is involved in the Wnt signaling pathway. Noggin is thought to inhibit the activity of the Wnt signaling pathway, which can prevent excessive cell growth and differentiation. In the gallbladder, noggin may play a role in regulating the growth and function of biliary epithelial cells.\nHowever, it is important to note that the function of R-spondin 1 and noggin in non-damaged gallbladders is not well understood. Further research is needed to fully understand the role of these proteins in gallbladder development and function.",
    "llama-7b_fact_raw": "1. R-spondin 1 is involved in the Wnt signaling pathway.\n2. R-spondin 1 promotes the differentiation of biliary epithelial cells in the gallbladder.\n3. The differentiation of biliary epithelial cells is important for the normal function of the gallbladder.\n4. Noggin is involved in the Wnt signaling pathway and is thought to inhibit its activity.\n5. Noggin may regulate the growth and function of biliary epithelial cells in the gallbladder.",
    "llama-7b_fact": [
      "R-spondin 1 is involved in the Wnt signaling pathway.",
      "R-spondin 1 promotes the differentiation of biliary epithelial cells in the gallbladder.",
      "The differentiation of biliary epithelial cells is important for the normal function of the gallbladder.",
      "Noggin is involved in the Wnt signaling pathway and is thought to inhibit its activity.",
      "Noggin may regulate the growth and function of biliary epithelial cells in the gallbladder."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. FALSE [correction]: Noggin is involved in the BMP (Bone Morphogenetic Protein) signaling pathway, not the Wnt signaling pathway, and it is known to inhibit BMP activity.\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 1937,
    "user_query": "Does NADPH oxidase 5 require any subunit for function?",
    "llama-7b_response": "NADPH oxidase 5 (NOX5) is a complex enzyme that requires several subunits for its proper function. These subunits include p22phox, p40phox, p47phox, and gp91phox. \nNADPH oxidase 5 is a member of the NOX family of enzymes, which are responsible for producing reactive oxygen species (ROS) in cells. ROS are important signaling molecules that play a role in a variety of biological processes, including cellular proliferation, differentiation, and apoptosis.\np22phox is the catalytic subunit of NOX5 and is responsible for catalyzing the conversion of NADPH into ROS. p40phox and p47phox are non-catalytic subunits that bind to p22phox and promote the assembly of the NOX5 complex. gp91phox is another non-catalytic subunit that binds to p22phox and p47phox and facilitates the transfer of electrons from NADPH to the catalytic center of the enzyme.\nWithout any of these subunits, NOX5 cannot function properly and cannot produce ROS. Therefore, the answer to the question is yes, NADPH oxidase 5 requires all of its subunits for function.",
    "llama-7b_fact_raw": "1. NADPH oxidase 5 (NOX5) requires several subunits for its proper function.\n2. The subunits required for NOX5 function include p22phox, p40phox, p47phox, and gp91phox.\n3. p22phox is the catalytic subunit of NOX5 responsible for catalyzing the conversion of NADPH into reactive oxygen species (ROS).\n4. p40phox and p47phox are non-catalytic subunits that promote the assembly of the NOX5 complex.\n5. gp91phox is a non-catalytic subunit that facilitates the transfer of electrons from NADPH to the catalytic center of the enzyme.",
    "llama-7b_fact": [
      "NADPH oxidase 5 (NOX5) requires several subunits for its proper function.",
      "The subunits required for NOX5 function include p22phox, p40phox, p47phox, and gp91phox.",
      "p22phox is the catalytic subunit of NOX5 responsible for catalyzing the conversion of NADPH into reactive oxygen species (ROS).",
      "p40phox and p47phox are non-catalytic subunits that promote the assembly of the NOX5 complex.",
      "gp91phox is a non-catalytic subunit that facilitates the transfer of electrons from NADPH to the catalytic center of the enzyme."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: NADPH oxidase 5 (NOX5) is unique among NOX isoforms because it does not require additional subunits for its proper function; it is calcium-dependent and functions independently.\n2. FALSE [correction]: The subunits p22phox, p40phox, p47phox, and gp91phox are not required for NOX5 function; these subunits are associated with other NOX isoforms, such as NOX2.\n3. FALSE [correction]: p22phox is not the catalytic subunit of NOX5; NOX5 itself is the catalytic subunit responsible for catalyzing the conversion of NADPH into reactive oxygen species (ROS). p22phox is associated with NOX2 as a stabilizing subunit.\n4. FALSE [correction]: p40phox and p47phox are not involved in the assembly of the NOX5 complex; they are associated with the NOX2 complex.\n5. FALSE [correction]: gp91phox, also known as NOX2, is the catalytic subunit of the NOX2 complex, not a non-catalytic subunit. It facilitates the transfer of electrons from NADPH to oxygen, generating ROS. It is not associated with NOX5.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 1944,
    "user_query": "What is the connection between furin and hepcidin?",
    "llama-7b_response": "Furin and hepcidin are two different proteins that have no direct connection with each other. Furin is a protein that is involved in the processing and activation of other proteins, while hepcidin is a protein that regulates iron absorption and homeostasis in the body. \nHepcidin is produced by hepatocytes in the liver and is released into the bloodstream. It binds to iron and prevents it from being absorbed from the gut. Furin is not involved in the regulation of iron absorption or homeostasis. \nIn summary, while furin and hepcidin are two different proteins, they have no direct connection with each other. Furin is involved in the processing and activation of other proteins, while hepcidin regulates iron absorption and homeostasis in the body.",
    "llama-7b_fact_raw": "1. Furin is a protein involved in the processing and activation of other proteins.\n2. Hepcidin is a protein that regulates iron absorption and homeostasis in the body.\n3. Hepcidin is produced by hepatocytes in the liver.\n4. Hepcidin is released into the bloodstream and binds to iron to prevent its absorption from the gut.\n5. Furin is not involved in the regulation of iron absorption or homeostasis.",
    "llama-7b_fact": [
      "Furin is a protein involved in the processing and activation of other proteins.",
      "Hepcidin is a protein that regulates iron absorption and homeostasis in the body.",
      "Hepcidin is produced by hepatocytes in the liver.",
      "Hepcidin is released into the bloodstream and binds to iron to prevent its absorption from the gut.",
      "Furin is not involved in the regulation of iron absorption or homeostasis."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Hepcidin is released into the bloodstream and binds to the iron transporter ferroportin, causing its internalization and degradation, which prevents iron absorption from the gut.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 1956,
    "user_query": "Which is the largest metabolic gene cluster in yeast?",
    "llama-7b_response": "The largest metabolic gene cluster in yeast is the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene cluster, also known as the glyceraldehyde-3-phosphate dehydrogenase (G3PDH) gene cluster. It is located on chromosome XII of the Saccharomyces cerevisiae genome and consists of 13 genes that are involved in glycolysis and the pentose phosphate pathway. The GAPDH gene cluster is the largest metabolic gene cluster in yeast because it contains the most genes involved in metabolic processes.",
    "llama-7b_fact_raw": "1. The largest metabolic gene cluster in yeast is the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene cluster.\n2. This gene cluster is also known as the glyceraldehyde-3-phosphate dehydrogenase (G3PDH) gene cluster.\n3. It is located on chromosome XII of the Saccharomyces cerevisiae genome.\n4. The GAPDH gene cluster consists of 13 genes.\n5. These genes are involved in glycolysis and the pentose phosphate pathway.",
    "llama-7b_fact": [
      "The largest metabolic gene cluster in yeast is the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene cluster.",
      "This gene cluster is also known as the glyceraldehyde-3-phosphate dehydrogenase (G3PDH) gene cluster.",
      "It is located on chromosome XII of the Saccharomyces cerevisiae genome.",
      "The GAPDH gene cluster consists of 13 genes.",
      "These genes are involved in glycolysis and the pentose phosphate pathway."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 1967,
    "user_query": "What is the role of LIMT lncRNA?",
    "llama-7b_response": "LIMT lncRNA, also known as long intergenic non-coding RNA, is a non-coding RNA molecule that has been found to play a crucial role in various biological processes. One of the primary functions of LIMT lncRNA is to regulate gene expression by interacting with chromatin-modifying proteins and other transcriptional regulators.\n\nRecent studies have shown that LIMT lncRNA is involved in several important biological processes, including cell proliferation, differentiation, and apoptosis. For example, LIMT lncRNA has been found to promote cell proliferation by regulating the expression of genes involved in cell cycle progression. Additionally, LIMT lncRNA has been shown to play a role in cell differentiation by regulating the expression of genes involved in cell fate determination.\n\nFurthermore, LIMT lncRNA has also been implicated in the regulation of apoptosis, or programmed cell death. Studies have shown that LIMT lncRNA can promote apoptosis by regulating the expression of genes involved in the intrinsic apoptotic pathway.\n\nOverall, the role of LIMT lncRNA is complex and multifaceted, and further research is needed to fully understand the scope of its biological functions. However, it is clear that LIMT lncRNA plays an important role in regulating gene expression and participating in various biological processes.",
    "llama-7b_fact_raw": "1. LIMT lncRNA is a long intergenic non-coding RNA molecule.\n2. LIMT lncRNA regulates gene expression by interacting with chromatin-modifying proteins and transcriptional regulators.\n3. LIMT lncRNA is involved in cell proliferation by regulating the expression of genes involved in cell cycle progression.\n4. LIMT lncRNA plays a role in cell differentiation by regulating the expression of genes involved in cell fate determination.\n5. LIMT lncRNA has been implicated in the regulation of apoptosis by affecting the expression of genes in the intrinsic apoptotic pathway.",
    "llama-7b_fact": [
      "LIMT lncRNA is a long intergenic non-coding RNA molecule.",
      "LIMT lncRNA regulates gene expression by interacting with chromatin-modifying proteins and transcriptional regulators.",
      "LIMT lncRNA is involved in cell proliferation by regulating the expression of genes involved in cell cycle progression.",
      "LIMT lncRNA plays a role in cell differentiation by regulating the expression of genes involved in cell fate determination.",
      "LIMT lncRNA has been implicated in the regulation of apoptosis by affecting the expression of genes in the intrinsic apoptotic pathway."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe statements about LIMT lncRNA being a long intergenic non-coding RNA molecule and that it regulates gene expression by interacting with chromatin-modifying proteins and transcriptional regulators are generally consistent with the known functions of lncRNAs. However, without specific references to research on LIMT lncRNA, the statements regarding its involvement in cell proliferation, cell differentiation, and the regulation of apoptosis are difficult to verify and thus are marked as UNKNOWN.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 1984,
    "user_query": "Which R / bioconductor package is used for performing SNP enrichment analysis?",
    "llama-7b_response": "The R / bioconductor package used for performing SNP enrichment analysis is called \"Enrichr\". It is a web-based tool that allows users to enrich for genetic variants of interest, such as single nucleotide polymorphisms (SNPs), in a given dataset. Enrichr uses a combination of statistical and functional annotation approaches to identify genetic variants that are significantly associated with a particular trait or disease. It is designed to be user-friendly and intuitive, with a simple web interface that allows users to upload their own datasets or use pre-built datasets from the Enrichr database. Enrichr also provides a range of customization options, such as selecting specific genes or pathways to enrich for, and adjusting the threshold for statistical significance. Overall, Enrichr is a powerful and flexible tool for performing SNP enrichment analysis in R / bioconductor.",
    "llama-7b_fact_raw": "1. The R / bioconductor package used for performing SNP enrichment analysis is called \"Enrichr\".\n2. Enrichr is a web-based tool.\n3. Enrichr allows users to enrich for genetic variants, such as single nucleotide polymorphisms (SNPs), in a dataset.\n4. Enrichr uses statistical and functional annotation approaches to identify genetic variants associated with traits or diseases.\n5. Enrichr provides customization options, including selecting specific genes or pathways and adjusting the threshold for statistical significance.",
    "llama-7b_fact": [
      "The R / bioconductor package used for performing SNP enrichment analysis is called \"Enrichr\".",
      "Enrichr is a web-based tool.",
      "Enrichr allows users to enrich for genetic variants, such as single nucleotide polymorphisms (SNPs), in a dataset.",
      "Enrichr uses statistical and functional annotation approaches to identify genetic variants associated with traits or diseases.",
      "Enrichr provides customization options, including selecting specific genes or pathways and adjusting the threshold for statistical significance."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The R / bioconductor package used for performing SNP enrichment analysis is not called \"Enrichr\". A package for this purpose could be \"SNPsea\" or other specialized packages in Bioconductor, but not \"Enrichr\".\n2. TRUE: Enrichr is indeed a web-based tool for gene set enrichment analysis.\n3. FALSE [correction]: Enrichr is designed for gene set enrichment analysis, not specifically for enriching genetic variants like SNPs. It is used to find associations between gene sets and biological pathways, diseases, or functions.\n4. TRUE: While Enrichr is not for SNP enrichment, it does use statistical and functional annotation approaches to identify associations of gene sets with traits or diseases.\n5. TRUE: Enrichr provides customization options for users to select specific genes or pathways and adjust the threshold for statistical significance in the context of gene set enrichment analysis.",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2015,
    "user_query": "Which are the key players on radial glial specification to ependymal cells?",
    "llama-7b_response": "The key players on radial glial specification to ependymal cells are transcription factors. Specifically, the transcription factor Sox2 is crucial for the specification of radial glial cells and their subsequent differentiation into ependymal cells. Other transcription factors that have been implicated in this process include Olig2, Nkx2.2, and Emx2. These transcription factors work in concert to activate genes that are necessary for the development of ependymal cells, such as genes involved in cell-cell adhesion, cytoskeletal organization, and ion channel formation. Additionally, signaling molecules such as Wnt and Notch also play important roles in regulating radial glial specification and ependymal cell differentiation.",
    "llama-7b_fact_raw": "1. The transcription factor Sox2 is crucial for the specification of radial glial cells and their differentiation into ependymal cells.\n2. Other transcription factors involved in radial glial specification to ependymal cells include Olig2, Nkx2.2, and Emx2.\n3. These transcription factors activate genes necessary for the development of ependymal cells.\n4. Genes involved in cell-cell adhesion, cytoskeletal organization, and ion channel formation are important for ependymal cell development.\n5. Signaling molecules such as Wnt and Notch play roles in regulating radial glial specification and ependymal cell differentiation.",
    "llama-7b_fact": [
      "The transcription factor Sox2 is crucial for the specification of radial glial cells and their differentiation into ependymal cells.",
      "Other transcription factors involved in radial glial specification to ependymal cells include Olig2, Nkx2.2, and Emx2.",
      "These transcription factors activate genes necessary for the development of ependymal cells.",
      "Genes involved in cell-cell adhesion, cytoskeletal organization, and ion channel formation are important for ependymal cell development.",
      "Signaling molecules such as Wnt and Notch play roles in regulating radial glial specification and ependymal cell differentiation."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided are specific to the field of developmental neurobiology, and without the specific context or reference to the latest research, it is difficult to confirm the accuracy of statement 2. However, Sox2's role in neural development, the importance of gene activation for ependymal cell development, the relevance of genes involved in cell-cell adhesion, cytoskeletal organization, and ion channel formation, as well as the roles of signaling molecules like Wnt and Notch in neural development, are well-established concepts in the field.",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2065,
    "user_query": "How are triple negative gliomas characterized?",
    "llama-7b_response": "Triple negative gliomas are a type of brain tumor that are characterized by the absence of three key proteins: estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). These proteins are typically found in normal brain tissue and are important in regulating cell growth and division. The absence of these proteins in triple negative gliomas suggests that these tumors may be more aggressive and difficult to treat compared to other types of gliomas.\nIn addition to the absence of these proteins, triple negative gliomas may also be characterized by the presence of certain genetic abnormalities, such as mutations in the IDH1 or IDH2 genes. These mutations can lead to the production of abnormal proteins that may contribute to the growth and spread of the tumor.\nOther characteristics that may be present in triple negative gliomas include a high-grade tumor histology, which means that the tumor cells appear more abnormal and aggressive under the microscope, and the presence of necrosis, or dead tissue, within the tumor.\nOverall, the diagnosis of triple negative gliomas is typically made based on a combination of clinical and pathological features, including the absence of ER, PR, and HER2 proteins, the presence of genetic abnormalities such as IDH1 or IDH2 mutations, and the presence of high-grade tumor histology and necrosis.",
    "llama-7b_fact_raw": "1. Triple negative gliomas are characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).\n2. These proteins (ER, PR, HER2) are typically found in normal brain tissue.\n3. Triple negative gliomas may have mutations in the IDH1 or IDH2 genes.\n4. High-grade tumor histology, indicating more abnormal and aggressive cells, may be a characteristic of triple negative gliomas.\n5. Necrosis within the tumor can be a characteristic of triple negative gliomas.",
    "llama-7b_fact": [
      "Triple negative gliomas are characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).",
      "These proteins (ER, PR, HER2) are typically found in normal brain tissue.",
      "Triple negative gliomas may have mutations in the IDH1 or IDH2 genes.",
      "High-grade tumor histology, indicating more abnormal and aggressive cells, may be a characteristic of triple negative gliomas.",
      "Necrosis within the tumor can be a characteristic of triple negative gliomas."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Triple negative gliomas are characterized by the absence of specific biomarkers, but the term \"triple negative\" is more commonly associated with breast cancer, not gliomas. Gliomas are typically characterized by other molecular markers, not ER, PR, and HER2.\n2. FALSE [correction]: ER, PR, and HER2 are proteins typically associated with breast tissue, not normal brain tissue.\n3. TRUE: Gliomas, including some triple negative ones, may have mutations in the IDH1 or IDH2 genes, which are often associated with better prognosis in gliomas.\n4. TRUE: High-grade tumor histology is often a characteristic of more aggressive gliomas, which can include triple negative gliomas.\n5. TRUE: Necrosis within the tumor is a feature that can be associated with high-grade, more aggressive gliomas, including potentially triple negative gliomas.",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2069,
    "user_query": "What is TOPAZ1?",
    "llama-7b_response": "TOPAZ1 is a cryptographic algorithm developed by Microsoft that is used to encrypt and decrypt data. It is a symmetric encryption algorithm that uses a single key to both encrypt and decrypt data. TOPAZ1 is designed to be fast and efficient, making it ideal for use in applications that require real-time encryption and decryption of data. TOPAZ1 is also designed to be secure and resistant to attacks, making it a popular choice for encrypting sensitive data.",
    "llama-7b_fact_raw": "1. TOPAZ1 is a cryptographic algorithm developed by Microsoft.\n2. TOPAZ1 is used to encrypt and decrypt data.\n3. It is a symmetric encryption algorithm that uses a single key for both encryption and decryption.\n4. TOPAZ1 is designed to be fast and efficient for real-time encryption and decryption.\n5. TOPAZ1 is intended to be secure and resistant to attacks.",
    "llama-7b_fact": [
      "TOPAZ1 is a cryptographic algorithm developed by Microsoft.",
      "TOPAZ1 is used to encrypt and decrypt data.",
      "It is a symmetric encryption algorithm that uses a single key for both encryption and decryption.",
      "TOPAZ1 is designed to be fast and efficient for real-time encryption and decryption.",
      "TOPAZ1 is intended to be secure and resistant to attacks."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: There is no widely recognized cryptographic algorithm known as TOPAZ1 developed by Microsoft or any other entity. It's possible that TOPAZ1 is a fictional or proprietary algorithm not publicly known.\n2. UNKNOWN: Since TOPAZ1 is not a recognized cryptographic algorithm, its use to encrypt and decrypt data cannot be confirmed.\n3. UNKNOWN: Without confirmation of the existence of TOPAZ1, the details of whether it is a symmetric encryption algorithm cannot be determined.\n4. UNKNOWN: The design intentions regarding speed and efficiency for TOPAZ1 cannot be confirmed without more information about the algorithm.\n5. UNKNOWN: The security and resistance to attacks of TOPAZ1 cannot be evaluated without further information on the algorithm.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2075,
    "user_query": "Which gene controls the expression of GATA-1 isoforms?",
    "llama-7b_response": "The gene that controls the expression of GATA-1 isoforms is GATA1. GATA-1 is a transcription factor that plays a crucial role in the development and function of various tissues, including the heart, kidneys, and blood cells. GATA-1 isoforms are generated by alternative splicing of its mRNA, which results in the production of multiple protein isoforms with different amino acid sequences and biological functions. The expression of GATA-1 isoforms is regulated by a variety of factors, including transcriptional activators and repressors, post-transcriptional modifications, and protein-protein interactions. The precise mechanisms underlying the regulation of GATA-1 isoform expression remain poorly understood, but ongoing research in this area is shedding new light on this important topic.",
    "llama-7b_fact_raw": "1. The GATA1 gene controls the expression of GATA-1 isoforms.\n2. GATA-1 is a transcription factor involved in the development and function of the heart, kidneys, and blood cells.\n3. GATA-1 isoforms are generated by alternative splicing of the GATA1 mRNA.\n4. The expression of GATA-1 isoforms is regulated by transcriptional activators and repressors, post-transcriptional modifications, and protein-protein interactions.\n5. The regulation of GATA-1 isoform expression is not fully understood.",
    "llama-7b_fact": [
      "The GATA1 gene controls the expression of GATA-1 isoforms.",
      "GATA-1 is a transcription factor involved in the development and function of the heart, kidneys, and blood cells.",
      "GATA-1 isoforms are generated by alternative splicing of the GATA1 mRNA.",
      "The expression of GATA-1 isoforms is regulated by transcriptional activators and repressors, post-transcriptional modifications, and protein-protein interactions.",
      "The regulation of GATA-1 isoform expression is not fully understood."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: GATA-1 is a transcription factor primarily involved in the development and function of erythroid and megakaryocytic lineages, not the heart and kidneys.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2076,
    "user_query": "What is MIRA-seq?",
    "llama-7b_response": "MIRA-seq (Micrococcal Nuclease-mediated Integration of Randomly Spliced Adenovirus) is a high-throughput sequencing technique that allows researchers to analyze the splicing patterns of RNA transcripts in a genome-wide manner. \n\nMIRA-seq involves the use of micrococcal nuclease (MNase) to digest RNA transcripts into smaller fragments that can be separated based on their length. The resulting fragments are then sequenced using high-throughput sequencing technologies such as Illumina or PacBio. \n\nThe advantage of MIRA-seq over other RNA sequencing techniques is that it allows researchers to analyze the splicing patterns of RNA transcripts in a genome-wide manner. Splicing is the process by which introns are removed from pre-mRNA transcripts and exons are joined together to form a mature mRNA molecule. MIRA-seq can detect the presence of alternative splicing events, which occur when different exons are included or excluded from the final mature mRNA transcript. \n\nMIRA-seq has been used to study a variety of biological processes, including gene expression, alternative splicing, and RNA editing. It has also been used to identify genes and pathways involved in diseases such as cancer and neurological disorders. Overall, MIRA-seq is a powerful tool for analyzing RNA splicing patterns and has the potential to revolutionize our understanding of RNA biology.",
    "llama-7b_fact_raw": "1. MIRA-seq stands for Micrococcal Nuclease-mediated Integration of Randomly Spliced Adenovirus.\n2. MIRA-seq is a high-throughput sequencing technique used to analyze RNA splicing patterns genome-wide.\n3. Micrococcal nuclease (MNase) is used in MIRA-seq to digest RNA transcripts into smaller fragments.\n4. High-throughput sequencing technologies such as Illumina or PacBio are used to sequence the fragments in MIRA-seq.\n5. MIRA-seq can detect alternative splicing events in RNA transcripts.",
    "llama-7b_fact": [
      "MIRA-seq stands for Micrococcal Nuclease-mediated Integration of Randomly Spliced Adenovirus.",
      "MIRA-seq is a high-throughput sequencing technique used to analyze RNA splicing patterns genome-wide.",
      "Micrococcal nuclease (MNase) is used in MIRA-seq to digest RNA transcripts into smaller fragments.",
      "High-throughput sequencing technologies such as Illumina or PacBio are used to sequence the fragments in MIRA-seq.",
      "MIRA-seq can detect alternative splicing events in RNA transcripts."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: MIRA-seq stands for Methylation-dependent Isolation by Restriction Enzyme Analysis sequencing.\n2. FALSE [correction]: MIRA-seq is a high-throughput sequencing technique used to analyze DNA methylation patterns genome-wide, not RNA splicing patterns.\n3. FALSE [correction]: In MIRA-seq, micrococcal nuclease (MNase) is not used to digest RNA transcripts; instead, a methylation-sensitive restriction enzyme is used to digest genomic DNA to study methylation patterns.\n4. TRUE: High-throughput sequencing technologies such as Illumina or PacBio can be used to sequence the fragments in MIRA-seq, as well as in other sequencing techniques.\n5. FALSE [correction]: MIRA-seq is used to detect DNA methylation, not alternative splicing events in RNA transcripts. Alternative splicing events are typically studied using RNA-seq.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2108,
    "user_query": "What is the indication of ARCALYST?",
    "llama-7b_response": "ARCALYST is an injectable medication that is used to treat a rare autoimmune disorder called systemic juvenile idiopathic arthritis (sJIA). sJIA is a chronic condition that affects children and teenagers, and it causes joint pain, swelling, and stiffness. ARCALYST works by suppressing the immune system, which helps to reduce the inflammation and symptoms of sJIA.\n\nIt is important to note that ARCALYST is not a cure for sJIA, and it must be continued indefinitely to maintain symptom control. Additionally, ARCALYST can have serious side effects, including an increased risk of infections and cancer. Therefore, it is important to carefully weigh the benefits and risks of using ARCALYST with your healthcare provider before starting treatment.",
    "llama-7b_fact_raw": "1. ARCALYST is an injectable medication used to treat systemic juvenile idiopathic arthritis (sJIA).\n2. Systemic juvenile idiopathic arthritis affects children and teenagers.\n3. ARCALYST works by suppressing the immune system to reduce inflammation and symptoms of sJIA.\n4. ARCALYST is not a cure for sJIA and must be continued indefinitely to maintain symptom control.\n5. ARCALYST can have serious side effects, including an increased risk of infections and cancer.",
    "llama-7b_fact": [
      "ARCALYST is an injectable medication used to treat systemic juvenile idiopathic arthritis (sJIA).",
      "Systemic juvenile idiopathic arthritis affects children and teenagers.",
      "ARCALYST works by suppressing the immune system to reduce inflammation and symptoms of sJIA.",
      "ARCALYST is not a cure for sJIA and must be continued indefinitely to maintain symptom control.",
      "ARCALYST can have serious side effects, including an increased risk of infections and cancer."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The need for ongoing treatment with ARCALYST depends on the patient's response and the doctor's recommendation; it is not necessarily required to be continued indefinitely for all patients.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 2170,
    "user_query": "List the human acrocentric chromosomes that are involved in Robertsonian translocation.",
    "llama-7b_response": "Robertsonian translocation is a type of chromosomal rearrangement that involves the fusion of two acrocentric chromosomes. The human acrocentric chromosomes are chromosomes 5, 16, 21, and 22. In a Robertsonian translocation, the short arm of one acrocentric chromosome fuses with the long arm of another acrocentric chromosome. \nFor example, in a Robertsonian translocation involving chromosomes 5 and 16, the short arm of chromosome 5 fuses with the long arm of chromosome 16. This results in the formation of a derivative chromosome 16, which has a short arm derived from chromosome 5 and a long arm derived from chromosome 16. The derivative chromosome 16 is then balanced by a reciprocal translocation involving the long arm of chromosome 16 and the short arm of another acrocentric chromosome, such as chromosome 21 or 22. \nTherefore, in a Robertsonian translocation involving acrocentric chromosomes, the short arm of one acrocentric chromosome fuses with the long arm of another acrocentric chromosome to form a derivative chromosome. The derivative chromosome is then balanced by a reciprocal translocation involving the long arm of another acrocentric chromosome and the short arm of another acrocentric chromosome.",
    "llama-7b_fact_raw": "1. Robertsonian translocation involves the fusion of two acrocentric chromosomes.\n2. The human acrocentric chromosomes are chromosomes 13, 14, 15, 21, and 22.\n3. In a Robertsonian translocation, the short arm of one acrocentric chromosome fuses with the long arm of another acrocentric chromosome.\n4. The derivative chromosome formed in a Robertsonian translocation has a short arm derived from one acrocentric chromosome and a long arm derived from another acrocentric chromosome.\n5. The derivative chromosome in a Robertsonian translocation is balanced by a reciprocal translocation involving the long arm of another acrocentric chromosome and the short arm of another acrocentric chromosome.",
    "llama-7b_fact": [
      "Robertsonian translocation involves the fusion of two acrocentric chromosomes.",
      "The human acrocentric chromosomes are chromosomes 13, 14, 15, 21, and 22.",
      "In a Robertsonian translocation, the short arm of one acrocentric chromosome fuses with the long arm of another acrocentric chromosome.",
      "The derivative chromosome formed in a Robertsonian translocation has a short arm derived from one acrocentric chromosome and a long arm derived from another acrocentric chromosome.",
      "The derivative chromosome in a Robertsonian translocation is balanced by a reciprocal translocation involving the long arm of another acrocentric chromosome and the short arm of another acrocentric chromosome."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: In a Robertsonian translocation, the long arms of two acrocentric chromosomes fuse together, typically resulting in the loss of the short arms.\n4. TRUE\n5. FALSE [correction]: The derivative chromosome in a Robertsonian translocation is not balanced by a reciprocal translocation. Instead, it is typically the result of the fusion of the long arms of two acrocentric chromosomes, and the short arms are usually lost. A reciprocal translocation, on the other hand, involves the exchange of segments between two non-homologous chromosomes and is a different type of chromosomal rearrangement.",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2237,
    "user_query": "Which R package could be used for the identification of pediatric brain tumors?",
    "llama-7b_response": "There is no single R package that can be used for the identification of pediatric brain tumors. However, there are several R packages that can be used for analyzing and visualizing medical data related to brain tumors. Some of the popular R packages for medical data analysis include:\n1. ggplot2: This package is used for creating high-quality graphs and charts.\n2. dplyr: This package is used for data manipulation and filtering.\n3. tidyr: This package is used for data tidying and reshaping.\n4. caret: This package is used for machine learning and predictive modeling.\n5. tidyverse: This package is a suite of R packages that includes ggplot2, dplyr, tidyr, and caret.\nTo identify pediatric brain tumors, one would need to collect and analyze data related to the tumors, such as patient demographics, tumor location, size, and type, as well as treatment outcomes and survival rates. This data can then be analyzed using various statistical methods and visualized using R packages such as ggplot2 and tidyverse. However, it is important to note that the identification of pediatric brain tumors is a complex medical process that requires the expertise of trained medical professionals.",
    "llama-7b_fact_raw": "1. ggplot2 is an R package used for creating graphs and charts.\n2. dplyr is an R package used for data manipulation and filtering.\n3. tidyr is an R package used for data tidying and reshaping.\n4. caret is an R package used for machine learning and predictive modeling.\n5. tidyverse is a suite of R packages that includes ggplot2, dplyr, tidyr, and caret.",
    "llama-7b_fact": [
      "ggplot2 is an R package used for creating graphs and charts.",
      "dplyr is an R package used for data manipulation and filtering.",
      "tidyr is an R package used for data tidying and reshaping.",
      "caret is an R package used for machine learning and predictive modeling.",
      "tidyverse is a suite of R packages that includes ggplot2, dplyr, tidyr, and caret."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: tidyverse is a suite of R packages that includes ggplot2, dplyr, and tidyr, but does not include caret. Caret is not part of the tidyverse collection.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 2246,
    "user_query": "Is NEMO a zinc finger protein?",
    "llama-7b_response": "No, NEMO is not a zinc finger protein. NEMO is an acronym for Nuclear Factor of Activated T Cells, which is a transcription factor that plays a crucial role in the signaling pathway of T cells. Zinc finger proteins, on the other hand, are a family of proteins that contain a zinc-binding motif called a zinc finger. These proteins are involved in a variety of cellular processes, including transcription regulation, DNA repair, and protein-protein interactions. While NEMO and zinc finger proteins share some similarities in their biological functions, they are distinct proteins with different structures and mechanisms of action.",
    "llama-7b_fact_raw": "1. NEMO is an acronym for Nuclear Factor of Activated T Cells.\n2. NEMO is a transcription factor involved in the signaling pathway of T cells.\n3. Zinc finger proteins contain a zinc-binding motif called a zinc finger.\n4. Zinc finger proteins are involved in transcription regulation, DNA repair, and protein-protein interactions.\n5. NEMO and zinc finger proteins are distinct proteins with different structures and mechanisms of action.",
    "llama-7b_fact": [
      "NEMO is an acronym for Nuclear Factor of Activated T Cells.",
      "NEMO is a transcription factor involved in the signaling pathway of T cells.",
      "Zinc finger proteins contain a zinc-binding motif called a zinc finger.",
      "Zinc finger proteins are involved in transcription regulation, DNA repair, and protein-protein interactions.",
      "NEMO and zinc finger proteins are distinct proteins with different structures and mechanisms of action."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: NEMO is an acronym for NF-kappaB Essential Modulator.\n2. FALSE [correction]: NEMO is not a transcription factor itself but is a regulatory protein that is part of the NF-kappaB signaling pathway.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2247,
    "user_query": "Does TFIIS affect nucleosome positioning?",
    "llama-7b_response": "Yes, TFIIS (Transcription Factor IIS) can affect nucleosome positioning. TFIIS is a general transcription factor that is involved in the initiation of RNA polymerase II-mediated transcription. It binds to the promoter region of a gene and facilitates the assembly of the pre-initiation complex, which consists of RNA polymerase II, TFIIA, TFIIB, TFIIE, TFIIF, and TFIIS.\nThe assembly of the pre-initiation complex is a critical step in the process of gene expression. The positioning of nucleosomes around the promoter region of a gene can affect the ability of RNA polymerase II to initiate transcription. Nucleosomes are composed of histone proteins and DNA, and they compact DNA into chromatin, which makes it more difficult for RNA polymerase II to access the promoter region and initiate transcription.\nTFIIS has been shown to play a role in the remodeling of chromatin and the movement of nucleosomes. It has been reported that TFIIS can interact with histone-modifying enzymes, such as histone acetyltransferases and histone deacetylases, which can affect the acetylation and deacetylation of histones. These modifications can alter the structure of chromatin and make it more or less accessible to RNA polymerase II.\nIn summary, TFIIS can affect nucleosome positioning by interacting with histone-modifying enzymes and remodeling chromatin structure, which can either facilitate or hinder the ability of RNA polymerase II to initiate transcription.",
    "llama-7b_fact_raw": "1. TFIIS is involved in the initiation of RNA polymerase II-mediated transcription.\n2. TFIIS binds to the promoter region of a gene and facilitates the assembly of the pre-initiation complex.\n3. The pre-initiation complex includes RNA polymerase II, TFIIA, TFIIB, TFIIE, TFIIF, and TFIIS.\n4. Nucleosomes, which are composed of histone proteins and DNA, compact DNA into chromatin.\n5. TFIIS can interact with histone-modifying enzymes, affecting the acetylation and deacetylation of histones.",
    "llama-7b_fact": [
      "TFIIS is involved in the initiation of RNA polymerase II-mediated transcription.",
      "TFIIS binds to the promoter region of a gene and facilitates the assembly of the pre-initiation complex.",
      "The pre-initiation complex includes RNA polymerase II, TFIIA, TFIIB, TFIIE, TFIIF, and TFIIS.",
      "Nucleosomes, which are composed of histone proteins and DNA, compact DNA into chromatin.",
      "TFIIS can interact with histone-modifying enzymes, affecting the acetylation and deacetylation of histones."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: TFIIS is involved in the elongation phase of RNA polymerase II-mediated transcription, not the initiation.\n2. FALSE [correction]: TFIIS does not bind to the promoter region to facilitate the assembly of the pre-initiation complex; it is involved in the process of transcription elongation by enhancing the RNA polymerase II's ability to read through transcriptional blocks.\n3. FALSE [correction]: The pre-initiation complex includes RNA polymerase II, TFIIA, TFIIB, TFIIE, TFIIF, and TFIID (not TFIIS).\n4. TRUE\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2262,
    "user_query": "Do origins of replication close to yeast centromeres fire early or late?",
    "llama-7b_response": "The answer to the question \"Do origins of replication close to yeast centromeres fire early or late?\" depends on the context in which it is being asked. \nIf the question is referring to the timing of replication initiation at specific origins of replication in yeast cells, then the answer is that the timing of replication initiation can vary depending on the specific origin of replication and the cell cycle stage. \nHowever, if the question is referring to the location of origins of replication relative to yeast centromeres, then the answer is that many origins of replication are located close to yeast centromeres. In fact, many yeast chromosomes have multiple origins of replication that are clustered near the centromere. \nIn general, origins of replication that are located closer to the centromere tend to fire earlier in the cell cycle than origins that are located further away from the centromere. This is because origins that are closer to the centromere are typically associated with regions of the chromosome that are actively being duplicated during S phase, while origins that are further away from the centromere may be associated with regions of the chromosome that are being replicated less frequently or not at all. \nOverall, the answer to the question \"Do origins of replication close to yeast centromeres fire early or late?\" is that it can vary depending on the specific origin of replication and the cell cycle stage, but many origins of replication that are located close to yeast centromeres tend to fire earlier in the cell cycle.",
    "llama-7b_fact_raw": "1. Many origins of replication are located close to yeast centromeres.\n2. Yeast chromosomes often have multiple origins of replication clustered near the centromere.\n3. Origins of replication closer to the centromere generally fire earlier in the cell cycle.\n4. The timing of replication initiation at specific origins of replication in yeast cells can vary depending on the cell cycle stage.\n5. Origins of replication that are further away from the centromere may be associated with regions of the chromosome that are replicated less frequently or not at all.",
    "llama-7b_fact": [
      "Many origins of replication are located close to yeast centromeres.",
      "Yeast chromosomes often have multiple origins of replication clustered near the centromere.",
      "Origins of replication closer to the centromere generally fire earlier in the cell cycle.",
      "The timing of replication initiation at specific origins of replication in yeast cells can vary depending on the cell cycle stage.",
      "Origins of replication that are further away from the centromere may be associated with regions of the chromosome that are replicated less frequently or not at all."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Many origins of replication are not typically located close to yeast centromeres; they are usually distributed throughout the chromosome.\n2. FALSE [correction]: Yeast chromosomes do not often have multiple origins of replication clustered near the centromere; instead, origins of replication are usually interspersed along the chromosomes.\n3. FALSE [correction]: Origins of replication closer to the centromere do not generally fire earlier in the cell cycle; the timing of replication initiation can be influenced by various factors, but proximity to the centromere is not a general rule for the timing of origin firing.\n4. TRUE: The timing of replication initiation at specific origins of replication in yeast cells can indeed vary depending on the cell cycle stage and other regulatory mechanisms.\n5. FALSE [correction]: Origins of replication that are further away from the centromere are not necessarily associated with regions of the chromosome that are replicated less frequently or not at all; all origins are part of the replication program and are typically used during the replication process, although the timing may vary.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2268,
    "user_query": "Which are the properties of mammalian GA-sequences?",
    "llama-7b_response": "Mammalian GA-sequences are characterized by the following properties:\n1. They are composed of three nucleotide bases: Adenine (A), Thymine (T), and Guanine (G).\n2. The sequence of nucleotides in a GA-sequence can be read in either direction, from 5' to 3' or from 3' to 5'.\n3. The sequence of nucleotides in a GA-sequence is always complementary to itself, meaning that if you read the sequence 5' to 3', the complement of that sequence would be read from 3' to 5'.\n4. The sequence of nucleotides in a GA-sequence can form hydrogen bonds with complementary sequences, which allows for the formation of double-stranded DNA.\n5. The length of a GA-sequence can vary from a few nucleotides to millions of nucleotides.\n6. Mammalian GA-sequences are organized into chromosomes, which are found in the nucleus of cells and carry genetic information.\n7. The sequence of nucleotides in a GA-sequence can determine the traits of an organism, such as eye color, height, and susceptibility to certain diseases.",
    "llama-7b_fact_raw": "1. Mammalian GA-sequences are composed of three nucleotide bases: Adenine (A), Thymine (T), and Guanine (G).\n2. The sequence of nucleotides in a GA-sequence can be read in either direction, from 5' to 3' or from 3' to 5'.\n3. The sequence of nucleotides in a GA-sequence is always complementary to itself.\n4. The sequence of nucleotides in a GA-sequence can form hydrogen bonds with complementary sequences.\n5. Mammalian GA-sequences are organized into chromosomes, which are found in the nucleus of cells.",
    "llama-7b_fact": [
      "Mammalian GA-sequences are composed of three nucleotide bases: Adenine (A), Thymine (T), and Guanine (G).",
      "The sequence of nucleotides in a GA-sequence can be read in either direction, from 5' to 3' or from 3' to 5'.",
      "The sequence of nucleotides in a GA-sequence is always complementary to itself.",
      "The sequence of nucleotides in a GA-sequence can form hydrogen bonds with complementary sequences.",
      "Mammalian GA-sequences are organized into chromosomes, which are found in the nucleus of cells."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Mammalian genetic sequences are composed of four nucleotide bases: Adenine (A), Thymine (T), Guanine (G), and Cytosine (C).\n2. TRUE\n3. FALSE [correction]: The sequence of nucleotides in a DNA strand is complementary to its partner strand, not to itself. For example, Adenine (A) pairs with Thymine (T), and Guanine (G) pairs with Cytosine (C).\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2291,
    "user_query": "How many Groucho-related genes (GRG) are contained in the mouse genome?",
    "llama-7b_response": "I'm sorry, but there is no gene in the mouse genome that is specifically named \"Groucho.\" However, there are several genes that are related to the Groucho family of genes, which are known to play a role in embryonic development and cell-cell communication. \nThe Groucho family of genes is named after the Drosophila melanogaster gene called \"Groucho,\" which is involved in embryonic development and cell-cell communication. The Groucho family of genes includes several related genes that are found in many different organisms, including mice. \nIn the mouse genome, there are several genes that are related to the Groucho family of genes, including Grb10, Grb14, Grb17, and Grb20. These genes are all involved in different aspects of embryonic development and cell-cell communication, and they share some similarities with the Groucho gene in Drosophila melanogaster. \nHowever, it is important to note that these genes are not specifically named \"Groucho\" and they are not located in the same region of the mouse genome as the Groucho gene in Drosophila melanogaster.",
    "llama-7b_fact_raw": "1. There is no gene specifically named \"Groucho\" in the mouse genome.\n2. The Groucho family of genes is named after the Drosophila melanogaster gene \"Groucho.\"\n3. The Groucho gene in Drosophila melanogaster is involved in embryonic development and cell-cell communication.\n4. Genes related to the Groucho family, such as Grb10, Grb14, Grb17, and Grb20, are found in the mouse genome.\n5. The genes Grb10, Grb14, Grb17, and Grb20 in the mouse genome are involved in embryonic development and cell-cell communication.",
    "llama-7b_fact": [
      "There is no gene specifically named \"Groucho\" in the mouse genome.",
      "The Groucho family of genes is named after the Drosophila melanogaster gene \"Groucho.\"",
      "The Groucho gene in Drosophila melanogaster is involved in embryonic development and cell-cell communication.",
      "Genes related to the Groucho family, such as Grb10, Grb14, Grb17, and Grb20, are found in the mouse genome.",
      "The genes Grb10, Grb14, Grb17, and Grb20 in the mouse genome are involved in embryonic development and cell-cell communication."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: There are no genes named Grb17 and Grb20 in the mouse genome. The correct names for the related genes in the mouse genome are Grb10 and Grb14, which are part of the growth factor receptor-bound protein family.\n5. FALSE [correction]: While Grb10 and Grb14 are indeed involved in cellular signaling processes, they are not directly related to the Groucho family of genes and their specific roles may differ from those of the Drosophila Groucho gene. Grb10 and Grb14 are more specifically involved in growth factor receptor signaling rather than general embryonic development and cell-cell communication. Additionally, there are no genes named Grb17 and Grb20.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2304,
    "user_query": "Which RNA polymerase II subunit carries RNA cleavage activity?",
    "llama-7b_response": "RNA cleavage activity is carried out by a specific subunit of RNA polymerase II, which is called the RNase III (RNAase III) subunit. RNase III is a conserved enzyme that is found in all eukaryotes and some prokaryotes. It is a single-stranded RNA-specific endoribonuclease that cleaves RNA molecules at specific nucleotide sequences. \nIn RNA polymerase II, the RNase III subunit is located at the C-terminal region of the polymerase and is responsible for cleaving the RNA transcripts that are being synthesized by the polymerase. The RNase III subunit binds to the 3' end of the RNA transcript and cleaves it at a specific nucleotide sequence, known as the RNase III cleavage site. \nThe RNase III subunit is essential for the normal functioning of RNA polymerase II, as it is required for the termination of transcription and the processing of pre-mRNA molecules. Without the RNase III subunit, the polymerase would be unable to cleave the RNA transcripts and would continue to synthesize them indefinitely.",
    "llama-7b_fact_raw": "1. The RNase III subunit of RNA polymerase II carries RNA cleavage activity.\n2. RNase III is an enzyme found in all eukaryotes and some prokaryotes.\n3. RNase III is a single-stranded RNA-specific endoribonuclease.\n4. The RNase III subunit is located at the C-terminal region of RNA polymerase II.\n5. The RNase III subunit is essential for the termination of transcription and the processing of pre-mRNA molecules in RNA polymerase II.",
    "llama-7b_fact": [
      "The RNase III subunit of RNA polymerase II carries RNA cleavage activity.",
      "RNase III is an enzyme found in all eukaryotes and some prokaryotes.",
      "RNase III is a single-stranded RNA-specific endoribonuclease.",
      "The RNase III subunit is located at the C-terminal region of RNA polymerase II.",
      "The RNase III subunit is essential for the termination of transcription and the processing of pre-mRNA molecules in RNA polymerase II."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The RNase III subunit is not a part of RNA polymerase II; it is a separate enzyme that carries RNA cleavage activity.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: The RNase III subunit is not located at the C-terminal region of RNA polymerase II, as it is not a part of this polymerase.\n5. FALSE [correction]: The RNase III enzyme is involved in the processing of various RNA molecules, but it is not a subunit of RNA polymerase II, which is responsible for synthesizing mRNA. The termination of transcription and processing of pre-mRNA molecules in RNA polymerase II involves other factors and enzymes.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2321,
    "user_query": "What is the genetic basis of Ohdo syndrome?",
    "llama-7b_response": "Ohdo syndrome is a rare genetic disorder that is characterized by a variety of symptoms, including developmental delay, intellectual disability, seizures, and distinctive facial features. The genetic basis of Ohdo syndrome is complex and not fully understood, but it is believed to be caused by mutations in multiple genes.\nOne of the genes that has been associated with Ohdo syndrome is the ATP1A2 gene. Mutations in this gene have been found in a small percentage of individuals with Ohdo syndrome, and they are thought to be responsible for some of the symptoms of the disorder, such as seizures and developmental delay.\nAnother gene that has been implicated in Ohdo syndrome is the CDKL5 gene. Mutations in this gene have been found in a significant percentage of individuals with Ohdo syndrome, and they are thought to be responsible for many of the symptoms of the disorder, including developmental delay, intellectual disability, and seizures.\nIn addition to these two genes, other genes that may be involved in Ohdo syndrome include the KCNQ2 gene, the KCNQ3 gene, and the ATP1B1 gene. Further research is needed to fully understand the genetic basis of Ohdo syndrome and the role of these and other genes in the disorder.",
    "llama-7b_fact_raw": "1. Ohdo syndrome is a rare genetic disorder characterized by developmental delay, intellectual disability, seizures, and distinctive facial features.\n2. Mutations in the ATP1A2 gene have been found in a small percentage of individuals with Ohdo syndrome.\n3. Mutations in the CDKL5 gene have been found in a significant percentage of individuals with Ohdo syndrome.\n4. The KCNQ2 gene and the KCNQ3 gene may be involved in Ohdo syndrome.\n5. The ATP1B1 gene may also be involved in Ohdo syndrome.",
    "llama-7b_fact": [
      "Ohdo syndrome is a rare genetic disorder characterized by developmental delay, intellectual disability, seizures, and distinctive facial features.",
      "Mutations in the ATP1A2 gene have been found in a small percentage of individuals with Ohdo syndrome.",
      "Mutations in the CDKL5 gene have been found in a significant percentage of individuals with Ohdo syndrome.",
      "The KCNQ2 gene and the KCNQ3 gene may be involved in Ohdo syndrome.",
      "The ATP1B1 gene may also be involved in Ohdo syndrome."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Mutations in the SALL1 gene have been found in individuals with Ohdo syndrome, specifically the Maat-Kievit-Brunner type.\n3. FALSE [correction]: Mutations in the CDKL5 gene are associated with a different condition known as CDKL5 deficiency disorder, which can also involve intellectual disability and seizures, but it is not typically associated with Ohdo syndrome.\n4. UNKNOWN: While the KCNQ2 and KCNQ3 genes are associated with a form of epilepsy, there is no clear evidence in the provided context to confirm their involvement in Ohdo syndrome.\n5. UNKNOWN: Without specific context or evidence provided, it is unclear whether the ATP1B1 gene is involved in Ohdo syndrome.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2331,
    "user_query": "Which R/Bioconductor package has been developed for the analysis of psychiatric disease genes?",
    "llama-7b_response": "The R/Bioconductor package that has been developed for the analysis of psychiatric disease genes is called \"PsychiatricGWAS\". This package provides tools for genome-wide association studies (GWAS) of psychiatric diseases, such as schizophrenia, bipolar disorder, and major depressive disorder. The package includes functions for data preprocessing, quality control, and association analysis, as well as visualization tools for exploring the genetic associations.",
    "llama-7b_fact_raw": "1. The R/Bioconductor package developed for the analysis of psychiatric disease genes is called \"PsychiatricGWAS\".\n2. \"PsychiatricGWAS\" provides tools for genome-wide association studies (GWAS) of psychiatric diseases.\n3. The package is used for diseases such as schizophrenia, bipolar disorder, and major depressive disorder.\n4. \"PsychiatricGWAS\" includes functions for data preprocessing, quality control, and association analysis.\n5. The package also offers visualization tools for exploring genetic associations.",
    "llama-7b_fact": [
      "The R/Bioconductor package developed for the analysis of psychiatric disease genes is called \"PsychiatricGWAS\".",
      "\"PsychiatricGWAS\" provides tools for genome-wide association studies (GWAS) of psychiatric diseases.",
      "The package is used for diseases such as schizophrenia, bipolar disorder, and major depressive disorder.",
      "\"PsychiatricGWAS\" includes functions for data preprocessing, quality control, and association analysis.",
      "The package also offers visualization tools for exploring genetic associations."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: There is no specific R/Bioconductor package named \"PsychiatricGWAS\" known as of my knowledge cutoff date. However, there are various packages available for GWAS analysis in general.\n2. UNKNOWN: Since \"PsychiatricGWAS\" is not a recognized package, the statement about its functionality cannot be confirmed.\n3. UNKNOWN: As \"PsychiatricGWAS\" is not identified as an existing package, it is unclear whether it is used for diseases such as schizophrenia, bipolar disorder, and major depressive disorder.\n4. UNKNOWN: Without confirmation of the existence of \"PsychiatricGWAS,\" the statement about its functions for data preprocessing, quality control, and association analysis cannot be verified.\n5. UNKNOWN: The availability of visualization tools within \"PsychiatricGWAS\" cannot be confirmed due to the lack of information on the existence of such a package.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2360,
    "user_query": "Describe swirl sign in intracerebral hemorrhage.",
    "llama-7b_response": "Intracerebral hemorrhage (ICH) is a type of stroke that occurs when a blood vessel in the brain ruptures and bleeding occurs within the brain tissue. One of the characteristic findings on imaging studies of ICH is the presence of a swirl sign.\nThe swirl sign is a pattern of blood within the brain tissue that resembles a swirl or a corkscrew. It is often seen on computed tomography (CT) or magnetic resonance imaging (MRI) scans of the brain in patients with ICH. The swirl sign is caused by the movement of blood within the brain tissue as it drains away from the site of the hemorrhage.\nThe presence of the swirl sign on imaging studies is associated with a poor prognosis in patients with ICH. It is a sign of ongoing bleeding within the brain and can indicate the need for urgent treatment to stop the bleeding.\nIn summary, the swirl sign is a characteristic finding on imaging studies of ICH that is associated with poor prognosis. It is caused by the movement of blood within the brain tissue as it drains away from the site of the hemorrhage.",
    "llama-7b_fact_raw": "1. Intracerebral hemorrhage (ICH) occurs when a blood vessel in the brain ruptures, causing bleeding within the brain tissue.\n2. The swirl sign is a pattern of blood within the brain tissue that can be seen on imaging studies of ICH.\n3. The swirl sign resembles a swirl or a corkscrew on computed tomography (CT) or magnetic resonance imaging (MRI) scans.\n4. The presence of the swirl sign on imaging studies is associated with a poor prognosis in patients with ICH.\n5. The swirl sign indicates ongoing bleeding within the brain and can signal the need for urgent treatment.",
    "llama-7b_fact": [
      "Intracerebral hemorrhage (ICH) occurs when a blood vessel in the brain ruptures, causing bleeding within the brain tissue.",
      "The swirl sign is a pattern of blood within the brain tissue that can be seen on imaging studies of ICH.",
      "The swirl sign resembles a swirl or a corkscrew on computed tomography (CT) or magnetic resonance imaging (MRI) scans.",
      "The presence of the swirl sign on imaging studies is associated with a poor prognosis in patients with ICH.",
      "The swirl sign indicates ongoing bleeding within the brain and can signal the need for urgent treatment."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2392,
    "user_query": "What induces Arabidopsis ROF1 expression?",
    "llama-7b_response": "Arabidopsis ROF1 expression is induced by a variety of stimuli, including abiotic stresses such as drought, salt, and temperature stress, as well as biotic stresses such as fungal and bacterial pathogens. The exact mechanisms by which these stimuli induce ROF1 expression are complex and not fully understood, but it is believed to involve a combination of transcriptional and post-transcriptional regulation.\nOne of the key transcriptional regulators of ROF1 expression is the stress hormone abscisic acid (ABA). ABA is a plant hormone that is produced in response to a variety of abiotic stresses, including drought and salt stress. ABA has been shown to bind to and activate the ABA-responsive element (ABRE) in the ROF1 promoter, leading to increased ROF1 transcription.\nIn addition to ABA, other stress hormones such as jasmonic acid and ethylene may also play a role in ROF1 expression. For example, jasmonic acid has been shown to induce ROF1 expression in response to fungal pathogens, while ethylene has been shown to induce ROF1 expression in response to both biotic and abiotic stresses.\nPost-transcriptional regulation of ROF1 expression may also play a role in response to different stimuli. For example, ROF1 mRNA levels have been shown to be regulated by microRNAs (miRNAs), small non-coding RNAs that can regulate gene expression by targeting specific mRNAs for degradation or translational repression. miRNAs have been shown to regulate ROF1 expression both positively and negatively, depending on the specific miRNA and the stimulus involved.\nOverall, the regulation of ROF1 expression is complex and involves a combination of transcriptional and post-transcriptional mechanisms that are influenced by a variety of stimuli, including abiotic and biotic stresses.",
    "llama-7b_fact_raw": "1. Arabidopsis ROF1 expression is induced by abiotic stresses such as drought, salt, and temperature stress.\n2. Arabidopsis ROF1 expression is also induced by biotic stresses such as fungal and bacterial pathogens.\n3. The plant hormone abscisic acid (ABA) is a key transcriptional regulator of ROF1 expression and is produced in response to abiotic stresses.\n4. ABA can bind to and activate the ABA-responsive element (ABRE) in the ROF1 promoter, leading to increased transcription of ROF1.\n5. ROF1 mRNA levels can be regulated by microRNAs (miRNAs), which can target mRNAs for degradation or translational repression.",
    "llama-7b_fact": [
      "Arabidopsis ROF1 expression is induced by abiotic stresses such as drought, salt, and temperature stress.",
      "Arabidopsis ROF1 expression is also induced by biotic stresses such as fungal and bacterial pathogens.",
      "The plant hormone abscisic acid (ABA) is a key transcriptional regulator of ROF1 expression and is produced in response to abiotic stresses.",
      "ABA can bind to and activate the ABA-responsive element (ABRE) in the ROF1 promoter, leading to increased transcription of ROF1.",
      "ROF1 mRNA levels can be regulated by microRNAs (miRNAs), which can target mRNAs for degradation or translational repression."
    ],
    "llama-7b_judge_raw": "1. TRUE: Arabidopsis ROF1 (AtROF1) expression is known to be induced by various abiotic stresses, including drought, salt, and temperature stress, which is consistent with the role of many heat shock proteins (HSPs) in stress responses.\n2. TRUE: While Arabidopsis ROF1 is primarily studied in the context of abiotic stress, there is evidence that suggests it can also be induced by biotic stresses such as those caused by fungal and bacterial pathogens.\n3. TRUE: The plant hormone abscisic acid (ABA) is indeed a key regulator in response to abiotic stress, and it can regulate the expression of stress-responsive genes, including ROF1.\n4. UNKNOWN: While ABA is a key regulator of stress responses and can activate ABREs in promoters of ABA-responsive genes, without specific evidence for the ROF1 promoter, it is not possible to confirm that ABA directly binds to and activates the ABRE in the ROF1 promoter.\n5. TRUE: MicroRNAs (miRNAs) are known to play a role in regulating mRNA levels by targeting them for degradation or translational repression, and this mechanism is broadly applicable to various mRNAs, including those involved in stress responses. However, specific miRNAs targeting ROF1 mRNA would need to be identified to confirm this statement for ROF1 specifically.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2398,
    "user_query": "What protein is the most common cause of hereditary  renal amyloidosis?",
    "llama-7b_response": "The most common cause of hereditary renal amyloidosis is transthyretin (TTR). TTR is a protein that is normally found in the blood and is responsible for transporting thyroid hormone and retinol (vitamin A) throughout the body. In hereditary renal amyloidosis, mutations in the TTR gene cause the production of abnormal TTR protein that accumulates in the tissues and organs, including the kidneys. This can lead to the formation of amyloid fibrils, which can cause damage to the kidneys and other organs. Other proteins that can cause hereditary renal amyloidosis include immunoglobulin light chains and alpha-synuclein.",
    "llama-7b_fact_raw": "1. Transthyretin (TTR) is the most common cause of hereditary renal amyloidosis.\n2. TTR is a protein responsible for transporting thyroid hormone and retinol (vitamin A) throughout the body.\n3. Mutations in the TTR gene can lead to the production of abnormal TTR protein.\n4. Abnormal TTR protein can accumulate in tissues and organs, including the kidneys.\n5. Accumulation of abnormal TTR protein can lead to the formation of amyloid fibrils that damage the kidneys and other organs.",
    "llama-7b_fact": [
      "Transthyretin (TTR) is the most common cause of hereditary renal amyloidosis.",
      "TTR is a protein responsible for transporting thyroid hormone and retinol (vitamin A) throughout the body.",
      "Mutations in the TTR gene can lead to the production of abnormal TTR protein.",
      "Abnormal TTR protein can accumulate in tissues and organs, including the kidneys.",
      "Accumulation of abnormal TTR protein can lead to the formation of amyloid fibrils that damage the kidneys and other organs."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Transthyretin (TTR) is not the most common cause of hereditary renal amyloidosis; it is more commonly associated with hereditary transthyretin amyloidosis (ATTR), which primarily affects the nervous system and the heart.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2407,
    "user_query": "Has the proteome of mice hippocampus been analysed?",
    "llama-7b_response": "Yes, the proteome of mice hippocampus has been analyzed. Proteomics is the study of the entire complement of proteins expressed in a particular cell, tissue, or organism. The proteome of mice hippocampus has been extensively studied using various proteomic techniques such as two-dimensional gel electrophoresis, mass spectrometry, and bioinformatics analysis. \nSeveral studies have reported the identification and characterization of hundreds of proteins in the mouse hippocampus proteome. These proteins are involved in various biological processes such as synaptic plasticity, memory formation, and neurodegeneration. \nFor example, a study published in the journal Molecular and Cellular Proteomics in 2010 identified over 1,000 proteins in the mouse hippocampus proteome using a combination of two-dimensional gel electrophoresis and mass spectrometry. The study also provided functional annotation for many of the identified proteins based on their subcellular localization, protein-protein interactions, and biological functions. \nAnother study published in the journal Brain, Behavior, and Immunity in 2015 analyzed the proteome of the mouse hippocampus using label-free quantitative proteomics and identified over 1,500 proteins. The study found that many of the identified proteins were involved in inflammatory and immune responses, suggesting that the hippocampus plays a critical role in regulating these processes. \nIn summary, the proteome of mice hippocampus has been extensively studied using various proteomic techniques, and hundreds of proteins have been identified and characterized. These proteins are involved in various biological processes such as synaptic plasticity, memory formation, and neurodegeneration.",
    "llama-7b_fact_raw": "1. The proteome of mice hippocampus has been analyzed using proteomic techniques.\n2. Techniques used to study the mouse hippocampus proteome include two-dimensional gel electrophoresis, mass spectrometry, and bioinformatics analysis.\n3. A study published in Molecular and Cellular Proteomics in 2010 identified over 1,000 proteins in the mouse hippocampus proteome.\n4. The 2010 study provided functional annotation for the identified proteins, including subcellular localization, protein-protein interactions, and biological functions.\n5. A study published in Brain, Behavior, and Immunity in 2015 identified over 1,500 proteins in the mouse hippocampus and linked many of them to inflammatory and immune responses.",
    "llama-7b_fact": [
      "The proteome of mice hippocampus has been analyzed using proteomic techniques.",
      "Techniques used to study the mouse hippocampus proteome include two-dimensional gel electrophoresis, mass spectrometry, and bioinformatics analysis.",
      "A study published in Molecular and Cellular Proteomics in 2010 identified over 1,000 proteins in the mouse hippocampus proteome.",
      "The 2010 study provided functional annotation for the identified proteins, including subcellular localization, protein-protein interactions, and biological functions.",
      "A study published in Brain, Behavior, and Immunity in 2015 identified over 1,500 proteins in the mouse hippocampus and linked many of them to inflammatory and immune responses."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout access to the specific studies mentioned in statements 3, 4, and 5, it is not possible to verify the exact number of proteins identified or the details of the findings. Therefore, the truthfulness of these statements remains unknown.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2409,
    "user_query": "Are mouse chromosomes acrocentric?",
    "llama-7b_response": "No, mouse chromosomes are not acrocentric. Acrocentric chromosomes are a type of chromosome that have a short arm and a long arm, with the centromere (the point where the two arms meet) being closer to the short arm than the long arm. In contrast, mouse chromosomes have two long arms and two short arms, with the centromere being evenly spaced between the two arms. Therefore, mouse chromosomes are not acrocentric.",
    "llama-7b_fact_raw": "1. Mouse chromosomes are not acrocentric.\n2. Acrocentric chromosomes have a short arm and a long arm with the centromere closer to the short arm.\n3. Mouse chromosomes have two long arms and two short arms.\n4. The centromere in mouse chromosomes is evenly spaced between the two arms.",
    "llama-7b_fact": [
      "Mouse chromosomes are not acrocentric.",
      "Acrocentric chromosomes have a short arm and a long arm with the centromere closer to the short arm.",
      "Mouse chromosomes have two long arms and two short arms.",
      "The centromere in mouse chromosomes is evenly spaced between the two arms."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Mouse chromosomes are acrocentric.\n2. TRUE\n3. FALSE [correction]: Mouse chromosomes have one long arm and one very short arm (which may be hard to observe), not two long arms and two short arms.\n4. FALSE [correction]: The centromere in mouse chromosomes is not evenly spaced between the two arms; it is closer to the short arm, as mouse chromosomes are acrocentric.",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2417,
    "user_query": "Which siRNA based drug is in clinical trials for the treatment of pancreatic cancer?",
    "llama-7b_response": "There are several siRNA-based drugs in clinical trials for the treatment of pancreatic cancer, but one of the most promising is called Gossypol. Gossypol is a natural compound found in the seeds of the cotton plant, and it has been shown to have potent anti-cancer properties. \nIn clinical trials, Gossypol has been shown to inhibit the growth of pancreatic cancer cells in vitro and in vivo, and to induce apoptosis (programmed cell death) in these cells. It has also been shown to have anti-angiogenic effects, which means that it can prevent the formation of new blood vessels that tumors need to grow and spread.\nCurrently, a phase II clinical trial is underway to evaluate the safety and efficacy of Gossypol in patients with advanced pancreatic cancer. The results of this trial are expected to be released in the coming years.",
    "llama-7b_fact_raw": "1. Gossypol is a siRNA-based drug in clinical trials for the treatment of pancreatic cancer.\n2. Gossypol is a natural compound found in the seeds of the cotton plant.\n3. Gossypol has been shown to inhibit the growth of pancreatic cancer cells in vitro and in vivo.\n4. Gossypol has been shown to induce apoptosis in pancreatic cancer cells.\n5. A phase II clinical trial is underway to evaluate the safety and efficacy of Gossypol in patients with advanced pancreatic cancer.",
    "llama-7b_fact": [
      "Gossypol is a siRNA-based drug in clinical trials for the treatment of pancreatic cancer.",
      "Gossypol is a natural compound found in the seeds of the cotton plant.",
      "Gossypol has been shown to inhibit the growth of pancreatic cancer cells in vitro and in vivo.",
      "Gossypol has been shown to induce apoptosis in pancreatic cancer cells.",
      "A phase II clinical trial is underway to evaluate the safety and efficacy of Gossypol in patients with advanced pancreatic cancer."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Gossypol is not an siRNA-based drug; it is a natural compound that has been studied for its potential anti-cancer properties.\n2. TRUE\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2419,
    "user_query": "What is the HPG pore?",
    "llama-7b_response": "The HPG pore, also known as the hypothalamic-pituitary-gonadal (HPG) axis, is a complex system of interactions between the hypothalamus, pituitary gland, and gonads (testes or ovaries) that regulates reproductive functions and maintains homeostasis in the body. The HPG axis is responsible for controlling the release of sex hormones, such as testosterone and estrogen, which play a critical role in the development and function of the reproductive system, as well as other physiological processes such as growth, metabolism, and immune function. \n\nThe hypothalamus, located in the brain, senses changes in the body's environment and triggers the release of gonadotropin-releasing hormone (GnRH), which signals the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH and FSH then travel to the gonads, where they stimulate the production and release of sex hormones. \n\nThe HPG axis is also responsible for regulating the menstrual cycle in females and spermatogenesis in males. Disruptions in the HPG axis can lead to a variety of reproductive disorders, such as polycystic ovary syndrome (PCOS), hypogonadism, and infertility. \n\nIn summary, the HPG pore is a complex system of interactions between the hypothalamus, pituitary gland, and gonads that regulates reproductive functions and maintains homeostasis in the body.",
    "llama-7b_fact_raw": "1. The HPG pore, or hypothalamic-pituitary-gonadal axis, regulates reproductive functions and maintains homeostasis in the body.\n2. The HPG axis controls the release of sex hormones, including testosterone and estrogen.\n3. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which signals the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH).\n4. The HPG axis regulates the menstrual cycle in females and spermatogenesis in males.\n5. Disruptions in the HPG axis can lead to reproductive disorders such as polycystic ovary syndrome (PCOS), hypogonadism, and infertility.",
    "llama-7b_fact": [
      "The HPG pore, or hypothalamic-pituitary-gonadal axis, regulates reproductive functions and maintains homeostasis in the body.",
      "The HPG axis controls the release of sex hormones, including testosterone and estrogen.",
      "The hypothalamus releases gonadotropin-releasing hormone (GnRH), which signals the pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH).",
      "The HPG axis regulates the menstrual cycle in females and spermatogenesis in males.",
      "Disruptions in the HPG axis can lead to reproductive disorders such as polycystic ovary syndrome (PCOS), hypogonadism, and infertility."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2472,
    "user_query": "What is the 959 Nematode Genomes initiative?",
    "llama-7b_response": "The 959 Nematode Genomes initiative is a collaborative effort between researchers from around the world to sequence and analyze the genomes of 959 species of nematodes, a group of roundworms that includes parasitic and free-living species. The initiative aims to provide a comprehensive understanding of the diversity and evolution of nematodes, as well as to identify genes and mechanisms that are conserved or unique to this group of organisms.\nThe sequencing of the 959 nematode genomes is expected to reveal new insights into the biology of these organisms, including their roles in ecological systems, their interactions with other organisms, and their potential as models for studying human diseases. The data generated by the initiative will also be made available to the scientific community for further analysis and research.\nOverall, the 959 Nematode Genomes initiative represents a significant effort to advance our understanding of nematodes and their role in the natural world, and to provide new tools and resources for researchers in a wide range of fields.",
    "llama-7b_fact_raw": "1. The 959 Nematode Genomes initiative is a collaborative effort to sequence and analyze the genomes of 959 species of nematodes.\n2. The initiative includes both parasitic and free-living species of nematodes.\n3. The goal of the initiative is to provide a comprehensive understanding of the diversity and evolution of nematodes.\n4. The initiative aims to identify genes and mechanisms that are conserved or unique to nematodes.\n5. The data from the 959 Nematode Genomes initiative will be made available to the scientific community for further research.",
    "llama-7b_fact": [
      "The 959 Nematode Genomes initiative is a collaborative effort to sequence and analyze the genomes of 959 species of nematodes.",
      "The initiative includes both parasitic and free-living species of nematodes.",
      "The goal of the initiative is to provide a comprehensive understanding of the diversity and evolution of nematodes.",
      "The initiative aims to identify genes and mechanisms that are conserved or unique to nematodes.",
      "The data from the 959 Nematode Genomes initiative will be made available to the scientific community for further research."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nThe statements provided are consistent with the goals and practices of large-scale genomic initiatives, which typically aim to understand diversity and evolution, identify conserved and unique genes, and share data with the scientific community. However, without specific details about the \"959 Nematode Genomes initiative,\" the responses are based on general knowledge of such projects. If the \"959 Nematode Genomes initiative\" is a real and specific initiative, the responses assume that the statements accurately describe its goals and practices. If the initiative is hypothetical or not well-documented, the responses could be different.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2557,
    "user_query": "Which R package has been developed for analyzing Non-invasive prenatal testing (NIPT) data?",
    "llama-7b_response": "There is no single R package that has been developed specifically for analyzing Non-invasive prenatal testing (NIPT) data. However, there are several R packages that can be used for analyzing genetic data in general, including:\n1. Bioconductor: This is a collection of R packages for bioinformatics and computational biology. Some of the packages that can be used for analyzing genetic data include:\n   - GenABEL: This package provides tools for analyzing genome-wide association studies (GWAS) and other genetic association studies.\n   - PLINK: This package provides tools for managing and analyzing large-scale genetic association studies.\n   - GCTA: This package provides tools for analyzing genome-wide association studies and other complex genetic data.\n2. R/qtl: This package provides tools for analyzing quantitative trait loci (QTL) data, which can be used to study genetic variations that affect traits such as height, weight, and intelligence.\n3. R/BGLR: This package provides tools for analyzing binary genetic data, which can be used to study genetic variations that affect traits such as disease susceptibility and drug response.\nOverall, the choice of which R package to use for analyzing genetic data will depend on the specific research question and the type of genetic data being analyzed.",
    "llama-7b_fact_raw": "1. Bioconductor is a collection of R packages for bioinformatics and computational biology.\n2. GenABEL is an R package that provides tools for analyzing genome-wide association studies (GWAS) and other genetic association studies.\n3. PLINK is an R package that provides tools for managing and analyzing large-scale genetic association studies.\n4. GCTA is an R package that provides tools for analyzing genome-wide association studies and other complex genetic data.\n5. R/qtl is an R package that provides tools for analyzing quantitative trait loci (QTL) data.",
    "llama-7b_fact": [
      "Bioconductor is a collection of R packages for bioinformatics and computational biology.",
      "GenABEL is an R package that provides tools for analyzing genome-wide association studies (GWAS) and other genetic association studies.",
      "PLINK is an R package that provides tools for managing and analyzing large-scale genetic association studies.",
      "GCTA is an R package that provides tools for analyzing genome-wide association studies and other complex genetic data.",
      "R/qtl is an R package that provides tools for analyzing quantitative trait loci (QTL) data."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: PLINK is not an R package; it is a standalone software tool that provides tools for managing and analyzing large-scale genetic association studies.\n4. FALSE [correction]: GCTA is not an R package; it is a standalone software tool that provides tools for analyzing complex trait associated with genetic markers.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 2560,
    "user_query": "Describe Achenbach’s syndrome.",
    "llama-7b_response": "Achenbach's syndrome is a rare genetic disorder that affects the nervous system. It is characterized by seizures, developmental delay, and intellectual disability. The syndrome is caused by mutations in the ATP1A2 gene, which encodes a protein involved in the transport of potassium ions across cell membranes.\n\nIndividuals with Achenbach's syndrome may experience seizures that begin in infancy or early childhood. These seizures may be generalized or focal, and may be resistant to treatment. Developmental delay is also a common feature of the syndrome, with affected individuals often experiencing delays in language, motor skills, and intellectual development.\n\nOther symptoms of Achenbach's syndrome may include muscle weakness, tremors, and abnormal eye movements. Some individuals with the syndrome may also experience heart rhythm abnormalities.\n\nDiagnosis of Achenbach's syndrome is typically made through a combination of genetic testing and clinical evaluation. Treatment may include antiepileptic medications, physical therapy, and other interventions to manage symptoms. Supportive care, including education and counseling, may also be provided to help individuals and their families cope with the challenges of the syndrome.",
    "llama-7b_fact_raw": "1. Achenbach's syndrome is characterized by seizures, developmental delay, and intellectual disability.\n2. The syndrome is caused by mutations in the ATP1A2 gene.\n3. Seizures in individuals with Achenbach's syndrome may begin in infancy or early childhood.\n4. Achenbach's syndrome can include symptoms such as muscle weakness, tremors, and abnormal eye movements.\n5. Diagnosis of Achenbach's syndrome is made through genetic testing and clinical evaluation.",
    "llama-7b_fact": [
      "Achenbach's syndrome is characterized by seizures, developmental delay, and intellectual disability.",
      "The syndrome is caused by mutations in the ATP1A2 gene.",
      "Seizures in individuals with Achenbach's syndrome may begin in infancy or early childhood.",
      "Achenbach's syndrome can include symptoms such as muscle weakness, tremors, and abnormal eye movements.",
      "Diagnosis of Achenbach's syndrome is made through genetic testing and clinical evaluation."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Achenbach's syndrome is characterized by sudden bruising on the hands or fingers without any known trauma or injury, not by seizures, developmental delay, and intellectual disability.\n2. FALSE [correction]: Achenbach's syndrome is not caused by mutations in the ATP1A2 gene. The cause is not well understood, but it is not thought to be genetic.\n3. FALSE [correction]: Since Achenbach's syndrome is not characterized by seizures, the statement about the onset of seizures is incorrect.\n4. FALSE [correction]: Achenbach's syndrome is not typically associated with muscle weakness, tremors, and abnormal eye movements. It primarily involves spontaneous bruising.\n5. FALSE [correction]: Diagnosis of Achenbach's syndrome is typically made based on clinical history and physical examination, not through genetic testing, as it is not a genetic disorder.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2581,
    "user_query": "Which algorithm is used for detection of long repeat expansions?",
    "llama-7b_response": "There are several algorithms used for the detection of long repeat expansions, but one of the most commonly used is the Burrows-Wheeler Aligner (BWA) algorithm. \nThe BWA algorithm is a bioinformatics tool that is used for aligning short sequence reads to a reference genome or transcriptome. It is particularly useful for detecting long repeat expansions because it can identify regions of high similarity between the read and the reference sequence, which are likely to be due to repeat expansions.\nThe BWA algorithm works by first aligning the read to a reference sequence using a dynamic programming approach. It then identifies regions of high similarity between the read and the reference sequence, which are likely to be due to repeat expansions. These regions are flagged as potential repeat expansions and can be further analyzed to determine the exact size and nature of the expansion.\nOverall, the BWA algorithm is a powerful tool for detecting long repeat expansions and has been widely used in genome-wide studies of repeat expansions in various organisms, including humans.",
    "llama-7b_fact_raw": "1. The Burrows-Wheeler Aligner (BWA) algorithm is commonly used for the detection of long repeat expansions.\n2. The BWA algorithm aligns short sequence reads to a reference genome or transcriptome.\n3. It identifies regions of high similarity between the read and the reference sequence, which are indicative of repeat expansions.\n4. The BWA algorithm uses a dynamic programming approach for aligning reads to a reference sequence.\n5. The BWA algorithm has been widely used in genome-wide studies of repeat expansions in various organisms, including humans.",
    "llama-7b_fact": [
      "The Burrows-Wheeler Aligner (BWA) algorithm is commonly used for the detection of long repeat expansions.",
      "The BWA algorithm aligns short sequence reads to a reference genome or transcriptome.",
      "It identifies regions of high similarity between the read and the reference sequence, which are indicative of repeat expansions.",
      "The BWA algorithm uses a dynamic programming approach for aligning reads to a reference sequence.",
      "The BWA algorithm has been widely used in genome-wide studies of repeat expansions in various organisms, including humans."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Burrows-Wheeler Aligner (BWA) algorithm is commonly used for aligning short sequence reads to a reference genome or transcriptome, not specifically for the detection of long repeat expansions.\n2. TRUE\n3. FALSE [correction]: The BWA algorithm identifies regions of high similarity between the read and the reference sequence to align them, but this is not specifically indicative of repeat expansions.\n4. FALSE [correction]: The BWA algorithm uses the Burrows-Wheeler Transform (BWT) for aligning reads to a reference sequence, not a dynamic programming approach.\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2582,
    "user_query": "Which brain tumors does neuroligin-3 promote?",
    "llama-7b_response": "Neuroligin-3 is a protein that is involved in the development and maintenance of neural connections in the brain. It is thought to play a role in the formation of synapses, which are the junctions between neurons where signals are transmitted. \nStudies have shown that neuroligin-3 may be involved in the development of certain types of brain tumors. In particular, neuroligin-3 has been found to be overexpressed in some types of gliomas, which are tumors that arise from glial cells in the brain. Gliomas can be either benign or malignant, and the overexpression of neuroligin-3 has been linked to the development of malignant gliomas.\nAdditionally, neuroligin-3 has been found to be overexpressed in other types of tumors, such as astrocytomas and ependymomas. However, the role of neuroligin-3 in the development of these tumors is not yet fully understood.\nOverall, while neuroligin-3 has been found to be overexpressed in some types of brain tumors, the exact role that it plays in tumor development is still being studied. Further research is needed to fully understand the potential therapeutic implications of targeting neuroligin-3 in the treatment of brain tumors.",
    "llama-7b_fact_raw": "1. Neuroligin-3 is involved in the development and maintenance of neural connections in the brain.\n2. Neuroligin-3 plays a role in the formation of synapses between neurons.\n3. Neuroligin-3 has been found to be overexpressed in some types of gliomas.\n4. Gliomas are tumors that arise from glial cells in the brain.\n5. Neuroligin-3 overexpression has been linked to the development of malignant gliomas.",
    "llama-7b_fact": [
      "Neuroligin-3 is involved in the development and maintenance of neural connections in the brain.",
      "Neuroligin-3 plays a role in the formation of synapses between neurons.",
      "Neuroligin-3 has been found to be overexpressed in some types of gliomas.",
      "Gliomas are tumors that arise from glial cells in the brain.",
      "Neuroligin-3 overexpression has been linked to the development of malignant gliomas."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2586,
    "user_query": "What is the approximate size of gas vesicles?",
    "llama-7b_response": "The size of gas vesicles can vary depending on the type of organism and the environment in which it lives. However, on average, gas vesicles are approximately 0.1 to 10 micrometers in size.",
    "llama-7b_fact_raw": "1. Gas vesicles can vary in size depending on the organism and environment.\n2. On average, gas vesicles are approximately 0.1 to 10 micrometers in size.",
    "llama-7b_fact": [
      "Gas vesicles can vary in size depending on the organism and environment.",
      "On average, gas vesicles are approximately 0.1 to 10 micrometers in size."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE",
    "llama-7b_judge": [
      "true",
      "true"
    ]
  },
  {
    "id": 2589,
    "user_query": "List BET proteins.",
    "llama-7b_response": "BET (Bromodomain and Extra-Terminal) proteins are a family of proteins that contain bromodomains and extra-terminal (BET) domains. Bromodomains are protein motifs that recognize and bind to acetylated lysine residues on histones and other proteins, while the BET domains have been implicated in transcriptional regulation and chromatin remodeling. \n\nThere are several BET proteins, including:\n\n1. BRD2 (Bromodomain-containing protein 2)\n2. BRD3 (Bromodomain-containing protein 3)\n3. BRD4 (Bromodomain-containing protein 4)\n4. BRDT (Bromodomain-containing protein 5)\n5. BPTF (Bromodomain-containing protein 6)\n6. PHF8 (Bromodomain-containing protein 7)\n7. SAP130 (Bromodomain-containing protein 8)\n8. SAP30 (Bromodomain-containing protein 9)\n9. SAP43 (Bromodomain-containing protein 10)\n10. SAP57 (Bromodomain-containing protein 11)\n11. SAP64 (Bromodomain-containing protein 12)\n12. SAP72 (Bromodomain-containing protein 13)\n13. SAP97 (Bromodomain-containing protein 14)\n14. SAP102 (Bromodomain-containing protein 15)\n15. SAP130L1 (Bromodomain-containing protein 16)\n16. SAP130L2 (Bromodomain-containing protein 17)\n17. SAP130L3 (Bromodomain-containing protein 18)\n18. SAP130L4 (Bromodomain-containing protein 19)\n19. SAP130L5 (Bromodomain",
    "llama-7b_fact_raw": "1. BET proteins are a family of proteins that contain bromodomains and extra-terminal (BET) domains.\n2. Bromodomains are protein motifs that recognize and bind to acetylated lysine residues on histones and other proteins.\n3. BET domains have been implicated in transcriptional regulation and chromatin remodeling.\n4. BRD2, BRD3, and BRD4 are examples of BET proteins.\n5. BRDT is also known as Bromodomain-containing protein 5.\n\nNote: The list provided in the answer contains inaccuracies regarding the naming and numbering of BET proteins and other bromodomain-containing proteins. For example, BPTF, PHF8, SAP130, and others listed are not typically classified under BET proteins. The standard BET proteins include BRD2, BRD3, BRD4, and BRDT. The other proteins mentioned have bromodomains but are not classified as BET proteins. Therefore, only the first four factual statements are accurate and relevant to the query about BET proteins.",
    "llama-7b_fact": [
      "BET proteins are a family of proteins that contain bromodomains and extra-terminal (BET) domains.",
      "Bromodomains are protein motifs that recognize and bind to acetylated lysine residues on histones and other proteins.",
      "BET domains have been implicated in transcriptional regulation and chromatin remodeling.",
      "BRD2, BRD3, and BRD4 are examples of BET proteins.",
      "BRDT is also known as Bromodomain-containing protein 5.",
      "te: The list provided in the answer contains inaccuracies regarding the naming and numbering of BET proteins and other bromodomain-containing proteins. For example, BPTF, PHF8, SAP130, and others listed are not typically classified under BET proteins. The standard BET proteins include BRD2, BRD3, BRD4, and BRDT. The other proteins mentioned have bromodomains but are not classified as BET proteins. Therefore, only the first four factual statements are accurate and relevant to the query about BET proteins."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: BRDT is known as Bromodomain Testis-Specific Protein, not Bromodomain-containing protein 5.\n6. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 2610,
    "user_query": "Which algorithm has been developed for prediction of protein subcellular localization using deep learning?",
    "llama-7b_response": "There are several algorithms that have been developed for the prediction of protein subcellular localization using deep learning. One such algorithm is the Deep Learning Subcellular Localization Prediction (DeepLSLP) algorithm, which was developed by researchers at the University of California, San Francisco. \nThe DeepLSLP algorithm uses a deep neural network to predict the subcellular localization of a protein based on its amino acid sequence. The algorithm was trained on a large dataset of protein sequences and their corresponding subcellular localizations, and was shown to achieve high accuracy in predicting the subcellular localization of proteins.\nAnother algorithm that has been developed for protein subcellular localization prediction using deep learning is the DeepSubRL algorithm, which was developed by researchers at the University of Illinois at Urbana-Champaign. The DeepSubRL algorithm also uses a deep neural network to predict the subcellular localization of a protein based on its amino acid sequence.\nOverall, both the DeepLSLP and DeepSubRL algorithms have shown promising results in predicting the subcellular localization of proteins using deep learning techniques.",
    "llama-7b_fact_raw": "1. The Deep Learning Subcellular Localization Prediction (DeepLSLP) algorithm was developed by researchers at the University of California, San Francisco.\n2. The DeepLSLP algorithm uses a deep neural network to predict the subcellular localization of proteins.\n3. The DeepLSLP algorithm was trained on a dataset of protein sequences and their corresponding subcellular localizations.\n4. The DeepSubRL algorithm was developed by researchers at the University of Illinois at Urbana-Champaign.\n5. The DeepSubRL algorithm also uses a deep neural network to predict the subcellular localization of proteins based on their amino acid sequence.",
    "llama-7b_fact": [
      "The Deep Learning Subcellular Localization Prediction (DeepLSLP) algorithm was developed by researchers at the University of California, San Francisco.",
      "The DeepLSLP algorithm uses a deep neural network to predict the subcellular localization of proteins.",
      "The DeepLSLP algorithm was trained on a dataset of protein sequences and their corresponding subcellular localizations.",
      "The DeepSubRL algorithm was developed by researchers at the University of Illinois at Urbana-Champaign.",
      "The DeepSubRL algorithm also uses a deep neural network to predict the subcellular localization of proteins based on their amino acid sequence."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 2634,
    "user_query": "What is MULTOVL?",
    "llama-7b_response": "MULTOVL is an acronym that stands for Multi-Modal Transportation Optimization and Visualization Laboratory. It is a research laboratory that focuses on developing innovative solutions for transportation optimization and visualization. The laboratory is located at the Department of Civil and Environmental Engineering at the University of Illinois at Urbana-Champaign.\n\nThe MULTOVL laboratory conducts research on various aspects of transportation optimization and visualization, including:\n\n1. Multi-modal transportation optimization: The laboratory develops algorithms and models that can optimize transportation networks that involve multiple modes of transportation, such as cars, buses, trains, and planes.\n\n2. Real-time transportation optimization: The laboratory develops algorithms and models that can optimize transportation networks in real-time, taking into account current traffic conditions, road closures, and other factors that can affect travel times.\n\n3. Visualization of transportation networks: The laboratory develops interactive visualization tools that can help transportation planners and policymakers to better understand transportation networks and identify areas for improvement.\n\n4. Human factors in transportation: The laboratory conducts research on how human behavior and decision-making affect transportation networks, and develops models and algorithms that can incorporate these factors into transportation optimization.\n\nOverall, the MULTOVL laboratory is dedicated to developing innovative solutions for transportation optimization and visualization, with the goal of improving transportation systems and reducing transportation-related emissions and congestion.",
    "llama-7b_fact_raw": "1. MULTOVL stands for Multi-Modal Transportation Optimization and Visualization Laboratory.\n2. MULTOVL is a research laboratory located at the Department of Civil and Environmental Engineering at the University of Illinois at Urbana-Champaign.\n3. The laboratory develops algorithms and models for optimizing multi-modal transportation networks.\n4. MULTOVL works on real-time transportation optimization considering current traffic conditions and other dynamic factors.\n5. The laboratory also focuses on the visualization of transportation networks and the study of human factors in transportation.",
    "llama-7b_fact": [
      "MULTOVL stands for Multi-Modal Transportation Optimization and Visualization Laboratory.",
      "MULTOVL is a research laboratory located at the Department of Civil and Environmental Engineering at the University of Illinois at Urbana-Champaign.",
      "The laboratory develops algorithms and models for optimizing multi-modal transportation networks.",
      "MULTOVL works on real-time transportation optimization considering current traffic conditions and other dynamic factors.",
      "The laboratory also focuses on the visualization of transportation networks and the study of human factors in transportation."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nWithout additional context or information that contradicts these statements, they all appear to be reasonable descriptions of what a Multi-Modal Transportation Optimization and Visualization Laboratory might do, and there is no evidence to suggest they are false.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2660,
    "user_query": "Can GDF15 be a biomarker for metformin treatment?",
    "llama-7b_response": "GDF15 is a biomarker that has been studied as a potential indicator of the effectiveness of metformin treatment in patients with type 2 diabetes. Metformin is a commonly prescribed medication for type 2 diabetes that works by reducing blood sugar levels by decreasing glucose production in the liver and increasing insulin sensitivity.\nStudies have shown that GDF15 levels are elevated in patients with type 2 diabetes, and that these levels are reduced following metformin treatment. This suggests that GDF15 may be a useful biomarker for monitoring the effectiveness of metformin treatment in patients with type 2 diabetes.\nHowever, it is important to note that GDF15 is not the only biomarker that has been studied as a potential indicator of metformin treatment effectiveness. Other biomarkers such as HOMA-IR and fasting insulin levels have also been investigated.\nOverall, while GDF15 may be a useful biomarker for monitoring the effectiveness of metformin treatment in patients with type 2 diabetes, it is important to consider other biomarkers as well when evaluating treatment effectiveness.",
    "llama-7b_fact_raw": "1. GDF15 has been studied as a potential indicator of the effectiveness of metformin treatment in patients with type 2 diabetes.\n2. Metformin is a medication prescribed for type 2 diabetes that reduces blood sugar levels by decreasing glucose production in the liver and increasing insulin sensitivity.\n3. Studies indicate that GDF15 levels are elevated in patients with type 2 diabetes.\n4. GDF15 levels are reduced following metformin treatment in patients with type 2 diabetes.\n5. Other biomarkers, such as HOMA-IR and fasting insulin levels, have also been investigated as potential indicators of metformin treatment effectiveness.",
    "llama-7b_fact": [
      "GDF15 has been studied as a potential indicator of the effectiveness of metformin treatment in patients with type 2 diabetes.",
      "Metformin is a medication prescribed for type 2 diabetes that reduces blood sugar levels by decreasing glucose production in the liver and increasing insulin sensitivity.",
      "Studies indicate that GDF15 levels are elevated in patients with type 2 diabetes.",
      "GDF15 levels are reduced following metformin treatment in patients with type 2 diabetes.",
      "Other biomarkers, such as HOMA-IR and fasting insulin levels, have also been investigated as potential indicators of metformin treatment effectiveness."
    ],
    "llama-7b_judge_raw": "1. TRUE: GDF15 (Growth Differentiation Factor 15) has been studied as a potential biomarker for various conditions, including its role in indicating the effectiveness of metformin treatment in patients with type 2 diabetes.\n2. TRUE: Metformin is indeed a medication prescribed for type 2 diabetes that primarily reduces blood sugar levels by decreasing hepatic glucose production and by increasing insulin sensitivity in muscle and fat tissues.\n3. TRUE: Research has shown that GDF15 levels are often elevated in patients with type 2 diabetes, which may reflect underlying pathophysiological processes.\n4. TRUE: Some studies have reported that metformin treatment can lead to reduced GDF15 levels in patients with type 2 diabetes, suggesting a potential link between GDF15 levels and metformin's mechanisms of action.\n5. TRUE: Other biomarkers, such as the Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) and fasting insulin levels, are commonly used to assess insulin resistance and have been investigated to evaluate the effectiveness of metformin treatment in patients with type 2 diabetes.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2664,
    "user_query": "Is recursive splicing more common in short introns?",
    "llama-7b_response": "The question of whether recursive splicing is more common in short introns is an interesting one. Recursive splicing refers to the process by which an intron is spliced out of a pre-mRNA molecule and then inserted back into the same pre-mRNA molecule to form a mature mRNA molecule. \nThere are several factors that could influence the frequency of recursive splicing, including the length of the intron, the sequence of the intron, and the overall structure of the pre-mRNA molecule. \nIn terms of the length of the intron, it is possible that shorter introns are more likely to undergo recursive splicing. This is because shorter introns may be more flexible and easier to splice out and insert back into the pre-mRNA molecule. However, it is also possible that longer introns may be more likely to undergo recursive splicing, as they may have more opportunities to be spliced out and inserted back into the pre-mRNA molecule.\nIn terms of the sequence of the intron, it is possible that certain sequences may be more prone to recursive splicing. For example, sequences that are highly conserved or have specific structural features may be more likely to be spliced out and inserted back into the pre-mRNA molecule.\nFinally, the overall structure of the pre-mRNA molecule could also influence the frequency of recursive splicing. For example, pre-mRNA molecules that have multiple introns may be more likely to undergo recursive splicing, as there may be more opportunities for introns to be spliced out and inserted back into the pre-mRNA molecule.\nOverall, while there may be some evidence to suggest that recursive splicing is more common in short introns, the frequency of recursive splicing is likely influenced by a variety of factors and may vary depending on the specific pre-mRNA molecule and cellular context.",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 2679,
    "user_query": "What is the TALE-iD method used for?",
    "llama-7b_response": "The TALE-iD method is used for identifying and characterizing transposable elements (TEs) in eukaryotic genomes. TEs are mobile genetic elements that can copy and insert themselves into new locations in the genome, often disrupting gene expression and contributing to genetic diversity. The TALE-iD method is a high-throughput approach that uses transposase-mediated insertion of transposable elements (TMEIs) to identify and characterize TEs in a genome. \n\nThe TALE-iD method involves three main steps: \n\n1. Transposase-mediated insertion of transposable elements (TMEIs): The TMEIs are designed to target specific regions of the genome where TEs are known to be present. The TMEIs are then inserted into the genome using a transposase enzyme, which is a protein required for the mobility of TEs. \n\n2. Capture and sequencing of TMEIs: Once the TMEIs are inserted into the genome, they are isolated and sequenced. The sequencing data is then analyzed to identify the specific TEs that are present in the genome. \n\n3. Characterization of TEs: The TEs that are identified using the TALE-iD method are then characterized using various molecular biology techniques, such as PCR, Southern blotting, and sequencing. This allows researchers to determine the size, sequence, and copy number of each TE in the genome. \n\nOverall, the TALE-iD method is a powerful tool for identifying and characterizing TEs in eukaryotic genomes, which has important implications for understanding the evolution and function of these mobile genetic elements.",
    "llama-7b_fact_raw": "1. The TALE-iD method is used for identifying and characterizing transposable elements in eukaryotic genomes.\n2. Transposable elements (TEs) are mobile genetic elements that can move and insert themselves into new locations in the genome.\n3. The TALE-iD method uses transposase-mediated insertion of transposable elements (TMEIs) for its process.\n4. The TALE-iD method includes a step where TMEIs that have been inserted into the genome are isolated and sequenced.\n5. The TALE-iD method allows researchers to determine the size, sequence, and copy number of each transposable element identified.",
    "llama-7b_fact": [
      "The TALE-iD method is used for identifying and characterizing transposable elements in eukaryotic genomes.",
      "Transposable elements (TEs) are mobile genetic elements that can move and insert themselves into new locations in the genome.",
      "The TALE-iD method uses transposase-mediated insertion of transposable elements (TMEIs) for its process.",
      "The TALE-iD method includes a step where TMEIs that have been inserted into the genome are isolated and sequenced.",
      "The TALE-iD method allows researchers to determine the size, sequence, and copy number of each transposable element identified."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The TALE-iD method does not use transposase-mediated insertion of transposable elements (TMEIs) for its process. Instead, it is a bioinformatics tool used for identifying and characterizing transposable elements based on their sequence features.\n4. UNKNOWN\n5. UNKNOWN\n\nNote: The TALE-iD method is a specific technique, and without detailed information about the method, it is difficult to confirm the exact steps involved, such as the isolation and sequencing of TMEIs or the determination of size, sequence, and copy number of each transposable element. Therefore, statements 4 and 5 are marked as UNKNOWN.",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2747,
    "user_query": "Which Lisp framework has been developed for image processing?",
    "llama-7b_response": "There are several Lisp frameworks that have been developed for image processing, but one of the most popular ones is the Common Lisp Image Processing (CL-IP) library. CL-IP is an open-source library that provides a set of functions and tools for image processing tasks such as image filtering, segmentation, and feature extraction. It is written in Common Lisp, a powerful and flexible programming language that is well-suited for image processing tasks. CL-IP is cross-platform compatible and can be used on various operating systems, including Linux, macOS, and Windows. It is also regularly updated and maintained by a community of developers, ensuring that it remains a reliable and useful tool for image processing tasks.",
    "llama-7b_fact_raw": "1. The Common Lisp Image Processing (CL-IP) library is a Lisp framework developed for image processing.\n2. CL-IP is an open-source library.\n3. The CL-IP library provides functions and tools for tasks such as image filtering, segmentation, and feature extraction.\n4. CL-IP is written in Common Lisp.\n5. The CL-IP library is compatible with various operating systems, including Linux, macOS, and Windows.",
    "llama-7b_fact": [
      "The Common Lisp Image Processing (CL-IP) library is a Lisp framework developed for image processing.",
      "CL-IP is an open-source library.",
      "The CL-IP library provides functions and tools for tasks such as image filtering, segmentation, and feature extraction.",
      "CL-IP is written in Common Lisp.",
      "The CL-IP library is compatible with various operating systems, including Linux, macOS, and Windows."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN\n\nWithout specific information about the Common Lisp Image Processing (CL-IP) library, I cannot verify the accuracy of statements 1, 2, 3, and 5. However, if CL-IP is indeed a Lisp framework, then statement 4 would be true as it is written in Common Lisp by definition.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2759,
    "user_query": "How many genes in S. cerevisiae are the result of an ancient whole genome duplication?",
    "llama-7b_response": "The yeast species Saccharomyces cerevisiae underwent a whole genome duplication (WGD) event approximately 100 million years ago, which resulted in the duplication of its entire genome. This event has had a significant impact on the evolution of the yeast species and has contributed to its adaptability and diversity. \nStudies have estimated that approximately 75% of the genes in S. cerevisiae are the result of this ancient WGD event. This means that the majority of the genes in the yeast genome were duplicated and diverged after the WGD event. However, it is important to note that there are still many genes in the yeast genome that are unique to S. cerevisiae and were not duplicated as a result of the WGD event. \nOverall, the ancient WGD event that occurred in S. cerevisiae has had a significant impact on the genetic makeup of the species and has contributed to its adaptability and diversity.",
    "llama-7b_fact_raw": "1. Saccharomyces cerevisiae underwent a whole genome duplication event approximately 100 million years ago.\n2. The whole genome duplication resulted in the duplication of the entire genome of Saccharomyces cerevisiae.\n3. Approximately 75% of the genes in S. cerevisiae are the result of the ancient whole genome duplication event.\n4. The whole genome duplication event has contributed to the adaptability and diversity of Saccharomyces cerevisiae.\n5. There are genes in the yeast genome of S. cerevisiae that are unique and were not duplicated as a result of the whole genome duplication event.",
    "llama-7b_fact": [
      "Saccharomyces cerevisiae underwent a whole genome duplication event approximately 100 million years ago.",
      "The whole genome duplication resulted in the duplication of the entire genome of Saccharomyces cerevisiae.",
      "Approximately 75% of the genes in S. cerevisiae are the result of the ancient whole genome duplication event.",
      "The whole genome duplication event has contributed to the adaptability and diversity of Saccharomyces cerevisiae.",
      "There are genes in the yeast genome of S. cerevisiae that are unique and were not duplicated as a result of the whole genome duplication event."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Saccharomyces cerevisiae is believed to have undergone a whole genome duplication event approximately 100 to 150 million years ago, but the exact timing is still debated among scientists.\n2. TRUE\n3. FALSE [correction]: It is estimated that only about 10% to 15% of the genes in S. cerevisiae are the result of the ancient whole genome duplication event.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 2763,
    "user_query": "Which complex is bound by estrogen-related receptor β (Esrrb)?",
    "llama-7b_response": "Estrogen-related receptor β (Esrrb) is a nuclear receptor that binds to DNA and regulates the expression of genes involved in various biological processes, including cell proliferation, differentiation, and apoptosis. Esrrb is known to bind to a variety of ligands, including estrogen, progesterone, and selective estrogen receptor modulators (SERMs).\nOne complex that is bound by Esrrb is the estrogen receptor complex (ERC), which consists of Esrrb and the estrogen receptor α (ERα). The ERC is responsible for regulating the expression of genes that are involved in the development and maintenance of female reproductive tissues, as well as other tissues such as bone, breast, and skin.\nAnother complex that is bound by Esrrb is the androgen receptor complex (ARC), which consists of Esrrb and the androgen receptor (AR). The ARC is responsible for regulating the expression of genes that are involved in the development and maintenance of male reproductive tissues, as well as other tissues such as bone, muscle, and skin.\nOverall, Esrrb plays a crucial role in regulating the expression of genes involved in various biological processes by binding to a variety of ligands and forming complexes with other nuclear receptors.",
    "llama-7b_fact_raw": "1. Estrogen-related receptor β (Esrrb) binds to DNA and regulates gene expression.\n2. Esrrb is known to bind to ligands such as estrogen, progesterone, and selective estrogen receptor modulators (SERMs).\n3. The estrogen receptor complex (ERC) consists of Esrrb and the estrogen receptor α (ERα).\n4. The ERC regulates the expression of genes involved in the development and maintenance of female reproductive tissues and other tissues like bone, breast, and skin.\n5. The androgen receptor complex (ARC) consists of Esrrb and the androgen receptor (AR) and regulates gene expression related to male reproductive tissues and other tissues such as bone, muscle, and skin.",
    "llama-7b_fact": [
      "Estrogen-related receptor β (Esrrb) binds to DNA and regulates gene expression.",
      "Esrrb is known to bind to ligands such as estrogen, progesterone, and selective estrogen receptor modulators (SERMs).",
      "The estrogen receptor complex (ERC) consists of Esrrb and the estrogen receptor α (ERα).",
      "The ERC regulates the expression of genes involved in the development and maintenance of female reproductive tissues and other tissues like bone, breast, and skin.",
      "The androgen receptor complex (ARC) consists of Esrrb and the androgen receptor (AR) and regulates gene expression related to male reproductive tissues and other tissues such as bone, muscle, and skin."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Estrogen-related receptor β (Esrrb) is an orphan receptor and does not bind to ligands such as estrogen, progesterone, or selective estrogen receptor modulators (SERMs); it is constitutively active.\n3. FALSE [correction]: The estrogen receptor complex (ERC) does not consist of Esrrb and the estrogen receptor α (ERα). Esrrb is a different type of receptor and functions independently of the estrogen receptor complex, which typically consists of estrogen receptor α (ERα) and/or estrogen receptor β (ERβ).\n4. TRUE\n5. FALSE [correction]: The androgen receptor complex (ARC) does not consist of Esrrb and the androgen receptor (AR). The ARC typically refers to the complex formed by androgens binding to the androgen receptor (AR), and Esrrb is not part of this complex.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 2842,
    "user_query": "What is the role of ZCCHC17?",
    "llama-7b_response": "ZCCHC17 is a gene that encodes a protein called ZC3H17, which is a member of the ZC3H family of proteins. The ZC3H family of proteins are involved in a variety of cellular processes, including DNA repair, transcription regulation, and cell cycle progression. Specifically, ZC3H17 has been shown to play a role in DNA repair by participating in the repair of DNA double-strand breaks. This protein interacts with other DNA repair proteins, such as BRCA1 and RAD51, to facilitate the repair process. Additionally, ZC3H17 has been implicated in the regulation of cell proliferation and apoptosis, suggesting that it may play a role in tumor suppression. Further studies are needed to fully understand the functions of ZC3H17 in various biological processes.",
    "llama-7b_fact_raw": "1. ZCCHC17 is a gene that encodes a protein known as ZC3H17.\n2. ZC3H17 is a member of the ZC3H family of proteins.\n3. The ZC3H family of proteins is involved in cellular processes such as DNA repair, transcription regulation, and cell cycle progression.\n4. ZC3H17 plays a role in the repair of DNA double-strand breaks.\n5. ZC3H17 interacts with other DNA repair proteins, including BRCA1 and RAD51.",
    "llama-7b_fact": [
      "ZCCHC17 is a gene that encodes a protein known as ZC3H17.",
      "ZC3H17 is a member of the ZC3H family of proteins.",
      "The ZC3H family of proteins is involved in cellular processes such as DNA repair, transcription regulation, and cell cycle progression.",
      "ZC3H17 plays a role in the repair of DNA double-strand breaks.",
      "ZC3H17 interacts with other DNA repair proteins, including BRCA1 and RAD51."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: ZCCHC17 is a gene that encodes a protein known as ZC3H17, not ZC3H17.\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nThe correction for statement 1 is based on the standard nomenclature for genes and proteins where the gene symbol is often in uppercase (ZCCHC17), and the protein it encodes is written in a mix of uppercase and lowercase (ZC3H17). Statements 4 and 5 require specific knowledge about the functions and interactions of the ZC3H17 protein, which are not provided in the context.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2861,
    "user_query": "Which proteins form the nuclear pore basket in human cells?",
    "llama-7b_response": "The proteins that form the nuclear pore basket in human cells are called nuclear pore complex proteins (NPCs). These proteins are responsible for regulating the movement of molecules between the nucleus and the cytoplasm. \nThe nuclear pore basket is a complex structure that surrounds the nuclear pore, which is a large protein channel in the nuclear membrane. The nuclear pore basket is composed of multiple proteins, including FG repeat proteins, A-type lamin proteins, and B-type lamin proteins.\nFG repeat proteins are the most abundant proteins in the nuclear pore basket and play a crucial role in the assembly and maintenance of the nuclear pore complex. A-type lamin proteins are structural proteins that provide stability to the nuclear pore basket, while B-type lamin proteins regulate the movement of molecules through the nuclear pore.\nOther proteins that are involved in the formation of the nuclear pore basket include nucleoporins, which are proteins that bind to the nuclear pore complex and help to regulate its function.\nIn summary, the nuclear pore basket in human cells is composed of multiple proteins, including FG repeat proteins, A-type lamin proteins, B-type lamin proteins, nucleoporins, and other proteins. These proteins work together to regulate the movement of molecules between the nucleus and the cytoplasm, ensuring the proper functioning of the cell.",
    "llama-7b_fact_raw": "1. Nuclear pore complex proteins (NPCs) are responsible for regulating the movement of molecules between the nucleus and the cytoplasm in human cells.\n2. The nuclear pore basket is composed of multiple proteins, including FG repeat proteins, A-type lamin proteins, and B-type lamin proteins.\n3. FG repeat proteins are the most abundant proteins in the nuclear pore basket and play a crucial role in the assembly and maintenance of the nuclear pore complex.\n4. A-type lamin proteins are structural proteins that provide stability to the nuclear pore basket.\n5. B-type lamin proteins regulate the movement of molecules through the nuclear pore.",
    "llama-7b_fact": [
      "Nuclear pore complex proteins (NPCs) are responsible for regulating the movement of molecules between the nucleus and the cytoplasm in human cells.",
      "The nuclear pore basket is composed of multiple proteins, including FG repeat proteins, A-type lamin proteins, and B-type lamin proteins.",
      "FG repeat proteins are the most abundant proteins in the nuclear pore basket and play a crucial role in the assembly and maintenance of the nuclear pore complex.",
      "A-type lamin proteins are structural proteins that provide stability to the nuclear pore basket.",
      "B-type lamin proteins regulate the movement of molecules through the nuclear pore."
    ],
    "llama-7b_judge_raw": "1. TRUE: Nuclear pore complex proteins (NPCs) are indeed responsible for regulating the movement of molecules between the nucleus and the cytoplasm in eukaryotic cells, including human cells.\n\n2. FALSE [correction]: The nuclear pore basket is composed of multiple proteins, including FG repeat proteins, but A-type and B-type lamin proteins are not components of the nuclear pore basket. Instead, they are part of the nuclear lamina, a network that provides structural support to the nuclear envelope.\n\n3. TRUE: FG repeat proteins are indeed abundant in the nuclear pore complex and play a crucial role in the assembly and function of the NPC, including the selective transport of molecules.\n\n4. FALSE [correction]: A-type lamin proteins are not part of the nuclear pore basket. They are structural proteins that are part of the nuclear lamina, which provides mechanical support to the nuclear envelope and is involved in various nuclear processes.\n\n5. FALSE [correction]: B-type lamin proteins are not responsible for regulating the movement of molecules through the nuclear pore. They are part of the nuclear lamina and are involved in maintaining the integrity and shape of the nucleus, as well as playing roles in DNA replication and cell division. The regulation of molecule movement through the nuclear pore is primarily the function of the NPC proteins, including FG repeat proteins.",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 2919,
    "user_query": "What type of topoisomerase inhibitor is gepotidacin?",
    "llama-7b_response": "Gepotidacin is a type of topoisomerase inhibitor that belongs to the anthracycline family. Topoisomerase enzymes are responsible for regulating the movement of DNA within a cell, and inhibitors like gepotidacin bind to these enzymes and prevent them from functioning properly, causing DNA damage and cell death.",
    "llama-7b_fact_raw": "1. Gepotidacin is a topoisomerase inhibitor.\n2. Gepotidacin belongs to the anthracycline family.\n3. Topoisomerase enzymes regulate the movement of DNA within a cell.\n4. Inhibitors like gepotidacin bind to topoisomerase enzymes and prevent them from functioning properly.\n5. The binding of inhibitors like gepotidacin to topoisomerase enzymes can cause DNA damage and cell death.",
    "llama-7b_fact": [
      "Gepotidacin is a topoisomerase inhibitor.",
      "Gepotidacin belongs to the anthracycline family.",
      "Topoisomerase enzymes regulate the movement of DNA within a cell.",
      "Inhibitors like gepotidacin bind to topoisomerase enzymes and prevent them from functioning properly.",
      "The binding of inhibitors like gepotidacin to topoisomerase enzymes can cause DNA damage and cell death."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Gepotidacin does not belong to the anthracycline family; it is a novel bacterial topoisomerase inhibitor of a new class called triazaacenaphthylene antibacterial agents.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 2943,
    "user_query": "Describe Canvas SPW",
    "llama-7b_response": "As an AI language model, I do not have personal opinions or beliefs. However, I can provide an objective description of Canvas SPW.\n\nCanvas SPW is a software development kit (SDK) that allows developers to create mobile applications for Android and iOS devices using HTML5, CSS3, and JavaScript. It is a cross-platform development framework that allows developers to write code once and deploy it across multiple platforms, including Android, iOS, Windows, and BlackBerry.\n\nCanvas SPW provides a range of features and tools that make it easy for developers to create mobile applications quickly and efficiently. These include a drag-and-drop interface for designing user interfaces, a code editor that integrates with popular code editors like Visual Studio Code and Atom, and a built-in debugger that allows developers to test and debug their code.\n\nCanvas SPW also includes a range of APIs that allow developers to access device features like the camera, GPS, and sensors. This allows developers to create mobile applications that are more interactive and engaging.\n\nOverall, Canvas SPW is a powerful and flexible development framework that makes it easy for developers to create mobile applications for multiple platforms using HTML5, CSS3, and JavaScript.",
    "llama-7b_fact_raw": "1. Canvas SPW is a software development kit (SDK) for creating mobile applications.\n2. It allows developers to use HTML5, CSS3, and JavaScript for app development.\n3. Canvas SPW enables cross-platform development for Android, iOS, Windows, and BlackBerry platforms.\n4. The SDK includes a drag-and-drop interface for designing user interfaces.\n5. Canvas SPW provides APIs for accessing device features like the camera, GPS, and sensors.",
    "llama-7b_fact": [
      "Canvas SPW is a software development kit (SDK) for creating mobile applications.",
      "It allows developers to use HTML5, CSS3, and JavaScript for app development.",
      "Canvas SPW enables cross-platform development for Android, iOS, Windows, and BlackBerry platforms.",
      "The SDK includes a drag-and-drop interface for designing user interfaces.",
      "Canvas SPW provides APIs for accessing device features like the camera, GPS, and sensors."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN: Without additional context or information about \"Canvas SPW,\" it is not possible to determine the accuracy of this statement. \"Canvas SPW\" is not a widely recognized software development kit in the public domain as of my knowledge cutoff date.\n2. UNKNOWN: If \"Canvas SPW\" is indeed an SDK as claimed in statement 1, and it allows for HTML5, CSS3, and JavaScript development, this could be true. However, without confirmation of the capabilities of \"Canvas SPW,\" the truth of this statement cannot be determined.\n3. UNKNOWN: Similar to the previous statements, without specific information about \"Canvas SPW,\" it is not possible to verify whether it supports cross-platform development for the mentioned platforms.\n4. UNKNOWN: The presence of a drag-and-drop interface for designing user interfaces is a feature of some SDKs, but without concrete information about \"Canvas SPW,\" the truth of this statement cannot be ascertained.\n5. UNKNOWN: Many SDKs provide APIs for accessing device features, but without knowing what \"Canvas SPW\" is, it is not possible to confirm whether it offers such APIs.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 2960,
    "user_query": "List STING agonists.",
    "llama-7b_response": "STING (Stimulator of Interferon Genes) is a receptor found on the surface of cells that plays a critical role in the immune system's response to viral infections and tumors. Agonists of STING are molecules that bind to and activate the receptor, leading to the production of interferon, a protein that helps fight off viral infections and cancer cells. Here are some examples of STING agonists:\n\n1. Cyclic di-GMP (c-di-GMP) - a bacterial second messenger that binds to and activates STING in mammalian cells.\n\n2. Poly(I:C) - a synthetic double-stranded RNA molecule that mimics the structure of viral RNA and binds to STING to activate the immune response.\n\n3. CpG oligodeoxynucleotides - short segments of DNA that contain unmethylated CpG dinucleotides, which bind to STING and activate the immune response.\n\n4. Flagellin - a protein found in the flagella of bacteria that binds to STING and activates the immune response.\n\n5. Peptidoglycan - a major component of the cell wall of bacteria that binds to STING and activates the immune response.\n\nOverall, these STING agonists play a critical role in activating the immune system to fight off viral infections and cancer cells.",
    "llama-7b_fact_raw": "1. STING is a receptor that plays a role in the immune system's response to viral infections and tumors.\n2. Cyclic di-GMP (c-di-GMP) is a bacterial second messenger that activates STING in mammalian cells.\n3. Poly(I:C) is a synthetic double-stranded RNA molecule that activates the immune response by binding to STING.\n4. CpG oligodeoxynucleotides are short segments of DNA that contain unmethylated CpG dinucleotides and activate the immune response by binding to STING.\n5. Flagellin is a protein found in bacterial flagella that activates the immune response by binding to STING.",
    "llama-7b_fact": [
      "STING is a receptor that plays a role in the immune system's response to viral infections and tumors.",
      "Cyclic di-GMP (c-di-GMP) is a bacterial second messenger that activates STING in mammalian cells.",
      "Poly(I:C) is a synthetic double-stranded RNA molecule that activates the immune response by binding to STING.",
      "CpG oligodeoxynucleotides are short segments of DNA that contain unmethylated CpG dinucleotides and activate the immune response by binding to STING.",
      "Flagellin is a protein found in bacterial flagella that activates the immune response by binding to STING."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Cyclic di-GMP (c-di-GMP) is a bacterial second messenger, but it does not activate STING in mammalian cells. Instead, cyclic GMP-AMP (cGAMP) is a second messenger that activates STING in mammalian cells.\n3. FALSE [correction]: Poly(I:C) is a synthetic double-stranded RNA molecule that mimics viral infection and activates the immune response, but it does not bind to STING directly. It typically activates the immune response through pattern recognition receptors like TLR3 or MDA5, not STING.\n4. FALSE [correction]: CpG oligodeoxynucleotides contain unmethylated CpG dinucleotides and can activate the immune response, but they do so primarily through Toll-like receptor 9 (TLR9), not STING.\n5. FALSE [correction]: Flagellin is a protein found in bacterial flagella that can activate the immune response, but it does so through Toll-like receptor 5 (TLR5) and the NLRC4 inflammasome, not by binding to STING.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 2964,
    "user_query": "Describe SLIC-CAGE",
    "llama-7b_response": "SLIC-CAGE is a system developed by the National Institute of Standards and Technology (NIST) to provide a standardized method for identifying and categorizing cybersecurity threats. The acronym SLIC-CAGE stands for System and Organization Controls - Cyber Asset Governance and Evaluation.\n\nThe SLIC-CAGE system is designed to help organizations identify and prioritize their cybersecurity risks by categorizing them based on their potential impact on the organization's operations, assets, and stakeholders. The system provides a framework for evaluating the effectiveness of an organization's cybersecurity controls and identifying gaps that need to be addressed.\n\nThe SLIC-CAGE system consists of five levels of categorization, each with its own set of criteria for identifying and prioritizing cybersecurity threats. These levels are:\n\n1. System and Organization Controls (SOC)\n2. Cyber Asset Governance and Evaluation (CAGE)\n3. Information System (IS)\n4. Asset\n5. Stakeholder\n\nThe SOC level is the highest level of categorization and encompasses all of the organization's cybersecurity controls. The CAGE level is the next level down and focuses on the organization's cyber assets, including hardware, software, and data. The IS level is the next level down and focuses on individual information systems within the organization. The Asset level is the lowest level of categorization and focuses on individual assets within the organization. The Stakeholder level is the highest level of categorization and focuses on the impact of cybersecurity threats on the organization's stakeholders.\n\nThe SLIC-CAGE system provides a standardized method for evaluating the effectiveness of an organization's cybersecurity controls and identifying gaps that need to be addressed. By categorizing cybersecurity threats based on their potential impact on the organization's operations, assets, and stakeholders, organizations can prioritize their cybersecurity efforts and allocate resources more effectively.",
    "llama-7b_fact_raw": "1. SLIC-CAGE is a system developed by the National Institute of Standards and Technology (NIST).\n2. SLIC-CAGE stands for System and Organization Controls - Cyber Asset Governance and Evaluation.\n3. The system is designed to help organizations identify and prioritize their cybersecurity risks.\n4. SLIC-CAGE consists of five levels of categorization: System and Organization Controls (SOC), Cyber Asset Governance and Evaluation (CAGE), Information System (IS), Asset, and Stakeholder.\n5. The SOC level is the highest level of categorization within the SLIC-CAGE system.",
    "llama-7b_fact": [
      "SLIC-CAGE is a system developed by the National Institute of Standards and Technology (NIST).",
      "SLIC-CAGE stands for System and Organization Controls - Cyber Asset Governance and Evaluation.",
      "The system is designed to help organizations identify and prioritize their cybersecurity risks.",
      "SLIC-CAGE consists of five levels of categorization: System and Organization Controls (SOC), Cyber Asset Governance and Evaluation (CAGE), Information System (IS), Asset, and Stakeholder.",
      "The SOC level is the highest level of categorization within the SLIC-CAGE system."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: SLIC-CAGE does not stand for System and Organization Controls - Cyber Asset Governance and Evaluation. The acronym SLIC-CAGE does not have a widely recognized meaning associated with the National Institute of Standards and Technology (NIST).\n3. UNKNOWN\n4. FALSE [correction]: Since SLIC-CAGE is not a recognized system, the statement about it consisting of five levels of categorization is incorrect.\n5. FALSE [correction]: As SLIC-CAGE is not a recognized system, there is no SOC level or any level of categorization within it.",
    "llama-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "false",
      "false"
    ]
  },
  {
    "id": 2978,
    "user_query": "What are the roles of LEM-3?",
    "llama-7b_response": "LEM-3, also known as leucine-rich repeat-containing G-protein-coupled receptor 3, is a protein that belongs to the G-protein-coupled receptor family. It is primarily expressed in the brain and plays important roles in various physiological processes. \n\nOne of the primary roles of LEM-3 is to regulate synaptic transmission, which is the process by which neurons communicate with each other. LEM-3 binds to neurotransmitters such as glutamate and GABA, which are released by neurons during synaptic transmission. By binding to these neurotransmitters, LEM-3 modulates their activity, which in turn affects the strength of the synaptic connection between neurons.\n\nAnother important role of LEM-3 is in the regulation of apoptosis, or programmed cell death. LEM-3 has been shown to interact with a number of proteins involved in apoptosis, including caspases and Bcl-2 family proteins. By interacting with these proteins, LEM-3 may play a role in regulating the initiation and execution of apoptosis.\n\nFinally, LEM-3 has been implicated in the regulation of cell proliferation and differentiation. LEM-3 has been shown to interact with a number of growth factor receptors, including the epidermal growth factor receptor (EGFR). By interacting with EGFR, LEM-3 may play a role in regulating cell proliferation and differentiation in a variety of tissues.\n\nOverall, LEM-3 is a complex protein that plays important roles in a variety of physiological processes, including synaptic transmission, apoptosis, and cell proliferation and differentiation.",
    "llama-7b_fact_raw": "1. LEM-3 is a protein that belongs to the G-protein-coupled receptor family.\n2. LEM-3 is primarily expressed in the brain.\n3. LEM-3 regulates synaptic transmission by binding to neurotransmitters such as glutamate and GABA.\n4. LEM-3 interacts with proteins involved in apoptosis, including caspases and Bcl-2 family proteins.\n5. LEM-3 has been shown to interact with growth factor receptors like the epidermal growth factor receptor (EGFR).",
    "llama-7b_fact": [
      "LEM-3 is a protein that belongs to the G-protein-coupled receptor family.",
      "LEM-3 is primarily expressed in the brain.",
      "LEM-3 regulates synaptic transmission by binding to neurotransmitters such as glutamate and GABA.",
      "LEM-3 interacts with proteins involved in apoptosis, including caspases and Bcl-2 family proteins.",
      "LEM-3 has been shown to interact with growth factor receptors like the epidermal growth factor receptor (EGFR)."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: LEM-3 is not a protein that belongs to the G-protein-coupled receptor family. LEM domain-containing protein 3 (LEM-3) is involved in DNA damage response and repair.\n2. UNKNOWN: Without specific information about the expression pattern of LEM-3, it is not possible to confirm whether it is primarily expressed in the brain.\n3. FALSE [correction]: LEM-3 does not regulate synaptic transmission by binding to neurotransmitters such as glutamate and GABA. LEM-3 is involved in the maintenance of nuclear and genomic integrity.\n4. TRUE: LEM-3 interacts with proteins involved in apoptosis, including caspases and Bcl-2 family proteins, as part of its role in DNA damage response and repair.\n5. UNKNOWN: Without specific information regarding LEM-3's interaction with growth factor receptors like EGFR, it is not possible to confirm the accuracy of this statement.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 2992,
    "user_query": "List the releases of tmVar",
    "llama-7b_response": "As an AI language model, I do not have access to real-time information or the ability to browse the internet. However, I can provide you with general information about tmVar.\n\ntmVar is a free and open-source software package developed by the National Institute of Standards and Technology (NIST) for managing and analyzing time-series data. It provides a wide range of tools for data preprocessing, visualization, and statistical analysis.\n\nHere are some of the releases of tmVar:\n\n1. tmVar 1.0.0 - Released in 2015\n2. tmVar 1.1.0 - Released in 2016\n3. tmVar 1.2.0 - Released in 2017\n4. tmVar 1.3.0 - Released in 2018\n5. tmVar 1.4.0 - Released in 2019\n6. tmVar 1.5.0 - Released in 2020\n7. tmVar 1.6.0 - Released in 2021",
    "llama-7b_fact_raw": "1. tmVar is a software package developed by the National Institute of Standards and Technology (NIST).\n2. tmVar is designed for managing and analyzing time-series data.\n3. tmVar 1.0.0 was released in 2015.\n4. tmVar 1.4.0 was released in 2019.\n5. tmVar 1.6.0 was released in 2021.",
    "llama-7b_fact": [
      "tmVar is a software package developed by the National Institute of Standards and Technology (NIST).",
      "tmVar is designed for managing and analyzing time-series data.",
      "tmVar 1.0.0 was released in 2015.",
      "tmVar 1.4.0 was released in 2019.",
      "tmVar 1.6.0 was released in 2021."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: tmVar is not a software package developed by the National Institute of Standards and Technology (NIST); it is a text-mining tool for recognizing and normalizing genetic variants in the literature, developed by the National Center for Biotechnology Information (NCBI).\n2. FALSE [correction]: tmVar is not designed for managing and analyzing time-series data; it is designed for extracting genetic variant information from text.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "false",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3018,
    "user_query": "Which is the database of somatic mutations in normal cells?",
    "llama-7b_response": "The database of somatic mutations in normal cells is called the Cancer Genome Atlas (CGA). It is a collaborative effort between the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI), both of which are part of the United States National Institutes of Health (NIH). The CGA aims to create a comprehensive understanding of the genomic changes that occur in cancer cells, with the ultimate goal of improving cancer diagnosis, treatment, and prevention. The CGA has generated extensive data on somatic mutations in normal cells, including mutation rates, types of mutations, and their associations with different cancer types.",
    "llama-7b_fact_raw": "1. The Cancer Genome Atlas (CGA) is a database of somatic mutations in normal cells.\n2. The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) collaborate on the CGA.\n3. Both the NCI and NHGRI are part of the United States National Institutes of Health (NIH).\n4. The CGA's goal is to understand the genomic changes in cancer cells to improve cancer diagnosis, treatment, and prevention.\n5. The CGA has generated data on mutation rates, types of mutations, and their associations with different cancer types.",
    "llama-7b_fact": [
      "The Cancer Genome Atlas (CGA) is a database of somatic mutations in normal cells.",
      "The National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) collaborate on the CGA.",
      "Both the NCI and NHGRI are part of the United States National Institutes of Health (NIH).",
      "The CGA's goal is to understand the genomic changes in cancer cells to improve cancer diagnosis, treatment, and prevention.",
      "The CGA has generated data on mutation rates, types of mutations, and their associations with different cancer types."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Cancer Genome Atlas (TCGA) is a database of somatic mutations in cancer cells, not normal cells.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3037,
    "user_query": "Are there graph kernel libraries available implemented in JAVA?",
    "llama-7b_response": "Yes, there are several graph kernel libraries available implemented in Java. Some of the popular ones are:\n1. JUNG (Java Universal Network/Graph Framework)\n2. GraphStream\n3. GraphDB\n4. Neo4j\n5. Apache TinkerPop\nJUNG is a popular graph processing library that provides a set of tools for analyzing, visualizing, and manipulating graphs. It supports various graph types, including directed, undirected, weighted, and unweighted graphs.\nGraphStream is a lightweight graph processing library that is designed for real-time applications. It supports various graph types and provides a set of tools for graph traversal, aggregation, and transformation.\nGraphDB is a graph database management system that provides a set of tools for storing, managing, and querying graphs. It supports various graph types and provides a set of APIs for graph processing.\nNeo4j is a popular graph database that provides a set of tools for storing, managing, and querying graphs. It supports various graph types and provides a set of APIs for graph processing.\nApache TinkerPop is a graph computing framework that provides a set of tools for traversing, querying, and manipulating graphs. It supports various graph types and provides a set of APIs for graph processing.",
    "llama-7b_fact_raw": "1. JUNG (Java Universal Network/Graph Framework) is a graph processing library implemented in Java.\n2. GraphStream is a Java library designed for real-time graph processing applications.\n3. GraphDB is a graph database management system implemented in Java.\n4. Neo4j is a graph database that provides tools for storing, managing, and querying graphs and is implemented in Java.\n5. Apache TinkerPop is a graph computing framework that supports various graph types and provides APIs for graph processing in Java.",
    "llama-7b_fact": [
      "JUNG (Java Universal Network/Graph Framework) is a graph processing library implemented in Java.",
      "GraphStream is a Java library designed for real-time graph processing applications.",
      "GraphDB is a graph database management system implemented in Java.",
      "Neo4j is a graph database that provides tools for storing, managing, and querying graphs and is implemented in Java.",
      "Apache TinkerPop is a graph computing framework that supports various graph types and provides APIs for graph processing in Java."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: GraphDB is a graph database management system, but it is not limited to being implemented in Java; it can be accessed using various programming languages through its APIs.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3045,
    "user_query": "List the four advances integrated into the SHERLOCKv2 platform.",
    "llama-7b_response": "Sure, I'd be happy to explain the four advances integrated into the SHERLOCKv2 platform.\n1. Artificial Intelligence: SHERLOCKv2 uses artificial intelligence to analyze data and provide insights. This includes machine learning algorithms that can identify patterns and make predictions based on data.\n2. Natural Language Processing: SHERLOCKv2 also uses natural language processing to understand human language and provide relevant responses. This allows users to interact with the platform in a more natural and intuitive way.\n3. Contextual Understanding: SHERLOCKv2 has the ability to understand the context of a query or request, which allows it to provide more accurate and relevant results. This is achieved through the use of semantic analysis and knowledge graphs.\n4. Integration with Third-Party Apps: SHERLOCKv2 can integrate with third-party apps and services, allowing users to access and analyze data from multiple sources in a single platform. This can help users to gain a more comprehensive understanding of their data and make more informed decisions.",
    "llama-7b_fact_raw": "1. SHERLOCKv2 uses artificial intelligence, including machine learning algorithms, to analyze data and provide insights.\n2. SHERLOCKv2 incorporates natural language processing to understand human language and provide relevant responses.\n3. The platform has the capability to understand the context of queries or requests through semantic analysis and knowledge graphs.\n4. SHERLOCKv2 is designed to integrate with third-party apps and services to allow users to access and analyze data from multiple sources.",
    "llama-7b_fact": [
      "SHERLOCKv2 uses artificial intelligence, including machine learning algorithms, to analyze data and provide insights.",
      "SHERLOCKv2 incorporates natural language processing to understand human language and provide relevant responses.",
      "The platform has the capability to understand the context of queries or requests through semantic analysis and knowledge graphs.",
      "SHERLOCKv2 is designed to integrate with third-party apps and services to allow users to access and analyze data from multiple sources."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n\nNote: While the statements about SHERLOCKv2 are generally consistent with the capabilities of advanced AI systems, without specific information about a platform named \"SHERLOCKv2,\" the responses are based on typical features of AI systems that include machine learning, natural language processing, semantic analysis, and integration capabilities. If \"SHERLOCKv2\" is a hypothetical or proprietary system not publicly documented, the responses would be speculative.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3078,
    "user_query": "Describe the bartender algorithm",
    "llama-7b_response": "The bartender algorithm is a simple yet effective algorithm used in computer science to solve the problem of finding the k-nearest neighbors (k-NN) in a set of data points. The algorithm works by creating a matrix where each row represents a data point and each column represents a neighboring data point. The algorithm then calculates the Euclidean distance between each data point and its k nearest neighbors, and assigns a score to each data point based on the number of neighbors it has. The data point with the highest score is then selected as the k-nearest neighbor.\n\nThe bartender algorithm gets its name from a story where a bartender is asked to find the k-nearest drinks to a customer's taste. The bartender takes a glass, fills it to the top with the drink that the customer likes the most, and then fills in the rest of the glasses with drinks that are similar to the one the customer likes. The k-nearest drinks to the customer's taste are the ones that are closest to the one they like the most.\n\nIn summary, the bartender algorithm is a simple yet effective algorithm used to find the k-nearest neighbors in a set of data points. It works by creating a matrix where each row represents a data point and each column represents a neighboring data point. The algorithm then calculates the Euclidean distance between each data point and its k nearest neighbors, and assigns a score to each data point based on the number of neighbors it has. The data point with the highest score is then selected as the k-nearest neighbor.",
    "llama-7b_fact_raw": "1. The bartender algorithm is used to solve the problem of finding the k-nearest neighbors (k-NN) in a set of data points.\n2. It creates a matrix where each row represents a data point and each column represents a neighboring data point.\n3. The algorithm calculates the Euclidean distance between each data point and its k nearest neighbors.\n4. Each data point is assigned a score based on the number of neighbors it has.\n5. The data point with the highest score is selected as the k-nearest neighbor.",
    "llama-7b_fact": [
      "The bartender algorithm is used to solve the problem of finding the k-nearest neighbors (k-NN) in a set of data points.",
      "It creates a matrix where each row represents a data point and each column represents a neighboring data point.",
      "The algorithm calculates the Euclidean distance between each data point and its k nearest neighbors.",
      "Each data point is assigned a score based on the number of neighbors it has.",
      "The data point with the highest score is selected as the k-nearest neighbor."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The bartender algorithm is not a recognized algorithm for finding the k-nearest neighbors (k-NN) in a set of data points. The k-nearest neighbors algorithm itself is used for this purpose.\n2. FALSE [correction]: In k-NN, a matrix is not typically described in terms of rows representing data points and columns representing neighboring data points. Instead, a distance matrix might be created where each element represents the distance between a pair of data points.\n3. TRUE: The k-nearest neighbors algorithm does calculate the Euclidean distance (or other distances) between data points to determine the nearest neighbors.\n4. FALSE [correction]: In k-NN, each data point is not assigned a score based on the number of neighbors it has. Instead, a data point is typically classified based on the majority vote or average of its k-nearest neighbors.\n5. FALSE [correction]: The k-nearest neighbors algorithm does not select a single data point with the highest score as the k-nearest neighbor. It identifies the k-nearest neighbors for a given data point and uses these neighbors to perform classification or regression.",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3100,
    "user_query": "Which web-based pedigree editors are available?",
    "llama-7b_response": "There are several web-based pedigree editors available, including:\n1. Geni.com\n2. Ancestry.com\n3. MyHeritage.com\n4. FamilySearch.org\n5. WeRelate.org\n6. WikiTree.com\n7. LegacyFamilyTree.com\n8. RootsMagic.com\n9. GenealogyWise.com\n10. GEDmatch.org\nThese web-based pedigree editors allow users to create and share family trees, collaborate with others, and connect with relatives. They offer a variety of features and tools to help users research and organize their family history information.",
    "llama-7b_fact_raw": "1. Geni.com is a web-based pedigree editor.\n2. Ancestry.com is a web-based pedigree editor.\n3. MyHeritage.com is a web-based pedigree editor.\n4. FamilySearch.org is a web-based pedigree editor.\n5. WeRelate.org is a web-based pedigree editor.",
    "llama-7b_fact": [
      "Geni.com is a web-based pedigree editor.",
      "Ancestry.com is a web-based pedigree editor.",
      "MyHeritage.com is a web-based pedigree editor.",
      "FamilySearch.org is a web-based pedigree editor.",
      "WeRelate.org is a web-based pedigree editor."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nAll the mentioned websites offer web-based tools for creating, editing, and researching family trees or pedigrees.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3107,
    "user_query": "Which curated databases exist for spider-venom toxins?",
    "llama-7b_response": "There are several curated databases that exist for spider venom toxins. One such database is the Spider Toxin Database, which is maintained by the University of Melbourne in Australia. This database contains information on the toxins found in the venom of various spider species, including their chemical structure, function, and biological activity.\nAnother database is the World Spider Catalog, which is maintained by the American Museum of Natural History. This database includes information on the venomous properties of various spider species, as well as their taxonomic classification and distribution.\nThe Venomous Animals and Their Toxins database, maintained by the National Institute of Neurological Disorders and Stroke, also includes information on spider venom toxins. This database provides information on the chemical structure and biological activity of various toxins found in spider venom, as well as their potential therapeutic uses.\nFinally, the Reptile and Amphibian Toxins database, maintained by the University of Florida, includes information on the toxins found in the venom of various reptile and amphibian species, including spiders. This database provides information on the chemical structure and biological activity of various toxins, as well as their potential therapeutic uses.",
    "llama-7b_fact_raw": "1. The Spider Toxin Database is maintained by the University of Melbourne in Australia.\n2. The World Spider Catalog is maintained by the American Museum of Natural History.\n3. The Venomous Animals and Their Toxins database is maintained by the National Institute of Neurological Disorders and Stroke.\n4. The Reptile and Amphibian Toxins database includes information on spider venom toxins and is maintained by the University of Florida.",
    "llama-7b_fact": [
      "The Spider Toxin Database is maintained by the University of Melbourne in Australia.",
      "The World Spider Catalog is maintained by the American Museum of Natural History.",
      "The Venomous Animals and Their Toxins database is maintained by the National Institute of Neurological Disorders and Stroke.",
      "The Reptile and Amphibian Toxins database includes information on spider venom toxins and is maintained by the University of Florida."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: The Venomous Animals and Their Toxins database is not maintained by the National Institute of Neurological Disorders and Stroke; it is not a known database maintained by this institute.\n4. UNKNOWN",
    "llama-7b_judge": [
      "unknown",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3111,
    "user_query": "Does Axitinib prolong survival of Pancreatic Cancer patients?",
    "llama-7b_response": "Yes, Axitinib has been shown to prolong survival of pancreatic cancer patients in several clinical trials. Axitinib is a tyrosine kinase inhibitor that blocks the growth and spread of cancer cells by interfering with the signals that tell cells to divide and grow. \nOne study published in the Journal of Clinical Oncology found that Axitinib significantly prolonged survival in patients with advanced pancreatic cancer who had already received chemotherapy. The study found that patients who received Axitinib had a median survival time of 6.7 months, compared to 4.7 months for those who received placebo. \nAnother study published in the Lancet Oncology found that Axitinib significantly improved survival in patients with advanced pancreatic cancer who had not yet received chemotherapy. The study found that patients who received Axitinib had a median survival time of 7.4 months, compared to 4.9 months for those who received placebo. \nOverall, these studies suggest that Axitinib can be an effective treatment for pancreatic cancer, and can help to prolong survival in patients with advanced disease. However, it is important to note that these results are based on clinical trials and may not necessarily apply to all patients. It is always recommended to consult with a healthcare professional before starting any new treatment.",
    "llama-7b_fact_raw": "1. Axitinib is a tyrosine kinase inhibitor used in the treatment of pancreatic cancer.\n2. Clinical trials have shown that Axitinib can prolong survival in pancreatic cancer patients.\n3. A study published in the Journal of Clinical Oncology reported that Axitinib increased the median survival time to 6.7 months for patients with advanced pancreatic cancer post-chemotherapy, compared to 4.7 months for those who received a placebo.\n4. Another study in the Lancet Oncology indicated that Axitinib improved the median survival time to 7.4 months for patients with advanced pancreatic cancer who had not received chemotherapy, versus 4.9 months for those given a placebo.\n5. The effectiveness of Axitinib in prolonging survival in pancreatic cancer patients is based on the results of clinical trials.",
    "llama-7b_fact": [
      "Axitinib is a tyrosine kinase inhibitor used in the treatment of pancreatic cancer.",
      "Clinical trials have shown that Axitinib can prolong survival in pancreatic cancer patients.",
      "A study published in the Journal of Clinical Oncology reported that Axitinib increased the median survival time to 6.7 months for patients with advanced pancreatic cancer post-chemotherapy, compared to 4.7 months for those who received a placebo.",
      "Another study in the Lancet Oncology indicated that Axitinib improved the median survival time to 7.4 months for patients with advanced pancreatic cancer who had not received chemotherapy, versus 4.9 months for those given a placebo.",
      "The effectiveness of Axitinib in prolonging survival in pancreatic cancer patients is based on the results of clinical trials."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Axitinib is a tyrosine kinase inhibitor used in the treatment of advanced renal cell carcinoma, not specifically approved for pancreatic cancer.\n2. UNKNOWN: Without specific clinical trial data or references, it is not possible to confirm the effectiveness of Axitinib in pancreatic cancer patients.\n3. FALSE [correction]: There is no widely recognized study that reports these specific survival times for Axitinib in the treatment of advanced pancreatic cancer post-chemotherapy. This statement may be incorrect or based on hypothetical or non-existent data.\n4. FALSE [correction]: Similar to the previous statement, there is no widely recognized study that reports these specific survival times for Axitinib in the treatment of advanced pancreatic cancer in chemotherapy-naive patients. This statement may also be incorrect or based on hypothetical or non-existent data.\n5. UNKNOWN: Since the previous statements about the effectiveness of Axitinib in pancreatic cancer are either false or unverified, it is not possible to confirm that the effectiveness of Axitinib in prolonging survival in pancreatic cancer patients is based on clinical trial results.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "false",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3113,
    "user_query": "Through which protein interaction does MLP regulate F-actin dynamics?",
    "llama-7b_response": "MLP (Mechano Growth Factor-Induced Protein) is a protein that plays a crucial role in regulating F-actin dynamics. F-actin is a component of the cytoskeleton that provides structural support and enables movement within cells. MLP interacts with a number of other proteins to regulate F-actin dynamics, but one of the most important interactions is with the Arp2/3 complex.\nThe Arp2/3 complex is a protein complex that is responsible for nucleating the formation of new F-actin filaments. MLP binds to the Arp2/3 complex and stabilizes it, preventing it from dissociating and allowing it to continue nucleating new F-actin filaments. This stabilization of the Arp2/3 complex is important for maintaining the integrity of the cytoskeleton and enabling cell movement and division.\nIn addition to interacting with the Arp2/3 complex, MLP also interacts with a number of other proteins that regulate F-actin dynamics, including WASP, N-WASP, and SCAR/WAVE. These interactions help to regulate the activity of the Arp2/3 complex and ensure that F-actin dynamics are properly balanced within the cell. Overall, MLP plays a critical role in regulating F-actin dynamics and maintaining the integrity of the cytoskeleton.",
    "llama-7b_fact_raw": "1. MLP (Mechano Growth Factor-Induced Protein) regulates F-actin dynamics.\n2. F-actin is a component of the cytoskeleton that provides structural support and enables movement within cells.\n3. MLP interacts with the Arp2/3 complex to regulate F-actin dynamics.\n4. The Arp2/3 complex is responsible for nucleating the formation of new F-actin filaments.\n5. MLP stabilizes the Arp2/3 complex, which is important for maintaining the integrity of the cytoskeleton and enabling cell movement and division.",
    "llama-7b_fact": [
      "MLP (Mechano Growth Factor-Induced Protein) regulates F-actin dynamics.",
      "F-actin is a component of the cytoskeleton that provides structural support and enables movement within cells.",
      "MLP interacts with the Arp2/3 complex to regulate F-actin dynamics.",
      "The Arp2/3 complex is responsible for nucleating the formation of new F-actin filaments.",
      "MLP stabilizes the Arp2/3 complex, which is important for maintaining the integrity of the cytoskeleton and enabling cell movement and division."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN\n\nThe statements regarding MLP (Mechano Growth Factor-Induced Protein) and its specific interactions with the Arp2/3 complex are highly specialized and would require specific scientific literature to confirm their accuracy. Without the context of the passage or access to relevant scientific studies, it is not possible to determine the truthfulness of statements 1, 3, and 5.",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3125,
    "user_query": "How many pseudokinases are there in the human kinome?",
    "llama-7b_response": "There are 51 pseudokinases in the human kinome. Pseudokinases are protein domains that resemble kinase catalytic domains but do not have the ability to phosphorylate protein substrates. They play important roles in various cellular processes such as signal transduction, gene expression, and cell cycle regulation.",
    "llama-7b_fact_raw": "1. There are 51 pseudokinases in the human kinome.\n2. Pseudokinases resemble kinase catalytic domains.\n3. Pseudokinases do not have the ability to phosphorylate protein substrates.\n4. Pseudokinases are involved in cellular processes such as signal transduction, gene expression, and cell cycle regulation.",
    "llama-7b_fact": [
      "There are 51 pseudokinases in the human kinome.",
      "Pseudokinases resemble kinase catalytic domains.",
      "Pseudokinases do not have the ability to phosphorylate protein substrates.",
      "Pseudokinases are involved in cellular processes such as signal transduction, gene expression, and cell cycle regulation."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: While traditionally thought to be inactive, some pseudokinases have been found to have the ability to phosphorylate protein substrates, albeit often at lower activity levels compared to typical kinases, or they may have other functions.\n4. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "false",
      "true"
    ]
  },
  {
    "id": 3139,
    "user_query": "List 3 apoE mimetics.",
    "llama-7b_response": "ApoE mimetics are compounds that mimic the function of apolipoprotein E (apoE), a protein that plays a crucial role in lipid metabolism and the transport of cholesterol in the bloodstream. Here are three examples of apoE mimetics:\n1. Pravastatin: Pravastatin is a cholesterol-lowering drug that works by inhibiting an enzyme called HMG-CoA reductase, which is involved in the production of cholesterol in the liver. Pravastatin has been shown to increase levels of apoE in the blood, which may help to reduce the risk of heart disease.\n2. Resveratrol: Resveratrol is a compound found in grapes and other fruits that has been shown to have anti-inflammatory and antioxidant properties. Some studies have suggested that resveratrol may also increase levels of apoE in the blood, which could help to reduce the risk of heart disease.\n3. Omega-3 fatty acids: Omega-3 fatty acids are found in fish oil and other sources of fatty fish. These fatty acids have been shown to have a range of health benefits, including reducing inflammation and lowering the risk of heart disease. Some studies have suggested that omega-3 fatty acids may also increase levels of apoE in the blood, which could help to reduce the risk of heart disease.",
    "llama-7b_fact_raw": "1. Pravastatin is a cholesterol-lowering drug that inhibits the enzyme HMG-CoA reductase.\n2. Resveratrol is a compound found in grapes and other fruits that has anti-inflammatory and antioxidant properties.\n3. Omega-3 fatty acids are found in fish oil and other sources of fatty fish and are associated with health benefits such as reducing inflammation and lowering the risk of heart disease.",
    "llama-7b_fact": [
      "Pravastatin is a cholesterol-lowering drug that inhibits the enzyme HMG-CoA reductase.",
      "Resveratrol is a compound found in grapes and other fruits that has anti-inflammatory and antioxidant properties.",
      "Omega-3 fatty acids are found in fish oil and other sources of fatty fish and are associated with health benefits such as reducing inflammation and lowering the risk of heart disease."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3140,
    "user_query": "What are there sex differences in SAMHD1 activity?",
    "llama-7b_response": "There are sex differences in the activity of SAMHD1, a protein that plays a critical role in regulating the spread of viruses in cells. SAMHD1 is known to inhibit the replication of various viruses, including HIV, by degrading the nucleotide precursors required for viral DNA synthesis. \nStudies have shown that SAMHD1 activity is higher in females compared to males. This may be due to differences in sex hormones, such as estrogen, which have been shown to affect SAMHD1 expression and activity. For example, estrogen has been shown to increase SAMHD1 expression in some cell types, which may contribute to the lower susceptibility of females to certain viral infections.\nAdditionally, there are also differences in SAMHD1 activity between different ethnic groups. For example, individuals of African descent have been found to have higher levels of SAMHD1 activity compared to individuals of European or Asian descent. This may be due to differences in genetic variations that affect SAMHD1 expression and activity.\nOverall, these sex and ethnic differences in SAMHD1 activity may have important implications for viral infection and disease progression, and further research is needed to fully understand the mechanisms underlying these differences.",
    "llama-7b_fact_raw": "1. SAMHD1 is a protein that inhibits the replication of various viruses, including HIV.\n2. SAMHD1 activity is higher in females compared to males.\n3. Estrogen has been shown to increase SAMHD1 expression in some cell types.\n4. Individuals of African descent have higher levels of SAMHD1 activity compared to individuals of European or Asian descent.\n5. Differences in sex hormones, such as estrogen, may affect SAMHD1 expression and activity.",
    "llama-7b_fact": [
      "SAMHD1 is a protein that inhibits the replication of various viruses, including HIV.",
      "SAMHD1 activity is higher in females compared to males.",
      "Estrogen has been shown to increase SAMHD1 expression in some cell types.",
      "Individuals of African descent have higher levels of SAMHD1 activity compared to individuals of European or Asian descent.",
      "Differences in sex hormones, such as estrogen, may affect SAMHD1 expression and activity."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3205,
    "user_query": "Does RUNX2 inhibit astrocyte differentiation?",
    "llama-7b_response": "Yes, RUNX2 has been shown to inhibit astrocyte differentiation. RUNX2 is a transcription factor that plays a critical role in the differentiation of many cell types, including astrocytes. Studies have shown that overexpression of RUNX2 in cultured astrocytes can inhibit their differentiation into mature astrocytes, while knockdown of RUNX2 expression can promote astrocyte differentiation. These findings suggest that RUNX2 may play a critical role in regulating astrocyte development and function.",
    "llama-7b_fact_raw": "1. RUNX2 inhibits astrocyte differentiation.\n2. RUNX2 is a transcription factor involved in the differentiation of various cell types, including astrocytes.\n3. Overexpression of RUNX2 in cultured astrocytes can inhibit their differentiation into mature astrocytes.\n4. Knockdown of RUNX2 expression can promote astrocyte differentiation.\n5. RUNX2 may play a critical role in regulating astrocyte development and function.",
    "llama-7b_fact": [
      "RUNX2 inhibits astrocyte differentiation.",
      "RUNX2 is a transcription factor involved in the differentiation of various cell types, including astrocytes.",
      "Overexpression of RUNX2 in cultured astrocytes can inhibit their differentiation into mature astrocytes.",
      "Knockdown of RUNX2 expression can promote astrocyte differentiation.",
      "RUNX2 may play a critical role in regulating astrocyte development and function."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: RUNX2 promotes astrocyte differentiation.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3209,
    "user_query": "Where, in the body, would the Cobb-Stainsby excision arthroplasty be performed?",
    "llama-7b_response": "The Cobb-Stainsby excision arthroplasty would be performed in the shoulder joint. It is a surgical procedure used to treat shoulder instability caused by a torn rotator cuff. During the procedure, the surgeon removes a small piece of bone from the top of the shoulder blade to create more space for the rotator cuff to heal. The surgery is typically performed arthroscopically, which means the surgeon makes small incisions and uses a camera to visualize the joint. The Cobb-Stainsby excision arthroplasty is often used in combination with other procedures to treat shoulder instability, such as the Bankart repair or the Latarjet procedure.",
    "llama-7b_fact_raw": "1. The Cobb-Stainsby excision arthroplasty is a surgical procedure performed on the shoulder joint.\n2. This procedure is used to treat shoulder instability caused by a torn rotator cuff.\n3. It involves the removal of a small piece of bone from the top of the shoulder blade.\n4. The Cobb-Stainsby excision arthroplasty is typically performed arthroscopically.\n5. It is often used in combination with other procedures like the Bankart repair or the Latarjet procedure to treat shoulder instability.",
    "llama-7b_fact": [
      "The Cobb-Stainsby excision arthroplasty is a surgical procedure performed on the shoulder joint.",
      "This procedure is used to treat shoulder instability caused by a torn rotator cuff.",
      "It involves the removal of a small piece of bone from the top of the shoulder blade.",
      "The Cobb-Stainsby excision arthroplasty is typically performed arthroscopically.",
      "It is often used in combination with other procedures like the Bankart repair or the Latarjet procedure to treat shoulder instability."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Cobb-Stainsby excision arthroplasty is a surgical procedure performed on the hip joint, not the shoulder joint.\n2. FALSE [correction]: Since the Cobb-Stainsby excision arthroplasty is a procedure for the hip joint, it is not used to treat shoulder instability caused by a torn rotator cuff.\n3. FALSE [correction]: The procedure involves the removal of a portion of the femoral head (not from the shoulder blade) and the interposition of soft tissue to create a pseudarthrosis.\n4. FALSE [correction]: The Cobb-Stainsby excision arthroplasty is not typically performed arthroscopically; it is an open surgical procedure.\n5. FALSE [correction]: As the Cobb-Stainsby excision arthroplasty is for the hip joint, it is not used in combination with shoulder procedures like the Bankart repair or the Latarjet procedure, which are specific to the shoulder.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3243,
    "user_query": "Does GRHL2 over-expression lead to EMT?",
    "llama-7b_response": "Yes, GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT). EMT is a process by which epithelial cells lose their cell-cell adhesion and acquire migratory and invasive properties, leading to the formation of mesenchymal cells. GRHL2 is a transcription factor that regulates the expression of genes involved in cell-cell adhesion and migration. Over-expression of GRHL2 has been shown to disrupt these processes, leading to the loss of cell-cell adhesion and the acquisition of migratory and invasive properties. Therefore, GRHL2 over-expression can lead to EMT.",
    "llama-7b_fact_raw": "1. GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT).\n2. EMT is a process where epithelial cells lose cell-cell adhesion and gain migratory and invasive properties.\n3. GRHL2 is a transcription factor that regulates genes involved in cell-cell adhesion and migration.\n4. Over-expression of GRHL2 disrupts cell-cell adhesion and migration processes.\n5. The disruption caused by GRHL2 over-expression results in the loss of cell-cell adhesion and the acquisition of migratory and invasive properties.",
    "llama-7b_fact": [
      "GRHL2 over-expression has been shown to lead to epithelial-to-mesenchymal transition (EMT).",
      "EMT is a process where epithelial cells lose cell-cell adhesion and gain migratory and invasive properties.",
      "GRHL2 is a transcription factor that regulates genes involved in cell-cell adhesion and migration.",
      "Over-expression of GRHL2 disrupts cell-cell adhesion and migration processes.",
      "The disruption caused by GRHL2 over-expression results in the loss of cell-cell adhesion and the acquisition of migratory and invasive properties."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: GRHL2 over-expression has been shown to suppress epithelial-to-mesenchymal transition (EMT), not lead to it.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: Over-expression of GRHL2 typically promotes cell-cell adhesion and suppresses migration processes, contrary to disrupting them.\n5. FALSE [correction]: The disruption in cell-cell adhesion and acquisition of migratory and invasive properties are characteristics of EMT, which is suppressed by GRHL2 over-expression, not caused by it.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3254,
    "user_query": "Which T-UCRs have been implicated in lung cancer?",
    "llama-7b_response": "There are several T-UCRs that have been implicated in lung cancer. One of the most well-known is TP53, also known as the \"guardian of the genome.\" TP53 is a tumor suppressor gene that plays a critical role in preventing the development of cancer. When TP53 is mutated or dysfunctional, it can allow cancer cells to grow and divide uncontrollably, leading to the development of lung cancer.\nAnother T-UCR that has been implicated in lung cancer is RB1. RB1 is a tumor suppressor gene that is involved in regulating cell growth and division. When RB1 is mutated or dysfunctional, it can allow cancer cells to grow and divide uncontrollably, leading to the development of lung cancer.\nOther T-UCRs that have been implicated in lung cancer include CDKN2A, CDK4, and MYC. These genes play critical roles in regulating cell growth and division, and when they are mutated or dysfunctional, they can contribute to the development of lung cancer.",
    "llama-7b_fact_raw": "1. TP53, also known as the \"guardian of the genome,\" is a T-UCR implicated in lung cancer.\n2. TP53 is a tumor suppressor gene that plays a critical role in preventing the development of cancer.\n3. RB1 is a tumor suppressor gene implicated in lung cancer that is involved in regulating cell growth and division.\n4. Mutations or dysfunction in RB1 can lead to the uncontrollable growth and division of cancer cells, contributing to lung cancer.\n5. T-UCRs such as CDKN2A, CDK4, and MYC have been implicated in lung cancer and are involved in regulating cell growth and division.",
    "llama-7b_fact": [
      "TP53, also known as the \"guardian of the genome,\" is a T-UCR implicated in lung cancer.",
      "TP53 is a tumor suppressor gene that plays a critical role in preventing the development of cancer.",
      "RB1 is a tumor suppressor gene implicated in lung cancer that is involved in regulating cell growth and division.",
      "Mutations or dysfunction in RB1 can lead to the uncontrollable growth and division of cancer cells, contributing to lung cancer.",
      "T-UCRs such as CDKN2A, CDK4, and MYC have been implicated in lung cancer and are involved in regulating cell growth and division."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: TP53, also known as the \"guardian of the genome,\" is not a T-UCR but a tumor suppressor gene implicated in lung cancer.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: CDKN2A and CDK4 are not T-UCRs; they are genes that can be involved in cell cycle regulation. MYC is an oncogene, not a T-UCR, and it is also involved in cell growth and division. T-UCRs (Transcribed Ultraconserved Regions) are a different class of elements that may be involved in gene regulation.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3268,
    "user_query": "What is known about the orphan receptor GPR151?",
    "llama-7b_response": "GPR151 is an orphan receptor that belongs to the G protein-coupled receptor (GPCR) family. It was first identified in 2002 and has since been studied extensively for its potential role in various physiological and pathological processes. \nGPR151 is expressed primarily in the central nervous system (CNS), including the brain and spinal cord. It has been found to be localized in several regions of the brain, including the hippocampus, amygdala, and hypothalamus. \nThe function of GPR151 is not fully understood, but it has been suggested to play a role in various physiological processes, such as neurotransmission, synaptic plasticity, and stress response. For example, studies have shown that GPR151 is upregulated in the hippocampus of mice exposed to chronic stress, suggesting that it may play a role in the stress response. \nIn addition, GPR151 has been implicated in several pathological processes, such as addiction and neurodegenerative diseases. For example, studies have found that GPR151 is upregulated in the brains of individuals with addiction, suggesting that it may play a role in the development and progression of addiction. \nOverall, while much remains to be learned about GPR151, it is clear that this orphan receptor plays an important role in various physiological and pathological processes in the CNS. Further research is needed to fully understand the function of GPR151 and its potential as a target for therapeutic interventions.",
    "llama-7b_fact_raw": "1. GPR151 is an orphan receptor that is part of the G protein-coupled receptor (GPCR) family.\n2. GPR151 was first identified in 2002.\n3. GPR151 is primarily expressed in the central nervous system, including the brain and spinal cord.\n4. The receptor has been found to be localized in several regions of the brain, such as the hippocampus, amygdala, and hypothalamus.\n5. Studies have shown that GPR151 is upregulated in the hippocampus of mice exposed to chronic stress.",
    "llama-7b_fact": [
      "GPR151 is an orphan receptor that is part of the G protein-coupled receptor (GPCR) family.",
      "GPR151 was first identified in 2002.",
      "GPR151 is primarily expressed in the central nervous system, including the brain and spinal cord.",
      "The receptor has been found to be localized in several regions of the brain, such as the hippocampus, amygdala, and hypothalamus.",
      "Studies have shown that GPR151 is upregulated in the hippocampus of mice exposed to chronic stress."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. UNKNOWN\n\nThe statements about GPR151 being an orphan receptor in the GPCR family, its expression in the central nervous system, and localization in several brain regions are consistent with scientific knowledge about G protein-coupled receptors. However, without specific references to the years of discovery or particular studies regarding its upregulation in the hippocampus of mice exposed to chronic stress, the truthfulness of statements 2 and 5 cannot be determined from the information provided.",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3285,
    "user_query": "List the attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine.",
    "llama-7b_response": "The attenuated live viruses contained in the Fluzone intradermal quadrivalent vaccine are:\n1. Influenza virus type A (H1N1)\n2. Influenza virus type A (H1N2)\n3. Influenza virus type A (H3N2)\n4. Influenza virus type B",
    "llama-7b_fact_raw": "NO FACTS",
    "llama-7b_fact": [],
    "llama-7b_judge": []
  },
  {
    "id": 3345,
    "user_query": "Which part of the TNFR2 gene is genetically associated with Systemic Lupus Erythematosus?",
    "llama-7b_response": "The TNFR2 gene, also known as the tumor necrosis factor receptor 2 gene, is located on chromosome 6p21.3 and contains multiple variants that have been associated with systemic lupus erythematosus (SLE). One of these variants is a single-nucleotide polymorphism (SNP) known as rs763780, which is located in the 3' untranslated region (UTR) of the TNFR2 gene.\nStudies have shown that individuals with SLE who carry the rs763780 GG genotype have a higher risk of developing the disease compared to those with other genotypes. Additionally, the rs763780 GG genotype has been found to be associated with increased levels of TNF-alpha, a cytokine that plays a key role in the pathogenesis of SLE.\nOverall, the TNFR2 gene and its variants, particularly the rs763780 GG genotype, are genetically associated with the development and severity of SLE.",
    "llama-7b_fact_raw": "1. The TNFR2 gene is located on chromosome 6p21.3.\n2. The TNFR2 gene has variants that are associated with systemic lupus erythematosus (SLE).\n3. A single-nucleotide polymorphism (SNP) in the TNFR2 gene associated with SLE is known as rs763780.\n4. The rs763780 SNP is located in the 3' untranslated region (UTR) of the TNFR2 gene.\n5. Individuals with the rs763780 GG genotype have a higher risk of developing SLE.",
    "llama-7b_fact": [
      "The TNFR2 gene is located on chromosome 6p21.3.",
      "The TNFR2 gene has variants that are associated with systemic lupus erythematosus (SLE).",
      "A single-nucleotide polymorphism (SNP) in the TNFR2 gene associated with SLE is known as rs763780.",
      "The rs763780 SNP is located in the 3' untranslated region (UTR) of the TNFR2 gene.",
      "Individuals with the rs763780 GG genotype have a higher risk of developing SLE."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The SNP rs763780 is associated with inflammatory bowel disease, not SLE. The SNP rs1061622 (also known as TNFRSF1B +676 T>G) is associated with SLE.\n4. UNKNOWN\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3353,
    "user_query": "Is there a vaccine for peanut allergy?",
    "llama-7b_response": "Yes, there is a vaccine for peanut allergy. The vaccine is called Palforzia (peanut allergy immunotherapy) and it was approved by the FDA in 2020. Palforzia is a sublingual tablet that contains peanut protein and is administered under the supervision of a healthcare provider. The goal of the vaccine is to gradually increase the patient's tolerance to peanut protein over time, reducing the risk of a severe allergic reaction if they accidentally consume peanuts. Palforzia is recommended for individuals ages 4 to 17 years old who have a severe peanut allergy and are able to carry and use an epinephrine auto-injector. It is important to note that Palforzia is not a cure for peanut allergy and long-term effects are still being studied.",
    "llama-7b_fact_raw": "1. Palforzia is a vaccine for peanut allergy.\n2. The FDA approved Palforzia in 2020.\n3. Palforzia is a sublingual tablet that contains peanut protein.\n4. Palforzia is intended to increase a patient's tolerance to peanut protein over time.\n5. Palforzia is recommended for individuals ages 4 to 17 years old with a severe peanut allergy.",
    "llama-7b_fact": [
      "Palforzia is a vaccine for peanut allergy.",
      "The FDA approved Palforzia in 2020.",
      "Palforzia is a sublingual tablet that contains peanut protein.",
      "Palforzia is intended to increase a patient's tolerance to peanut protein over time.",
      "Palforzia is recommended for individuals ages 4 to 17 years old with a severe peanut allergy."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Palforzia is not a vaccine; it is an oral immunotherapy treatment for peanut allergy.\n2. TRUE\n3. FALSE [correction]: Palforzia is not a sublingual tablet; it is an oral powder that is mixed with food.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3365,
    "user_query": "What is particular about the mouse Fxy gene's chromosomal position?",
    "llama-7b_response": "The mouse Fxy gene is located on the X chromosome, which is unique in that it is one of the two sex chromosomes that determine gender in mammals. Females have two X chromosomes, while males have one X chromosome and one Y chromosome. The Fxy gene is also located in a region of the X chromosome that is known to be particularly active in female reproductive tissues, including the ovaries and uterus. This region of the X chromosome is often referred to as the \"female-specific region\" or \"female-limited region\". The Fxy gene is one of several genes located in this region that are involved in the development and function of reproductive tissues.",
    "llama-7b_fact_raw": "1. The mouse Fxy gene is located on the X chromosome.\n2. The X chromosome is one of the two sex chromosomes that determine gender in mammals.\n3. Females have two X chromosomes, while males have one X chromosome and one Y chromosome.\n4. The Fxy gene is located in a region of the X chromosome that is active in female reproductive tissues.\n5. The region of the X chromosome where the Fxy gene is located is often referred to as the \"female-specific region\" or \"female-limited region\".",
    "llama-7b_fact": [
      "The mouse Fxy gene is located on the X chromosome.",
      "The X chromosome is one of the two sex chromosomes that determine gender in mammals.",
      "Females have two X chromosomes, while males have one X chromosome and one Y chromosome.",
      "The Fxy gene is located in a region of the X chromosome that is active in female reproductive tissues.",
      "The region of the X chromosome where the Fxy gene is located is often referred to as the \"female-specific region\" or \"female-limited region\"."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. TRUE\n4. UNKNOWN\n5. FALSE [correction]: The region of the X chromosome where genes like Fxy are located is not typically referred to as the \"female-specific region\" or \"female-limited region.\" Instead, it may be part of regions that escape X-inactivation or have specific functions, but these terms are not standard nomenclature for regions of the X chromosome.",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3397,
    "user_query": "What is the basis of the methidiumpropyl-EDTA sequencing (MPE-seq) method?",
    "llama-7b_response": "Methidiumpropyl-EDTA sequencing (MPE-seq) is a method used for DNA sequencing that is based on the ability of methidiumpropyl-EDTA (MPE) to bind to double-stranded DNA. The MPE-seq method involves the following steps:\n1. The DNA sample is denatured by heating it to 95°C for 5 minutes.\n2. The denatured DNA is then mixed with MPE, which binds to the double-stranded DNA.\n3. The mixture is allowed to cool to room temperature, and the MPE-DNA complexes form.\n4. The complexes are then separated by gel electrophoresis, and the DNA is visualized by staining with a fluorescent dye.\n5. The DNA is sequenced by detecting the fluorescent signal emitted by the dye, which corresponds to the position of the DNA fragment on the gel.\nThe basis of the MPE-seq method is the ability of MPE to bind to double-stranded DNA, which allows for the separation of the DNA fragments by gel electrophoresis. The method is also based on the detection of the fluorescent signal emitted by the dye, which provides a means of sequencing the DNA fragments. Overall, the MPE-seq method is a simple and efficient method for DNA sequencing that has been widely used in research and clinical applications.",
    "llama-7b_fact_raw": "1. Methidiumpropyl-EDTA sequencing (MPE-seq) is a DNA sequencing method.\n2. MPE-seq is based on the ability of methidiumpropyl-EDTA (MPE) to bind to double-stranded DNA.\n3. The DNA sample in MPE-seq is denatured by heating it to 95°C for 5 minutes.\n4. After binding with MPE, the DNA is visualized by staining with a fluorescent dye during MPE-seq.\n5. The DNA is sequenced in MPE-seq by detecting the fluorescent signal emitted by the dye.",
    "llama-7b_fact": [
      "Methidiumpropyl-EDTA sequencing (MPE-seq) is a DNA sequencing method.",
      "MPE-seq is based on the ability of methidiumpropyl-EDTA (MPE) to bind to double-stranded DNA.",
      "The DNA sample in MPE-seq is denatured by heating it to 95°C for 5 minutes.",
      "After binding with MPE, the DNA is visualized by staining with a fluorescent dye during MPE-seq.",
      "The DNA is sequenced in MPE-seq by detecting the fluorescent signal emitted by the dye."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe first two statements are true as they correctly describe the nature of Methidiumpropyl-EDTA sequencing (MPE-seq) and the binding properties of MPE. However, the specific details of the MPE-seq procedure, such as the denaturation temperature and time, the staining process, and the sequencing method, are not standard knowledge and would require specific information from the passage or source that introduced these statements. Without that information, the veracity of statements 3, 4, and 5 cannot be determined.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3400,
    "user_query": "Which programming language has been used for implementing GWAR?",
    "llama-7b_response": "I'm sorry, but GWAR is not a programming language. GWAR is an acronym that stands for \"GNU Win32 API Wrapper\". It is a library that allows developers to use the Windows API from their Linux or other Unix-based operating systems. Therefore, GWAR is not a programming language, but a library or framework that can be used to develop software applications.",
    "llama-7b_fact_raw": "1. GWAR stands for \"GNU Win32 API Wrapper\".\n2. GWAR is a library, not a programming language.\n3. GWAR allows developers to use the Windows API on Linux or other Unix-based operating systems.",
    "llama-7b_fact": [
      "GWAR stands for \"GNU Win32 API Wrapper\".",
      "GWAR is a library, not a programming language.",
      "GWAR allows developers to use the Windows API on Linux or other Unix-based operating systems."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: GWAR stands for \"God What an Awful Racket,\" which is a satirical heavy metal band and not related to a Win32 API Wrapper.\n2. TRUE\n3. FALSE [correction]: GWAR is not a library for using the Windows API on Linux or other Unix-based operating systems. The statement might be confusing GWAR with \"Wine\" or \"Winelib,\" which are designed for that purpose.",
    "llama-7b_judge": [
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3406,
    "user_query": "Does xaliproden improve prognosis of amyotrophic lateral sclerosis?",
    "llama-7b_response": "Xaliproden is a drug that has been studied for its potential to improve the prognosis of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. ALS is a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness, paralysis, and eventual death.\nSeveral clinical trials have been conducted to evaluate the effectiveness of xaliproden in treating ALS. One randomized, double-blind, placebo-controlled trial published in the Journal of Neurology, Neurosurgery, and Psychiatry in 2014 found that xaliproden did not significantly improve the survival rate or delay the progression of ALS compared to placebo. However, another randomized, double-blind, placebo-controlled trial published in the Lancet Neurology in 2018 found that xaliproden did improve the survival rate and delay the progression of ALS compared to placebo.\nThe results of these studies are conflicting, and more research is needed to determine the effectiveness of xaliproden in improving the prognosis of ALS. It is important to note that xaliproden is not currently approved by the FDA for the treatment of ALS.",
    "llama-7b_fact_raw": "1. Xaliproden has been studied for its potential to improve the prognosis of amyotrophic lateral sclerosis (ALS).\n2. ALS is a progressive neurodegenerative disease that leads to muscle weakness, paralysis, and eventual death.\n3. A trial published in the Journal of Neurology, Neurosurgery, and Psychiatry in 2014 found that xaliproden did not significantly improve the survival rate or delay the progression of ALS compared to placebo.\n4. A trial published in the Lancet Neurology in 2018 found that xaliproden did improve the survival rate and delay the progression of ALS compared to placebo.\n5. Xaliproden is not currently approved by the FDA for the treatment of ALS.",
    "llama-7b_fact": [
      "Xaliproden has been studied for its potential to improve the prognosis of amyotrophic lateral sclerosis (ALS).",
      "ALS is a progressive neurodegenerative disease that leads to muscle weakness, paralysis, and eventual death.",
      "A trial published in the Journal of Neurology, Neurosurgery, and Psychiatry in 2014 found that xaliproden did not significantly improve the survival rate or delay the progression of ALS compared to placebo.",
      "A trial published in the Lancet Neurology in 2018 found that xaliproden did improve the survival rate and delay the progression of ALS compared to placebo.",
      "Xaliproden is not currently approved by the FDA for the treatment of ALS."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. FALSE [correction]: There is no evidence provided that such a trial was published in Lancet Neurology in 2018 showing that xaliproden improved the survival rate and delayed the progression of ALS. Without specific evidence or a reference to verify this claim, it cannot be accepted as true.\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3410,
    "user_query": "In which chromosome are transgenes inserted in the case of the LiPS-A3S line?",
    "llama-7b_response": "The LiPS-A3S line is a transgenic line that expresses the A3S gene under the control of the LiPS promoter. The A3S gene is located on chromosome 3 of the mouse genome. Therefore, the transgenes in the LiPS-A3S line are inserted on chromosome 3.",
    "llama-7b_fact_raw": "1. The LiPS-A3S line is a transgenic line.\n2. The A3S gene in the LiPS-A3S line is under the control of the LiPS promoter.\n3. The A3S gene is located on chromosome 3 of the mouse genome.\n4. Transgenes in the LiPS-A3S line are inserted on chromosome 3.",
    "llama-7b_fact": [
      "The LiPS-A3S line is a transgenic line.",
      "The A3S gene in the LiPS-A3S line is under the control of the LiPS promoter.",
      "The A3S gene is located on chromosome 3 of the mouse genome.",
      "Transgenes in the LiPS-A3S line are inserted on chromosome 3."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n\nWithout specific context or additional information about the LiPS-A3S line, the location of the A3S gene in the mouse genome, and the specific insertion site of the transgenes, it is not possible to verify statements 3 and 4.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3430,
    "user_query": "Which tool exist for predicting drug synergy with deep learning?",
    "llama-7b_response": "There are several tools available for predicting drug synergy with deep learning. One such tool is the Deep Synergy Finder (DSF), which is a deep learning algorithm developed by researchers at the University of California, San Francisco. DSF uses a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs) to predict synergy between drugs.\nAnother tool is the Deep Drug Combination Analysis (DeepDCA), which is a deep learning algorithm developed by researchers at the University of Tokyo. DeepDCA uses a combination of CNNs and generative adversarial networks (GANs) to predict synergy between drugs.\nThere are also several open-source libraries available for predicting drug synergy with deep learning, such as TensorFlow, Keras, and PyTorch. These libraries can be used to develop custom deep learning models for predicting drug synergy.",
    "llama-7b_fact_raw": "1. The Deep Synergy Finder (DSF) is a deep learning algorithm developed by researchers at the University of California, San Francisco.\n2. DSF uses a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs) to predict drug synergy.\n3. The Deep Drug Combination Analysis (DeepDCA) is a deep learning algorithm developed by researchers at the University of Tokyo.\n4. DeepDCA uses a combination of CNNs and generative adversarial networks (GANs) to predict drug synergy.\n5. TensorFlow, Keras, and PyTorch are open-source libraries that can be used for predicting drug synergy with deep learning.",
    "llama-7b_fact": [
      "The Deep Synergy Finder (DSF) is a deep learning algorithm developed by researchers at the University of California, San Francisco.",
      "DSF uses a combination of convolutional neural networks (CNNs) and recurrent neural networks (RNNs) to predict drug synergy.",
      "The Deep Drug Combination Analysis (DeepDCA) is a deep learning algorithm developed by researchers at the University of Tokyo.",
      "DeepDCA uses a combination of CNNs and generative adversarial networks (GANs) to predict drug synergy.",
      "TensorFlow, Keras, and PyTorch are open-source libraries that can be used for predicting drug synergy with deep learning."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3433,
    "user_query": "Which cloud-based platform has been developed for comparing GWAS?",
    "llama-7b_response": "There is no cloud-based platform specifically developed for comparing GWAS. However, there are several cloud-based platforms available that can be used for genetic analysis and data management, including Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). These platforms offer a range of tools and services for genetic analysis, including tools for managing and analyzing genetic data, as well as for comparing genetic variants and performing genome-wide association studies (GWAS). Additionally, there are several open-source tools and software packages available for genetic analysis and GWAS, many of which can be run on cloud-based platforms.",
    "llama-7b_fact_raw": "1. Amazon Web Services (AWS) is a cloud-based platform that can be used for genetic analysis and data management.\n2. Microsoft Azure is a cloud-based platform that offers tools and services for genetic analysis.\n3. Google Cloud Platform (GCP) provides tools for managing and analyzing genetic data.\n4. Cloud-based platforms offer services for comparing genetic variants and performing genome-wide association studies (GWAS).\n5. There are open-source tools and software packages available for genetic analysis and GWAS that can be run on cloud-based platforms.",
    "llama-7b_fact": [
      "Amazon Web Services (AWS) is a cloud-based platform that can be used for genetic analysis and data management.",
      "Microsoft Azure is a cloud-based platform that offers tools and services for genetic analysis.",
      "Google Cloud Platform (GCP) provides tools for managing and analyzing genetic data.",
      "Cloud-based platforms offer services for comparing genetic variants and performing genome-wide association studies (GWAS).",
      "There are open-source tools and software packages available for genetic analysis and GWAS that can be run on cloud-based platforms."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3434,
    "user_query": "Can CMB305 be used against sarcomas?",
    "llama-7b_response": "CMB305 is a type of immunotherapy that uses a patient's own immune system to fight cancer cells. It works by training the immune system to recognize and attack cancer cells while leaving healthy cells unharmed. \nWhile CMB305 has shown promising results in treating some types of cancer, such as melanoma and lung cancer, its effectiveness against sarcomas is still being studied. \nSarcomas are a type of cancer that develops in the soft tissues of the body, such as muscles, tendons, and nerves. They are rare and aggressive cancers that can be difficult to treat. \nCurrently, there is limited evidence to suggest that CMB305 is effective in treating sarcomas. However, ongoing clinical trials are investigating the use of CMB305 in combination with other treatments, such as chemotherapy, for the treatment of sarcomas. \nIt is important to note that CMB305 should only be used under the supervision of a qualified healthcare professional and should not be used as a substitute for standard cancer treatment.",
    "llama-7b_fact_raw": "1. CMB305 is a type of immunotherapy that uses a patient's own immune system to fight cancer cells.\n2. CMB305 has shown promising results in treating some types of cancer, such as melanoma and lung cancer.\n3. The effectiveness of CMB305 against sarcomas is still being studied.\n4. Sarcomas are a type of cancer that develops in the soft tissues of the body.\n5. Ongoing clinical trials are investigating the use of CMB305 in combination with other treatments for the treatment of sarcomas.",
    "llama-7b_fact": [
      "CMB305 is a type of immunotherapy that uses a patient's own immune system to fight cancer cells.",
      "CMB305 has shown promising results in treating some types of cancer, such as melanoma and lung cancer.",
      "The effectiveness of CMB305 against sarcomas is still being studied.",
      "Sarcomas are a type of cancer that develops in the soft tissues of the body.",
      "Ongoing clinical trials are investigating the use of CMB305 in combination with other treatments for the treatment of sarcomas."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. UNKNOWN\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3461,
    "user_query": "What are manifestations of the Saint's Triad?",
    "llama-7b_response": "The Saint's Triad is a concept in Christian theology that refers to the three manifestations of God's grace: the Father, the Son, and the Holy Spirit. These three manifestations of God's grace are often represented in Christian art and iconography as a triangle, with the Father at the top, the Son in the middle, and the Holy Spirit at the bottom.\nThe manifestations of the Saint's Triad can be seen in various ways in the lives of Christians. For example, the Father's manifestation can be seen in the creation of the world and the gift of life, the Son's manifestation can be seen in the incarnation of Jesus Christ and his sacrifice on the cross, and the Holy Spirit's manifestation can be seen in the gift of the Holy Spirit and the power of prayer.\nIn addition, the Saint's Triad can also be seen in the sacraments of the Catholic Church, such as baptism, which represents the Father's manifestation, confirmation, which represents the Son's manifestation, and the Eucharist, which represents the Holy Spirit's manifestation.\nOverall, the manifestations of the Saint's Triad can be seen in various aspects of Christian life and worship, reminding Christians of the love and grace of God.",
    "llama-7b_fact_raw": "1. The Saint's Triad in Christian theology refers to the three manifestations of God's grace: the Father, the Son, and the Holy Spirit.\n2. In Christian art and iconography, the Saint's Triad is often represented as a triangle with the Father at the top, the Son in the middle, and the Holy Spirit at the bottom.\n3. The Father's manifestation is seen in the creation of the world and the gift of life.\n4. The Son's manifestation is seen in the incarnation of Jesus Christ and his sacrifice on the cross.\n5. The Holy Spirit's manifestation is seen in the gift of the Holy Spirit and the power of prayer.",
    "llama-7b_fact": [
      "The Saint's Triad in Christian theology refers to the three manifestations of God's grace: the Father, the Son, and the Holy Spirit.",
      "In Christian art and iconography, the Saint's Triad is often represented as a triangle with the Father at the top, the Son in the middle, and the Holy Spirit at the bottom.",
      "The Father's manifestation is seen in the creation of the world and the gift of life.",
      "The Son's manifestation is seen in the incarnation of Jesus Christ and his sacrifice on the cross.",
      "The Holy Spirit's manifestation is seen in the gift of the Holy Spirit and the power of prayer."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The term \"Saint's Triad\" is not a standard term in Christian theology. The correct term for the three manifestations of God's grace is the \"Holy Trinity\" or simply \"Trinity.\"\n2. FALSE [correction]: In Christian art and iconography, the Trinity is often represented with various symbols, such as a triangle or three interlocking circles, but there is no standard representation with the Father at the top, the Son in the middle, and the Holy Spirit at the bottom. The representation can vary, and the positions are not fixed in this manner.\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3470,
    "user_query": "Is overexpression of LY6K associated with better prognosis for non-small cell lung cancer patients?",
    "llama-7b_response": "There have been several studies investigating the association between overexpression of LY6K and the prognosis of non-small cell lung cancer (NSCLC) patients. LY6K is a protein that plays a role in cell proliferation, migration, and apoptosis.\nOne study published in the Journal of Thoracic Oncology found that overexpression of LY6K was associated with better overall survival and progression-free survival in NSCLC patients. The study analyzed data from 192 patients with NSCLC and found that those with high levels of LY6K had a significantly improved survival rate compared to those with low levels of LY6K.\nAnother study published in the International Journal of Cancer found that overexpression of LY6K was associated with a better prognosis in NSCLC patients. The study analyzed data from 366 patients with NSCLC and found that those with high levels of LY6K had a lower risk of death and recurrence compared to those with low levels of LY6K.\nHowever, it is important to note that these studies are not without limitations. For example, the studies used different methods to measure LY6K expression, which may have affected the results. Additionally, the sample sizes of the studies were relatively small, which limits the generalizability of the findings.\nOverall, the evidence suggests that overexpression of LY6K may be associated with a better prognosis in NSCLC patients. However, further research is needed to confirm these findings and to determine the exact role of LY6K in NSCLC prognosis.",
    "llama-7b_fact_raw": "1. LY6K is a protein that plays a role in cell proliferation, migration, and apoptosis.\n2. A study published in the Journal of Thoracic Oncology found that overexpression of LY6K was associated with better overall survival and progression-free survival in NSCLC patients.\n3. The study from the Journal of Thoracic Oncology analyzed data from 192 patients with NSCLC.\n4. Another study published in the International Journal of Cancer found that overexpression of LY6K was associated with a better prognosis in NSCLC patients.\n5. The study from the International Journal of Cancer analyzed data from 366 patients with NSCLC.",
    "llama-7b_fact": [
      "LY6K is a protein that plays a role in cell proliferation, migration, and apoptosis.",
      "A study published in the Journal of Thoracic Oncology found that overexpression of LY6K was associated with better overall survival and progression-free survival in NSCLC patients.",
      "The study from the Journal of Thoracic Oncology analyzed data from 192 patients with NSCLC.",
      "Another study published in the International Journal of Cancer found that overexpression of LY6K was associated with a better prognosis in NSCLC patients.",
      "The study from the International Journal of Cancer analyzed data from 366 patients with NSCLC."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Overexpression of LY6K is generally associated with poor prognosis in cancer patients, including those with non-small cell lung cancer (NSCLC), not better overall survival and progression-free survival.\n3. UNKNOWN\n4. FALSE [correction]: Overexpression of LY6K is generally associated with poor prognosis in cancer patients, including those with non-small cell lung cancer (NSCLC), not a better prognosis.\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3473,
    "user_query": "List Cdk targets that are dephosphorylated during cytokinesis",
    "llama-7b_response": "During cytokinesis, several CDK (Cyclin-Dependent Kinase) targets are dephosphorylated. Here are some of the key CDK targets that are dephosphorylated during cytokinesis:\n1. Plk1 (Polo-like kinase 1): Plk1 is a key CDK target that is dephosphorylated during cytokinesis. This leads to the activation of Plk1, which is essential for the completion of cytokinesis.\n2. Cdc14 (Cell division cycle protein 14): Cdc14 is another CDK target that is dephosphorylated during cytokinesis. This leads to the activation of Cdc14, which is essential for the completion of cytokinesis.\n3. Aurora B: Aurora B is a CDK target that is dephosphorylated during cytokinesis. This leads to the activation of Aurora B, which is essential for the completion of cytokinesis.\n4. BubR1 (Budding uninhibited by benzimidazoles 1): BubR1 is a CDK target that is dephosphorylated during cytokinesis. This leads to the activation of BubR1, which is essential for the completion of cytokinesis.\n5. Cenp-E (Centromere protein E): Cenp-E is a CDK target that is dephosphorylated during cytokinesis. This leads to the activation of Cenp-E, which is essential for the completion of cytokinesis.\nOverall, the dephosphorylation of these CDK targets is essential for the completion of cytokinesis, which is the process of dividing a cell into two daughter cells.",
    "llama-7b_fact_raw": "1. Plk1 (Polo-like kinase 1) is dephosphorylated during cytokinesis.\n2. Cdc14 (Cell division cycle protein 14) is dephosphorylated during cytokinesis.\n3. Aurora B is dephosphorylated during cytokinesis.\n4. BubR1 (Budding uninhibited by benzimidazoles 1) is dephosphorylated during cytokinesis.\n5. Cenp-E (Centromere protein E) is dephosphorylated during cytokinesis.",
    "llama-7b_fact": [
      "Plk1 (Polo-like kinase 1) is dephosphorylated during cytokinesis.",
      "Cdc14 (Cell division cycle protein 14) is dephosphorylated during cytokinesis.",
      "Aurora B is dephosphorylated during cytokinesis.",
      "BubR1 (Budding uninhibited by benzimidazoles 1) is dephosphorylated during cytokinesis.",
      "Cenp-E (Centromere protein E) is dephosphorylated during cytokinesis."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Plk1 (Polo-like kinase 1) is phosphorylated during mitosis and its activity is required for progression through various stages of mitosis, including cytokinesis.\n2. TRUE: Cdc14 (Cell division cycle protein 14) is known to be dephosphorylated during cytokinesis, which is part of its role in the exit from mitosis.\n3. FALSE [correction]: Aurora B is a kinase, and it is typically active during mitosis, including cytokinesis. It is not dephosphorylated during cytokinesis; instead, it is part of the chromosome passenger complex and plays a role in correcting kinetochore-microtubule attachments and in the completion of cytokinesis.\n4. UNKNOWN: The phosphorylation state of BubR1 (Budding uninhibited by benzimidazoles 1) during cytokinesis can vary, and it is involved in checkpoint regulation. Without specific context, it is difficult to determine the phosphorylation state of BubR1 during cytokinesis.\n5. UNKNOWN: Cenp-E (Centromere protein E) is a kinesin-like motor protein that is involved in the alignment of chromosomes during mitosis. Its phosphorylation state can change during mitosis, but without specific context, it is difficult to determine the phosphorylation state of Cenp-E during cytokinesis.",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3508,
    "user_query": "What is Xanamem?",
    "llama-7b_response": "Xanamem is a medication that is used to treat moderate to severe Alzheimer's disease. It is a type of drug called a cholinesterase inhibitor, which works by increasing the levels of a neurotransmitter called acetylcholine in the brain. Acetylcholine is important for memory and cognitive function, and by increasing its levels, Xanamem can improve symptoms of Alzheimer's disease such as memory loss, confusion, and difficulty with thinking and problem-solving.\n\nXanamem is available in tablet form and is usually taken twice a day, with meals. It can be taken alone or in combination with other Alzheimer's disease medications. It is important to follow the instructions of a healthcare provider when taking Xanamem, as it may take several weeks to see improvements in symptoms.\n\nSide effects of Xanamem can include nausea, vomiting, diarrhea, and constipation. In some cases, Xanamem may also cause confusion, agitation, or hallucinations. It is important to monitor for these side effects and report them to a healthcare provider if they become bothersome or severe.\n\nOverall, Xanamem is an effective medication for the treatment of Alzheimer's disease, and can help improve symptoms and quality of life for individuals with this condition.",
    "llama-7b_fact_raw": "1. Xanamem is used to treat moderate to severe Alzheimer's disease.\n2. Xanamem is a cholinesterase inhibitor that increases levels of acetylcholine in the brain.\n3. Acetylcholine is important for memory and cognitive function.\n4. Xanamem is typically taken twice a day with meals.\n5. Side effects of Xanamem can include nausea, vomiting, diarrhea, constipation, confusion, agitation, and hallucinations.",
    "llama-7b_fact": [
      "Xanamem is used to treat moderate to severe Alzheimer's disease.",
      "Xanamem is a cholinesterase inhibitor that increases levels of acetylcholine in the brain.",
      "Acetylcholine is important for memory and cognitive function.",
      "Xanamem is typically taken twice a day with meals.",
      "Side effects of Xanamem can include nausea, vomiting, diarrhea, constipation, confusion, agitation, and hallucinations."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Xanamem is not a cholinesterase inhibitor; it is designed to block the production of excess cortisol by inhibiting the activity of the enzyme 11β-HSD1 within the brain.\n3. TRUE\n4. UNKNOWN\n5. UNKNOWN\n\nNote: While statement 3 is generally true about acetylcholine, the status and details of Xanamem (such as dosing frequency and side effects) as of my last update in 2023 may not be fully established or could vary based on ongoing clinical trials and regulatory approvals. Therefore, statements 1, 4, and 5 are marked as UNKNOWN without specific and current information from clinical guidelines or regulatory sources.",
    "llama-7b_judge": [
      "unknown",
      "false",
      "true",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3520,
    "user_query": "What is the role of the Hof1-Cyk3 interaction in yeast?",
    "llama-7b_response": "The Hof1-Cyk3 interaction plays a critical role in regulating the cell cycle progression in yeast. Hof1 is a ubiquitin-conjugating enzyme that catalyzes the attachment of ubiquitin molecules to target proteins, while Cyk3 is a cyclin-dependent kinase that is involved in the regulation of cell cycle progression.\nThe Hof1-Cyk3 interaction is important for the activation of Cyk3, which is required for the initiation of DNA replication and the G1-S phase transition. During this transition, Cyk3 phosphorylates several target proteins, including the retinoblastoma protein (Rb), which is a key regulator of the cell cycle.\nThe phosphorylation of Rb by Cyk3 allows it to dissociate from the E2F transcription factor, which is required for the transcription of genes involved in S phase. This leads to the activation of genes that are required for DNA replication, such as CDK1 and CDK8.\nFurthermore, the Hof1-Cyk3 interaction is also important for the degradation of target proteins through the ubiquitin-proteasome pathway. Cyk3 phosphorylates and activates Hof1, which then conjugates ubiquitin molecules to target proteins, leading to their degradation by the proteasome.\nIn summary, the Hof1-Cyk3 interaction plays a critical role in regulating the cell cycle progression in yeast by activating Cyk3, phosphorylating Rb, activating genes involved in S phase, and promoting the degradation of target proteins through the ubiquitin-proteasome pathway.",
    "llama-7b_fact_raw": "1. The Hof1-Cyk3 interaction regulates cell cycle progression in yeast.\n2. Hof1 is a ubiquitin-conjugating enzyme that attaches ubiquitin molecules to target proteins.\n3. Cyk3 is a cyclin-dependent kinase involved in the regulation of cell cycle progression.\n4. The activation of Cyk3 is required for the initiation of DNA replication and the G1-S phase transition in yeast.\n5. The phosphorylation of the retinoblastoma protein (Rb) by Cyk3 leads to the dissociation of Rb from the E2F transcription factor, which is necessary for the transcription of genes involved in the S phase.",
    "llama-7b_fact": [
      "The Hof1-Cyk3 interaction regulates cell cycle progression in yeast.",
      "Hof1 is a ubiquitin-conjugating enzyme that attaches ubiquitin molecules to target proteins.",
      "Cyk3 is a cyclin-dependent kinase involved in the regulation of cell cycle progression.",
      "The activation of Cyk3 is required for the initiation of DNA replication and the G1-S phase transition in yeast.",
      "The phosphorylation of the retinoblastoma protein (Rb) by Cyk3 leads to the dissociation of Rb from the E2F transcription factor, which is necessary for the transcription of genes involved in the S phase."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Hof1 is not a ubiquitin-conjugating enzyme; it is a protein involved in cytokinesis in yeast.\n3. FALSE [correction]: Cyk3 is not a cyclin-dependent kinase; it is a protein that interacts with Hof1 and is involved in cell wall remodeling during cytokinesis.\n4. FALSE [correction]: The activation of Cyk3 is not required for the initiation of DNA replication and the G1-S phase transition in yeast. This role is typically associated with cyclin-dependent kinases, not Cyk3.\n5. FALSE [correction]: The phosphorylation of the retinoblastoma protein (Rb) by cyclin-dependent kinases, not Cyk3, leads to the dissociation of Rb from the E2F transcription factor, which is necessary for the transcription of genes involved in the S phase. Cyk3 does not have this function in yeast.",
    "llama-7b_judge": [
      "true",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3598,
    "user_query": "Which T-UCRs have been implicated in gastric cancer?",
    "llama-7b_response": "There are several T-UCRs that have been implicated in gastric cancer. One of the most well-known is the tumor suppressor gene TP53, which is mutated in up to 90% of gastric cancers. Other T-UCRs that have been linked to gastric cancer include:\n1. CDH1: A gene that encodes a protein involved in the formation and maintenance of cell junctions. Mutations in CDH1 have been found in up to 10% of gastric cancers.\n2. EGFR: A receptor tyrosine kinase that plays a role in cell growth and division. Mutations in EGFR have been found in up to 15% of gastric cancers.\n3. KRAS: Another receptor tyrosine kinase that is often mutated in gastric cancer. Mutations in KRAS have been found in up to 90% of gastric cancers.\n4. PIK3CA: A gene that encodes a protein involved in cell growth and division. Mutations in PIK3CA have been found in up to 10% of gastric cancers.\n5. BRAF: Another receptor tyrosine kinase that is often mutated in gastric cancer. Mutations in BRAF have been found in up to 10% of gastric cancers.\nOverall, these T-UCRs play important roles in cell growth and division, and mutations in these genes can lead to uncontrolled cell proliferation and the development of gastric cancer.",
    "llama-7b_fact_raw": "1. The tumor suppressor gene TP53 is mutated in up to 90% of gastric cancers.\n2. Mutations in the CDH1 gene have been found in up to 10% of gastric cancers.\n3. Mutations in the EGFR gene have been found in up to 15% of gastric cancers.\n4. Mutations in the KRAS gene have been found in up to 90% of gastric cancers.\n5. Mutations in the PIK3CA gene have been found in up to 10% of gastric cancers.",
    "llama-7b_fact": [
      "The tumor suppressor gene TP53 is mutated in up to 90% of gastric cancers.",
      "Mutations in the CDH1 gene have been found in up to 10% of gastric cancers.",
      "Mutations in the EGFR gene have been found in up to 15% of gastric cancers.",
      "Mutations in the KRAS gene have been found in up to 90% of gastric cancers.",
      "Mutations in the PIK3CA gene have been found in up to 10% of gastric cancers."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The tumor suppressor gene TP53 is mutated in approximately 50% of gastric cancers.\n2. TRUE\n3. FALSE [correction]: Mutations in the EGFR gene are not commonly found in gastric cancers; the prevalence is much lower than 15%.\n4. FALSE [correction]: Mutations in the KRAS gene are found in a smaller percentage of gastric cancers, not up to 90%.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 3607,
    "user_query": "What is the Lupus Severity Index (LSI)?",
    "llama-7b_response": "The Lupus Severity Index (LSI) is a tool used to measure the severity of systemic lupus erythematosus (SLE), a chronic autoimmune disease that affects the skin, joints, kidneys, and other organs. The LSI was developed by a team of researchers in the United States in the 1980s and is based on a combination of clinical and laboratory criteria.\nThe LSI takes into account a range of factors that can affect the severity of SLE, including the presence and extent of organ damage, the frequency and severity of flares, the use of medications, and the patient's overall quality of life. The index is scored on a scale of 0 to 100, with higher scores indicating more severe disease.\nThe LSI has been widely used in clinical trials and research studies to assess the effectiveness of new treatments for SLE and to monitor the progression of the disease over time. It is also used by healthcare providers to help determine the appropriate treatment plan for individual patients based on their level of severity.",
    "llama-7b_fact_raw": "1. The Lupus Severity Index (LSI) is used to measure the severity of systemic lupus erythematosus (SLE).\n2. The LSI was developed by researchers in the United States in the 1980s.\n3. The LSI includes clinical and laboratory criteria to assess the severity of SLE.\n4. The LSI is scored on a scale of 0 to 100, with higher scores indicating more severe disease.\n5. The LSI is utilized in clinical trials, research studies, and by healthcare providers to assess and monitor SLE.",
    "llama-7b_fact": [
      "The Lupus Severity Index (LSI) is used to measure the severity of systemic lupus erythematosus (SLE).",
      "The LSI was developed by researchers in the United States in the 1980s.",
      "The LSI includes clinical and laboratory criteria to assess the severity of SLE.",
      "The LSI is scored on a scale of 0 to 100, with higher scores indicating more severe disease.",
      "The LSI is utilized in clinical trials, research studies, and by healthcare providers to assess and monitor SLE."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN: The existence of a specific \"Lupus Severity Index\" (LSI) is not a well-established fact in medical literature. There are various tools and indices used to measure the severity of systemic lupus erythematosus (SLE), such as the SLE Disease Activity Index (SLEDAI), but without more context, it's unclear whether LSI refers to one of these or is a fictional or less commonly used index.\n\n2. UNKNOWN: Since the existence of the LSI as a specific and recognized tool is not established, the origin and time of its development are also unknown.\n\n3. UNKNOWN: If the LSI were a recognized tool, this statement might be true as many indices for SLE do include clinical and laboratory criteria. However, without confirmation of the LSI's existence and its components, this statement's accuracy cannot be determined.\n\n4. UNKNOWN: The scoring scale for the LSI cannot be confirmed without specific knowledge of the index. Different indices have different scoring systems, and without knowing if the LSI is a recognized tool, the scoring range cannot be verified.\n\n5. UNKNOWN: The use of the LSI in clinical trials, research studies, and by healthcare providers cannot be confirmed without knowing if it is a recognized and established tool in the medical community for assessing and monitoring SLE.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3615,
    "user_query": "Which disorders are caused by de novo mutations in ZSWIM6?",
    "llama-7b_response": "De novo mutations are genetic variations that arise for the first time in an individual and are not inherited from their parents. ZSWIM6 is a gene that has not been previously studied in relation to any specific disorders. However, de novo mutations in this gene could potentially cause genetic disorders if they result in a change to the function of the ZSWIM6 protein.\nWithout more information about the specific de novo mutations that have been identified in ZSWIM6, it is difficult to determine which disorders they could potentially cause. However, some examples of genetic disorders that can be caused by de novo mutations include cystic fibrosis, muscular dystrophy, and cancer.\nIt is important to note that de novo mutations are a relatively rare cause of genetic disorders, and most genetic disorders are inherited from one's parents. However, if a de novo mutation in ZSWIM6 is found to be associated with a specific disorder, it could provide important insights into the genetic basis of that disorder and potentially lead to new treatments or interventions.",
    "llama-7b_fact_raw": "1. De novo mutations are genetic variations that arise for the first time in an individual and are not inherited from their parents.\n2. ZSWIM6 is a gene that has not been previously studied in relation to any specific disorders.\n3. De novo mutations in ZSWIM6 could potentially cause genetic disorders if they result in a change to the function of the ZSWIM6 protein.\n4. Genetic disorders such as cystic fibrosis, muscular dystrophy, and cancer can be caused by de novo mutations.\n5. De novo mutations are a relatively rare cause of genetic disorders.",
    "llama-7b_fact": [
      "De novo mutations are genetic variations that arise for the first time in an individual and are not inherited from their parents.",
      "ZSWIM6 is a gene that has not been previously studied in relation to any specific disorders.",
      "De novo mutations in ZSWIM6 could potentially cause genetic disorders if they result in a change to the function of the ZSWIM6 protein.",
      "Genetic disorders such as cystic fibrosis, muscular dystrophy, and cancer can be caused by de novo mutations.",
      "De novo mutations are a relatively rare cause of genetic disorders."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: While the statement is vague without specific time context, ZSWIM6 has been studied in relation to specific disorders, such as intellectual disability and developmental delay.\n3. TRUE\n4. TRUE\n5. FALSE [correction]: De novo mutations are not necessarily a rare cause of genetic disorders; they can be a significant factor in the occurrence of many genetic disorders, especially those that are not typically passed down from one generation to the next.",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3626,
    "user_query": "Which disease can be classified using the Koos Classification?",
    "llama-7b_response": "The Koos Classification is a system used to classify and describe the severity of knee osteoarthritis (OA). It was developed by Dr. John Koopman in the 1970s and has since been widely used in clinical practice and research. The Koos Classification is based on the degree of joint space narrowing (JSN) in the knee, which is a hallmark feature of knee OA. The classification includes four grades of severity, ranging from grade 1 (mild) to grade 4 (severe), with grade 3 being the most common. Other factors that can affect the severity of knee OA include the patient's age, weight, and activity level.",
    "llama-7b_fact_raw": "1. The Koos Classification is used to classify the severity of knee osteoarthritis.\n2. Dr. John Koopman developed the Koos Classification in the 1970s.\n3. The Koos Classification uses the degree of joint space narrowing in the knee to determine the severity of osteoarthritis.\n4. The Koos Classification includes four grades of severity, from grade 1 (mild) to grade 4 (severe).\n5. Grade 3 is the most common severity level in the Koos Classification for knee osteoarthritis.",
    "llama-7b_fact": [
      "The Koos Classification is used to classify the severity of knee osteoarthritis.",
      "Dr. John Koopman developed the Koos Classification in the 1970s.",
      "The Koos Classification uses the degree of joint space narrowing in the knee to determine the severity of osteoarthritis.",
      "The Koos Classification includes four grades of severity, from grade 1 (mild) to grade 4 (severe).",
      "Grade 3 is the most common severity level in the Koos Classification for knee osteoarthritis."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The correct classification system for the severity of knee osteoarthritis is the Kellgren-Lawrence (KL) grading system, not the \"Koos Classification.\"\n2. FALSE [correction]: Since the Koos Classification does not exist for knee osteoarthritis, it was not developed by Dr. John Koopman in the 1970s. The Kellgren-Lawrence grading system was developed by James Kellgren and Jeffrey Lawrence.\n3. TRUE: The Kellgren-Lawrence grading system, which is the correct system for classifying knee osteoarthritis, does use the degree of joint space narrowing to determine the severity of osteoarthritis.\n4. FALSE [correction]: The Kellgren-Lawrence grading system includes five grades of severity, from grade 0 (no radiographic features of osteoarthritis) to grade 4 (severe).\n5. UNKNOWN: Without specific epidemiological data, it is not possible to confirm if grade 3 is the most common severity level in the Kellgren-Lawrence grading system for knee osteoarthritis. This would require specific research or data.",
    "llama-7b_judge": [
      "false",
      "false",
      "true",
      "false",
      "unknown"
    ]
  },
  {
    "id": 3628,
    "user_query": "What are the in vivo effects of AZD8601?",
    "llama-7b_response": "AZD8601 is a small molecule inhibitor that has been studied for its potential to treat various cancers. In vivo, AZD8601 has been shown to exhibit anti-tumor activity in several preclinical models. For example, in a study of AZD8601 in combination with chemotherapy in mouse models of breast cancer, the combination therapy resulted in increased tumor growth inhibition and improved survival compared to chemotherapy alone. Additionally, AZD8601 has been shown to induce apoptosis (programmed cell death) in cancer cells in vitro and in vivo. Overall, the in vivo effects of AZD8601 suggest that it has potential as an effective anti-cancer agent. However, further clinical trials are needed to fully evaluate the safety and efficacy of AZD8601 in humans.",
    "llama-7b_fact_raw": "1. AZD8601 is a small molecule inhibitor studied for the potential treatment of various cancers.\n2. In vivo, AZD8601 has demonstrated anti-tumor activity in several preclinical models.\n3. A study showed that AZD8601 in combination with chemotherapy increased tumor growth inhibition and improved survival in mouse models of breast cancer compared to chemotherapy alone.\n4. AZD8601 has been shown to induce apoptosis in cancer cells both in vitro and in vivo.\n5. Further clinical trials are needed to fully evaluate the safety and efficacy of AZD8601 in humans.",
    "llama-7b_fact": [
      "AZD8601 is a small molecule inhibitor studied for the potential treatment of various cancers.",
      "In vivo, AZD8601 has demonstrated anti-tumor activity in several preclinical models.",
      "A study showed that AZD8601 in combination with chemotherapy increased tumor growth inhibition and improved survival in mouse models of breast cancer compared to chemotherapy alone.",
      "AZD8601 has been shown to induce apoptosis in cancer cells both in vitro and in vivo.",
      "Further clinical trials are needed to fully evaluate the safety and efficacy of AZD8601 in humans."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: AZD8601 is not a small molecule inhibitor; it is an mRNA-based therapy that encodes for vascular endothelial growth factor A (VEGF-A) studied for its potential in regenerative medicine, particularly in cardiac diseases.\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3640,
    "user_query": "How are SAHFS created?",
    "llama-7b_response": "As an AI language model, I don't have personal experiences or emotions, but I can provide you with a detailed answer to your question.\n\nA SAHF (Sexual and Gender-Based Violence Surveillance) is a system that collects, analyzes, and reports data on sexual and gender-based violence (SGBV) incidents. It is an essential tool for policymakers, program managers, and researchers to understand the prevalence, nature, and impact of SGBV on individuals and communities.\n\nThe process of creating a SAHF involves several steps, including:\n\n1. Data Collection: The first step in creating a SAHF is to collect data on SGBV incidents. This can be done through various methods, such as surveys, interviews, and medical records.\n\n2. Data Analysis: Once the data is collected, it needs to be analyzed to identify patterns, trends, and risk factors associated with SGBV.\n\n3. Data Reporting: The results of the analysis are then reported in a format that is easy to understand and use. This can be in the form of a report, dashboard, or data visualization tool.\n\n4. Monitoring and Evaluation: A SAHF should be regularly monitored and evaluated to ensure that it is effective and relevant. This involves tracking changes in the prevalence and nature of SGBV over time and making adjustments to the SAHF as needed.\n\nIn summary, creating a SAHF involves collecting, analyzing, reporting, and monitoring data on SGBV incidents. It is an essential tool for policymakers, program managers, and researchers to understand the prevalence, nature, and impact of SGBV on individuals and communities.",
    "llama-7b_fact_raw": "1. A SAHF (Sexual and Gender-Based Violence Surveillance) collects, analyzes, and reports data on sexual and gender-based violence incidents.\n2. Data collection for a SAHF can be conducted through surveys, interviews, and medical records.\n3. Data analysis in a SAHF identifies patterns, trends, and risk factors associated with sexual and gender-based violence.\n4. The results of a SAHF analysis are reported in formats such as reports, dashboards, or data visualization tools.\n5. A SAHF should be regularly monitored and evaluated to track changes in the prevalence and nature of sexual and gender-based violence.",
    "llama-7b_fact": [
      "A SAHF (Sexual and Gender-Based Violence Surveillance) collects, analyzes, and reports data on sexual and gender-based violence incidents.",
      "Data collection for a SAHF can be conducted through surveys, interviews, and medical records.",
      "Data analysis in a SAHF identifies patterns, trends, and risk factors associated with sexual and gender-based violence.",
      "The results of a SAHF analysis are reported in formats such as reports, dashboards, or data visualization tools.",
      "A SAHF should be regularly monitored and evaluated to track changes in the prevalence and nature of sexual and gender-based violence."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: A SAHF (Sexual Assault Forensic Examiner) is a healthcare professional trained to provide comprehensive care to sexual assault survivors, not a surveillance system. The term SAHF does not stand for Sexual and Gender-Based Violence Surveillance.\n2. UNKNOWN: Without the correct context for what a SAHF is, it's unclear whether data collection through surveys, interviews, and medical records is accurate for a SAHF's role.\n3. UNKNOWN: Since the first statement about SAHF is incorrect, the role of data analysis in a SAHF cannot be determined.\n4. UNKNOWN: The results of a SAHF's work being reported in various formats cannot be confirmed without the correct understanding of what a SAHF is.\n5. UNKNOWN: The statement about regular monitoring and evaluation of a SAHF to track changes in sexual and gender-based violence cannot be confirmed without accurate information about what a SAHF does.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3672,
    "user_query": "What is the function of the PDZ domain in SATB1?",
    "llama-7b_response": "The PDZ domain is a protein interaction domain found in many proteins that binds to other proteins through a zinc-binding motif. The function of the PDZ domain in SATB1 is not well understood, but it is believed to play a role in regulating the activity of other proteins. \nSATB1 is a transcription factor that plays a critical role in regulating gene expression during embryonic development. The PDZ domain in SATB1 may interact with other proteins to modulate the activity of SATB1 and regulate gene expression. For example, the PDZ domain in SATB1 may bind to other proteins that regulate the activity of SATB1, such as transcriptional co-activators or corepressors. \nFurther research is needed to fully understand the function of the PDZ domain in SATB1 and its role in regulating gene expression.",
    "llama-7b_fact_raw": "1. The PDZ domain is a protein interaction domain that binds to other proteins through a zinc-binding motif.\n2. SATB1 is a transcription factor that regulates gene expression during embryonic development.\n3. The function of the PDZ domain in SATB1 is believed to play a role in regulating the activity of other proteins.\n4. The PDZ domain in SATB1 may interact with proteins that regulate the activity of SATB1, such as transcriptional co-activators or corepressors.\n5. Further research is required to fully understand the function of the PDZ domain in SATB1.",
    "llama-7b_fact": [
      "The PDZ domain is a protein interaction domain that binds to other proteins through a zinc-binding motif.",
      "SATB1 is a transcription factor that regulates gene expression during embryonic development.",
      "The function of the PDZ domain in SATB1 is believed to play a role in regulating the activity of other proteins.",
      "The PDZ domain in SATB1 may interact with proteins that regulate the activity of SATB1, such as transcriptional co-activators or corepressors.",
      "Further research is required to fully understand the function of the PDZ domain in SATB1."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The PDZ domain is a protein interaction domain that typically binds to specific sequences at the C-termini of other proteins, not through a zinc-binding motif.\n2. TRUE\n3. UNKNOWN: Without specific context or research data, it's unclear whether the PDZ domain has a function in SATB1 or what that function might be.\n4. UNKNOWN: Similarly, without specific information, it's not possible to confirm if the PDZ domain in SATB1 interacts with proteins that regulate the activity of SATB1.\n5. TRUE: This is a general statement that applies to most scientific inquiries, including the study of protein domains and their functions.",
    "llama-7b_judge": [
      "false",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3678,
    "user_query": "What is the basis of the BLISS technique?",
    "llama-7b_response": "The BLISS technique is based on the concept of mindfulness, which involves being present in the moment and fully aware of one's thoughts, feelings, and surroundings. The technique is designed to help individuals develop a greater sense of self-awareness and self-compassion, which can lead to improved emotional regulation and overall well-being.\n\nThe BLISS technique is an acronym that stands for Breathing, Loving-kindness, Investigation, Self-compassion, and Surrender. Each component of the technique is designed to help individuals cultivate different aspects of mindfulness and self-awareness.\n\nBreathing is a common practice in many meditation traditions and is used to help individuals focus their attention and calm their minds. Loving-kindness is a practice that involves cultivating feelings of warmth, kindness, and compassion towards oneself and others. Investigation involves observing one's thoughts and feelings without judgment or criticism. Self-compassion involves treating oneself with the same kindness and understanding that one would show to a good friend. Finally, surrender involves letting go of control and trusting in the process of mindfulness and self-awareness.\n\nOverall, the BLISS technique is designed to help individuals develop a more positive and compassionate relationship with themselves and their experiences, leading to greater emotional resilience and well-being.",
    "llama-7b_fact_raw": "1. The BLISS technique is based on the concept of mindfulness.\n2. Mindfulness involves being present in the moment and fully aware of one's thoughts, feelings, and surroundings.\n3. The BLISS acronym stands for Breathing, Loving-kindness, Investigation, Self-compassion, and Surrender.\n4. Breathing in the BLISS technique is used to focus attention and calm the mind.\n5. Loving-kindness in the BLISS technique involves cultivating feelings of warmth and compassion towards oneself and others.",
    "llama-7b_fact": [
      "The BLISS technique is based on the concept of mindfulness.",
      "Mindfulness involves being present in the moment and fully aware of one's thoughts, feelings, and surroundings.",
      "The BLISS acronym stands for Breathing, Loving-kindness, Investigation, Self-compassion, and Surrender.",
      "Breathing in the BLISS technique is used to focus attention and calm the mind.",
      "Loving-kindness in the BLISS technique involves cultivating feelings of warmth and compassion towards oneself and others."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "unknown",
      "true",
      "true"
    ]
  },
  {
    "id": 3679,
    "user_query": "List 3 NK3R antagonists.",
    "llama-7b_response": "Sure, here are three NK3R antagonists:\n1. Aprepitant (Fosaprepitant)\n2. Granisetron\n3. Palonosetron",
    "llama-7b_fact_raw": "1. Aprepitant is an NK3R antagonist.\n2. Granisetron is an NK3R antagonist.\n3. Palonosetron is an NK3R antagonist.",
    "llama-7b_fact": [
      "Aprepitant is an NK3R antagonist.",
      "Granisetron is an NK3R antagonist.",
      "Palonosetron is an NK3R antagonist."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Aprepitant is an NK1 receptor antagonist.\n2. FALSE [correction]: Granisetron is a serotonin (5-HT3) receptor antagonist.\n3. FALSE [correction]: Palonosetron is a serotonin (5-HT3) receptor antagonist.",
    "llama-7b_judge": [
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3691,
    "user_query": "Which drug is the first oral ghrelin receptor inverse agonist to be profiled in healthy subjects?",
    "llama-7b_response": "The first oral ghrelin receptor inverse agonist to be profiled in healthy subjects is known as GHRP-6 (Growth Hormone Releasing Peptide-6). It is a synthetic peptide that mimics the actions of ghrelin, a natural hormone produced by the stomach that stimulates the release of growth hormone from the pituitary gland. GHRP-6 works by binding to the ghrelin receptor in the stomach and stimulating the release of growth hormone, which can lead to increased muscle mass and improved body composition. It is currently being studied as a potential treatment for a variety of conditions, including obesity, sarcopenia (age-related muscle loss), and growth hormone deficiency.",
    "llama-7b_fact_raw": "1. GHRP-6 (Growth Hormone Releasing Peptide-6) is the first oral ghrelin receptor inverse agonist profiled in healthy subjects.\n2. Ghrelin is a natural hormone produced by the stomach.\n3. Ghrelin stimulates the release of growth hormone from the pituitary gland.\n4. GHRP-6 is being studied as a potential treatment for obesity, sarcopenia, and growth hormone deficiency.",
    "llama-7b_fact": [
      "GHRP-6 (Growth Hormone Releasing Peptide-6) is the first oral ghrelin receptor inverse agonist profiled in healthy subjects.",
      "Ghrelin is a natural hormone produced by the stomach.",
      "Ghrelin stimulates the release of growth hormone from the pituitary gland.",
      "GHRP-6 is being studied as a potential treatment for obesity, sarcopenia, and growth hormone deficiency."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: GHRP-6 (Growth Hormone Releasing Peptide-6) is not an inverse agonist; it is a synthetic agonist of the ghrelin receptor, which has been studied for its effects on stimulating the release of growth hormone.\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3693,
    "user_query": "What is the protective efficacy of vaxchora against moderate to severe cholera?",
    "llama-7b_response": "Vaxchora is a vaccine that is approved for the prevention of cholera caused by the bacterium Vibrio cholerae. The protective efficacy of Vaxchora against moderate to severe cholera is estimated to be around 76%. This means that if a person receives two doses of Vaxchora, approximately 76 out of every 100 people will not develop moderate to severe cholera after exposure to the bacterium. It is important to note that Vaxchora is not 100% effective and may not protect against all cases of cholera. Additionally, Vaxchora should be used in conjunction with other preventive measures, such as proper sanitation and hygiene, to reduce the risk of cholera transmission.",
    "llama-7b_fact_raw": "1. Vaxchora is a vaccine approved for the prevention of cholera caused by Vibrio cholerae.\n2. The protective efficacy of Vaxchora against moderate to severe cholera is estimated to be around 76%.\n3. Vaxchora is not 100% effective in preventing cholera.\n4. Vaxchora should be used in conjunction with other preventive measures like proper sanitation and hygiene.",
    "llama-7b_fact": [
      "Vaxchora is a vaccine approved for the prevention of cholera caused by Vibrio cholerae.",
      "The protective efficacy of Vaxchora against moderate to severe cholera is estimated to be around 76%.",
      "Vaxchora is not 100% effective in preventing cholera.",
      "Vaxchora should be used in conjunction with other preventive measures like proper sanitation and hygiene."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3716,
    "user_query": "Which was the first cholera vaccine approved in the US?",
    "llama-7b_response": "The first cholera vaccine approved in the US was the killed-bacteria vaccine called Dukoral, which was approved by the US Food and Drug Administration (FDA) in 2000.",
    "llama-7b_fact_raw": "1. The first cholera vaccine approved in the US was called Dukoral.\n2. Dukoral is a killed-bacteria vaccine.\n3. The US Food and Drug Administration (FDA) approved Dukoral in 2000.",
    "llama-7b_fact": [
      "The first cholera vaccine approved in the US was called Dukoral.",
      "Dukoral is a killed-bacteria vaccine.",
      "The US Food and Drug Administration (FDA) approved Dukoral in 2000."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The first cholera vaccine approved in the US was called Vaxchora, not Dukoral.\n2. TRUE\n3. FALSE [correction]: The US Food and Drug Administration (FDA) approved Dukoral in 2003, not 2000. However, it is important to note that Dukoral has not been approved for use in the United States; Vaxchora, which is a different cholera vaccine, was approved by the FDA in 2016.",
    "llama-7b_judge": [
      "false",
      "true",
      "false"
    ]
  },
  {
    "id": 3737,
    "user_query": "Which is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans?",
    "llama-7b_response": "The most common monogenic cause of common variable immunodeficiency (CVID) in Europeans is the autoimmune regulator (AIRE) gene. CVID is a rare immunodeficiency disorder that affects the body's immune system, making it difficult for the body to fight off infections. The AIRE gene plays a critical role in the development and function of the thymus gland, which is responsible for producing immune cells that fight infections. Mutations in the AIRE gene can cause a reduction in the number of immune cells produced by the thymus gland, leading to CVID.",
    "llama-7b_fact_raw": "1. The autoimmune regulator (AIRE) gene is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.\n2. CVID is a rare immunodeficiency disorder that impairs the immune system's ability to fight off infections.\n3. The AIRE gene is critical for the development and function of the thymus gland.\n4. The thymus gland is responsible for producing immune cells that fight infections.\n5. Mutations in the AIRE gene can lead to a reduction in the number of immune cells produced, resulting in CVID.",
    "llama-7b_fact": [
      "The autoimmune regulator (AIRE) gene is the most common monogenic cause of common variable immunodeficiency (CVID) in Europeans.",
      "CVID is a rare immunodeficiency disorder that impairs the immune system's ability to fight off infections.",
      "The AIRE gene is critical for the development and function of the thymus gland.",
      "The thymus gland is responsible for producing immune cells that fight infections.",
      "Mutations in the AIRE gene can lead to a reduction in the number of immune cells produced, resulting in CVID."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The autoimmune regulator (AIRE) gene is associated with Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED), not common variable immunodeficiency (CVID). The most common genetic cause of CVID is not well-defined, as it is a heterogeneous disorder with various genetic associations.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Mutations in the AIRE gene can lead to autoimmune issues due to a failure in central tolerance, where the immune system attacks the body's own tissues. This is different from CVID, which is characterized by a primary immunodeficiency and not directly caused by mutations in the AIRE gene.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 3743,
    "user_query": "Which is the role of the IFIT1 gene in Systemic Lupus Erythematosus (SLE)?",
    "llama-7b_response": "The IFIT1 gene plays a crucial role in the development of Systemic Lupus Erythematosus (SLE). It is a gene that encodes for a protein called Interferon, alpha-induced protein with tetratricopeptide repeats 1 (IFIT1). This protein is involved in the regulation of the immune system and plays a critical role in the development of autoimmune diseases like SLE.\nSLE is an autoimmune disease that affects various organs in the body, including the skin, joints, kidneys, and brain. In SLE, the immune system attacks the body's own tissues, leading to inflammation and tissue damage. The exact cause of SLE is not known, but it is believed to be a combination of genetic and environmental factors.\nResearch has shown that IFIT1 plays a critical role in the development of SLE. Studies have found that individuals with SLE have higher levels of IFIT1 in their blood compared to healthy individuals. Additionally, genetic variations in the IFIT1 gene have been linked to an increased risk of developing SLE.\nFurthermore, IFIT1 has been found to play a critical role in the activation of immune cells called T cells. T cells are responsible for fighting infections and diseases, but in SLE, they become overactive and attack healthy tissues. IFIT1 has been found to regulate the activation of T cells and prevent them from attacking healthy tissues.\nIn summary, the IFIT1 gene plays a critical role in the development of Systemic Lupus Erythematosus (SLE). It is involved in the regulation of the immune system and plays a critical role in the activation of T cells. Genetic variations in the IFIT1 gene have been linked to an increased risk of developing SLE, and higher levels of IFIT1 in the blood have been found in individuals with SLE.",
    "llama-7b_fact_raw": "1. The IFIT1 gene encodes for a protein called Interferon, alpha-induced protein with tetratricopeptide repeats 1 (IFIT1).\n2. Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect various organs including the skin, joints, kidneys, and brain.\n3. Individuals with SLE have been found to have higher levels of IFIT1 in their blood compared to healthy individuals.\n4. Genetic variations in the IFIT1 gene have been linked to an increased risk of developing SLE.\n5. IFIT1 is involved in the regulation of T cell activation, which is a critical aspect of the immune response in SLE.",
    "llama-7b_fact": [
      "The IFIT1 gene encodes for a protein called Interferon, alpha-induced protein with tetratricopeptide repeats 1 (IFIT1).",
      "Systemic Lupus Erythematosus (SLE) is an autoimmune disease that can affect various organs including the skin, joints, kidneys, and brain.",
      "Individuals with SLE have been found to have higher levels of IFIT1 in their blood compared to healthy individuals.",
      "Genetic variations in the IFIT1 gene have been linked to an increased risk of developing SLE.",
      "IFIT1 is involved in the regulation of T cell activation, which is a critical aspect of the immune response in SLE."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. FALSE [correction]: IFIT1 is involved in the innate immune response, particularly in the antiviral response to interferon. It is not directly involved in the regulation of T cell activation, which is a part of the adaptive immune response.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3752,
    "user_query": "What is the use of the Liverpool Elbow Score?",
    "llama-7b_response": "The Liverpool Elbow Score (LES) is a clinical scoring system used to assess the severity of elbow osteoarthritis (OA) in patients. It was developed by a team of researchers at the University of Liverpool in the United Kingdom and was first published in the Journal of Bone and Joint Surgery in 2004.\n\nThe LES is based on a combination of patient-reported pain and physical examination findings, including range of motion, grip strength, and joint line tenderness. The score ranges from 0 to 100, with higher scores indicating more severe OA.\n\nThe LES has been validated in several studies and has been shown to be a reliable and sensitive measure of elbow OA severity. It has also been used as a outcome measure in clinical trials evaluating treatments for elbow OA.\n\nThe LES can be used by healthcare providers to assess the severity of elbow OA in patients and to monitor changes in disease progression over time. It can also be used to guide treatment decisions, such as whether to recommend surgical intervention or to initiate non-surgical therapies such as physical therapy or pain management.\n\nOverall, the Liverpool Elbow Score is a valuable tool for healthcare providers in the assessment and management of elbow OA.",
    "llama-7b_fact_raw": "1. The Liverpool Elbow Score (LES) is used to assess the severity of elbow osteoarthritis in patients.\n2. The LES was developed by researchers at the University of Liverpool in the United Kingdom.\n3. The Liverpool Elbow Score was first published in the Journal of Bone and Joint Surgery in 2004.\n4. The score ranges from 0 to 100, with higher scores indicating more severe elbow osteoarthritis.\n5. The LES has been validated in several studies as a reliable and sensitive measure of elbow OA severity.",
    "llama-7b_fact": [
      "The Liverpool Elbow Score (LES) is used to assess the severity of elbow osteoarthritis in patients.",
      "The LES was developed by researchers at the University of Liverpool in the United Kingdom.",
      "The Liverpool Elbow Score was first published in the Journal of Bone and Joint Surgery in 2004.",
      "The score ranges from 0 to 100, with higher scores indicating more severe elbow osteoarthritis.",
      "The LES has been validated in several studies as a reliable and sensitive measure of elbow OA severity."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: The Liverpool Elbow Score (LES) is used to assess the outcome of patients with elbow pathology, not specifically the severity of elbow osteoarthritis.\n2. TRUE\n3. UNKNOWN\n4. FALSE [correction]: The score ranges from 0 to 100, with higher scores indicating better elbow function, not more severe elbow osteoarthritis.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "unknown",
      "false",
      "true"
    ]
  },
  {
    "id": 3763,
    "user_query": "Describe efforts on Sarcoma from the 100,000 Genomes Project",
    "llama-7b_response": "The 100,000 Genomes Project is a UK-based initiative that aims to sequence 100,000 whole genomes from NHS patients with rare diseases or cancers. As part of this project, efforts have been made to sequence genomes of patients with sarcoma, a type of cancer that affects the bones, muscles, nerves, and other connective tissues.\n\nOne of the key goals of the 100,000 Genomes Project is to identify new genetic variants that are associated with rare diseases and cancers. In the case of sarcoma, researchers have sequenced the genomes of over 100 patients with this disease and have identified several new genetic variants that are associated with an increased risk of developing sarcoma.\n\nThese variants have been studied in more detail, and researchers have been able to identify specific genes and pathways that are involved in the development and progression of sarcoma. This information can be used to develop new diagnostic tools and treatments for this disease.\n\nIn addition to identifying new genetic variants, the 100,000 Genomes Project has also helped to improve our understanding of the biology of sarcoma. By analyzing the genomes of sarcoma patients, researchers have been able to identify key genes and pathways that are involved in the development and progression of this disease.\n\nOverall, the 100,000 Genomes Project has made significant contributions to our understanding of sarcoma and has paved the way for the development of new diagnostic tools and treatments for this disease.",
    "llama-7b_fact_raw": "1. The 100,000 Genomes Project is a UK-based initiative that aims to sequence 100,000 whole genomes from NHS patients with rare diseases or cancers.\n2. The project has included efforts to sequence the genomes of patients with sarcoma.\n3. Researchers have sequenced the genomes of over 100 patients with sarcoma as part of the project.\n4. New genetic variants associated with an increased risk of developing sarcoma have been identified through the project.\n5. The project has contributed to the understanding of the biology of sarcoma and the identification of key genes and pathways involved in its development and progression.",
    "llama-7b_fact": [
      "The 100,000 Genomes Project is a UK-based initiative that aims to sequence 100,000 whole genomes from NHS patients with rare diseases or cancers.",
      "The project has included efforts to sequence the genomes of patients with sarcoma.",
      "Researchers have sequenced the genomes of over 100 patients with sarcoma as part of the project.",
      "New genetic variants associated with an increased risk of developing sarcoma have been identified through the project.",
      "The project has contributed to the understanding of the biology of sarcoma and the identification of key genes and pathways involved in its development and progression."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "true"
    ]
  },
  {
    "id": 3777,
    "user_query": "Does protein ALEX1 contain armadillo repeats?",
    "llama-7b_response": "Yes, protein ALEX1 contains armadillo repeats. Armadillo repeats are a type of protein sequence motif that is found in a variety of proteins, including ALEX1. Armadillo repeats are composed of a sequence of approximately 30 amino acids that are repeated in a tandem fashion. ALEX1 contains multiple copies of these repeats, which are thought to be important for the protein's function.",
    "llama-7b_fact_raw": "1. Protein ALEX1 contains armadillo repeats.\n2. Armadillo repeats are a type of protein sequence motif.\n3. Armadillo repeats consist of a sequence of approximately 30 amino acids.\n4. These repeats in ALEX1 are repeated in a tandem fashion.\n5. ALEX1 contains multiple copies of armadillo repeats.",
    "llama-7b_fact": [
      "Protein ALEX1 contains armadillo repeats.",
      "Armadillo repeats are a type of protein sequence motif.",
      "Armadillo repeats consist of a sequence of approximately 30 amino acids.",
      "These repeats in ALEX1 are repeated in a tandem fashion.",
      "ALEX1 contains multiple copies of armadillo repeats."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. TRUE\n3. FALSE [correction]: Armadillo repeats consist of a sequence of approximately 40 amino acids.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "unknown",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3789,
    "user_query": "List enzymes that removes histone modifications.",
    "llama-7b_response": "There are several enzymes that remove histone modifications, including:\n1. Histone deacetylases (HDACs): These enzymes remove acetyl groups from lysine residues on histone tails, which can alter the structure and function of the chromatin.\n2. Histone methyltransferases (HMTs): These enzymes add methyl groups to lysine residues on histone tails, which can also alter the structure and function of the chromatin.\n3. Histone demethylases (HDMs): These enzymes remove methyl groups from lysine residues on histone tails, which can also alter the structure and function of the chromatin.\n4. Lysine-specific demethylase 1 (LSD1): This enzyme removes methyl groups from lysine residues on histone tails, which can also alter the structure and function of the chromatin.\n5. Jumonji C (JMJC) domain-containing histone demethylases: These enzymes remove methyl groups from lysine residues on histone tails, which can also alter the structure and function of the chromatin.\nOverall, these enzymes play a critical role in regulating chromatin structure and function, which in turn affects gene expression and cellular processes.",
    "llama-7b_fact_raw": "1. Histone deacetylases (HDACs) remove acetyl groups from lysine residues on histone tails.\n2. Histone demethylases (HDMs) remove methyl groups from lysine residues on histone tails.\n3. Lysine-specific demethylase 1 (LSD1) removes methyl groups from lysine residues on histone tails.\n4. Jumonji C (JMJC) domain-containing histone demethylases remove methyl groups from lysine residues on histone tails.\n5. The removal of histone modifications by these enzymes can alter the structure and function of chromatin.",
    "llama-7b_fact": [
      "Histone deacetylases (HDACs) remove acetyl groups from lysine residues on histone tails.",
      "Histone demethylases (HDMs) remove methyl groups from lysine residues on histone tails.",
      "Lysine-specific demethylase 1 (LSD1) removes methyl groups from lysine residues on histone tails.",
      "Jumonji C (JMJC) domain-containing histone demethylases remove methyl groups from lysine residues on histone tails.",
      "The removal of histone modifications by these enzymes can alter the structure and function of chromatin."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3806,
    "user_query": "Does head ct increase brain tumor risk?",
    "llama-7b_response": "The answer to the question \"Does head CT increase brain tumor risk?\" is complex and depends on several factors. \nA head CT scan, also known as a computed tomography scan, is a diagnostic imaging test that uses X-rays and a computer to create detailed images of the head and brain. It is commonly used to detect and diagnose a variety of conditions, including brain tumors.\nHowever, it is important to note that radiation exposure from medical imaging tests like CT scans can increase the risk of developing cancer, including brain tumors. The amount of radiation exposure from a CT scan depends on several factors, including the type of scan, the body part being scanned, and the amount of radiation used by the facility performing the scan.\nStudies have shown that repeated exposure to radiation from CT scans can increase the risk of developing brain tumors, particularly in children and young adults. However, the risk is still relatively low, and the benefits of CT scans in diagnosing and treating certain conditions outweigh the potential risks in most cases.\nIt is important to talk to your healthcare provider about the risks and benefits of any medical imaging test, including CT scans, and to follow established guidelines for radiation exposure to minimize the risk of harm.",
    "llama-7b_fact_raw": "1. A head CT scan uses X-rays and a computer to create detailed images of the head and brain.\n2. Radiation exposure from medical imaging tests like CT scans can increase the risk of developing cancer, including brain tumors.\n3. The amount of radiation exposure from a CT scan varies based on the type of scan, the body part being scanned, and the radiation used by the facility.\n4. Repeated exposure to radiation from CT scans can increase the risk of developing brain tumors, especially in children and young adults.\n5. The benefits of CT scans in diagnosing and treating certain conditions generally outweigh the potential risks in most cases.",
    "llama-7b_fact": [
      "A head CT scan uses X-rays and a computer to create detailed images of the head and brain.",
      "Radiation exposure from medical imaging tests like CT scans can increase the risk of developing cancer, including brain tumors.",
      "The amount of radiation exposure from a CT scan varies based on the type of scan, the body part being scanned, and the radiation used by the facility.",
      "Repeated exposure to radiation from CT scans can increase the risk of developing brain tumors, especially in children and young adults.",
      "The benefits of CT scans in diagnosing and treating certain conditions generally outweigh the potential risks in most cases."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE\n\nEach of these statements is generally considered true, though the last statement (5) can be somewhat subjective and depends on the specific medical context and the judgment of healthcare professionals.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3809,
    "user_query": "Which type of pluripotency is Otx2 associated with?",
    "llama-7b_response": "Otx2 is associated with the type of pluripotency known as transcriptional regulation. Specifically, Otx2 is a transcription factor that plays a crucial role in the regulation of gene expression during embryonic development. It is involved in the formation of various tissues and organs, including the brain, eye, and ear. Otx2 is essential for the proper development of these structures and is required for the maintenance of pluripotent stem cells.",
    "llama-7b_fact_raw": "1. Otx2 is associated with the type of pluripotency known as transcriptional regulation.\n2. Otx2 is a transcription factor that regulates gene expression during embryonic development.\n3. Otx2 is involved in the formation of the brain, eye, and ear during embryonic development.\n4. Otx2 is essential for the proper development of the brain, eye, and ear.\n5. Otx2 is required for the maintenance of pluripotent stem cells.",
    "llama-7b_fact": [
      "Otx2 is associated with the type of pluripotency known as transcriptional regulation.",
      "Otx2 is a transcription factor that regulates gene expression during embryonic development.",
      "Otx2 is involved in the formation of the brain, eye, and ear during embryonic development.",
      "Otx2 is essential for the proper development of the brain, eye, and ear.",
      "Otx2 is required for the maintenance of pluripotent stem cells."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Otx2 is associated with the type of pluripotency known as transcriptional regulation, but it is more accurate to say that Otx2 is a transcription factor involved in the development of certain structures during embryogenesis rather than being associated with pluripotency itself.\n2. TRUE\n3. TRUE\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3815,
    "user_query": "How many DNaseI hypersensitive sites (DHS) mark the murine beta globin locus region?",
    "llama-7b_response": "The murine beta globin locus region contains several DNaseI hypersensitive sites (DHS). The exact number of DHS that mark the murine beta globin locus region can vary depending on the study and the method used for detection. However, a study published in the journal Genome Research in 2001 found that the murine beta globin locus region contains at least 15 DHS.",
    "llama-7b_fact_raw": "1. The murine beta globin locus region contains several DNaseI hypersensitive sites (DHS).\n2. The exact number of DHS in the murine beta globin locus region can vary based on the study and detection method.\n3. A study published in the journal Genome Research in 2001 reported at least 15 DHS in the murine beta globin locus region.",
    "llama-7b_fact": [
      "The murine beta globin locus region contains several DNaseI hypersensitive sites (DHS).",
      "The exact number of DHS in the murine beta globin locus region can vary based on the study and detection method.",
      "A study published in the journal Genome Research in 2001 reported at least 15 DHS in the murine beta globin locus region."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3822,
    "user_query": "List as many European influenza vaccines as possible.",
    "llama-7b_response": "There are several European influenza vaccines available, including:\n1. AstraZeneca's FluMist Quadrivalent\n2. GlaxoSmithKline's Fluarix Quadrivalent\n3. Novartis's Fluvirin Quadrivalent\n4. Pfizer's FluLaval Quadrivalent\n5. Sanofi Pasteur's Fluzone Quadrivalent\n6. Seqirus's Flucelvax Quadrivalent\nThese vaccines are designed to protect against four different influenza viruses that are most likely to cause illness during the upcoming flu season. The vaccines are administered via injection or nasal spray and are recommended for individuals who are six months of age or older.",
    "llama-7b_fact_raw": "1. AstraZeneca's FluMist Quadrivalent is a European influenza vaccine.\n2. GlaxoSmithKline's Fluarix Quadrivalent is a European influenza vaccine.\n3. Novartis's Fluvirin Quadrivalent is a European influenza vaccine.\n4. Pfizer's FluLaval Quadrivalent is a European influenza vaccine.\n5. Sanofi Pasteur's Fluzone Quadrivalent is a European influenza vaccine.",
    "llama-7b_fact": [
      "AstraZeneca's FluMist Quadrivalent is a European influenza vaccine.",
      "GlaxoSmithKline's Fluarix Quadrivalent is a European influenza vaccine.",
      "Novartis's Fluvirin Quadrivalent is a European influenza vaccine.",
      "Pfizer's FluLaval Quadrivalent is a European influenza vaccine.",
      "Sanofi Pasteur's Fluzone Quadrivalent is a European influenza vaccine."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: AstraZeneca's FluMist Quadrivalent is a live attenuated influenza vaccine primarily used in the United States.\n2. UNKNOWN: GlaxoSmithKline's Fluarix Quadrivalent is available in multiple regions, including Europe, but without specific information, it's unclear if it is exclusively a European influenza vaccine.\n3. FALSE [correction]: Novartis no longer produces influenza vaccines as their flu vaccine division was acquired by CSL's Seqirus in 2015.\n4. UNKNOWN: Pfizer's FluLaval Quadrivalent is available in multiple regions, including Europe, but without specific information, it's unclear if it is exclusively a European influenza vaccine.\n5. UNKNOWN: Sanofi Pasteur's Fluzone Quadrivalent is available in multiple regions, including Europe, but without specific information, it's unclear if it is exclusively a European influenza vaccine.",
    "llama-7b_judge": [
      "false",
      "unknown",
      "false",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 3832,
    "user_query": "Is the Paramyxovirus geneome segmented, negative-sense RNA?",
    "llama-7b_response": "Yes, the Paramyxovirus geneome is segmented, negative-sense RNA. Paramyxoviruses are a group of viruses that cause respiratory infections in humans and animals. They have a single-stranded, segmented RNA genome that is negative-sense, meaning that the genetic information is read from the 3' end to the 5' end of the RNA molecule. The Paramyxovirus genome is composed of 11 segments, which are organized into three groups of three segments each. Each segment is flanked by non-coding regions at both the 5' and 3' ends, and codes for a specific protein that is essential for virus replication and function.",
    "llama-7b_fact_raw": "1. Paramyxoviruses have a single-stranded RNA genome that is negative-sense.\n2. The genetic information in the Paramyxovirus genome is read from the 3' end to the 5' end of the RNA molecule.\n3. The Paramyxovirus genome is composed of 11 segments.\n4. Each segment of the Paramyxovirus genome is flanked by non-coding regions at both the 5' and 3' ends.\n5. Each segment of the Paramyxovirus genome codes for a specific protein essential for virus replication and function.",
    "llama-7b_fact": [
      "Paramyxoviruses have a single-stranded RNA genome that is negative-sense.",
      "The genetic information in the Paramyxovirus genome is read from the 3' end to the 5' end of the RNA molecule.",
      "The Paramyxovirus genome is composed of 11 segments.",
      "Each segment of the Paramyxovirus genome is flanked by non-coding regions at both the 5' and 3' ends.",
      "Each segment of the Paramyxovirus genome codes for a specific protein essential for virus replication and function."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: Paramyxoviruses have a non-segmented single-stranded RNA genome.\n4. FALSE [correction]: Since the Paramyxovirus genome is non-segmented, it does not have multiple segments flanked by non-coding regions; instead, it has one continuous strand of RNA with non-coding regions at the ends.\n5. FALSE [correction]: As the Paramyxovirus genome is non-segmented, it does not have separate segments each coding for a specific protein. Instead, the single continuous RNA molecule encodes multiple proteins.",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3869,
    "user_query": "Roflumilast Cream is effective for which disease?",
    "llama-7b_response": "Roflumilast cream is a prescription medication that is used to treat a certain type of lung disease called chronic obstructive pulmonary disease (COPD). COPD is a progressive disease that makes it difficult to breathe, and it is caused by the blockage of airflow in the lungs. Roflumilast cream works by reducing inflammation in the lungs, which can help to improve breathing and reduce symptoms of COPD. However, it is important to note that roflumilast cream is not a cure for COPD and should be used in combination with other medications and lifestyle changes to manage the disease.",
    "llama-7b_fact_raw": "1. Roflumilast cream is a prescription medication used to treat chronic obstructive pulmonary disease (COPD).\n2. COPD is a progressive disease that obstructs airflow in the lungs and makes it difficult to breathe.\n3. Roflumilast cream functions by reducing inflammation in the lungs.\n4. Roflumilast cream is not a cure for COPD.\n5. Roflumilast cream should be used in combination with other medications and lifestyle changes to manage COPD.",
    "llama-7b_fact": [
      "Roflumilast cream is a prescription medication used to treat chronic obstructive pulmonary disease (COPD).",
      "COPD is a progressive disease that obstructs airflow in the lungs and makes it difficult to breathe.",
      "Roflumilast cream functions by reducing inflammation in the lungs.",
      "Roflumilast cream is not a cure for COPD.",
      "Roflumilast cream should be used in combination with other medications and lifestyle changes to manage COPD."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Roflumilast is an oral medication, not a cream, used to treat chronic obstructive pulmonary disease (COPD).\n2. TRUE\n3. FALSE [correction]: Roflumilast is a phosphodiesterase-4 inhibitor that reduces inflammation in the lungs, but as an oral medication, not a cream.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3885,
    "user_query": "Which tools have been developed for identifying and visualising ncRNA promoters?",
    "llama-7b_response": "There are several tools available for identifying and visualizing ncRNA promoters. Some of the most commonly used tools are:\n1. RNAz: RNAz is a web-based tool that allows users to search for and visualize RNA polymerase II promoters in a genome-wide scale. It uses a combination of genomic data and transcription factor binding sites to identify promoters.\n2. ENCODE Transcription Factor ChIP-seq Data: The ENCODE project has generated a large amount of data on transcription factor ChIP-seq experiments. This data can be used to identify promoters of ncRNAs.\n3. DNase I Hypersensitivity Data: DNase I hypersensitivity data can be used to identify promoters of ncRNAs. This data is generated by treating cells with DNase I, which cleaves DNA at hypersensitive sites.\n4. ChIPseeker: ChIPseeker is a web-based tool that allows users to search for and visualize ChIP-seq data. It can be used to identify promoters of ncRNAs by analyzing ChIP-seq data from transcription factors and other regulatory proteins.\n5. MatInspector: MatInspector is a bioinformatics tool that can be used to identify promoters of ncRNAs. It uses a combination of genomic data and transcription factor binding sites to identify promoters.\nThese tools can be used to identify and visualize ncRNA promoters in a genome-wide scale.",
    "llama-7b_fact_raw": "1. RNAz is a tool that can identify and visualize RNA polymerase II promoters on a genome-wide scale.\n2. The ENCODE project provides transcription factor ChIP-seq data that can be used to identify ncRNA promoters.\n3. DNase I hypersensitivity data can be utilized to identify ncRNA promoters.\n4. ChIPseeker is a web-based tool designed for searching and visualizing ChIP-seq data to identify ncRNA promoters.\n5. MatInspector is a bioinformatics tool that identifies ncRNA promoters using genomic data and transcription factor binding sites.",
    "llama-7b_fact": [
      "RNAz is a tool that can identify and visualize RNA polymerase II promoters on a genome-wide scale.",
      "The ENCODE project provides transcription factor ChIP-seq data that can be used to identify ncRNA promoters.",
      "DNase I hypersensitivity data can be utilized to identify ncRNA promoters.",
      "ChIPseeker is a web-based tool designed for searching and visualizing ChIP-seq data to identify ncRNA promoters.",
      "MatInspector is a bioinformatics tool that identifies ncRNA promoters using genomic data and transcription factor binding sites."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: RNAz is a tool used to predict RNA secondary structures and does not specifically identify and visualize RNA polymerase II promoters on a genome-wide scale.\n2. TRUE\n3. TRUE\n4. FALSE [correction]: ChIPseeker is an R package designed for annotating ChIP-seq data and is not specifically a web-based tool nor is it designed solely to identify ncRNA promoters.\n5. FALSE [correction]: MatInspector is a bioinformatics tool that identifies transcription factor binding sites within DNA sequences but does not specifically identify ncRNA promoters.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "false",
      "false"
    ]
  },
  {
    "id": 3918,
    "user_query": "List example genes that SWIM tool has identified and which are down-regulated in glioblastoma",
    "llama-7b_response": "I'm sorry, but as an AI language model, I do not have access to specific information about the SWIM tool and its identified genes in glioblastoma. However, I can provide you with a general answer.\nGlioblastoma is a type of brain cancer that is characterized by the overexpression of certain genes that promote tumor growth and proliferation. The SWIM tool is a gene expression analysis tool that identifies genes that are down-regulated in various types of cancer, including glioblastoma. \nSome example genes that SWIM tool may have identified as being down-regulated in glioblastoma include:\n1. PTEN: This gene is often mutated or deleted in glioblastoma, and its down-regulation can promote tumor growth and proliferation.\n2. TP53: This tumor suppressor gene is frequently inactivated in glioblastoma, and its down-regulation can lead to chromosomal instability and tumor formation.\n3. CDKN2A: This gene encodes a tumor suppressor protein that is often inactivated in glioblastoma, and its down-regulation can promote cell proliferation and tumor growth.\n4. RB1: This gene encodes a tumor suppressor protein that is important for regulating cell growth and division, and its down-regulation can lead to uncontrolled cell proliferation and tumor formation.\n5. PDGFRA: This gene encodes a growth factor receptor that is often overexpressed in glioblastoma, and its down-regulation can inhibit tumor growth and proliferation.\nThese are just a few examples of the genes that SWIM tool may have identified as being down-regulated in glioblastoma.",
    "llama-7b_fact_raw": "1. The SWIM tool is a gene expression analysis tool that identifies genes that are down-regulated in various types of cancer, including glioblastoma.\n2. PTEN is a gene that can be down-regulated in glioblastoma, which can promote tumor growth and proliferation.\n3. TP53 is a tumor suppressor gene that can be inactivated in glioblastoma, leading to chromosomal instability and tumor formation.\n4. CDKN2A encodes a tumor suppressor protein that can be inactivated in glioblastoma, promoting cell proliferation and tumor growth.\n5. RB1 encodes a tumor suppressor protein that regulates cell growth and division, and its down-regulation can lead to uncontrolled cell proliferation and tumor formation.",
    "llama-7b_fact": [
      "The SWIM tool is a gene expression analysis tool that identifies genes that are down-regulated in various types of cancer, including glioblastoma.",
      "PTEN is a gene that can be down-regulated in glioblastoma, which can promote tumor growth and proliferation.",
      "TP53 is a tumor suppressor gene that can be inactivated in glioblastoma, leading to chromosomal instability and tumor formation.",
      "CDKN2A encodes a tumor suppressor protein that can be inactivated in glioblastoma, promoting cell proliferation and tumor growth.",
      "RB1 encodes a tumor suppressor protein that regulates cell growth and division, and its down-regulation can lead to uncontrolled cell proliferation and tumor formation."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN: Without specific information about the SWIM tool, it is not possible to confirm whether it specifically identifies genes that are down-regulated in various types of cancer, including glioblastoma.\n2. TRUE: PTEN is a tumor suppressor gene that can be down-regulated in glioblastoma, contributing to tumor growth and proliferation.\n3. TRUE: TP53 is a well-known tumor suppressor gene that can be inactivated in glioblastoma, which can lead to chromosomal instability and contribute to tumor formation.\n4. TRUE: CDKN2A encodes the tumor suppressor proteins p16INK4a and p14ARF, and its inactivation can lead to increased cell proliferation and is associated with glioblastoma.\n5. TRUE: RB1 encodes the retinoblastoma protein, which is a tumor suppressor protein that helps regulate the cell cycle. Down-regulation or inactivation of RB1 can lead to uncontrolled cell proliferation and contribute to tumor formation, including in glioblastoma.",
    "llama-7b_judge": [
      "unknown",
      "true",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 3926,
    "user_query": "Which R packages have been developed for studying TADs?",
    "llama-7b_response": "There are several R packages that have been developed for studying TADs (Transcriptional Activation Domains). Some of the popular ones are:\n1. TADsR: This package provides functions for analyzing and visualizing TADs data. It includes functions for mapping ChIP-seq data, detecting TADs, and visualizing the results.\n2. ChIPseeker: This package provides tools for analyzing ChIP-seq data, including functions for detecting TADs. It also includes functions for visualizing the results.\n3. TADCaller: This package provides a tool for calling TADs from ChIP-seq data. It uses a sliding window approach to identify regions of enrichment and calls TADs based on user-defined parameters.\n4. TADfinder: This package provides a tool for finding TADs in genomic data. It uses a sliding window approach to identify regions of enrichment and calls TADs based on user-defined parameters.\n5. TADtools: This package provides a suite of tools for analyzing and visualizing TADs data. It includes functions for mapping ChIP-seq data, detecting TADs, and visualizing the results.\nOverall, these packages provide a range of tools for analyzing and visualizing TADs data, making it easier for researchers to study these important regions of the genome.",
    "llama-7b_fact_raw": "1. TADsR is an R package that provides functions for analyzing and visualizing TADs data.\n2. ChIPseeker is an R package that includes functions for detecting TADs and visualizing ChIP-seq data.\n3. TADCaller is an R package that identifies TADs from ChIP-seq data using a sliding window approach.\n4. TADfinder is an R package designed to find TADs in genomic data, also using a sliding window approach.\n5. TADtools is an R package that offers a suite of tools for mapping ChIP-seq data, detecting TADs, and visualizing the results.",
    "llama-7b_fact": [
      "TADsR is an R package that provides functions for analyzing and visualizing TADs data.",
      "ChIPseeker is an R package that includes functions for detecting TADs and visualizing ChIP-seq data.",
      "TADCaller is an R package that identifies TADs from ChIP-seq data using a sliding window approach.",
      "TADfinder is an R package designed to find TADs in genomic data, also using a sliding window approach.",
      "TADtools is an R package that offers a suite of tools for mapping ChIP-seq data, detecting TADs, and visualizing the results."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN: Without specific information about the TADsR package, it is not possible to confirm or correct this statement.\n2. FALSE [correction]: ChIPseeker is an R package that is designed for annotating ChIP-seq data with known genes and visualizing the overlap of ChIP-seq peaks with genomic annotations, not for detecting TADs.\n3. UNKNOWN: Without specific information about the TADCaller package, it is not possible to confirm or correct this statement.\n4. UNKNOWN: Without specific information about the TADfinder package, it is not possible to confirm or correct this statement.\n5. FALSE [correction]: TADtools is an R package that provides functions for visualizing and analyzing TADs (Topologically Associating Domains) in genomic data, but it does not offer tools for mapping ChIP-seq data.",
    "llama-7b_judge": [
      "unknown",
      "false",
      "unknown",
      "unknown",
      "false"
    ]
  },
  {
    "id": 3927,
    "user_query": "Which bioconductor tool has been developed for accessing bacterial regulatory networks?",
    "llama-7b_response": "One bioconductor tool that has been developed for accessing bacterial regulatory networks is the \"Bacterial Regulatory Networks\" package. This package provides a set of functions for analyzing and visualizing bacterial regulatory networks, including gene expression data, protein-protein interactions, and metabolic pathways. The package can be used to identify genes and proteins that are involved in regulatory networks, as well as to analyze the dynamics of these networks in response to different environmental conditions. Overall, the Bacterial Regulatory Networks package is a valuable tool for researchers studying bacterial regulatory networks and their role in bacterial physiology and pathogenesis.",
    "llama-7b_fact_raw": "1. The \"Bacterial Regulatory Networks\" package is a bioconductor tool developed for accessing bacterial regulatory networks.\n2. The package includes functions for analyzing and visualizing bacterial regulatory networks.\n3. It provides analysis of gene expression data, protein-protein interactions, and metabolic pathways.\n4. The tool can identify genes and proteins involved in regulatory networks.\n5. It allows for the analysis of the dynamics of regulatory networks in response to environmental conditions.",
    "llama-7b_fact": [
      "The \"Bacterial Regulatory Networks\" package is a bioconductor tool developed for accessing bacterial regulatory networks.",
      "The package includes functions for analyzing and visualizing bacterial regulatory networks.",
      "It provides analysis of gene expression data, protein-protein interactions, and metabolic pathways.",
      "The tool can identify genes and proteins involved in regulatory networks.",
      "It allows for the analysis of the dynamics of regulatory networks in response to environmental conditions."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The \"Bacterial Regulatory Networks\" package is primarily focused on accessing, analyzing, and visualizing bacterial regulatory networks, not directly analyzing gene expression data, protein-protein interactions, and metabolic pathways. These aspects may be part of understanding regulatory networks but are not the main focus of the package.\n4. TRUE\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3933,
    "user_query": "What are the end products of the shikimate pathway?",
    "llama-7b_response": "The end products of the shikimate pathway are aromatic amino acids, which are essential building blocks for the biosynthesis of various secondary metabolites in bacteria and plants. Specifically, the shikimate pathway produces four aromatic amino acids: phenylalanine, tyrosine, tryptophan, and histidine. These amino acids are required for the synthesis of various proteins, including enzymes, hormones, and structural proteins. Without the shikimate pathway, bacteria and plants would not be able to synthesize these essential amino acids, which would have a significant impact on their growth and survival.",
    "llama-7b_fact_raw": "1. The shikimate pathway produces aromatic amino acids.\n2. Aromatic amino acids are essential for the biosynthesis of various secondary metabolites in bacteria and plants.\n3. The shikimate pathway specifically produces phenylalanine, tyrosine, tryptophan, and histidine.\n4. These amino acids are necessary for the synthesis of proteins, including enzymes, hormones, and structural proteins.\n5. The growth and survival of bacteria and plants are dependent on the shikimate pathway for the synthesis of these essential amino acids.",
    "llama-7b_fact": [
      "The shikimate pathway produces aromatic amino acids.",
      "Aromatic amino acids are essential for the biosynthesis of various secondary metabolites in bacteria and plants.",
      "The shikimate pathway specifically produces phenylalanine, tyrosine, tryptophan, and histidine.",
      "These amino acids are necessary for the synthesis of proteins, including enzymes, hormones, and structural proteins.",
      "The growth and survival of bacteria and plants are dependent on the shikimate pathway for the synthesis of these essential amino acids."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. FALSE [correction]: The shikimate pathway specifically produces phenylalanine, tyrosine, and tryptophan. Histidine is not synthesized through the shikimate pathway.\n4. TRUE\n5. TRUE",
    "llama-7b_judge": [
      "true",
      "true",
      "false",
      "true",
      "true"
    ]
  },
  {
    "id": 3936,
    "user_query": "Is cabergoline used for treatment of the Nelson's syndrome ?",
    "llama-7b_response": "No, cabergoline is not used for the treatment of Nelson's syndrome. Nelson's syndrome is a rare condition that occurs when prolactin-secreting pituitary tumors continue to grow after a patient has been treated for a prolactin-secreting pituitary adenoma. Cabergoline is typically used for the treatment of hyperprolactinemia, which is a condition characterized by excessive production of prolactin by the pituitary gland. However, cabergoline may be used off-label for the treatment of Nelson's syndrome in some cases.",
    "llama-7b_fact_raw": "1. Cabergoline is not typically used for the treatment of Nelson's syndrome.\n2. Nelson's syndrome is a condition that occurs when prolactin-secreting pituitary tumors continue to grow after treatment for a prolactin-secreting pituitary adenoma.\n3. Cabergoline is typically used for the treatment of hyperprolactinemia.\n4. Hyperprolactinemia is a condition characterized by excessive production of prolactin by the pituitary gland.\n5. Cabergoline may be used off-label for the treatment of Nelson's syndrome in some cases.",
    "llama-7b_fact": [
      "Cabergoline is not typically used for the treatment of Nelson's syndrome.",
      "Nelson's syndrome is a condition that occurs when prolactin-secreting pituitary tumors continue to grow after treatment for a prolactin-secreting pituitary adenoma.",
      "Cabergoline is typically used for the treatment of hyperprolactinemia.",
      "Hyperprolactinemia is a condition characterized by excessive production of prolactin by the pituitary gland.",
      "Cabergoline may be used off-label for the treatment of Nelson's syndrome in some cases."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: Nelson's syndrome is a condition that occurs when ACTH-secreting pituitary tumors continue to grow after the removal of the adrenal glands for the treatment of Cushing's disease.\n3. TRUE\n4. TRUE\n5. UNKNOWN",
    "llama-7b_judge": [
      "true",
      "false",
      "true",
      "true",
      "unknown"
    ]
  },
  {
    "id": 3939,
    "user_query": "What is the main manifestation of Liebenberg syndrome?",
    "llama-7b_response": "Liebenberg syndrome is a rare genetic disorder that affects the body's ability to produce and regulate thyroid hormones. The main manifestation of Liebenberg syndrome is a goiter, which is an enlarged thyroid gland that can cause a visible lump in the neck. Other symptoms of Liebenberg syndrome may include hypothyroidism, which is a condition where the thyroid gland does not produce enough thyroid hormone, and hyperthyroidism, which is a condition where the thyroid gland produces too much thyroid hormone. Other symptoms may include weight gain, fatigue, depression, and irregular menstrual cycles. These symptoms can vary in severity and may be present at different stages of life. It is important to seek medical attention if you suspect you may have Liebenberg syndrome or if you are experiencing any of these symptoms.",
    "llama-7b_fact_raw": "1. Liebenberg syndrome is a rare genetic disorder.\n2. The main manifestation of Liebenberg syndrome is a goiter, an enlarged thyroid gland.\n3. Symptoms of Liebenberg syndrome may include hypothyroidism, where the thyroid gland does not produce enough thyroid hormone.\n4. Symptoms of Liebenberg syndrome may also include hyperthyroidism, where the thyroid gland produces too much thyroid hormone.\n5. Other symptoms of Liebenberg syndrome can include weight gain, fatigue, depression, and irregular menstrual cycles.",
    "llama-7b_fact": [
      "Liebenberg syndrome is a rare genetic disorder.",
      "The main manifestation of Liebenberg syndrome is a goiter, an enlarged thyroid gland.",
      "Symptoms of Liebenberg syndrome may include hypothyroidism, where the thyroid gland does not produce enough thyroid hormone.",
      "Symptoms of Liebenberg syndrome may also include hyperthyroidism, where the thyroid gland produces too much thyroid hormone.",
      "Other symptoms of Liebenberg syndrome can include weight gain, fatigue, depression, and irregular menstrual cycles."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. FALSE [correction]: Liebenberg syndrome is characterized by the abnormal development of the upper limbs, which can resemble the lower limbs.\n3. FALSE [correction]: Symptoms of Liebenberg syndrome are related to limb malformations and do not typically include thyroid-related issues like hypothyroidism.\n4. FALSE [correction]: Symptoms of Liebenberg syndrome are related to limb malformations and do not typically include thyroid-related issues like hyperthyroidism.\n5. FALSE [correction]: Other symptoms of Liebenberg syndrome are related to the limb anomalies and do not typically include weight gain, fatigue, depression, and irregular menstrual cycles unless these are coincidental or due to another condition.",
    "llama-7b_judge": [
      "unknown",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 3977,
    "user_query": "List orally bioavailable MPS1 kinase inhibitors",
    "llama-7b_response": "Sure, here are some orally bioavailable MPS1 kinase inhibitors:\n1. Midostaurin (Rydapt)\n2. Pirfenidone (Esbriet)\n3. Pimecrolimus (Elidel)\n4. Nintedanib (BIBF 1120)\n5. Lorlatinib (Lorbrena)\n6. Alectinib (Alecensa)\n7. Crizotinib (Xalkori)\n8. Ceritinib (Zykadia)\n9. Pazopanib (Votrient)\n10. Axitinib (Inlyta)\nThese are just a few examples of orally bioavailable MPS1 kinase inhibitors. It's important to note that this list is not exhaustive and there may be other drugs that can inhibit MPS1 kinase activity.",
    "llama-7b_fact_raw": "1. Midostaurin is an orally bioavailable MPS1 kinase inhibitor.\n2. Pirfenidone is an orally bioavailable MPS1 kinase inhibitor.\n3. Pimecrolimus is an orally bioavailable MPS1 kinase inhibitor.\n4. Nintedanib is an orally bioavailable MPS1 kinase inhibitor.\n5. Lorlatinib is an orally bioavailable MPS1 kinase inhibitor.",
    "llama-7b_fact": [
      "Midostaurin is an orally bioavailable MPS1 kinase inhibitor.",
      "Pirfenidone is an orally bioavailable MPS1 kinase inhibitor.",
      "Pimecrolimus is an orally bioavailable MPS1 kinase inhibitor.",
      "Nintedanib is an orally bioavailable MPS1 kinase inhibitor.",
      "Lorlatinib is an orally bioavailable MPS1 kinase inhibitor."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Midostaurin is an orally bioavailable multi-kinase inhibitor that targets FLT3 and other kinases, not specifically MPS1 kinase.\n2. FALSE [correction]: Pirfenidone is an orally bioavailable medication used to treat idiopathic pulmonary fibrosis, not an MPS1 kinase inhibitor.\n3. FALSE [correction]: Pimecrolimus is an immunomodulating agent used for the treatment of skin conditions like eczema, not an MPS1 kinase inhibitor.\n4. FALSE [correction]: Nintedanib is an orally bioavailable tyrosine kinase inhibitor used to treat idiopathic pulmonary fibrosis and certain types of non-small cell lung cancer, not specifically an MPS1 kinase inhibitor.\n5. FALSE [correction]: Lorlatinib is an orally bioavailable ALK and ROS1 tyrosine kinase inhibitor used to treat non-small cell lung cancer, not an MPS1 kinase inhibitor.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "false"
    ]
  },
  {
    "id": 4031,
    "user_query": "Was golimumab tested for diabetes?",
    "llama-7b_response": "Golimumab is a medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. The FDA has not approved golimumab for the treatment of diabetes. \nHowever, there have been some studies conducted on the use of golimumab in patients with type 2 diabetes. One study published in the journal Arthritis Care & Research found that golimumab may improve blood sugar control in patients with type 2 diabetes who also have rheumatoid arthritis. The study found that after 24 weeks of treatment, patients who received golimumab had a significant reduction in hemoglobin A1c (HbA1c), a measure of long-term blood sugar control. \nIt is important to note that these results are preliminary and further research is needed to fully understand the potential benefits and risks of golimumab in patients with type 2 diabetes. As of now, golimumab is not approved for the treatment of diabetes and should only be used under the guidance of a healthcare provider.",
    "llama-7b_fact_raw": "1. Golimumab is approved by the U.S. Food and Drug Administration for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.\n2. The FDA has not approved golimumab for the treatment of diabetes.\n3. Studies have been conducted on the use of golimumab in patients with type 2 diabetes.\n4. A study published in the journal Arthritis Care & Research reported that golimumab may improve blood sugar control in patients with type 2 diabetes who also have rheumatoid arthritis.\n5. The study mentioned found a significant reduction in hemoglobin A1c (HbA1c) after 24 weeks of treatment with golimumab.",
    "llama-7b_fact": [
      "Golimumab is approved by the U.S. Food and Drug Administration for the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis.",
      "The FDA has not approved golimumab for the treatment of diabetes.",
      "Studies have been conducted on the use of golimumab in patients with type 2 diabetes.",
      "A study published in the journal Arthritis Care & Research reported that golimumab may improve blood sugar control in patients with type 2 diabetes who also have rheumatoid arthritis.",
      "The study mentioned found a significant reduction in hemoglobin A1c (HbA1c) after 24 weeks of treatment with golimumab."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe first two statements can be verified based on the FDA's approval records and known indications for golimumab. However, without specific references to the studies or access to the journal Arthritis Care & Research, the veracity of statements 3, 4, and 5 cannot be determined.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4055,
    "user_query": "Is progeria caused by an autosomal recessive gene?",
    "llama-7b_response": "Progeria is a rare genetic disorder that causes premature aging in children. It is caused by a mutation in a single gene, called the lamin A gene. This gene provides instructions for making a protein called lamin A, which is a component of the cell's nucleus. \nThe mutation that causes progeria results in the production of a defective form of lamin A. This defective protein accumulates in the cell's nucleus, causing damage to the cell's DNA and leading to premature aging. \nProgeria is inherited in an autosomal recessive pattern, which means that a child must inherit two copies of the mutated gene (one from each parent) to develop the disorder. If both parents are carriers of the mutated gene, there is a 25% chance that their child will inherit two mutated genes and develop progeria. \nIn summary, progeria is caused by a mutation in the lamin A gene that results in the production of a defective protein that causes premature aging. It is inherited in an autosomal recessive pattern.",
    "llama-7b_fact_raw": "1. Progeria is a rare genetic disorder that causes premature aging in children.\n2. The disorder is caused by a mutation in the lamin A gene.\n3. The lamin A gene provides instructions for making a protein called lamin A, which is a component of the cell's nucleus.\n4. The mutation in the lamin A gene leads to the production of a defective form of lamin A.\n5. Progeria is inherited in an autosomal recessive pattern, meaning a child must inherit two copies of the mutated gene to develop the disorder.",
    "llama-7b_fact": [
      "Progeria is a rare genetic disorder that causes premature aging in children.",
      "The disorder is caused by a mutation in the lamin A gene.",
      "The lamin A gene provides instructions for making a protein called lamin A, which is a component of the cell's nucleus.",
      "The mutation in the lamin A gene leads to the production of a defective form of lamin A.",
      "Progeria is inherited in an autosomal recessive pattern, meaning a child must inherit two copies of the mutated gene to develop the disorder."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Progeria is not inherited in an autosomal recessive pattern. It is usually caused by a new mutation that occurs during the early stages of embryo development, and it is typically not inherited from a child's parents. It follows an autosomal dominant pattern, but due to its severity, affected individuals rarely reproduce.",
    "llama-7b_judge": [
      "true",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4082,
    "user_query": "What are common variants at 12q14 and 12q24 associated with?",
    "llama-7b_response": "There are several common variants at 12q14 and 12q24 that have been associated with various conditions and traits. Here are some examples:\n12q14:\n- Variants at this location have been associated with an increased risk of developing schizophrenia and bipolar disorder.\n- One variant in particular, rs7631107, has been found to be more common in individuals with schizophrenia compared to healthy controls.\n12q24:\n- Variants at this location have been associated with an increased risk of developing type 2 diabetes, as well as with insulin resistance and obesity.\n- One variant in particular, rs7903146, has been found to be more common in individuals with type 2 diabetes compared to healthy controls.\nIt's important to note that these associations are not necessarily causal, and that there may be other factors involved in the development of these conditions. Additionally, the presence of a variant does not necessarily mean that an individual will develop the associated condition or trait.",
    "llama-7b_fact_raw": "1. Variants at 12q14 have been associated with an increased risk of developing schizophrenia and bipolar disorder.\n2. The variant rs7631107 at 12q14 has been found to be more common in individuals with schizophrenia compared to healthy controls.\n3. Variants at 12q24 have been associated with an increased risk of developing type 2 diabetes.\n4. Variants at 12q24 have been associated with insulin resistance and obesity.\n5. The variant rs7903146 at 12q24 has been found to be more common in individuals with type 2 diabetes compared to healthy controls.",
    "llama-7b_fact": [
      "Variants at 12q14 have been associated with an increased risk of developing schizophrenia and bipolar disorder.",
      "The variant rs7631107 at 12q14 has been found to be more common in individuals with schizophrenia compared to healthy controls.",
      "Variants at 12q24 have been associated with an increased risk of developing type 2 diabetes.",
      "Variants at 12q24 have been associated with insulin resistance and obesity.",
      "The variant rs7903146 at 12q24 has been found to be more common in individuals with type 2 diabetes compared to healthy controls."
    ],
    "llama-7b_judge_raw": "1. TRUE: Variants at 12q14 have been associated with an increased risk of developing schizophrenia and bipolar disorder, according to genetic studies.\n2. UNKNOWN: Without specific scientific literature or studies to confirm the prevalence of the variant rs7631107 at 12q14 in individuals with schizophrenia, the truth of this statement cannot be determined.\n3. TRUE: Variants at 12q24 have been associated with an increased risk of developing type 2 diabetes, as reported in genetic association studies.\n4. TRUE: Variants at 12q24 have been linked to insulin resistance and obesity, which are risk factors for type 2 diabetes.\n5. TRUE: The variant rs7903146 at 12q24 has been found to be more common in individuals with type 2 diabetes compared to healthy controls, as shown in genome-wide association studies.",
    "llama-7b_judge": [
      "true",
      "unknown",
      "true",
      "true",
      "true"
    ]
  },
  {
    "id": 4096,
    "user_query": "Which are the ligands of the Roundabout (Robo) receptors?",
    "llama-7b_response": "The ligands of the Roundabout (Robo) receptors are various proteins and peptides that bind to the extracellular domain of the receptor and regulate its signaling activity. Some of the known ligands of Robo receptors include:\n1. Robo1: This is the most well-known ligand of the Robo receptors. It is a protein that is expressed in various tissues during embryonic development and plays a crucial role in guiding axonal growth and pathfinding during embryonic development.\n2. Robo2: This protein is also a ligand of the Robo receptors and is expressed in various tissues during embryonic development. It has been shown to play a role in axonal pathfinding and guidance.\n3. Robo3: This protein is a ligand of the Robo receptors and is expressed in various tissues during embryonic development. It has been shown to play a role in axonal pathfinding and guidance.\n4. Robo4: This protein is a ligand of the Robo receptors and is expressed in various tissues during embryonic development. It has been shown to play a role in axonal pathfinding and guidance.\n5. Robo5: This protein is a ligand of the Robo receptors and is expressed in various tissues during embryonic development. It has been shown to play a role in axonal pathfinding and guidance.\n6. Robo6: This protein is a ligand of the Robo receptors and is expressed in various tissues during embryonic development. It has been shown to play a role in axonal pathfinding and guidance.\n7. Robo7: This protein is a ligand of the Robo receptors and is expressed in various tissues during embryonic development. It has been shown to play a role in axonal pathfinding and guidance.\nIn summary, the ligands of the Roundabout (Robo) receptors are various proteins and peptides that bind to the extracellular domain of the receptor and regulate its signaling activity. Robo1, Robo2, Robo3, Robo4, Robo5, Robo6, and Robo7 are some of the known ligands of the Robo receptors.",
    "llama-7b_fact_raw": "1. Robo1 is a ligand of the Roundabout (Robo) receptors and is involved in axonal growth and pathfinding during embryonic development.\n2. Robo2 is a ligand of the Robo receptors and plays a role in axonal pathfinding and guidance during embryonic development.\n3. Robo3 is a ligand of the Robo receptors and is involved in axonal pathfinding and guidance during embryonic development.\n4. Robo4 is a ligand of the Robo receptors and plays a role in axonal pathfinding and guidance during embryonic development.\n5. Ligands of the Roundabout (Robo) receptors bind to the extracellular domain of the receptor and regulate its signaling activity.",
    "llama-7b_fact": [
      "Robo1 is a ligand of the Roundabout (Robo) receptors and is involved in axonal growth and pathfinding during embryonic development.",
      "Robo2 is a ligand of the Robo receptors and plays a role in axonal pathfinding and guidance during embryonic development.",
      "Robo3 is a ligand of the Robo receptors and is involved in axonal pathfinding and guidance during embryonic development.",
      "Robo4 is a ligand of the Robo receptors and plays a role in axonal pathfinding and guidance during embryonic development.",
      "Ligands of the Roundabout (Robo) receptors bind to the extracellular domain of the receptor and regulate its signaling activity."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Robo1 is not a ligand but one of the Roundabout (Robo) receptors itself, which is involved in axonal growth and pathfinding during embryonic development.\n2. FALSE [correction]: Robo2 is not a ligand but one of the Robo receptors and plays a role in axonal pathfinding and guidance during embryonic development.\n3. FALSE [correction]: Robo3 is not a ligand but one of the Robo receptors and is involved in axonal pathfinding and guidance during embryonic development.\n4. FALSE [correction]: Robo4 is not a ligand but one of the Robo receptors and plays a role in axonal pathfinding and guidance during embryonic development.\n5. TRUE",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "false",
      "true"
    ]
  },
  {
    "id": 4112,
    "user_query": "Is there a role for TFII-I in megakaryopoiesis?",
    "llama-7b_response": "Yes, there is a role for TFII-I in megakaryopoiesis. TFII-I is a transcription factor that is involved in the regulation of gene expression. In megakaryopoiesis, TFII-I is required for the activation of genes that are involved in the differentiation and maturation of megakaryocytes. \nSpecifically, TFII-I binds to the promoters of genes that are involved in the production of platelet-derived growth factor (PDGF), which is a key factor in the differentiation of megakaryocytes. PDGF stimulates the proliferation and maturation of megakaryocytes, and TFII-I is required for the expression of PDGF receptors on the surface of megakaryocytes.\nFurthermore, TFII-I also binds to the promoters of genes that are involved in the production of cytokines, such as interleukin-6 (IL-6) and granulocyte-macrophage colony-stimulating factor (GM-CSF). These cytokines are important for the survival and function of mature megakaryocytes.\nIn summary, TFII-I plays a critical role in the differentiation and maturation of megakaryocytes by activating genes that produce PDGF and other cytokines that are important for the survival and function of mature megakaryocytes.",
    "llama-7b_fact_raw": "1. TFII-I is a transcription factor involved in the regulation of gene expression.\n2. In megakaryopoiesis, TFII-I is required for the activation of genes important for the differentiation and maturation of megakaryocytes.\n3. TFII-I binds to the promoters of genes involved in the production of platelet-derived growth factor (PDGF).\n4. PDGF is a key factor in the differentiation of megakaryocytes and stimulates their proliferation and maturation.\n5. TFII-I is necessary for the expression of PDGF receptors on the surface of megakaryocytes.",
    "llama-7b_fact": [
      "TFII-I is a transcription factor involved in the regulation of gene expression.",
      "In megakaryopoiesis, TFII-I is required for the activation of genes important for the differentiation and maturation of megakaryocytes.",
      "TFII-I binds to the promoters of genes involved in the production of platelet-derived growth factor (PDGF).",
      "PDGF is a key factor in the differentiation of megakaryocytes and stimulates their proliferation and maturation.",
      "TFII-I is necessary for the expression of PDGF receptors on the surface of megakaryocytes."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. TRUE\n3. UNKNOWN\n4. TRUE\n5. UNKNOWN\n\nExplanation:\n1. TFII-I is indeed a transcription factor that plays a role in the regulation of gene expression.\n2. TFII-I has been implicated in various cellular processes, including megakaryopoiesis, which is the process of differentiation and maturation of megakaryocytes, the cells that give rise to platelets.\n3. The specific binding of TFII-I to the promoters of genes involved in the production of PDGF is not a widely established fact and would require specific scientific evidence to confirm, hence the response is UNKNOWN.\n4. PDGF is known to be a significant factor in various cellular processes, including the proliferation and maturation of cells such as megakaryocytes.\n5. The necessity of TFII-I for the expression of PDGF receptors on megakaryocytes is a specific claim that would require scientific evidence to confirm, so the response is UNKNOWN without additional context.",
    "llama-7b_judge": [
      "true",
      "true",
      "unknown",
      "true",
      "unknown"
    ]
  },
  {
    "id": 4145,
    "user_query": "Is atenolol metabolized by CYP2D6?",
    "llama-7b_response": "Yes, atenolol is metabolized by CYP2D6. Atenolol is a beta-blocker medication that is used to treat hypertension, angina, and heart failure. CYP2D6 is a cytochrome P450 enzyme that is responsible for the metabolism of a wide range of drugs, including many beta-blockers. When atenolol is metabolized by CYP2D6, it is converted into inactive metabolites that are excreted from the body. Therefore, CYP2D6 plays a crucial role in the efficacy and side effects of atenolol therapy.",
    "llama-7b_fact_raw": "1. Atenolol is metabolized by CYP2D6.\n2. Atenolol is used to treat hypertension, angina, and heart failure.\n3. CYP2D6 is a cytochrome P450 enzyme.\n4. CYP2D6 is responsible for the metabolism of a wide range of drugs, including many beta-blockers.\n5. Metabolism of atenolol by CYP2D6 results in its conversion into inactive metabolites.",
    "llama-7b_fact": [
      "Atenolol is metabolized by CYP2D6.",
      "Atenolol is used to treat hypertension, angina, and heart failure.",
      "CYP2D6 is a cytochrome P450 enzyme.",
      "CYP2D6 is responsible for the metabolism of a wide range of drugs, including many beta-blockers.",
      "Metabolism of atenolol by CYP2D6 results in its conversion into inactive metabolites."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Atenolol is not significantly metabolized by the liver and does not undergo significant metabolism by CYP2D6.\n2. TRUE\n3. TRUE\n4. TRUE\n5. FALSE [correction]: Since atenolol is not significantly metabolized by CYP2D6, it is not converted into inactive metabolites by this enzyme. Atenolol is excreted primarily unchanged in the urine.",
    "llama-7b_judge": [
      "false",
      "true",
      "true",
      "true",
      "false"
    ]
  },
  {
    "id": 4158,
    "user_query": "List versions of ExpansionHunter",
    "llama-7b_response": "There are several versions of ExpansionHunter, including:\n\n1. ExpansionHunter Classic: This is the original version of ExpansionHunter, which was released in 2015. It is a turn-based strategy game that allows players to build and manage their own empires, explore new territories, and battle other players.\n\n2. ExpansionHunter Mobile: This is the mobile version of ExpansionHunter, which was released in 2016. It is a free-to-play game that is available on both iOS and Android devices. It features the same gameplay as the original version, but with a more streamlined interface and touch-based controls.\n\n3. ExpansionHunter Online: This is the online version of ExpansionHunter, which was released in 2017. It is a browser-based game that allows players to play against other players from around the world. It features the same gameplay as the original version, but with a more social and competitive focus.\n\n4. ExpansionHunter Reborn: This is the reborn version of ExpansionHunter, which was released in 2020. It is a complete overhaul of the original game, featuring a new graphics engine, updated gameplay mechanics, and a more immersive world. It is available on both PC and Mac platforms.\n\n5. ExpansionHunter Unleashed: This is the latest version of ExpansionHunter, which was released in 2021. It is a free-to-play game that is available on both PC and Mac platforms. It features the same gameplay as the original version, but with new units, buildings, and gameplay mechanics. It also includes a new story mode that takes players on a journey through different eras of human history.",
    "llama-7b_fact_raw": "1. ExpansionHunter Classic was released in 2015.\n2. ExpansionHunter Mobile was released in 2016 and is available on iOS and Android devices.\n3. ExpansionHunter Online was released in 2017 as a browser-based game.\n4. ExpansionHunter Reborn was released in 2020 and is available on both PC and Mac platforms.\n5. ExpansionHunter Unleashed was released in 2021 and includes a new story mode.",
    "llama-7b_fact": [
      "ExpansionHunter Classic was released in 2015.",
      "ExpansionHunter Mobile was released in 2016 and is available on iOS and Android devices.",
      "ExpansionHunter Online was released in 2017 as a browser-based game.",
      "ExpansionHunter Reborn was released in 2020 and is available on both PC and Mac platforms.",
      "ExpansionHunter Unleashed was released in 2021 and includes a new story mode."
    ],
    "llama-7b_judge_raw": "1. UNKNOWN\n2. UNKNOWN\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nWithout specific context or additional information about the \"ExpansionHunter\" series mentioned in the statements, it is not possible to determine the veracity of these statements. The name \"ExpansionHunter\" could refer to a software tool, a video game series, or something else entirely. If it is a software tool, for example, it might be related to genetic research, as there is a tool called \"ExpansionHunter\" used for detecting repeat expansions in genetic data. However, without clear context, no accurate assessment can be made.",
    "llama-7b_judge": [
      "unknown",
      "unknown",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4164,
    "user_query": "What is the role of Adamts18 in hormone receptor signaling?",
    "llama-7b_response": "Adamts18 is a protein that plays a critical role in hormone receptor signaling. It is a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) family of proteins, which are known for their ability to cleave and regulate the activity of other proteins.\nIn the context of hormone receptor signaling, Adamts18 has been found to interact with a number of different hormone receptors, including estrogen receptors, progesterone receptors, and androgen receptors. This interaction appears to be important for regulating the activity of these receptors and mediating their effects on target genes.\nFor example, Adamts18 has been found to interact with estrogen receptors and to play a role in regulating the activity of estrogen-responsive genes. In breast cancer cells, Adamts18 has been shown to promote the growth and survival of cells that express estrogen receptors.\nSimilarly, Adamts18 has been found to interact with androgen receptors and to play a role in regulating the activity of androgen-responsive genes. In prostate cancer cells, Adamts18 has been shown to promote the growth and survival of cells that express androgen receptors.\nOverall, Adamts18 appears to play an important role in regulating hormone receptor signaling and mediating the effects of hormones on target genes. Further research is needed to fully understand the mechanisms by which Adamts18 interacts with hormone receptors and regulates their activity.",
    "llama-7b_fact_raw": "1. Adamts18 is a member of the ADAMTS family of proteins.\n2. Adamts18 interacts with various hormone receptors, including estrogen, progesterone, and androgen receptors.\n3. Adamts18 plays a role in regulating the activity of estrogen-responsive genes in breast cancer cells.\n4. Adamts18 has been shown to promote the growth and survival of breast cancer cells that express estrogen receptors.\n5. Adamts18 is involved in regulating the activity of androgen-responsive genes in prostate cancer cells.",
    "llama-7b_fact": [
      "Adamts18 is a member of the ADAMTS family of proteins.",
      "Adamts18 interacts with various hormone receptors, including estrogen, progesterone, and androgen receptors.",
      "Adamts18 plays a role in regulating the activity of estrogen-responsive genes in breast cancer cells.",
      "Adamts18 has been shown to promote the growth and survival of breast cancer cells that express estrogen receptors.",
      "Adamts18 is involved in regulating the activity of androgen-responsive genes in prostate cancer cells."
    ],
    "llama-7b_judge_raw": "1. TRUE\n2. FALSE [correction]: ADAMTS proteins, including Adamts18, are primarily known for their roles in extracellular matrix organization, not for interacting with hormone receptors like estrogen, progesterone, and androgen receptors.\n3. UNKNOWN\n4. UNKNOWN\n5. UNKNOWN\n\nThe ADAMTS (A Disintegrin And Metalloproteinase with Thrombospondin Motifs) family is indeed involved in extracellular matrix remodeling, but without specific context or references, it's difficult to confirm the roles of Adamts18 in breast or prostate cancer cells as stated in statements 3, 4, and 5. These would require specific scientific evidence to verify.",
    "llama-7b_judge": [
      "true",
      "false",
      "unknown",
      "unknown",
      "unknown"
    ]
  },
  {
    "id": 4208,
    "user_query": "What is the mode of action of Thiazovivin?",
    "llama-7b_response": "Thiazovivin is a chemotherapeutic agent that belongs to the group of alkylating agents. It works by damaging the DNA of cancer cells, which prevents them from replicating and eventually leads to their death. Thiazovivin also affects normal cells to a lesser extent, which is why it is classified as a moderately toxic drug. The exact mechanism of action of Thiazovivin is not fully understood, but it is believed to interfere with the process of DNA synthesis and repair in cancer cells.",
    "llama-7b_fact_raw": "1. Thiazovivin is a chemotherapeutic agent.\n2. Thiazovivin belongs to the group of alkylating agents.\n3. Thiazovivin works by damaging the DNA of cancer cells, preventing them from replicating.\n4. Thiazovivin leads to the death of cancer cells.\n5. Thiazovivin is classified as a moderately toxic drug.",
    "llama-7b_fact": [
      "Thiazovivin is a chemotherapeutic agent.",
      "Thiazovivin belongs to the group of alkylating agents.",
      "Thiazovivin works by damaging the DNA of cancer cells, preventing them from replicating.",
      "Thiazovivin leads to the death of cancer cells.",
      "Thiazovivin is classified as a moderately toxic drug."
    ],
    "llama-7b_judge_raw": "1. FALSE [correction]: Thiazovivin is not a chemotherapeutic agent; it is a small molecule inhibitor used to enhance the survival of human pluripotent stem cells during reprogramming, cloning, and differentiation.\n2. FALSE [correction]: Since Thiazovivin is not a chemotherapeutic agent, it does not belong to the group of alkylating agents or any other chemotherapy drug classes.\n3. FALSE [correction]: Thiazovivin does not work by damaging the DNA of cancer cells, as it is not a chemotherapeutic agent. It acts by inhibiting the Rho-associated kinase (ROCK) pathway to enhance cell survival.\n4. UNKNOWN: Without specific context, it is unclear whether Thiazovivin leads to the death of cancer cells. It is primarily known for its role in enhancing stem cell survival, not for killing cells.\n5. UNKNOWN: The toxicity of Thiazovivin is not provided in the given statements, and without additional context, it is not possible to classify its toxicity.",
    "llama-7b_judge": [
      "false",
      "false",
      "false",
      "unknown",
      "unknown"
    ]
  }
]